Page last updated: 2024-09-27

ascorbic acid

Description

Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-ascorbic acid : The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

L-ascorbate : The L-enantiomer of ascorbate and conjugate base of L-ascorbic acid, arising from selective deprotonation of the 3-hydroxy group. Required for a range of essential metabolic reactions in all animals and plants. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

vitamin C : Any member of a group of vitamers that belong to the chemical structural class called butenolides that exhibit biological activity against vitamin C deficiency in animals. The vitamers include L-ascorbic acid and its salt, ionized and oxidized forms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
CitrusgenusA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.[MeSH]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID54670067
CHEMBL ID40274
CHEBI ID29073
CHEBI ID22652
CHEBI ID176783
SCHEMBL ID785
SCHEMBL ID4430
MeSH IDM0001797

Synonyms (343)

Synonym
(2r)-2-[(1s)-1,2-dihydroxyethyl]-4,5-dihydroxy-furan-3-one
MLS002153776
smr001233160
e300
acido ascorbico
acide ascorbique
e-300
acidum ascorbinicum
acidum ascorbicum
l-threo-hex-2-enono-1,4-lactone
ascorbinsaeure
(5r)-5-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5h)-one
CHEBI:29073 ,
l-(+)-ascorbic acid
proscorbin
cevex
antiscorbic vitamin
cee-vite
cenetone
cebione
vicelat
ascorb
hybrin
vitacee
3-keto-l-gulofuranolactone
ascor-b.i.d.
viscorin
celaskon
celin
vitacimin
vitamisin
cenolate
nsc-33832
redoxon
ascorteal
ascorin
cevitan
ceglion
cetane-caps td
component of cortalex
l-lyxoascorbic acid
cevi-bid
cereon
cegiolan
cebid
cetemican
ido-c
cevital
antiscorbutic vitamin
component of e and c-level
l(+)-ascorbic acid
planavit c
citriscorb
ce lent
meri-c
l-xyloascorbic acid
hicee
vitace
xitix
arco-cee
cevatine
cergona
cipca
scorbu-c
nci-c54808
cescorbat
adenex
component of ferancee
roscorbic
cevitamin
c-quin
cetamid
c-level
ribena
natrascorb injectable
l-3-ketothreohexuronic acid lactone
c-long
secorbate
cemagyl
vitacin
dora-c-500
ascoltin
ce-mi-lin
ascorbicap
ce-vi-sol
cantaxin
cemill
NSC33832 ,
ascorbajen
liqui-cee
davitamon c
colascor
cebicure
nsc-218455
D00018
ascor (tn)
ascorbic acid (jp17/usp/inn)
ascoltin (tn)
ascorbicap (tn)
hex-2-enonic acid gamma-lactone, l-threo-
ascorbicab
einecs 200-066-2
cevibid
kyselina askorbova [czech]
ferancee
acide ascorbique [inn-french]
stuartinic
tolfrinic
acido ascorbico [inn-spanish]
chromagen
acidum ascorbicum [inn-latin]
nsc 33832
scorbacid
cortalex
PRESTWICK3_000325
BPBIO1_000363
l-threo-ascorbic acid
(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one
cevitamic acid
cevimin
cantan
component of endoglobin forte
laroscorbine
cecon
vicomin c
c-span
vitascorbol
cebion
ascorvit
viforcit
testascorbic
catavin c
cee-caps td
allercorb
natrascorb
lemascorb
ascorbutina
concemin
c-vimin
ciamin
iron(ii) ascorbate
cevitex
3-oxo-l-gulofuranolactone
rovimix c
vasc
(+)-ascorbic acid
ronotec 100
citrovit
hsdb 818
fema no. 2109
juvamine
scorbu c
chewcee
cewin
ccris 57
caswell no. 061b
duoscorb
l-threo-hex-2-enonic acid, gamma-lactone
cetane-caps tc
3-oxo-l-gulofuranolactone (enol form)
rontex 100
NCGC00091517-01
2-(1,2-dihydroxyethyl)-4,5-dihydroxyfuran-3-one
AB00376923
l-ascorbic acid
ascorbic acid
C00072
l-ascorbate
50-81-7
vitamin c
l-ascorbic acid, reagent grade
l-ascorbic acid, meets usp testing specifications
l-ascorbic acid, analytical standard
l-ascorbic acid, reagent grade, crystalline
l-ascorbic acid, bioxtra, >=99.0%, crystalline
l-ascorbic acid, plant cell culture tested
l-ascorbic acid, powder, cell culture tested, gamma-irradiated
l-ascorbic acid, suitable for cell culture, suitable for plant cell culture, >=98%
l-ascorbic acid, fcc, fg
DB00126
l-ascorbic acid, acs reagent, >=99%
NCGC00164357-01
l-ascorbic acid, free acid
BSPBIO_000329
NCGC00091517-02
acid, ascorbic
ascorbyl radical
l-ascorbic acid, bioultra, >=99.5% (rt)
l-ascorbic acid, puriss. p.a., >=99.0% (rt)
l-ascorbic acid, 99%
l-ascorbic acid, puriss. p.a., acs reagent, reag. iso, reag. ph. eur., 99.7-100.5% (oxidimetric)
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
A0537
(r)-5-((s)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5h)-one
ascorbic acid [ban:inn:jan]
BMSE000182
kyselina askorbova
ins-300
ins no.300
ascorbic acid (vit c)
vitamin c (as ascorbic acid)
ascorbicum acidum
ascorbic acid, l-
(2r)-2-[(1s)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
NCGC00091517-03
NCGC00188972-01
HMS2096A11
ester c
dtxcid90106
dtxsid5020106 ,
tox21_302958
NCGC00256504-01
tox21_112104
NCGC00259676-01
tox21_202127
ester-c
53262-66-1
l-ascorbic acid, mixt. with vitamin b
parentrovite
tox21_110315
l-ascorbic acid, free radical form
6730-29-6
HMS2231N16
unii-pq6ck8pd0r
pq6ck8pd0r ,
ascorbic acid [usp:inn:ban:jan]
nsc 218455
ascor
BP-12831
ascorbic acid [mi]
ascorbic acid [vandf]
ascorbic acid [usp monograph]
ascorbic acid [fcc]
acidum ascorbicum [who-ip latin]
ascorbic acid [ep monograph]
2,3-dehydro-l-threo-hexono-1,4-lactone
ascorbic acid [ii]
ascorbic acid [who-ip]
ascorbic acid [inn]
ascorbic acid [hsdb]
ascorbic acid [who-dd]
ascorbic acid [orange book]
(5r)-5-((1s)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5h)-one
ascorbic acid [fhfi]
ascorbic acid [usp-rs]
ascorbic acid [jan]
ascorbic acid [inci]
ascorbic acid [mart.]
vitamin c [vandf]
l-threoascorbic acid
antiscorbutic factor
S3114
CHEMBL40274
[14c]ascorbic acid
gtpl4532
gtpl4781
(5r)-5-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one
[14c]-ascorbic acid
CCG-207946
HY-B0166
SCHEMBL785
SCHEMBL4430
NCGC00091517-06
tox21_112104_1
3EKA
2-(1,2-dihydroxyethyl)-4,5-dihydroxy-furan-3-one
CIWBSHSKHKDKBQ-JLAZNSOCSA-N
ascorbic acid, british pharmacopoeia (bp) reference standard
HB1238
AB00376923_05
AB00376923_04
ascorbic acid dc97sf
hex-1-enofuranos-3-ulose
mfcd00064328
l-ascorbic acid, tested according to ph.eur.
ascorbic acid, european pharmacopoeia (ep) reference standard
l-ascorbic acid, anhydrous, free-flowing, redi-dri(tm), acs reagent, >=99%
l-ascorbic acid, >=99.0%
ascorbic acid, united states pharmacopeia (usp) reference standard
l-ascorbic acid, jis special grade, >=99.0%
l-ascorbic acid, certified reference material, tracecert(r)
(r)-5-(1,2-dihydroxy-ethyl)-3,4-dihydroxy-5h-furan-2-one
l-ascorbic acid acs reagent grade
l-ascorbic acid, p.a., acs reagent, reag. iso, 99.7%
l-ascorbic acid, vetec(tm) reagent grade, 99%
l-ascorbic acid, p.a., acs reagent, 99.0%
l-ascorbic acid, ar, >=99.5%
ascorbic acid (l-ascorbic acid; vitamin c)
.ascorbinsaure
HMS3713A11
gamma-lactone l-threo-hex-2-enonate
cevitamate
l-lyxoascorbate
gamma-lactone l-threo-hex-2-enonic acid
l-(+)-ascorbate
l(+)-ascorbate
(+)-ascorbate
l-xyloascorbate
SW198791-2
l-threoascorbic acid,antiscorbutic factor,vitamin c;(r)-5-((s)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5h)-one
(5r)-5-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5h)-one (non-preferred name)
vitamin c (ascorbic acid)
vitamin c,(s)
DTXSID50986567
Q27101942
l-ascorbic acid 1000 microg/ml in acetonitrile
BCP27915
Q199678
4-((e)-2-[(2-hydroxyethyl)sulfanyl]diazenyl)benzenecarboxylicacid
l-ascorbic acid, cell culture
AKOS016843589
EN300-708766
E80759
l-ascorbic acid (gmp)
CS-0626121
HY-B0166G
hicell
dr cellapy sr premium
ascorbic acid (usp:inn:ban:jan)
asorbicap
celladix c.e.f advanced brightening ampoule
ascorbic acid (mart.)
chebi:22652
ascorbic acid (ii)
chebi:176783
vitamina c
dtxcid50820452
ascorbinezuur
acidum ascorbicum (inn-latin)
clairfore
aromacura shower filter
neo-valdrin
cleanflex
ascorbic acid1505
vitamine c
ascorbic acid (ep monograph)
vit c
ascorbic acid (usp-rs)
vita rich
ascorbic acid (usp monograph)
acido ascorbico (inn-spanish)
new clairfore
acide ascorbique (inn-french)

Roles (8)

RoleDescription
coenzymeA low-molecular-weight, non-protein organic compound participating in enzymatic reactions as dissociable acceptor or donor of chemical groups or electrons.
flour treatment agentA food additive which is added to flour or dough to improve baking quality and/or colour.
food antioxidantAn antioxidant that used as a food additives to help guard against food deterioration.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
cofactorAn organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).
skin lightening agentAny cosmetic used to lighten the colour of skin by reducing the concentration of melanin.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
food colour retention agentA food additive that intensifies, retains or stabilises the colour of a food.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
ascorbic acid
vitamin CAny member of a group of vitamers that belong to the chemical structural class called butenolides that exhibit biological activity against vitamin C deficiency in animals. The vitamers include L-ascorbic acid and its salt, ionized and oxidized forms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (29)

ascorbic acid is involved in 29 pathway(s), involving a total of 354 unique proteins and 1483 unique compounds

PathwayProteinsCompounds
Extracellular matrix organization13520
Collagen formation1914
Collagen biosynthesis and modifying enzymes89
Tyrosine Metabolism1657
Catecholamine Biosynthesis314
Aromatic L-Aminoacid Decarboxylase Deficiency314
Alkaptonuria1657
Hawkinsinuria1657
Tyrosinemia Type I1657
Disulfiram Action Pathway2366
Tyrosinemia, Transient, of the Newborn1657
Tyrosine Hydroxylase Deficiency314
Dopamine beta-Hydroxylase Deficiency1657
Monoamine Oxidase-A Deficiency (MAO-A)1657
Ascorbate Metabolism1318
Xanthophyll Cycle28
Ascorbate Biosynthesis414
Tyrosine metabolism ( Tyrosine metabolism )2841
Folic acid network070
Catecholamine synthesis012
Ascorbate and aldarate metabolism07
Cadmium and glutathione113
AtMetExpress overview0109
Differentiation pathway012
Selenium micronutrient network095
Vitamin B12 metabolism050
Effects of nitric oxide07
Pluripotent stem cell differentiation pathway011
Biochemical pathways: part I0466

Protein Targets (36)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency0.77620.002541.796015,848.9004AID1347398
RAR-related orphan receptor gammaMus musculus (house mouse)Potency19.46990.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency8.03190.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency9.51950.000221.22318,912.5098AID743035; AID743063
thioredoxin glutathione reductaseSchistosoma mansoniPotency22.38720.100022.9075100.0000AID485364
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency23.91850.01237.983543.2770AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency8.93990.000214.376460.0339AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency42.47370.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency24.33650.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency28.21400.000229.305416,493.5996AID743069; AID743075; AID743079; AID743080
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00200.023723.228263.5986AID588543
IDH1Homo sapiens (human)Potency5.17350.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency12.58930.035520.977089.1251AID504332
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency20.59620.00419.984825.9290AID504444
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency28.92400.000323.4451159.6830AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency36.87210.000627.21521,122.0200AID651741; AID743202; AID743219
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency0.63100.075215.225339.8107AID485360
gemininHomo sapiens (human)Potency0.18360.004611.374133.4983AID624297
lethal factor (plasmid)Bacillus anthracis str. A2012Potency2.51190.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency0.00250.891312.067628.1838AID1487
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency1.77830.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Hyaluronidase, phage associatedStreptococcus pyogenesIC50 (µMol)1,000.00001,000.00001,000.00001,000.0000AID977608
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)264.25000.03403.987110.0000AID1505136; AID1555220; AID1610412; AID687640
Pancreatic alpha-amylaseRattus norvegicus (Norway rat)IC50 (µMol)26.50000.04600.04600.0460AID36971
AlbuminBos taurus (cattle)IC50 (µMol)155.38003.00003.00003.0000AID1497073
UreaseCanavalia ensiformis (jack bean)IC50 (µMol)8.59000.45703.20238.5900AID1882616
TyrosinaseHomo sapiens (human)IC50 (µMol)32.50000.02304.459310.0000AID1193294
Solute carrier family 23 member 1Homo sapiens (human)IC50 (µMol)156.0000156.0000156.0000156.0000AID1794810
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Alpha-2B adrenergic receptorHomo sapiens (human)EC50 (µMol)0.00050.00051.36446.7100AID416324
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Egl nine homolog 1Homo sapiens (human)Km180.00002.00002.00002.0000AID506732
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (72)

Processvia Protein(s)Taxonomy
cellular response to starvationAlbuminBos taurus (cattle)
negative regulation of mitochondrial depolarizationAlbuminBos taurus (cattle)
cellular response to calcium ion starvationAlbuminBos taurus (cattle)
collagen fibril organizationProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
MAPK cascadeAlpha-2B adrenergic receptorHomo sapiens (human)
angiogenesisAlpha-2B adrenergic receptorHomo sapiens (human)
regulation of vascular associated smooth muscle contractionAlpha-2B adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2B adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-2B adrenergic receptorHomo sapiens (human)
female pregnancyAlpha-2B adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2B adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2B adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2B adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2B adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of neuron differentiationAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of blood pressureAlpha-2B adrenergic receptorHomo sapiens (human)
positive regulation of uterine smooth muscle contractionAlpha-2B adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2B adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2B adrenergic receptorHomo sapiens (human)
regulation of cell growthProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN2Homo sapiens (human)
intracellular estrogen receptor signaling pathwayProlyl hydroxylase EGLN2Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN2Homo sapiens (human)
cell redox homeostasisProlyl hydroxylase EGLN2Homo sapiens (human)
positive regulation of protein catabolic processProlyl hydroxylase EGLN2Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN2Homo sapiens (human)
response to hypoxiaEgl nine homolog 1Homo sapiens (human)
intracellular iron ion homeostasisEgl nine homolog 1Homo sapiens (human)
intracellular oxygen homeostasisEgl nine homolog 1Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityEgl nine homolog 1Homo sapiens (human)
regulation of angiogenesisEgl nine homolog 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEgl nine homolog 1Homo sapiens (human)
negative regulation of cyclic-nucleotide phosphodiesterase activityEgl nine homolog 1Homo sapiens (human)
cardiac muscle tissue morphogenesisEgl nine homolog 1Homo sapiens (human)
heart trabecula formationEgl nine homolog 1Homo sapiens (human)
ventricular septum morphogenesisEgl nine homolog 1Homo sapiens (human)
labyrinthine layer developmentEgl nine homolog 1Homo sapiens (human)
response to nitric oxideEgl nine homolog 1Homo sapiens (human)
regulation of modification of postsynaptic structureEgl nine homolog 1Homo sapiens (human)
regulation protein catabolic process at postsynapseEgl nine homolog 1Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineEgl nine homolog 1Homo sapiens (human)
cellular response to hypoxiaEgl nine homolog 1Homo sapiens (human)
response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
DNA damage responseProlyl hydroxylase EGLN3Homo sapiens (human)
protein hydroxylationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of cell population proliferationProlyl hydroxylase EGLN3Homo sapiens (human)
regulation of neuron apoptotic processProlyl hydroxylase EGLN3Homo sapiens (human)
cellular response to hypoxiaProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline hydroxylation to 4-hydroxy-L-prolineProlyl hydroxylase EGLN3Homo sapiens (human)
positive regulation of myoblast differentiationHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
negative regulation of Notch signaling pathwayHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
negative regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
positive regulation of vasculogenesisHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
sodium ion transportSolute carrier family 23 member 1Homo sapiens (human)
brain developmentSolute carrier family 23 member 1Homo sapiens (human)
response to toxic substanceSolute carrier family 23 member 1Homo sapiens (human)
urate transportSolute carrier family 23 member 1Homo sapiens (human)
nucleobase transportSolute carrier family 23 member 1Homo sapiens (human)
L-ascorbic acid transmembrane transportSolute carrier family 23 member 1Homo sapiens (human)
L-ascorbic acid metabolic processSolute carrier family 23 member 1Homo sapiens (human)
lung developmentSolute carrier family 23 member 1Homo sapiens (human)
sodium ion transmembrane transportSolute carrier family 23 member 1Homo sapiens (human)
dehydroascorbic acid transportSolute carrier family 23 member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (40)

Processvia Protein(s)Taxonomy
oxygen bindingAlbuminBos taurus (cattle)
DNA bindingAlbuminBos taurus (cattle)
fatty acid bindingAlbuminBos taurus (cattle)
protein bindingAlbuminBos taurus (cattle)
toxic substance bindingAlbuminBos taurus (cattle)
pyridoxal phosphate bindingAlbuminBos taurus (cattle)
metal ion bindingAlbuminBos taurus (cattle)
enterobactin bindingAlbuminBos taurus (cattle)
procollagen-proline 4-dioxygenase activityProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
iron ion bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
protein bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
L-ascorbic acid bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
identical protein bindingProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
alpha2-adrenergic receptor activityAlpha-2B adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2B adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2B adrenergic receptorHomo sapiens (human)
protein bindingProlyl hydroxylase EGLN2Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN2Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
oxygen sensor activityProlyl hydroxylase EGLN2Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN2Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN2Homo sapiens (human)
protein bindingEgl nine homolog 1Homo sapiens (human)
ferrous iron bindingEgl nine homolog 1Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityEgl nine homolog 1Homo sapiens (human)
enzyme bindingEgl nine homolog 1Homo sapiens (human)
L-ascorbic acid bindingEgl nine homolog 1Homo sapiens (human)
peptidyl-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityEgl nine homolog 1Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityEgl nine homolog 1Homo sapiens (human)
protein bindingProlyl hydroxylase EGLN3Homo sapiens (human)
2-oxoglutarate-dependent dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
L-ascorbic acid bindingProlyl hydroxylase EGLN3Homo sapiens (human)
peptidyl-proline 4-dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
hypoxia-inducible factor-proline dioxygenase activityProlyl hydroxylase EGLN3Homo sapiens (human)
ferrous iron bindingProlyl hydroxylase EGLN3Homo sapiens (human)
transcription corepressor activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
Notch bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
protein bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
ferrous iron bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
zinc ion bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
oxygen sensor activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
carboxylic acid bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
peptidyl-histidine dioxygenase activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
[protein]-asparagine 3-dioxygenase activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
protein homodimerization activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
NF-kappaB bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
peptidyl-aspartic acid 3-dioxygenase activityHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
ankyrin repeat bindingHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
protein bindingSolute carrier family 23 member 1Homo sapiens (human)
L-ascorbate:sodium symporter activitySolute carrier family 23 member 1Homo sapiens (human)
sodium ion transmembrane transporter activitySolute carrier family 23 member 1Homo sapiens (human)
urate transmembrane transporter activitySolute carrier family 23 member 1Homo sapiens (human)
nucleobase transmembrane transporter activitySolute carrier family 23 member 1Homo sapiens (human)
L-ascorbic acid transmembrane transporter activitySolute carrier family 23 member 1Homo sapiens (human)
dehydroascorbic acid transmembrane transporter activitySolute carrier family 23 member 1Homo sapiens (human)
transporter activitySolute carrier family 23 member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
extracellular regionAlbuminBos taurus (cattle)
extracellular spaceAlbuminBos taurus (cattle)
protein-containing complexAlbuminBos taurus (cattle)
mitochondrionProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
endoplasmic reticulumProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
endoplasmic reticulum lumenProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
membraneProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
intracellular membrane-bounded organelleProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
procollagen-proline 4-dioxygenase complexProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
endoplasmic reticulumProlyl 4-hydroxylase subunit alpha-1Homo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
cytosolAlpha-2B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2B adrenergic receptorHomo sapiens (human)
cell surfaceAlpha-2B adrenergic receptorHomo sapiens (human)
intracellular membrane-bounded organelleAlpha-2B adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2B adrenergic receptorHomo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
nucleusProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN2Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
cytosolEgl nine homolog 1Homo sapiens (human)
postsynaptic densityEgl nine homolog 1Homo sapiens (human)
intracellular membrane-bounded organelleEgl nine homolog 1Homo sapiens (human)
glutamatergic synapseEgl nine homolog 1Homo sapiens (human)
nucleusEgl nine homolog 1Homo sapiens (human)
cytoplasmEgl nine homolog 1Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
cytosolProlyl hydroxylase EGLN3Homo sapiens (human)
cytoplasmProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusProlyl hydroxylase EGLN3Homo sapiens (human)
nucleusHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
nucleoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytosolHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
perinuclear region of cytoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytoplasmHypoxia-inducible factor 1-alpha inhibitorHomo sapiens (human)
cytoplasmSolute carrier family 23 member 1Homo sapiens (human)
plasma membraneSolute carrier family 23 member 1Homo sapiens (human)
basal plasma membraneSolute carrier family 23 member 1Homo sapiens (human)
apical plasma membraneSolute carrier family 23 member 1Homo sapiens (human)
intracellular organelleSolute carrier family 23 member 1Homo sapiens (human)
extracellular exosomeSolute carrier family 23 member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1029)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1345074Human Sodium-dependent vitamin C transporter 1 (SLC23 family of ascorbic acid transporters)2002The British journal of nutrition, Feb, Volume: 87, Issue:2
Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID173159Antilipid peroxidation was determined1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID1896735Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition by microplate reader based assay2022Bioorganic & medicinal chemistry, Nov-05, Volume: 75Phenolic furanochromene hydrazone derivatives: Synthesis, antioxidant activity, ferroptosis inhibition, DNA cleavage and DNA molecular docking studies.
AID401061Antioxidant activity assessed as DPPH free radical scavenging activity1998Journal of natural products, May, Volume: 61, Issue:5
Antioxidant flavonoid glycosides from Daphniphyllum calycinum.
AID104665Inhibition of malt alpha-amylase1998Bioorganic & medicinal chemistry letters, Jul-07, Volume: 8, Issue:13
Ascorbic acid-based inhibitors of alpha-amylases.
AID463457Antioxidant activity against DPPH radical scavenging activity after 30 mins by ELISA2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity.
AID1071362Antioxidant activity assessed as DPPH free radical scavenging activity at 500 uM after 30 mins by spectrophotometry2014European journal of medicinal chemistry, Feb-12, Volume: 73Synthesis and antiproliferative activity of novel selenoester derivatives.
AID652726Antiviral activity against Herpes simplex virus type 1 infected in human RD cells assessed as inhibition of virus-induced cytopathic effect2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1331320Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.
AID1194982Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID389191Antioxidant activity assessed as oxygen radical absorbance capacity index value at 5 uM by pyrogallol red protection assay2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Antioxidant capacity of human blood plasma and human urine: simultaneous evaluation of the ORAC index and ascorbic acid concentration employing pyrogallol red as probe.
AID718314Antioxidant activity assessed as nitric oxide free radical scavenging activity by UV-visible spectroscopy2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Phenolic compounds from Caesalpinia sappan heartwood and their anti-inflammatory activity.
AID356320Antioxidant activity assessed as DPPH radical scavenging activity2003Journal of natural products, Aug, Volume: 66, Issue:8
Sulfemodin 8-O-beta-D-glucoside, a new sulfated anthraquinone glycoside, and antioxidant phenolic compounds from Rheum emodi.
AID771137Antioxidant activity assessed as DPPH radical scavenging activity incubated for 20 mins under dark condition by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID724078Antioxidant activity assessed as superoxide radical scavenging activity at 100 uM after 5 mins by NBT reduction assay2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Design, synthesis, characterization and biological evaluation of novel pyrazole integrated benzophenones.
AID405697Antioxidant activity assessed as oxygen radical scavenging activity by ORAC-fluorescence assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Antioxidant 2-phenylbenzofurans and a coumestan from Lespedeza virgata.
AID685399Antioxidant activity assessed as inhibition of superoxide radical-induced NBT reduction by alkaline DMSO method2012European journal of medicinal chemistry, Oct, Volume: 56Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors.
AID722717Antioxidant activity assessed as inhibition DPPH radical production after 15 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Jan-01, Volume: 21, Issue:1
Trisubstituted thiophene analogues of 1-thiazolyl-2-pyrazoline, super oxidase inhibitors and free radical scavengers.
AID652745Antioxidant activity using deaerated 0.1 M alpha-glycerophosphate as substrate assessed as inorganic phosphate level at 1 mmol/L after gamma-irradiation (Rvb = 3.44 +/- 0.12 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID619976Antioxidant activity assessed as nitric oxide scavenging activity at 50 ug/ml after 150 mins by Griess method relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1635489Cytotoxicity against human SH-SY5Y cells assessed as cell viability at 80 uM after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
AID1549507Haemolytic activity in human erythrocytes assessed as induction of hemolysis at 2.5 mM after 30 mins relative to H2022019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID294912Antioxidant activity assessed as nitric oxide radical scavenging activity at 0.1 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID1309174Ratio of resveratrol IC50 to compound IC50 for AAPH radical scavenging activity2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.
AID1301297Antioxidant activity assessed as ABTS radical scavenging activity after 60 mins2016Bioorganic & medicinal chemistry letters, 07-01, Volume: 26, Issue:13
Enantioselective synthesis and antioxidant activity of 3,4,5-substituted piperidine derivatives.
AID614053Inhibition of bovine testes hyaluronidase at 4200 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID754975Inhibition of N-terminal His6-tagged human reticulocyte 15-LOX1 pseudoperoxidase activity assessed as reduction of active ferric ion to inactive ferrous state measured decomposition of 13-(S)-HPODE at 40 uM after 30 mins by iron-xylenol orange staining as2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases.
AID1439751Antioxidant activity assessed as inhibition of superoxide radical generation at 1 mM after 5 mins by NBT reduction assay relative to control2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents.
AID1487135Antioxidant activity assessed as DPPH free radical scavenging activity measured after 30 mins in absence of light2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
Phenylsulfonylfuroxan NO-donor phenols: Synthesis and multifunctional activities evaluation.
AID1071363Antioxidant activity assessed as DPPH free radical scavenging activity at 150 uM after 30 mins by spectrophotometry2014European journal of medicinal chemistry, Feb-12, Volume: 73Synthesis and antiproliferative activity of novel selenoester derivatives.
AID1352202Antioxidant activity in PBS buffer assessed as NO scavenging activity after 90 mins in presence of sodium nitroprusside by Griess assay2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID1265669Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by plate reader analysis2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Indoline Amide Glucosides from Portulaca oleracea: Isolation, Structure, and DPPH Radical Scavenging Activity.
AID549278Inhibition of DOPA oxidase activity of tyrosinase in mouse B16 cells at 10 to 20 ug/ml after 72 hrs by colorimetry2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1896736Antioxidant activity assessed as trolox equivalent of Cu2+ reducing activity incubated for 30 mins by CUPRAC assay relative to trolox2022Bioorganic & medicinal chemistry, Nov-05, Volume: 75Phenolic furanochromene hydrazone derivatives: Synthesis, antioxidant activity, ferroptosis inhibition, DNA cleavage and DNA molecular docking studies.
AID294917Antioxidant activity assessed as nitric oxide radical scavenging activity at 1.0 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID1466640Antioxidant activity assessed as inhibition of DPPH free radical at 125 uM after 30 mins relative to control2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
Antioxidant and anticholinesterase potential of diterpenoid alkaloids from Aconitum heterophyllum.
AID1610482Inhibition of equine serum BuChE at 20 uM using butyrylcholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method relative to control2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
AID457086Antioxidant activity assessed as superoxide radical scavenging activity after 2 mins by NBT reduction assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Natural ortho-dihydroxyisoflavone derivatives from aged Korean fermented soybean paste as potent tyrosinase and melanin formation inhibitors.
AID721640Antioxidant activity assessed as trolox equivalent of DPPH radical scavenging activity by spectroscopic analysis2013European journal of medicinal chemistry, Feb, Volume: 60Monocyclic β-lactams as antibacterial agents: facing antioxidant activity of N-methylthio-azetidinones.
AID1867444Induction of ROS generation in fluconazole resistant Saccharomyces cerevisiae overexpressing CgCdr2p transporter assessed as increase in ROS level incubated for 90 mins by DCFH-DA dye based fluorescence assay2022Bioorganic & medicinal chemistry, 06-01, Volume: 63Effects of β-lapachone and β-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata.
AID289708Nitric oxide radical scavenging activity at 0.1 mg/ml2007Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3
Natural dibenzoxazepinones from leaves of Carex distachya: Structural elucidation and radical scavenging activity.
AID619974Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 30 mins by spectrophotometric analysis relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1071365Antioxidant activity assessed as DPPH free radical scavenging activity at 15 uM after 30 mins by spectrophotometry2014European journal of medicinal chemistry, Feb-12, Volume: 73Synthesis and antiproliferative activity of novel selenoester derivatives.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1730957Antioxidant activity assessed as DPPH radical scavenging activity at 25 ug/ml (Rvb = 22 to 40.2 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID1487136Antioxidant activity assessed as H2O2 radical scavenging activity after 60 mins2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
Phenylsulfonylfuroxan NO-donor phenols: Synthesis and multifunctional activities evaluation.
AID1113090Antioxidant activity assessed as superoxide anion radical scavenging activity at 5 mg/ml after 5 min by spectrophotometric analysis2013Journal of agricultural and food chemistry, Mar-27, Volume: 61, Issue:12
Isolation and characterization of new p-Terphenyls with antifungal, antibacterial, and antioxidant activities from halophilic actinomycete Nocardiopsis gilva YIM 90087.
AID619972Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug/ml after 30 mins by spectrophotometric analysis relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID476929Human intestinal absorption in po dosed human2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
AID762742Antioxidant activity assessed as DPPH free radical scavenging activity at 10 ug/ml after 20 mins2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID504290Antioxidant activity assessed as superoxide radical scavenging activity by NBT method2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Chlorinated iridoid glucosides from Veronica longifolia and their antioxidant activity.
AID283697DPPH radical scavenging activity at 200 umol/L relative to control2007Journal of natural products, Apr, Volume: 70, Issue:4
Bioactive metabolites from the Caribbean sponge Aka coralliphagum.
AID1556931Prooxidant activity in calf thymus DNA assessed as increase in bleomycin-induced DNA damage by measuring optical density at 2 mM incubated for 1 hr by spectrophotometry relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
AID724079Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 100 uM after 20 mins2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Design, synthesis, characterization and biological evaluation of novel pyrazole integrated benzophenones.
AID652906Antioxidant activity using deaerated 0.1 M alpha-glucosophosphate as substrate assessed as hydroxy radical level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1565350Antioxidant activity assessed as DPPH radical scavenging activity at 60 uM/ml incubated for 20 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
AID762737Antioxidant activity assessed as reducing power of ferric ion at 50 ug/ml after 20 mins2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID1071366Antioxidant activity assessed as DPPH free radical scavenging activity at 5 uM after 30 mins by spectrophotometry2014European journal of medicinal chemistry, Feb-12, Volume: 73Synthesis and antiproliferative activity of novel selenoester derivatives.
AID764769Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
AID590698Antioxidant activity against DPPH free radical scavenging activity at 100 uM after 20 mins by spectrophotometric analysis at pH 7.52011European journal of medicinal chemistry, Apr, Volume: 46, Issue:4
Synthesis and biological activity of 2-(bis((1,3,4-oxadiazolyl/1,3,4-thiadiazolyl)methylthio)methylene)malononitriles.
AID1651267Antioxidant activity assessed as hydroxyl radical scavenging activity incubated for 30 mins in water bath2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
AID453102Antioxidant activity assessed as DPPH free radical scavenging activity by measuring reduction in DPPH absorbance by ELISA relative to untreated control2009Bioorganic & medicinal chemistry, Dec-01, Volume: 17, Issue:23
Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones.
AID1453046Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins under dark condition by UV-Visible spectrophotometric analysis2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
AID515373Antioxidant activity assessed as hydrogen peroxide scavenging activity by spectrophotometry2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
2,3-diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: a structure-activity relationship study.
AID1753663Antioxidant activity assessed as bleomycin-Fe2+-induced DNA degradation by measuring absorbance at 0.1 mg/ml after 1 hr2021European journal of medicinal chemistry, Jun-05, Volume: 218New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
AID226689Free radical scavenging activity of DPPH was determined2004Bioorganic & medicinal chemistry letters, May-03, Volume: 14, Issue:9
Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells.
AID1651261Selectivity index, ratio of IC50 for equine serum BChE using butyrylthiocholine as substrate by Ellman's method to IC50 for electric eel AChE using acetylthiocholine as substrate by Ellman's method2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
AID1453461Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 25 umol/ml after 20 mins by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID1255363Antioxidant activity assessed as DPPH radical scavenging activity measured as discoloration incubated for 30 mins in dark2015European journal of medicinal chemistry, Oct-20, Volume: 103Correlation of antioxidant activities with theoretical studies for new hydrazone compounds bearing a 3,4,5-trimethoxy benzyl moiety.
AID734220Antioxidant activity assessed as concentration required for 50 % inhibition of micoM DPPH activity after 30 mins by UV-vis spectrophotometry2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
Fungal metabolites of xanthohumol with potent antiproliferative activity on human cancer cell lines in vitro.
AID1178158Antioxidant activity of the compound assessed as reduction in absorbance of DPPH after 60 mins incubation at 100 uM by DPPH radical scavenging /microplate assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis, antioxidant and photoprotection activities of hybrid derivatives useful to prevent skin cancer.
AID1594664Antioxidant activity assessed as DPPH radical scavenging activity at 1 mM after 30 mins under dark condition relative to untreated control2019Bioorganic & medicinal chemistry, 06-01, Volume: 27, Issue:11
Antioxidant, anti-tyrosinase and anti-melanogenic effects of (E)-2,3-diphenylacrylic acid derivatives.
AID761966Hemolysis of human erythrocytes after 30 mins by spectrophotometry2013European journal of medicinal chemistry, Aug, Volume: 66Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetamides as antioxidant and/or anti-inflammatory compounds.
AID416324Agonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
(-)-Dibromophakellin: an alpha2B adrenoceptor agonist isolated from the Australian marine sponge, Acanthella costata.
AID1322145Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins incubation in dark2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Thioflavones as novel neuroprotective agents.
AID1347585Upregulation of elastin mRNA expression in HDF at 100 uM after 48 hrs by RT-PCR analysis2017Journal of natural products, 11-22, Volume: 80, Issue:11
neo-Clerodane Diterpenoids from Salvia polystachya Stimulate the Expression of Extracellular Matrix Components in Human Dermal Fibroblasts.
AID1125421Antioxidant activity assessed as potassium ferric cyanide ion reducing power after 20 mins by absorbance analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Two sarcoviolins with antioxidative and α-glucosidase inhibitory activity from the edible mushroom Sarcodon leucopus collected in Tibet.
AID714928Antioxidant activity assessed as superoxide scavenging activity using xanthine-xanthine oxidase system by NBT dye reduction based assay2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues.
AID615294Antioxidant activity assessed as potassium ferricyanide ion reducing power after 20 mins by spectrophotometry2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis and bio-activity evaluation of tetraphenyl(phenylamino) methylene bisphosphonates as antioxidant agents and as potent inhibitors of osteoclasts in vitro.
AID614022Inhibition of Streptococcus pneumoniae hyaluronidase after 1 hr by microplate reader assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1202774Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured after 90 mins by hydrophilic-ORAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID1399488Antioxidant activity assessed as ABTS radical cation scavenging activity by measuring trolox equivalent antioxidant capacity at 20 uM after 1 hr by UV/Vis spectrophotometric analysis2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
AID1272818Antileishmanial activity against promastigotes of Leishmania donovani MHOM/IN/80/DD8 after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
AID1076256Antioxidant activity assessed as H2O2 radical scavenging activity2014European journal of medicinal chemistry, Mar-21, Volume: 75Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines.
AID1257012Antioxidant activity assessed as ABTS radical scavenging activity after 10 mins by UV-Visible spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Chrysin-benzothiazole conjugates as antioxidant and anticancer agents.
AID1191655Antioxidant activity assessed as ABTS scavenging activity after 6 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Schiff's bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants.
AID1194494Antioxidant activity assessed as ferric-reducing antioxidant power after 20 mins at 50 degC by UV spectrophotometry2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1453463Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity after 20 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID363318DPPH radical scavenging activity assessed as ratio of drug concentration to DPPH concentration producing 50% decrease in DPPH after 5 mins2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones.
AID1234179Antioxidative activity assessed as DPPH radical scavenging activity2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Indole Alkaloids from Chaetomium globosum.
AID764772Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
AID567049Antioxidant activity assessed as inhibition of heme protein-dependent lipid peroxidation at 1 mM2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
AID620060Antioxidant activity assessed as hydrogen peroxide scavenging activity at 100 ug/ml relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1193494Thermodynamic equilibrium solubility, log S of the compound in simulated gastric fluid at pH 1.2 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID625295Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1615198Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition2019European journal of medicinal chemistry, Oct-01, Volume: 179Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.
AID496830Antimicrobial activity against Leishmania major2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1193294Inhibition of tyrosinase (unknown origin)2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Effect of the tyrosinase inhibitor (S)-N-trans-feruloyloctopamine from garlic skin on tyrosinase gene expression and melanine accumulation in melanoma cells.
AID685398Antioxidant activity assessed as hydrogen peroxide radical scavenging activity2012European journal of medicinal chemistry, Oct, Volume: 56Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors.
AID1194493Antioxidant activity assessed as ABTS radical scavenging activity incubated for 6 mins2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID776428Antioxidant activity assessed as DPPH free radical scavenging activity after 20 mins by UV-visible spectrophotometric analysis2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives.
AID1650988Antioxidant activity assessed as reduction of colourless Fe3+-TPTZ complex to coloured Fe2+-TPTZ complex measured after 5 mins by FRAP assay2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
AID1313279Antioxidant activity assessed as DPPH radical scavenging activity at 20 ug/ml after 20 mins by spectrophotometry relative to control2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
AID1155650Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 10 uM after 24 hrs by MTT assay relative to control2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties.
AID1631497Antioxidant activity after 5 mins by NBT assay2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Minor Pyranonaphthoquinones from the Apothecia of the Lichen Ophioparma ventosa.
AID464441Antioxidant activity assessed as trolox equivalent of ABTS free radical scavenging activity after 6 mins by TRAP assay2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents.
AID549264Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/ml after 30 mins2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID539844Antioxidant activity assessed as DPPH radical scavenging activity at 500 ug by spectrophotometry relative to control2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Synthesis, antimicrobial and antioxidant evaluation of quinolines and bis(indolyl)methanes.
AID1692038Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins under dark condition by spectrophotometric analysis2020European journal of medicinal chemistry, Jul-01, Volume: 197Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-κB/ PON1 pathway.
AID1360873Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ at 40 ug/ml after 25 mins by FRAP assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID1570051Cytoprotective against H2O2-induced cell death in human U251 cells assessed as increase in cell viability at 100 uM preincubated for 24 hrs followed by H2O2 induction and measured after 1 hr by MTS assay (Rvb = 50%)2019European journal of medicinal chemistry, Oct-15, Volume: 180Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease.
AID401236Inhibition of superoxide production in PMNCs by NBT reduction assay2004Journal of natural products, Apr, Volume: 67, Issue:4
Madhucosides A and B, protobassic acid glycosides from Madhuca indica with inhibitory activity on free radical release from phagocytes.
AID386936Antioxidant activity assessed as hydroxyl radical scavenging activity2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
The antioxidant activity of 2-(4(or 2)-hydroxyl-5-chloride-1,3-benzene-di-sulfanimide)-chitosan.
AID246191Effective concentration to induce a quorum signal in Vibrio harveyi(by binding Lux P protein)2005Bioorganic & medicinal chemistry letters, May-02, Volume: 15, Issue:9
Quorum sensing in Vibrio harveyi: probing the specificity of the LuxP binding site.
AID496824Antimicrobial activity against Toxoplasma gondii2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID648401Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 200 ug/ml after 20 mins2012European journal of medicinal chemistry, May, Volume: 51Facile synthesis, characterization and pharmacological activities of 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 5,6-dihydro-3,6-disubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
AID1453052Antioxidant activity assessed as inhibition of DPPH radical generation at 0.01 mg/ml after 20 mins under dark condition by UV-Visible spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
AID1533608Selectivity index, ratio of IC50 for human serum BChE to IC50 for Electric eel AChE2019European journal of medicinal chemistry, Feb-01, Volume: 163Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
AID456320Antioxidant activity assessed as ABTS radical scavenging activity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID478246Antioxidant activity in Wistar albino rat assessed as reduced glutathione level2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID405490Antioxidant activity assessed as DPPH free radical scavenging activity at 1 mM2008Journal of natural products, Jun, Volume: 71, Issue:6
(Iso)-quinoline alkaloids from fungal fruiting bodies of Cortinarius subtortus.
AID762734Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 50 ug/ml after 1 hr2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID762899Total antioxidant capacity of the compound at 100 uM relative to control2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Phaeolschidins A-E, five hispidin derivatives with antioxidant activity from the fruiting body of Phaeolus schweinitzii collected in the Tibetan Plateau.
AID323921Enhancement of HCV RNA replication in OR6 cells after 72 hrs by luciferase reporter assay2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.
AID722940Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP at 50 uM after 30 mins by scintillation counting2013European journal of medicinal chemistry, Feb, Volume: 60Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.
AID437942Antioxidant activity in Wistar rat brain assessed as reduction in glutathione content2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID614058Inhibition of bovine testes hyaluronidase at 100 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1611501Antioxidant activity assessed as DPPH free radical scavenging activity at 300 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID327928DPPH radical scavenging activity2008Journal of natural products, Feb, Volume: 71, Issue:2
Structural characterization and DPPH radical scavenging activity of an arabinoglucogalactan from Panax notoginseng root.
AID427666Antioxidant activity assessed as superoxide anion radical scavenging activity by spectrophotometry2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID1498380Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/ml measured after 30 mins2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Synthesis of sulfadiazinyl acyl/aryl thiourea derivatives as calf intestinal alkaline phosphatase inhibitors, pharmacokinetic properties, lead optimization, Lineweaver-Burk plot evaluation and binding analysis.
AID614054Inhibition of bovine testes hyaluronidase at 460 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1347863Inhibition of alpha-MSH-induced TRP-1 expression in human A375 cells at 25 uM after 24 hrs by Western blot method2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1496217Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins in dark by spectrophotometric method2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID1053469DPPH radical scavenging activity assessed as reducing ability at 5 to 100 uM after 30 mins by spectrophotometry2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
AID1730962Antioxidant activity assessed as nitric oxide radical scavenging activity at 50 ug/ml (Rvb = 25.8 to 41.6 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID1250853Inhibition of baker's yeast alpha-glucosidase type-1 using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 30 mins followed by substrate addition measured after 20 mins by microplate reader analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals.
AID1663503Antioxidant activity assessed as reduction in lipid peroxidation2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects.
AID1555220Inhibition of mushroom tyrosinase using L-dopa as substrate incubated for 30 mins by spectrophotometric method
AID1693239Antioxidant activity assessed as DPPH radical scavenging activity incubated for 20 mins in dark conditions2021Bioorganic & medicinal chemistry letters, 01-15, Volume: 32Synthesis, biological evaluation, and NMR studies of 3-fluorinated derivatives of 3',4',5'-trihydroxyflavone and 3',4',5'-trimethoxyflavone.
AID1194495Antioxidant activity assessed as catalase activity by measuring hydrogen peroxide disappearance per mg protein measured for 1 min at 25 degC2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID382109Distribution coefficient, log D at pH 1.0 after 4 hrs by shake flask method2008Bioorganic & medicinal chemistry, May-01, Volume: 16, Issue:9
Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties.
AID762741Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 20 mins2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID409960Inhibition of bovine brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1487492Antioxidant activity assessed as H2O2 free radical scavenging activity by spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID1057590Antioxidant activity assessed as DPPH radical scavenging activity at 25 to 100 uM after 30 mins2013Journal of medicinal chemistry, Nov-27, Volume: 56, Issue:22
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
AID502059Antioxidant activity assessed as ABTS radical scavenging activity at 50 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID1242828Antioxidant activity assessed as DPPH redical scavenging activity incubated for 2 hrs in dark condition2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Dietziamides, novel tetramic acid dimers from Dietzia timorensis MZ-3 with antioxidative activity.
AID1453462Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 50 umol/ml after 20 mins by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID1594574Antioxidant activity assessed as DPPH radical scavenging activity incubated for 15 to 20 mins by UV-visible spectrometry2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Cu-mediated synthesis of differentially substituted diazepines as AChE inhibitors; validation through molecular docking and Lipinski's filter to develop novel anti-neurodegenerative drugs.
AID1366176Antioxidant activity assessed as DPPH free radical scavenging activity at 200 ug/ml after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID626498Antioxidant activity assessed as superoxide anioin radical scavenging activity after 5 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives.
AID1267476Antioxidant activity assessed as DPPH radical scavenging activity at 2 mM after 30 mins2016Bioorganic & medicinal chemistry letters, Jan-01, Volume: 26, Issue:1
Bioactive minor components of the total salvianolic acids injection prepared from Salvia miltiorrhiza Bge.
AID548961Antioxidant activity of the compound assessed as reducing activity of DPPH at 0.1 mM after 60 mins2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID416923Antioxidant activity assessed as superoxide anion scavenging activity by NBT reduction method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Cytotoxic, antioxidant activities and structure activity relationship of some newly synthesized terpenoidal oxaliplatin analogs.
AID232873Free radical scavenging assessed as color reduction of DPPH2002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.
AID387798Cytoprotective activity against hydrogen peroxide-induced cell death in human HL-60 cells assessed as cell viability at 30 uM after 24 hrs by trypan blue exclusion assay2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
2,2'-Pyridoin derivatives protect HL-60 cells against oxidative stress.
AID1268019Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 20 mins by UV-vis spectrophotometry analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
AID1610134Antiproliferative activity against human CFPAC-1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID687640Inhibition of mushroom tyrosinase using as L-DOPA substrate after 2 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
Tyrosinase inhibitory activity of a 6-isoprenoid-substituted flavanone isolated from Dalea elegans.
AID401336Antioxidant activity assessed by superoxide anion scavenging assay1996Journal of natural products, Feb, Volume: 59, Issue:2
Natural polyphenols (vegetable tannins) as drugs: possible modes of action.
AID496817Antimicrobial activity against Trypanosoma cruzi2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID497111Antioxidant activity assessed as DPPH free radical scavenging activity after 1 hr2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis and biological evaluation of arylidene analogues of Meldrum's acid as a new class of antimalarial and antioxidant agents.
AID1405935Antioxidant activity assessed as DPPH radical scavenging activity2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID174641Effect of AOS scavenger on ventricular fibrillation (VF), arrhythmias induced by ischemia-reperfusion in anesthetized rat, incidence at 3 mg/kg1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID1428663Antiradical activity assessed as gallic acid equivalents of Foline-Ciocalteu reagent reducing capacity at 1 mM preincubated for 5 mins followed by Na2CO3 addition measured after 90 mins2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID294918Antioxidant activity assessed as nitric oxide radical scavenging activity at 1.2 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID1663837Antioxidant activity assessed as trolox equivalent antioxidant capacity2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Isolation and biological activity of agrostophillinol from kaffir lime (Citrus hystrix) leaves.
AID1610138Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID446405Antioxidant activity assessed as DPPH radical scavenging activity2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.
AID1396238Antioxidant activity assessed as DPPH-radical scavenging activity at 1 mM incubated for 30 mins under dark condition2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-β-phenyl-α, β-unsaturated carbonyl scaffold.
AID592648Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM after 30 mins2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analogues.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID549265Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1462746Antioxidant activity assessed as DPPH free radical scavenging activity by measuring radical-scavenging activity factor (moles of radicals scavenged by each mol of antioxidant) at 20 uM measured at 15 mins by HPLC2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Structural evidence for the DPPH radical-scavenging mechanism of 2-O-α-d-glucopyranosyl-l-ascorbic acid.
AID448092Antioxidant activity assessed as DPPH radical scavenging after 30 mins2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety.
AID1599716Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 mins in dark condition by spectrophotometric analysis2019Bioorganic & medicinal chemistry, 10-15, Volume: 27, Issue:20
Synthesis of N-hydroxycinnamoyl amide derivatives and evaluation of their anti-oxidative and anti-tyrosinase activities.
AID1730960Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/ml (Rvb = 22 to 40.2 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID762334Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug after 30 mins by spectrophotometry2013European journal of medicinal chemistry, Aug, Volume: 66Microwave-assisted synthesis of some new pyrazolopyridines and their antioxidant, antitumor and antimicrobial activities.
AID1487483Antioxidant activity assessed as DPPH free radical scavenging activity at 60 ug/ml after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID1294868Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 mins in dark condition by spectrophotometric method2016Bioorganic & medicinal chemistry letters, 05-15, Volume: 26, Issue:10
Synthesis, molecular properties prediction and anticancer, antioxidant evaluation of new edaravone derivatives.
AID1762401Inhibition of porcine liver carboxylesterase using 4-NPA as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis2021European journal of medicinal chemistry, Jun-05, Volume: 218Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
AID1250854Inhibition of rat intestinal Maltase using maltose as substrate assessed as glucose release after 10 mins by glucose oxidase method2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals.
AID402015Antioxidant activity assessed as DPPH radical scavenging activity2005Journal of natural products, May, Volume: 68, Issue:5
Quinones from Chirita eburnea.
AID720995Antioxidant activity assessed as DPPH scavenging activity after 30 mins by spectrophotometry2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives.
AID382104Antioxidant activity Wistar rat hepatocyte membrane assessed as Fe(3+)-ADP/NADPH-induced lipid peroxidation at 50 uM by TBA assay2008Bioorganic & medicinal chemistry, May-01, Volume: 16, Issue:9
Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties.
AID1204902Antioxidant activity assessed as DPPH free radical scavenging activity measured as decoloration of a MeOH solution after 10 mins by spectrophotometry2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Iridoid glycosides from Barleria lupulina.
AID1663836Antioxidant activity assessed as DPPH radical scavenging activity2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Isolation and biological activity of agrostophillinol from kaffir lime (Citrus hystrix) leaves.
AID1264278Antioxidant activity assessed as DPPH free radical scavenging activity at 25 ug/ml after 30 mins by spectrophotometric assay2015European journal of medicinal chemistry, Nov-02, Volume: 104Synthesis and pharmacological evaluation of some new fluorine containing hydroxypyrazolines as potential anticancer and antioxidant agents.
AID1511011Antioxidant activity assessed as ABTS radical scavenging activity incubated for 40 mins2019European journal of medicinal chemistry, Oct-15, Volume: 180Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
AID1479538Antioxidant activity assessed as DPPH radical scavenging activity incubated in dark for 20 mins2018Journal of medicinal chemistry, 02-22, Volume: 61, Issue:4
The Synthesized Plant Metabolite 3,4,5-Tri-O-Galloylquinic Acid Methyl Ester Inhibits Calcium Oxalate Crystal Growth in a Drosophila Model, Downregulates Renal Cell Surface Annexin A1 Expression, and Decreases Crystal Adhesion to Cells.
AID691694Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 6.25 to 100 uM after 20 mins2012Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
Antioxidant properties of Mannich bases.
AID513611Inhibition of NO production in BAEC assessed as inhibition of Ca2+ influx at 1 mM2006Nature chemical biology, Nov, Volume: 2, Issue:11
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
AID1202844Antioxidant activity assessed as ferric reducing antioxidant power at 0.1 mg/ml by FRAP assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Puupehenol, a potent antioxidant antimicrobial meroterpenoid from a Hawaiian deep-water Dactylospongia sp. sponge.
AID770309Antioxidant activity assessed as inhibition of DPPH-induced free radical generation at 1 to 500 uM after 30 mins relative to control2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Discovery of novel (1S)-(-)-verbenone derivatives with anti-oxidant and anti-ischemic effects.
AID283705DPPH radical scavenging activity at 40 umol/L relative to control2007Journal of natural products, Apr, Volume: 70, Issue:4
Bioactive metabolites from the Caribbean sponge Aka coralliphagum.
AID1635491Neuroprotective activity against H2O2-induced oxidative damage in human SH-SY5Y cells assessed as increase in cell viability at 20 uM incubated for 2 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
AID1405942Antioxidant activity assessed as DPPH radical scavenging activity at 10 ug/ml after 20 mins by UV absorbance method relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID1168136Antioxidant activity assessed as DPPH free radical scavenging activity after 60 mins by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87PASS-assisted design, synthesis and antioxidant evaluation of new butylated hydroxytoluene derivatives.
AID374242Inhibition of bleomycin-induced DNA damage assessed as absorbance at 532 nm after 1 hr at 37 degC2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines.
AID1487490Antioxidant activity assessed as H2O2 free radical scavenging activity at 80 ug/ml after 10 to 15 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID1768734Inhibition of equine serum BuChE by Ellman's method2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID36973Inhibitory constant against Alpha-amylase2000Bioorganic & medicinal chemistry letters, Jul-17, Volume: 10, Issue:14
Kinetic characterisation of ene-diol-based inhibitors of alpha-amylase.
AID1202555Antioxidant activity assessed as inhibition of ABTS free radical scavenging activity after 10 mins by spectrophotometry relative to control2015European journal of medicinal chemistry, , Volume: 96Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
AID1420841Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM measured after 30 mins2018European journal of medicinal chemistry, Oct-05, Volume: 158Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
AID1496213Antioxidant activity assessed as DPPH free radical scavenging activity at 50 uM after 30 mins in dark by spectrophotometric method relative to control2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
AID549263Antioxidant activity assessed as DPPH radical scavenging activity at 20 ug/ml after 30 mins2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1268016Antioxidant activity assessed as DPPH free radical scavenging activity at 25 ug/ml after 20 mins by UV-vis spectrophotometry analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
AID1172552Antioxidant activity assessed as DPPH radical scavenging activity relative to untreated control2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthetic derivatives of aromatic abietane diterpenoids and their biological activities.
AID690850Antioxidant activity assessed as DPPH radical scavenging activity2012Journal of medicinal chemistry, 06-28, Volume: 55, Issue:12
Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agoni
AID1352204Antioxidant activity assessed as superoxide dismutase-like activity by measuring inhibition of xanthine oxidase-induced superoxide anion level measured ever 30 secs for 5 mins by NBT reduction assay2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID648403Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 800 ug/ml after 20 mins2012European journal of medicinal chemistry, May, Volume: 51Facile synthesis, characterization and pharmacological activities of 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 5,6-dihydro-3,6-disubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
AID1743176Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity measured after 1 hr by UV-vis spectrophotometric method2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID678494Antioxidant activity assessed as superoxide radical scavenging activity at 100 uM after 5 mins by NBT reduction assay2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
AID478248Antioxidant activity in Wistar albino rat assessed as catalase level2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID744461Antioxidant activity of the compound assessed as DPPH free radical scavenging activity at 250 uM after 60 mins by spectrophotometric analysis relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.
AID771144Antioxidant activity assessed as reduction of K3FeCN6 at 1 to 500 uM by spectrophotometric analysis in presence of FeCl32013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID1555975Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID491005Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and bioassay of pyrrolyl oxazolines and thiazolines.
AID365747Antioxidant activity assessed as DPPH radical scavenging activity2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effects of polymethoxy flavones isolated from Citrus reticulate on degranulation in rat basophilic leukemia RBL-2H3: enhanced inhibition by their combination.
AID401337Antioxidant activity assessed by hydroxyl radical scavenging assay1996Journal of natural products, Feb, Volume: 59, Issue:2
Natural polyphenols (vegetable tannins) as drugs: possible modes of action.
AID453276Antioxidant activity assessed as hydrogen peroxide scavenging activity by lucigenin oxidation assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Synthesis and antioxidant properties of new chromone derivatives.
AID1611502Antioxidant activity assessed as DPPH free radical scavenging activity at 200 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID1193498Thermodynamic equilibrium solubility, log S of the compound simulated gastric fluid at pH 1.2 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID678495Antioxidant activity assessed as H2O2-induced hydroxyl radical scavenging activity at 100 uM after 5 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
AID1155652Antioxidant activity assessed as ferric ion reducing activity expressed as Fe(II) using ferrous-TPTZ by FRAP assay2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors.
AID502058Antioxidant activity assessed as DPPH radical scavenging activity2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID219598Compound was tested for the inhibition of xanthine oxidase; Inactive2000Bioorganic & medicinal chemistry letters, Dec-18, Volume: 10, Issue:24
Antioxidant activity and xanthine oxidase inhibition activity of reductic acid: ascorbic acid analogue.
AID691692Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 50 uM2012Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
Antioxidant properties of Mannich bases.
AID693513Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity at 75 ug/mL by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID753094Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysis2013European journal of medicinal chemistry, Jun, Volume: 64Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group.
AID693512Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity at 50 ug/mL by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID449328Antioxidant activity assessed as DPPH radical scavenging activity by UV-visible spectrophotometry2009Bioorganic & medicinal chemistry letters, Sep-15, Volume: 19, Issue:18
Synthesis and biological evaluation of quinic acid derivatives as anti-inflammatory agents.
AID682620Antioxidant activity assessed as ABTS free radical scavenging activity at 1 mg/mL by spectroscopic analysis2012European journal of medicinal chemistry, Oct, Volume: 56Synthesis, antitumor, cytotoxic and antioxidant evaluation of some new pyrazolotriazines attached to antipyrine moiety.
AID380423Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1743179Antioxidant activity assessed as AAPH scavenging activity by measuring residual fluorescence at 50 uM measured at 1 min interval for 30 mins by ORAC fluorescein assay relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID719016Antioxidant activity of compound assessed as DPPH radical scavenging activity2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.
AID405699Inhibition of lipid peroxidation in renal failured rat plasma assessed as inhibition of malondialdehyde level by TBARS assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Antioxidant 2-phenylbenzofurans and a coumestan from Lespedeza virgata.
AID1753662Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition relative to vitamin C2021European journal of medicinal chemistry, Jun-05, Volume: 218New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
AID615466Antioxidant activity assessed as inhibition of lipid peroxidation using egg lecithin liposomes incubated for 1 hr2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
AID36970Inhibition of fungal alpha-amylase1998Bioorganic & medicinal chemistry letters, Jul-07, Volume: 8, Issue:13
Ascorbic acid-based inhibitors of alpha-amylases.
AID1167300Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry2014Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21
Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
AID1773259Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM incubated for 2 hrs by microplate reader method2021European journal of medicinal chemistry, Nov-05, Volume: 223Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
AID1370424Antioxidant activity assessed as DPPH radical scavenging activity incubated under dark condition for 30 mins by spectrophotometric analysis2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Design, synthesis and biological evaluation of glutamic acid derivatives as anti-oxidant and anti-inflammatory agents.
AID626496Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives.
AID1663502Antioxidant activity assessed as hydroxyl radicals scavenging activity2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects.
AID1505137Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins incubation under dark condition2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID478242Antioxidant activity in Wistar albino rat assessed as inhibition of lipid peroxidation2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID652744Antioxidant activity using deaerated 1 M ethylene glycol as substrate assessed as hydroxy radical additive level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1191657Antioxidant activity assessed as DMPD scavenging activity after 15 mins by spectrophotometry2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Schiff's bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants.
AID1635492Antioxidant activity assessed as DPPH free radical scavenging activity at 10 uM after 30 secs by spectrophotometry2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
AID349359Antioxidant activity assessed as inhibition of ROS-induced linoleic acid peroxidation at 1 mM after 15 mins at 100 degC by modified TBARS assay relative to control2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID1743660Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF
AID720998Antioxidant activity assessed as superoxide anion radical scavenging activity after 5 mins by spectrophotometry2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives.
AID439060Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID36971The compound was tested for inhibition of malt Alpha-amylase by Megazyme assay2000Bioorganic & medicinal chemistry letters, Jul-17, Volume: 10, Issue:14
Kinetic characterisation of ene-diol-based inhibitors of alpha-amylase.
AID1512368Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 30 mins under dark condition relative to control2019ACS medicinal chemistry letters, Oct-10, Volume: 10, Issue:10
Chalcone-Thiazole Hybrids: Rational Design, Synthesis, and Lead Identification against 5-Lipoxygenase.
AID447535Antioxidant activity assessed as DPPH free radical scavenging activity by UV spectroscopic method2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles.
AID1193499Thermodynamic equilibrium solubility, log S of the compound simulated intestinal fluid at pH 6.8 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID693511Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity at 25 ug/mL by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID1462745Antioxidant activity assessed as DPPH free radical scavenging activity by measuring radical-scavenging activity factor (moles of radicals scavenged by each mol of antioxidant) at 20 uM measured at 10 mins by HPLC2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Structural evidence for the DPPH radical-scavenging mechanism of 2-O-α-d-glucopyranosyl-l-ascorbic acid.
AID1867445Induction of ROS generation in fluconazole resistant Candida glabrata 109 overexpressing CgCdr1p transporter assessed as increase in ROS level incubated for 90 mins by DCFH-DA dye based fluorescence assay2022Bioorganic & medicinal chemistry, 06-01, Volume: 63Effects of β-lapachone and β-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata.
AID761704Antioxidant activity assessed as ABTS free radical scavenging activity by spectrophotometry2013European journal of medicinal chemistry, Aug, Volume: 66Selective cytotoxic effects on human breast carcinoma of new methoxylated flavonoids from Euryops arabicus grown in Saudi Arabia.
AID496825Antimicrobial activity against Leishmania mexicana2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID771143Antioxidant activity assessed as reduction of K3FeCN6 by spectrophotometric analysis in presence of FeCl32013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID1368752Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM by spectrphotomery2018Bioorganic & medicinal chemistry letters, 01-15, Volume: 28, Issue:2
Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells.
AID1575199Antioxidant activity assessed as ABTS radical scavenging activity at 20 uM measured at 30 sec interval over 60 mins2019Bioorganic & medicinal chemistry letters, 02-01, Volume: 29, Issue:3
Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast.
AID652736Antioxidant activity using deaerated ethanol as substrate assessed as 2,3-butanediol level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 2.05 +/- 0.09 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID666938Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID1730968Antioxidant activity assessed as hydrogen peroxide radical scavenging activity at 100 ug/ml (Rvb = 23.6 to 43.1 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID614099Antioxidant activity assessed as H2O2 scavenging activity at 12.5 to 250 ug/mL after 30 mins by spectrophotometric analysisic analysis2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Tylosema esculentum extractives and their bioactivity.
AID598649Anti-lipid peroxidation activity ferric chloride-induced lipid peroxidation using egg yolk homogenate at 40 ug/ml by TBARS assay2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles.
AID1405919Antioxidant activity assessed as inhibition of DPPH radical at 100 ug/ml relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID1596151Antioxidant activity assessed as DPPH radical scavenging activity incubated for 15 mins under dark condition by spectrophotometric method2019European journal of medicinal chemistry, Jul-15, Volume: 174A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1.
AID360503Antioxidant activity assessed as DPPH radical scavenging activity1995Journal of natural products, Nov, Volume: 58, Issue:11
Santolindiacetylene, a polyacetylene derivative isolated from the essential oil of Santolina canescens.
AID1768735Selectivity index, ratio of IC50 for electric eel AChE to IC50 for equine serum BuChE2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID693514Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity at 100 ug/mL by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID1549513Antioxidant activity assessed as ABTS radical scavenging activity by spectrophotometric method relative to ascorbic acid2019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID693508Antioxidant activity assessed as inhibition of nitric oxide free radical production at 75 ug/mL after 150 mins by Griess method relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID733738Antioxidant activity assessed as DPPH free radical scavenging activity after 15 mins by spectrophotometric analysis2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
AID1589004Antioxidant activity assessed as DPPH-radical scavenging activity at 1 mM incubated for 30 mins under dark condition by microplate reader based assay relative to control2019Bioorganic & medicinal chemistry, 09-01, Volume: 27, Issue:17
Inhibitory effects of N-(acryloyl)benzamide derivatives on tyrosinase and melanogenesis.
AID1567596Antioxidant activity in human blood assessed as total antioxidant capacity at 10 uM after 48 hrs (Rvb = 6.3 +/- 0.5 No_unit)2019European journal of medicinal chemistry, Sep-15, Volume: 178Carvacrol prodrugs as novel antimicrobial agents.
AID1326483Antioxidant activity assessed as DPPH radical scavenging activity at 1 uM after 30 mins in absence of light by spectrophotometric analysis2016European journal of medicinal chemistry, Oct-21, Volume: 122Combinatorial synthesis, in silico, molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinoma.
AID427307Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Cytotoxic activity and inhibitory effect on nitric oxide production of triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae).
AID1533605Inhibition of Electric eel AChE using acetylthiocholine iodide as substrate after 10 mins measured for every mins by Ellman's method2019European journal of medicinal chemistry, Feb-01, Volume: 163Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
AID1730959Antioxidant activity assessed as DPPH radical scavenging activity at 75 ug/ml (Rvb = 22 to 40.2 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID598279Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties.
AID1366175Antioxidant activity assessed as DPPH free radical scavenging activity at 150 ug/ml after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID1610140Cytotoxicity against human HFF cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID761965Antioxidant activity assessed as inhibition of lipid peroxidation activity after 15 mins by MDA assay2013European journal of medicinal chemistry, Aug, Volume: 66Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetamides as antioxidant and/or anti-inflammatory compounds.
AID1565347Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM/ml incubated for 20 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
AID1155573Inhibition of human recombinant 5-LO expressed in Escherichia coli Bl21 (DE3) using arachidonic acid as substrate preincubated for 10 mins measured after 10 mins by RP-HPLC analysis2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
AID448094Antimicrobial activity against Staphylococcus aureus NCIM 5021 after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety.
AID1487491Antioxidant activity assessed as H2O2 free radical scavenging activity at 100 ug/ml after 10 to 15 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID1565349Antioxidant activity assessed as DPPH radical scavenging activity at 40 uM/ml incubated for 20 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
AID1899549Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM incubated for 30 mins under dark condition by microplate reader based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships.
AID1399482Inhibition of equine serum BChE using butylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition by Ellman's method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
AID693501Antioxidant activity assessed as inhibition of DPPH free radical production at 25 ug/mL after 30 mins by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID1730967Antioxidant activity assessed as hydrogen peroxide radical scavenging activity at 75 ug/ml (Rvb = 23.6 to 43.1 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID1248400Inhibition of malt alpha-amylase2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID1453055Antioxidant activity assessed as inhibition of DPPH radical generation at 0.04 mg/ml after 20 mins under dark condition by UV-Visible spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
AID1126577Antioxidant activity assessed as trolox equivalents of cupric reducing antioxidant capacity after 30 mins2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and biological evaluation of N-dehydrodipeptidyl-N,N'-dicyclohexylurea analogs.
AID506733Activity of HIF prolyl hydroxylase-32007Nature chemical biology, Mar, Volume: 3, Issue:3
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
AID744460Antioxidant activity of the compound assessed as DPPH free radical scavenging activity at 312.5 uM after 60 mins by spectrophotometric analysis relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.
AID449287Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 30 mins by spectrophotometry2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
AID1875639Immunomodulatory activity in IL-17A Katushka/IL-10eGFP/Foxp3RFP reporter mouse cell trace violet-labelled CD4+ T cell derived TGF-beta1/IL-6/IL-23-polarized Th17 cells assessed as increase in IL-17 positive cell population at 5 to 20 uM measured after 3 d2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cellular Stress-Induced Metabolites in
AID1610412Inhibition of mushroom tyrosinase using L-dopa as substrate by spectrophotometric method2019European journal of medicinal chemistry, Dec-15, Volume: 184Benzo[b]thiophene-thiazoles as potent anti-Toxoplasma gondii agents: Design, synthesis, tyrosinase/tyrosine hydroxylase inhibitors, molecular docking study, and antioxidant activity.
AID1487482Antioxidant activity assessed as DPPH free radical scavenging activity at 40 ug/ml after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID506731Activity of HIF prolyl hydroxylase-12007Nature chemical biology, Mar, Volume: 3, Issue:3
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
AID674915Antioxidant activity assessed as DPPH scavenging activity after 30 mins by microplate reader method2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
The antioxidant effect of imine resveratrol analogues.
AID1503706Antioxidant activity assessed as H2O2 free radical scavenging activity after 1 hr by UV spectrophotometric analysis2017European journal of medicinal chemistry, Dec-01, Volume: 141Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.
AID1565351Antioxidant activity assessed as DPPH radical scavenging activity at 80 uM/ml incubated for 20 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
AID1377035Antioxidant activity assessed as DPPH radical scavenging activity at test compound/DPPH volume ratio 1:1 after 1 hr by UV-spectrophotometric method2017Journal of natural products, 06-23, Volume: 80, Issue:6
Derivatives of the Lignan 7'-Hydroxymatairesinol with Antioxidant Properties and Enhanced Lipophilicity.
AID1277565Antioxidant activity assessed as suppression of H2O2/cobalt2+-mediated hydroxyl radical formation by luminol-based fluorescence assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
AID724080Antioxidant activity assessed as hydroxyl radical scavenging activity at 100 uM after 5 mins2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Design, synthesis, characterization and biological evaluation of novel pyrazole integrated benzophenones.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID1501903Antioxidant activity assessed as redox reaction between compound and MTT in DMSO measured after 6 hrs2017Journal of natural products, 09-22, Volume: 80, Issue:9
Lipid Peroxidation and Cyclooxygenase Enzyme Inhibitory Compounds from Prangos haussknechtii.
AID491004Antioxidant activity assessed as inhibition of nitric oxide production at 100 uM2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and bioassay of pyrrolyl oxazolines and thiazolines.
AID1453457Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 1 umol/ml after 20 mins by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID1871454Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins in dark condition by spectrophotometrical analysis2022European journal of medicinal chemistry, Jan-05, Volume: 227Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
AID295621DPPH radical scavenging activity at 200 ppm2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit.
AID179357Effect of AOS scavenger on arrhythmias induced by ischemia-reperfusion in anesthetized rat measured as ventricular tachycardia (VT), frequency, times at 3 mg/kg1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID497110Antioxidant activity assessed as ABTS free radical scavenging activity at 100 uM after 12 hrs2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis and biological evaluation of arylidene analogues of Meldrum's acid as a new class of antimalarial and antioxidant agents.
AID693503Antioxidant activity assessed as inhibition of DPPH free radical production at 75 ug/mL after 30 mins by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID429185Antioxidant activity assessed as radical DPPH scavenging activity2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID652727Selectivity ratio of MNTD for human RD cells to EC50 for HSV12012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1155648Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.4 uM after 24 hrs by MTT assay relative to control2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties.
AID1810884Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins by spectrophotometric analysis
AID1370494Antioxidant activity assessed as DPPH radical scavenging activity after 20 to 30 mins2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Microwave-assisted synthesis of novel 5-substituted benzylidene amino-2-butyl benzofuran-3-yl-4-methoxyphenyl methanones as antileishmanial and antioxidant agents.
AID1385540Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins in dark condition2018Journal of natural products, 08-24, Volume: 81, Issue:8
Spiro-Phthalides and Isocoumarins Isolated from the Marine-Sponge-Derived Fungus Setosphaeria sp. SCSIO41009.
AID327008DPPH radical scavenging activity2008Journal of natural products, Jan, Volume: 71, Issue:1
Gentisyl alcohol derivatives from the marine-derived fungus Penicillium terrestre.
AID733736Antioxidant activity assessed as nitric oxide scavenging activity after 2.5 hrs by Griess assay2013European journal of medicinal chemistry, Apr, Volume: 62Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
AID1264277Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 30 mins by spectrophotometric assay2015European journal of medicinal chemistry, Nov-02, Volume: 104Synthesis and pharmacological evaluation of some new fluorine containing hydroxypyrazolines as potential anticancer and antioxidant agents.
AID1851303Antioxidant activity assessed as DPPH radical scavenging activity by absorbance based analysis2022Bioorganic & medicinal chemistry, 09-15, Volume: 70Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora.
AID1867443Induction of ROS generation in fluconazole resistant Saccharomyces cerevisiae overexpressing CgCdr1p transporter assessed as increase in ROS level incubated for 90 mins by DCFH-DA dye based fluorescence assay2022Bioorganic & medicinal chemistry, 06-01, Volume: 63Effects of β-lapachone and β-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata.
AID1428664Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric method2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID652740Antioxidant activity using deaerated 1 M ethanol as substrate assessed as hydroxy radical additive level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1169847Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Chlorinated polyketide obtained from a Daldinia sp. treated with the epigenetic modifier suberoylanilide hydroxamic acid.
AID598280Antioxidant activity in rat liver homogenates assessed as inhibition of iron-ascorbic acid mix-induced lipid peroxidation after 30 mins by TBARS assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties.
AID1360871Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ at 10 ug/ml after 25 mins by FRAP assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID1439804Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV/VIS Spectrophotometric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Biologically active perspective synthesis of heteroannulated 8-nitroquinolines with green chemistry approach.
AID1178159Antioxidant activity of the compound assessed as reduction in absorbance of DPPH after 60 mins incubation at 35 uM by DPPH radical scavenging /microplate assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis, antioxidant and photoprotection activities of hybrid derivatives useful to prevent skin cancer.
AID652733Antioxidant activity using 1M ethanol as substrate assessed as H2O2 level at 1 mmol/L after gamma-irradiation by spectrophotometry (Rvb = 2.73 +/- 0.18 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID502055Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID1428668Antioxidant activity against tert-butyl hydroperoxide-induced lipoperoxidation in rat liver microsomal membranes at 50 uM preincubated for 10 mins followed by tert-butyl hydroperoxide addition measured after 60 mins by TBARS assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID619975Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometric analysis2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID309192DPPH radical scavenging activity after 30 mins2007Bioorganic & medicinal chemistry letters, Oct-01, Volume: 17, Issue:19
Synthetic tyrosyl gallate derivatives as potent melanin formation inhibitors.
AID1248049Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation after 3 hrs by TBA-MDA test2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.
AID374240Antioxidant activity in Sprague-Dawley rat erythrocytes assessed as ABTS-induced hemolysis after 1 hr2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines.
AID598648Antioxidant activity assessed as DPPH radical scavenging activity at 10 ug/ml by UV-visible spectrophotometry2011Bioorganic & medicinal chemistry letters, Jun-15, Volume: 21, Issue:12
Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles.
AID1155577Aqueous stability of the compound in at 2 uM in 10 mM aqueous ammonium bicarbonate at pH 7.9 assessed as formation of trans-6-(4'-hydroxy-3'-methoxyphenyl)-2,4-dioxo-5-hexenal measured as residual amount of compound by reversed phase liquid chromatography2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
AID1405936Antioxidant activity assessed as ABTS radical scavenging activity2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID1464784Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition by UV-vis spectrophotometric method2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Design, synthesis and biological evaluation of 8-substituted-6-hydrazonoindolo[2,1-b]quinazolin-12(6H)-one scaffolds as potential cytotoxic agents: IDO-1 targeting molecular docking studies.
AID351092Antioxidant activity against FeSO4-induced lipid peroxidation in rat liver homogenate assessed as inhibition of malondialdehyde release after 1 hr by thiobarbituric acid assay2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID1882616Inhibition of jack bean urease2022European journal of medicinal chemistry, Apr-15, Volume: 234An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.
AID1762405Inhibition of equine serum BuChE using butyrylcholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method2021European journal of medicinal chemistry, Jun-05, Volume: 218Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
AID670405Antioxidant activity assessed as DPPH free radical scavenging activity2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone, 5-carboethoxymethyl-4',7-dihydroxyflavone and their analogues.
AID693504Antioxidant activity assessed as inhibition of DPPH free radical production at 100 ug/mL after 30 mins by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID736835Antioxidant activity assessed as DPPH free radical scavenging activity at 20 uM2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Structure-activity relationship study of vitamin k derivatives yields highly potent neuroprotective agents.
AID447537Antioxidant activity assessed as ABTS free radical scavenging activity by radical cation discoloration assay2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles.
AID351090Antioxidant activity assessed as superoxide radical scavenging activity by spectrophotometry2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID619978Antioxidant activity assessed as nitric oxide scavenging activity at 100 ug/ml after 150 mins by Griess method relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1858994Antioxidant activity assessed as DPPH radical scavenging activity2022European journal of medicinal chemistry, Jan-05, Volume: 227Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.
AID1366174Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID670408Antioxidant activity in erythrocytes assessed as inhibition of hemolysis2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone, 5-carboethoxymethyl-4',7-dihydroxyflavone and their analogues.
AID754977Inhibition of human leukocyte 5-LOX pseudoperoxidase activity assessed as reduction of active ferric ion to inactive ferrous state measured decomposition of 13-(S)-HPODE at 40 uM after 30 mins by iron-xylenol orange staining assay2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases.
AID754974Inhibition of N-terminal His6-tagged human prostate epithelial 15-LOX2 pseudoperoxidase activity assessed as reduction of active ferric ion to inactive ferrous state measured decomposition of 13-(S)-HPODE at 40 uM after 30 mins by iron-xylenol orange stai2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases.
AID678493Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 20 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
AID1585457Antioxidant activity assessed as DPPH free radical scavenging activity after 10 mins2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Dimeric cinnamoylamide analogues for regulation of tyrosinase activity in melanoma cells: A role of diamide-link chain length.
AID1497073Antiglycation activity in bovine serum albumin assessed as inhibition of advanced glycated end product formation after 24 hrs in presence of alpha-D-glucose by fluorescence assay2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID502061Antioxidant activity assessed as ABTS radical scavenging activity at 200 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID437950Antioxidant activity in Wistar rat brain assessed as catalase content2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID1430035Antioxidant activity assessed as DDQ radical scavenging activity by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Synthesis of new chromeno-carbamodithioate derivatives and preliminary evaluation of their antioxidant activity and molecular docking studies.
AID16878The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine1995Journal of medicinal chemistry, Jul-21, Volume: 38, Issue:15
Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.
AID1875640Immunomodulatory activity in IL-17A Katushka/IL-10eGFP/Foxp3RFP reporter mouse cell trace violet-labelled CD4+ T cell derived TGF-beta1/IL-6/IL-23-polarized Th17 cells assessed as increase in IL-10/IL-17 positive cell population at 5 to 20 uM measured aft2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cellular Stress-Induced Metabolites in
AID486892Antioxidant activity assessed as DPPH radical scavenging activity after 8 hrs2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Dihydro-beta-agarofuran sesquiterpenes and pentacyclic triterpenoids from the root bark of Osyris lanceolata.
AID375989Antioxidant activity assessed as superoxide anion scavenging activity by xanthine oxidase oxidation system relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID592649Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analogues.
AID292585DPPH radical scavenging activity at 25 uM2007Journal of natural products, Jul, Volume: 70, Issue:7
Kadsuphilols A-H, oxygenated lignans from Kadsura philippinensis.
AID1810880Inhibition of human BChE using butyrylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method
AID36969Inhibition of Alpha-amylase1998Bioorganic & medicinal chemistry letters, Jul-07, Volume: 8, Issue:13
Ascorbic acid-based inhibitors of alpha-amylases.
AID1610139Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID614063Inhibition of bovine testes hyaluronidase at 80 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID442292Antioxidant activity assessed as DPPH radical scavenging activity by microplate reader assay2010European journal of medicinal chemistry, Feb, Volume: 45, Issue:2
Synthesis, anti-HCV, antioxidant, and peroxynitrite inhibitory activity of fused benzosuberone derivatives.
AID722253Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 10 ug/mL2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.
AID764764Antioxidant activity assessed as DPPH radical scavenging activity at 30 uM after 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
AID652742Antioxidant activity using deaerated 3 M ethylene glycol as substrate assessed as hydroxy radical additive level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID689838Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2012Journal of natural products, Oct-26, Volume: 75, Issue:10
Diarylcyclopentendione metabolite obtained from a Preussia typharum isolate procured using an unconventional cultivation approach.
AID1453460Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 10 umol/ml after 20 mins by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID1313280Antioxidant activity assessed as DPPH radical scavenging activity at 40 ug/ml after 20 mins by spectrophotometry relative to control2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
AID1743181Antioxidant activity in human erythrocytes assessed as protection against AAPH-induced hemolysis at 400 uM preincubated for 20 mins followed by AAPH addition and measured after 2 hrs by spectrophotometric method relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID670407Antioxidant activity of the compound assessed as inhibition of lipid peroxidation2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone, 5-carboethoxymethyl-4',7-dihydroxyflavone and their analogues.
AID497113Antioxidant activity against DPPH free radical assessed as compound able to consume half the amount of free radical after 1 hr2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis and biological evaluation of arylidene analogues of Meldrum's acid as a new class of antimalarial and antioxidant agents.
AID403405Antioxidant activity in rat brain assessed as malondialdehyde level at 568 uM by thiobarbituric acid method2005Journal of natural products, Aug, Volume: 68, Issue:8
Neuroprotective and antioxidant activity of compounds from the aerial parts of Dioscorea opposita.
AID492088Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
(-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant.
AID1635488Cytotoxicity against human SH-SY5Y cells assessed as cell viability at 40 uM after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
AID1377034Lipophilicity, log P of the compound2017Journal of natural products, 06-23, Volume: 80, Issue:6
Derivatives of the Lignan 7'-Hydroxymatairesinol with Antioxidant Properties and Enhanced Lipophilicity.
AID767447Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2013European journal of medicinal chemistry, Sep, Volume: 67Regioselective synthesis of phenanthrenes and evaluation of their anti-oxidant based anti-inflammatory potential.
AID1268018Antioxidant activity assessed as DPPH free radical scavenging activity at 75 ug/ml after 20 mins by UV-vis spectrophotometry analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
AID722704Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells.
AID496821Antimicrobial activity against Leishmania2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1309171Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometry2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.
AID1250855Inhibition of rat intestinal Sucrase using sucrose as substrate assessed as glucose release after 40 mins by glucose oxidase method2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals.
AID496818Antimicrobial activity against Trypanosoma brucei brucei2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1405921Antioxidant activity assessed as DPPH radical scavenging activity relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID1506519Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins2017MedChemComm, Feb-01, Volume: 8, Issue:2
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
AID1352198Antioxidant activity assessed as inhibition of DPPH radical formation after 30 mins2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID1288029Antioxidant activity assessed as DPPH free radical scavenging activity by UV-visible spectrophotometric analysis2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Biological evaluation and molecular docking studies of new curcuminoid derivatives: Synthesis and characterization.
AID1126575Antioxidant activity assessed as hydroxyl radical scavenging activity after 15 mins2014European journal of medicinal chemistry, May-06, Volume: 78Synthesis and biological evaluation of N-dehydrodipeptidyl-N,N'-dicyclohexylurea analogs.
AID1173788Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones.
AID1506525Reducing power of the compound assessed as reducing Fe3+ power at 0.15 to 1.2 mM using potassium ferricyanide in pH 6.6 KH2PO4-K2HPO4 buffer by UV spectrophotometry2017MedChemComm, Feb-01, Volume: 8, Issue:2
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
AID652746Antioxidant activity using deaerated 0.1 M alpha-glycerophosphate as substrate assessed as hydroxy radical level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID548960Antioxidant activity of the compound assessed as reducing activity of DPPH at 0.1 mM after 20 mins2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Does conjugation of antioxidants improve their antioxidative/anti-inflammatory potential?
AID767448Antioxidant activity assessed as galvinoxyl free radical scavenging activity after 20 mins2013European journal of medicinal chemistry, Sep, Volume: 67Regioselective synthesis of phenanthrenes and evaluation of their anti-oxidant based anti-inflammatory potential.
AID1326485Pro-oxidant activity as bleomycin-Fe2+ induced calf thymus DNA damage measured as absorbance at 2 mM after 1 hr by thiobarbituric acid-based assay2016European journal of medicinal chemistry, Oct-21, Volume: 122Combinatorial synthesis, in silico, molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinoma.
AID1155643Antioxidant activity assessed as 150 uM DPPH free radical scavenging activity under dark condition after 30 mins by microplate reader analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties.
AID549275Cytotoxicity against mouse B16 cells up to 100 ug/ml after 72 hrs by MTT assay2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1202778Antioxidant activity assessed as H2O2 scavenging activity after 15 mins2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID626499Antioxidant activity assessed as hydroxyl radical scavenging activity after 1 hr by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives.
AID1382194Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ measured every 15 secs for 4 mins by FRAP assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects.
AID195224The compound was tested for the stimulation of lipid peroxidation in rat liver microsomes induced by [Fe2+] at a concentration of 10E-5 M.1991Journal of medicinal chemistry, Jul, Volume: 34, Issue:7
3-O-alkylascorbic acids as free-radical quenchers: synthesis and inhibitory effect on lipid peroxidation.
AID1730966Antioxidant activity assessed as hydrogen peroxide radical scavenging activity at 50 ug/ml (Rvb = 23.6 to 43.1 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID1784505Antioxidant activity assessed as free radical scavenging activity incubated for 30 mins under dark condition by DPPH assay2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID1668231Antioxidant activity assessed as DPPH radical scavenging activity2020Bioorganic & medicinal chemistry letters, 06-15, Volume: 30, Issue:12
Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.
AID363319Antioxidant activity assessed as inhibition of peroxynitrite-induced evans blue bleaching at 50 uM2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones.
AID1487481Antioxidant activity assessed as DPPH free radical scavenging activity at 20 ug/ml after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID496826Antimicrobial activity against Entamoeba histolytica2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID614052Inhibition of bovine testes hyaluronidase at 49 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID772993Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity at pH 7.4 by spectrophotometry2013European journal of medicinal chemistry, Oct, Volume: 68Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
AID1227882Antioxidant activity assessed as DPPH radical scavenging activity after 10 mins by spectrophotomteric analysis2015Bioorganic & medicinal chemistry letters, Jan-01, Volume: 25, Issue:1
Anti-inflammatory and antitumor phenylpropanoid sucrosides from the seeds of Raphanus sativus.
AID615464Antioxidant activity assessed as nitric oxide radical scavenging activity after 150 mins2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
AID1549512Antioxidant activity assessed as ABTS radical scavenging activity by spectrophotometric analysis relative to control2019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID1347860Growth inhibition of mouse B16 cells at 25 uM after 48 hrs by SRB assay relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1704055Antioxidant activity assessed as radical scavenging activity measured after 30 mins by DPPH assay2020European journal of medicinal chemistry, Oct-15, Volume: 204Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core.
AID1183315Nitric oxide scavenging activity by naphthylethylenediamine dihydrochloride based Griesse-Ilosavay method2014European journal of medicinal chemistry, Sep-12, Volume: 84Zwitterionic pyrimidinium adducts as antioxidants with therapeutic potential as nitric oxide scavenger.
AID722249Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 100 ug/mL2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.
AID1384553Antioxidant activity assessed as DPPH radical scavenging activity incubated under dark condition for 30 mins2018European journal of medicinal chemistry, Apr-25, Volume: 150Design and synthesis of novel pyrrolo[2,3-a]carbazoles: 7-Chloro-2-oxo-3a-(2'-oxo-2',3'-dihydro-1'H-indol-3'-yl)-2,3,3a,4,5,10-hexahydro-pyrrolo[3,2-a]carbazole-1-carbonitrile as an efficient anticancer agent.
AID567050Antioxidant activity assessed as reduction of ABTS radical at 0.1 mM2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
AID511051Antioxidant activity assessed as nitric oxide scavenging activity at 100 uM after 120 min by Griess assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and bioassay of aminosulfonyl-1,3,4-oxadiazoles and their interconversion to 1,3,4-thiadiazoles.
AID228869Free radical scavenging assessed as 50% reduction in DPPH absorbance (516 nm)2002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.
AID594792Antioxidant activity assessed as xanthine-xanthine oxidase generated superoxide anion scavenging after 20 mins2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
AID722251Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 25 ug/mL2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.
AID1453459Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 5 umol/ml after 20 mins by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID1530292Antioxidant activity assessed as DPPH radical scavenging activity at 1 mM after 30 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.
AID1555978Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM incubated for 2 hrs under dark condition relative to control2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID1428670Antiradical activity assessed as gallic acid equivalents of Foline-Ciocalteu reagent reducing capacity at 1 mM preincubated for 5 mins followed by Na2CO3 addition measured after 90 mins in presence of silybin2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID701010Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM2011Journal of medicinal chemistry, Jul-14, Volume: 54, Issue:13
Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
AID1238055Antioxidant activity assessed as nitric oxide radical scavenging activity at 500 uM incubated for 60 mins with light exposure at room temperature by Griess assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives.
AID1193492Thermodynamic equilibrium solubility, log S of the compound in water at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID549274Antioxidant activity in mouse BNL-CL2 cells assessed as inhibition of H2O2-induced ROS production at 20 ug/ml by DCFHDA assay2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID594174Antioxidant activity in rat erythrocytes assessed as inhibition of peroxyl radicals-induced hemolysis at 2 mM after 2 hrs2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.
AID1366172Antioxidant activity assessed as DPPH free radical scavenging activity at 25 ug/ml after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID1155644Antioxidant activity assessed as 300 uM DPPH free radical scavenging activity under dark condition after 30 mins by microplate reader analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties.
AID468431Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2009Journal of natural products, Oct, Volume: 72, Issue:10
Lipocarbazoles, secondary metabolites from Tsukamurella pseudospumae Acta 1857 with antioxidative activity.
AID1428680Cytoprotective activity against tert-butyl hydroperoxide-induced decrease in cell viability in human HepG2 cells at 5 uM pretreated for 1 hr followed by co-treatment with tert-butyl hydroperoxide for 3 hrs in presence of silybin by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID615460Antioxidant activity in rat liver cells assessed as inhibition of Fe(2+)-asocrbate complex system-induced lipid peroxidation by TBARS assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis and bio-activity evaluation of tetraphenyl(phenylamino) methylene bisphosphonates as antioxidant agents and as potent inhibitors of osteoclasts in vitro.
AID294916Antioxidant activity assessed as nitric oxide radical scavenging activity at 0.8 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID295620ABTS radical scavenging activity at 200 ppm2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit.
AID762740Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug/ml after 20 mins2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID764771Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM after 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
AID174639Effect of AOS scavenger on arrhythmias induced by ischemia-reperfusion in anesthetized rat measured as ventricular tachycardia (VT), duration at 3 mg/kg1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID1071364Antioxidant activity assessed as DPPH free radical scavenging activity at 50 uM after 30 mins by spectrophotometry2014European journal of medicinal chemistry, Feb-12, Volume: 73Synthesis and antiproliferative activity of novel selenoester derivatives.
AID439062Antioxidant activity in rat liver homogenate assessed as inhibition of iron-ascorbic acid mix-induced lipid peroxidation by TBARS assay2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID666942Antioxidant activity assessed as authentic peroxynitrite radical scavenging activity after 5 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea.
AID1508038Antioxidant activity in albino rat assessed as inhibition of catalase induced H2O2 production2017European journal of medicinal chemistry, Sep-29, Volume: 138Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.
AID762736Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 10 ug/ml after 1 hr2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID1391584Antioxidant activity assessed as hydroxyl radical scavenging activity at 2.5 mg/ml preincubated for 20 mins followed by salicylic acid addition measured after 60 mins by fenton reaction method relative to control2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Structural analysis and antioxidant activity of the glycoside from Imperial Chrysanthemum.
AID293286Inhibition of AAPH-induced ram erythrocyte hemolysis at 1 g/L2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Synthesis and antioxidant activity evaluation of new 7-aryl or 7-heteroarylamino-2,3-dimethylbenzo[b]thiophenes obtained by Buchwald-Hartwig C-N cross-coupling.
AID448093Antimicrobial activity against Bacillus subtilis NCIM 2010 after 24 hrs by disk diffusion method2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety.
AID463979Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrometric assay method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antioxidant properties of enone core based dendrimers with carbazole as surface group.
AID1762407Antioxidant activity assessed as trolox equivalent of ABTS radical cation scavenging activity incubated for 24 hrs by UV-Vis spectrophotometric analysis2021European journal of medicinal chemistry, Jun-05, Volume: 218Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
AID1668232Antioxidant activity assessed as nitric oxide radical scavenging activity2020Bioorganic & medicinal chemistry letters, 06-15, Volume: 30, Issue:12
Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.
AID626497Antioxidant activity assessed as ABTS radical scavenging activity after 3 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives.
AID464442Antioxidant activity assessed as reduction of F3+/ferricyanide complex after 20 mins by spectrophotometry2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents.
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1549506Haemolytic activity in human erythrocytes assessed as induction of hemolysis at 5 mM after 30 mins relative to H2022019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID762735Antioxidant activity against ferric chloride-induced lipid peroxidation using egg lecithin at 100 ug/ml after 1 hr2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID1362636Antioxidant activity assessed as AAPH radical scavenging activity at 1 to 16 uM by ORAC assay
AID1762403Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method2021European journal of medicinal chemistry, Jun-05, Volume: 218Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
AID187612Reducing activity determined by the use of stable radical alpha,alpha-di-phenyl-beta-picrylhydrazyl (DPPH)1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID1419294Antioxidant activity assessed as ferric ion reducing activity at 20 to 320 umol after 20 mins by FRAP assay2018Bioorganic & medicinal chemistry, 12-01, Volume: 26, Issue:22
Synthesis and in vitro antitumor activity of novel alkenyl derivatives of pyridoxine, bioisosteric analogs of feruloyl methane.
AID1437487Antioxidant activity assessed as ABTS radical scavenging activity2017Journal of natural products, 01-27, Volume: 80, Issue:1
Antioxidant Hydroanthraquinones from the Marine Algal-Derived Endophytic Fungus Talaromyces islandicus EN-501.
AID1651605Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins
AID1391579Antioxidant activity assessed as ABTS radical scavenging activity at 2.5 mg/ml after 6 mins relative to control2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Structural analysis and antioxidant activity of the glycoside from Imperial Chrysanthemum.
AID1610483Antioxidant activity assessed as decrease in ABTS radical cation scavenging activity every 1 min for 6 mins by UV-Vis spectrophotometric analysis2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID409958Inhibition of bovine brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1487486Antioxidant activity assessed as DPPH free radical scavenging activity measured after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID437951Antioxidant activity in Wistar rat brain assessed as lipid peroxidation2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID1366177Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID1810881Inhibition of human AChE using acetylthiocholine iodide as substrate incubated for 20 mins followed by substrate addition by Ellman's method
AID1267475Antioxidant activity assessed as DPPH radical scavenging activity at 0.5 mM after 30 mins2016Bioorganic & medicinal chemistry letters, Jan-01, Volume: 26, Issue:1
Bioactive minor components of the total salvianolic acids injection prepared from Salvia miltiorrhiza Bge.
AID1875631Immunomodulatory activity in IL-17A Katushka/IL-10eGFP/Foxp3RFP reporter mouse cell trace violet-labelled CD4+ T cell derived TGF-beta1/IL-6/IL-23-polarized Th17 cells assessed as increase in IL-10 positive cell population at 5 to 20 uM measured after 3 d2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cellular Stress-Induced Metabolites in
AID1428676Antioxidant activity against tert-butyl hydroperoxide-induced lipoperoxidation in rat liver microsomal membranes preincubated for 10 mins followed by tert-butyl hydroperoxide addition measured after 60 mins in presence of silybin by TBARS assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1172553Antioxidant activity assessed as DPPH radical scavenging activity2014European journal of medicinal chemistry, Nov-24, Volume: 87Synthetic derivatives of aromatic abietane diterpenoids and their biological activities.
AID1331318Antioxidant activity assessed as inhibition of peroxyl radical-induced oxidation at 10 uM by ORAC assay2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.
AID502057Antioxidant activity assessed as DPPH radical scavenging activity at 400 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID1202779Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity measured for 1 to 6 mins by lipophilic-TEAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID1331319Antioxidant activity assessed as ABTS free radical scavenging activity at 10 uM2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.
AID1663838Antioxidant activity assessed as ferric reducing ability2020Bioorganic & medicinal chemistry letters, 07-15, Volume: 30, Issue:14
Isolation and biological activity of agrostophillinol from kaffir lime (Citrus hystrix) leaves.
AID1347864Inhibition of alpha-MSH-induced TRP-2 expression in human A375 cells at 25 uM after 24 hrs by Western blot method2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1367017Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometric method2017Bioorganic & medicinal chemistry, 12-15, Volume: 25, Issue:24
Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
AID1125419Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Two sarcoviolins with antioxidative and α-glucosidase inhibitory activity from the edible mushroom Sarcodon leucopus collected in Tibet.
AID453281Antioxidant activity assessed as peroxyl radical scavenging activity by measuring oxygen radical absorbance capacity2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Synthesis and antioxidant properties of new chromone derivatives.
AID377603Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM2006Journal of natural products, Jun, Volume: 69, Issue:6
C18 dibenzocyclooctadiene lignans from Kadsura philippinensis.
AID396449Anti-aging activity in human dermal fibroblasts assessed as inhibition rate of MMP1 expression at 1 uM relative to control2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID1487715Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies.
AID652731Antioxidant activity using ethanol as substrate assessed as hydroxy radical additive level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1505136Inhibition of mushroom tyrosinase using L-tyrosine as substrate pretreated for 5 mins followed by substrate addition measured over 30 mins by spectrophotometric method2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID693506Antioxidant activity assessed as inhibition of nitric oxide free radical production at 25 ug/mL after 150 mins by Griess method relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID648402Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 400 ug/ml after 20 mins2012European journal of medicinal chemistry, May, Volume: 51Facile synthesis, characterization and pharmacological activities of 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 5,6-dihydro-3,6-disubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.
AID1153383Antioxidant activity assessed as DPPH radical scavenging activity2014Bioorganic & medicinal chemistry letters, Jul-01, Volume: 24, Issue:13
Conventional and microwave assisted synthesis of pyrazolone Mannich bases possessing anti-inflammatory, analgesic, ulcerogenic effect and antimicrobial properties.
AID1743178Antioxidant activity assessed as AAPH scavenging activity by measuring residual fluorescence at 10 uM measured at 1 min interval for 30 mins by ORAC fluorescein assay relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID722986Inhibition of Wistar albino rat xanthine oxidase isolated from liver using xanthine as substrate incubated for 15 mins prior to substrate addition by spectrophotometric analysis2013Bioorganic & medicinal chemistry, Jan-01, Volume: 21, Issue:1
Trisubstituted thiophene analogues of 1-thiazolyl-2-pyrazoline, super oxidase inhibitors and free radical scavengers.
AID1360874Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ at 80 ug/ml after 25 mins by FRAP assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID215973Compound (0.5 mM) was tested for percent inactivation of mushroom tyrosinase after 130 min with addition of enzyme2003Bioorganic & medicinal chemistry letters, Jul-21, Volume: 13, Issue:14
Identification of oxidation product of arbutin in mushroom tyrosinase assay system.
AID652905Antioxidant activity using deaerated 0.1 M alpha-glucosophosphate as substrate assessed as inorganic phosphate level at 1 mmol/L after gamma-irradiation (Rvb = 2.63 +/- 0.05 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID683417Antioxidant activity assessed as DPPH free radical scavenging activity incubated for 30 mins2012Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
Synthesis of novel Schiff base analogues of 4-amino-1,5-dimethyl-2-phenylpyrazol-3-one and their evaluation for antioxidant and anti-inflammatory activity.
AID1428666Antioxidant activity against tert-butyl hydroperoxide-induced lipoperoxidation in rat liver microsomal membranes preincubated for 10 mins followed by tert-butyl hydroperoxide addition measured after 60 mins by TBARS assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1663501Antioxidant activity assessed as DPPH radical scavenging activity2020Bioorganic & medicinal chemistry letters, 08-01, Volume: 30, Issue:15
3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects.
AID1768733Inhibition of electric eel AChE by Ellman's method2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID688614Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometry2011Journal of natural products, Aug-26, Volume: 74, Issue:8
Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro.
AID1194986Antioxidant activity assessed as FRAP values at 100 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1360876Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition by spectrophotometric method2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID762897Total antioxidant capacity of the compound at 25 uM relative to control2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Phaeolschidins A-E, five hispidin derivatives with antioxidant activity from the fruiting body of Phaeolus schweinitzii collected in the Tibetan Plateau.
AID1178157Antioxidant activity of the compound assessed as reduction in absorbance of DPPH after 60 mins incubation at 300 uM by DPPH radical scavenging /microplate assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis, antioxidant and photoprotection activities of hybrid derivatives useful to prevent skin cancer.
AID604088Antioxidant activity assessed as DPPH radical scavenging activity2011Bioorganic & medicinal chemistry, Jun-15, Volume: 19, Issue:12
Significant enhancement in radical-scavenging activity of curcuminoids conferred by acetoxy substituent at the central methylene carbon.
AID396447Toxicity against human dermal fibroblasts assessed as cell viability at 200 uM relative to control2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID496820Antimicrobial activity against Trypanosoma brucei2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1313281Antioxidant activity assessed as DPPH radical scavenging activity at 60 ug/ml after 20 mins by spectrophotometry relative to control2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
AID1730961Antioxidant activity assessed as nitric oxide radical scavenging activity at 25 ug/ml (Rvb = 25.8 to 41.6 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID496831Antimicrobial activity against Cryptosporidium parvum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1248048Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 200 ug/ml after 3 hrs by TBA-MDA test2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles.
AID1877876Antioxidant activity assessed as hydrogen peroxide scavenging activity
AID390103Antioxidant activity assessed as DPPH radical scavenging activity by Brand-Williams method2008Journal of natural products, Dec, Volume: 71, Issue:12
S-alkenyl cysteine sulfoxide and its antioxidant properties from Allium cepa var. tropeana (red onion) seeds.
AID1463492Neuroprotective activity against glutamate-induced neuronal cell death in mouse HT22 cells at 25 uM after 24 hrs by LDH-release assay relative to control2017Bioorganic & medicinal chemistry letters, 09-15, Volume: 27, Issue:18
Synthesis of 3-[4-(dimethylamino)phenyl]alkyl-2-oxindole derivatives and their effects on neuronal cell death.
AID1238916Antioxidant activity assessed as inhibition of DPPH radical generation at 100 ug/ml after 30 mins relative to control2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Synthesis, kinetic mechanism and docking studies of vanillin derivatives as inhibitors of mushroom tyrosinase.
AID1428665Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity at 100 uM measured at >= 5 mins2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID693502Antioxidant activity assessed as inhibition of DPPH free radical production at 50 ug/mL after 30 mins by spectrophotometric analysis relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID536046Antioxidant activity against ABTS radical assessed as Trolox equivalent2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Synthesis and antioxidant properties of pulvinic acids analogues.
AID666940Antioxidant activity assessed as DPPH radical scavenging activity a 50 ug/ml after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea.
AID1366173Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug/ml after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID396456Antioxidant activity assessed as free radical scavenging activity at 5 uM2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID427661Antioxidant activity assessed as inhibition of FeCl2-induced lipid peroxidation by thiocyanate method2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID1595269Acute toxicity in Swiss albino mouse assessed as reduction in mortality of animal at 200 to 800 mg/kg ip observed for 8 days2019European journal of medicinal chemistry, Jun-01, Volume: 171Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore.
AID1882443Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins
AID1193495Thermodynamic equilibrium solubility, log S of the compound in simulated intestinal fluid at pH 6.8 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID619973Antioxidant activity assessed as DPPH free radical scavenging activity at 75 ug/ml after 30 mins by spectrophotometric analysis relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1238015Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.
AID478244Antioxidant activity in Wistar albino rat assessed as inhibition of superoxide dismutase activity2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID1368750Inhibition of NOX4 in human ARPE19 cells assessed as protection against 4-HNE-induced cell death by measuring cell viability recovery at 10 uM incubated for 24 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 01-15, Volume: 28, Issue:2
Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells.
AID614061Inhibition of bovine testes hyaluronidase at 130 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID405698Antioxidant activity against 2,2'-azobis (2-amidinopropane) dihydrochloride-induced fluorescence decay at 1.5 uM assessed as trolox equivalents by ORAC-fluorescence assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Antioxidant 2-phenylbenzofurans and a coumestan from Lespedeza virgata.
AID549260Antioxidant activity assessed as DPPH radical scavenging activity at 1 ug/ml after 30 mins2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID614060Inhibition of bovine testes hyaluronidase at 3800 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID292587DPPH radical scavenging activity at 6.25 uM2007Journal of natural products, Jul, Volume: 70, Issue:7
Kadsuphilols A-H, oxygenated lignans from Kadsura philippinensis.
AID1405931Antioxidant activity assessed as ferric ion reducing activity after 20 mins in presence of potassium ferricyanide by FRAP assay relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID385146Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2008Journal of natural products, Apr, Volume: 71, Issue:4
Citrinin dimers from the halotolerant fungus Penicillium citrinum B-57.
AID1651260Inhibition of equine serum BChE using butyrylthiocholine as substrate by Ellman's method2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
AID1058428Antioxidant activity assessed as hydrogen peroxide radical scavenging activity2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
The ameliorating effects of 2,3-dihydroxy-4-methoxyacetophenone on scopolamine-induced memory impairment in mice and its neuroprotective activity.
AID401338Antioxidant activity assessed by singlet oxygen scavenging assay1996Journal of natural products, Feb, Volume: 59, Issue:2
Natural polyphenols (vegetable tannins) as drugs: possible modes of action.
AID1778222Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins under dark condition by DPPH assay relative to control2021European journal of medicinal chemistry, Aug-05, Volume: 220Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy.
AID292583DPPH radical scavenging activity at 100 uM2007Journal of natural products, Jul, Volume: 70, Issue:7
Kadsuphilols A-H, oxygenated lignans from Kadsura philippinensis.
AID657488Inhibition of desert banana tyrosinase using p-cresol as substrate2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
New saccharin derivatives as tyrosinase inhibitors.
AID1549505Haemolytic activity in human erythrocytes assessed as induction of hemolysis at 10 mM after 30 mins relative to H2022019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID1391583Antioxidant activity assessed as inhibition of superoxide radical generation up to 0.6 mg/ml after 4 mins by pyrogallol autoxidation method relative to control2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Structural analysis and antioxidant activity of the glycoside from Imperial Chrysanthemum.
AID1610136Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID323194Protection against photoirradiation-induced lipid peroxidation damage in rat liver mitochondria at 10 mM2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibitory property of the Piper betel phenolics against photosensitization-induced biological damages.
AID1255364Antioxidant activity assessed as DPPH radical scavenging activity measured as discoloration incubated for 30 mins in dark relative to control2015European journal of medicinal chemistry, Oct-20, Volume: 103Correlation of antioxidant activities with theoretical studies for new hydrazone compounds bearing a 3,4,5-trimethoxy benzyl moiety.
AID378650Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometer2000Journal of natural products, Dec, Volume: 63, Issue:12
A cyclohexanonyl bromophenol from the red alga Symphyocladia latiuscula.
AID1413964Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins
AID1272819Antioxidant activity of the compound assessed as DPPH radical scavenging after 30 mins by spectrophotometric analysis2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
AID1635490Neuroprotective activity against H2O2-induced oxidative damage in human SH-SY5Y cells assessed as increase in cell viability at 10 uM incubated for 2 hrs followed by H2O2 challenge measured after 24 hrs by MTT assay2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
AID762333Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometry2013European journal of medicinal chemistry, Aug, Volume: 66Microwave-assisted synthesis of some new pyrazolopyridines and their antioxidant, antitumor and antimicrobial activities.
AID1405932Antioxidant activity assessed as nitric oxide radical scavenging activity at 100 mM after 150 mins in presence of sodium nitroprusside relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID1234556Antioxidant activity assessed as DPPH radical scavenging activity after 30 min2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1234557Antioxidant activity assessed as superoxide anion radical scavenging activity after 20 mins by xanthine/xanthine oxidase method2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects.
AID1347579Upregulation of COL1A1 mRNA expression in HDF at 100 uM after 48 hrs by RT-PCR analysis2017Journal of natural products, 11-22, Volume: 80, Issue:11
neo-Clerodane Diterpenoids from Salvia polystachya Stimulate the Expression of Extracellular Matrix Components in Human Dermal Fibroblasts.
AID666943Antioxidant activity assessed as morpholinosydnonimine-derived peroxynitrite free radical scavenging activity after 5 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea.
AID1549511Antioxidant activity assessed as DPPH radical scavenging activity incubated in dark for 30 mins by spectrophotometric method relative to ascorbic acid2019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID1347859Growth inhibition of human A375 cells at 25 uM after 48 hrs by SRB assay relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID478241Antioxidant activity in Wistar albino rat assessed as inhibition of catalase activity2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID1193496Thermodynamic equilibrium solubility, log S of the compound in water at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID614064Inhibition of bovine testes hyaluronidase at 2000 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1762290Antioxidant activity assessed as DPPH radical scavenging activity2021Bioorganic & medicinal chemistry letters, 06-15, Volume: 42Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stress.
AID377909Antioxidant activity assessed as DPPH free radical scavenging activity2000Journal of natural products, Oct, Volume: 63, Issue:10
Urinary metabolites of gallic acid in rats and their radical-scavenging effects on 1,1-diphenyl-2-picrylhydrazyl radical.
AID720997Antioxidant activity assessed as ABTS radical scavenging activity after 3 mins by spectrophotometry2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives.
AID764457Antioxidant activity assessed as DPPH free radical scavenging activity under dark condition after 30 mins2013European journal of medicinal chemistry, Aug, Volume: 66Design, synthesis and evaluation of dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substituted pyridine-3,5-dicarboxylates as potential anticonvulsants and their molecular properties prediction.
AID470659Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2009Journal of natural products, Sep, Volume: 72, Issue:9
Cerebrosides of the halotolerant fungus Alternaria raphani isolated from a sea salt field.
AID594791Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
AID640884Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by microplate reader assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Antioxidative oligostilbenes from Caragana sinica.
AID1269943Antioxidant activity assessed as DPPH radical scavenging activity2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG).
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID614065Inhibition of bovine testes hyaluronidase at 150 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID666941Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/ml after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea.
AID1657449Antioxidant activity assessed as DPPH radical scavenging activity measured for 5 mins by UV absorbance analysis2020Bioorganic & medicinal chemistry, 04-15, Volume: 28, Issue:8
Investigations of antiproliferative and antioxidant activity of β-lactam morpholino-1,3,5-triazine hybrids.
AID614055Inhibition of bovine testes hyaluronidase at 180 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID378648Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2000Journal of natural products, Dec, Volume: 63, Issue:12
Activity-guided isolation of antioxidative constituents of Cotinus coggygria.
AID333821Antioxidant activity against LDL-susceptible to oxidation in New Zealand White rabbit plasma assessed as increase in conjugated diene formation at 12.5 ug/mL after 30 mins2004Journal of natural products, Dec, Volume: 67, Issue:12
Bioactive compounds from the seeds of Punica granatum (pomegranate).
AID1610480Inhibition of porcine liver carboxylesterase at 20 uM using 4-NPA as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis relative to control2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
AID615465Antioxidant activity assessed as hydrogen peroxide scavenging activity after 10 mins2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
AID1486133Antioxidant activity assessed as ABTS radical cation scavenging activity by measuring trolox equivalent antioxidant capacity at 20 uM after 1 hr by UV/Vis spectrophotometric analysis2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
AID403395Antioxidant activity in New Zealand White rabbit plasma assessed as increase in conjugated diene formation at 568 uM by thiobarbituric acid method2005Journal of natural products, Aug, Volume: 68, Issue:8
Neuroprotective and antioxidant activity of compounds from the aerial parts of Dioscorea opposita.
AID1453056Antioxidant activity assessed as inhibition of DPPH radical generation at 0.05 mg/ml after 20 mins under dark condition by UV-Visible spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
AID620058Antioxidant activity assessed as hydrogen peroxide scavenging activity at 50 ug/ml relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID591507Antihyperalgesic activity in rat assessed as reversal of oxaliplatin-induced mechanical hyperalgesia at 50 to 100 mg.kg, iv by paw pressure test2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs.
AID445598Antioxidant activity assessed as DPPH radical scavenging activity2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis and antioxidant properties of some novel 5H-dibenz[b,f]azepine derivatives in different in vitro model systems.
AID1462748Antioxidant activity assessed as DPPH free radical scavenging activity by measuring radical-scavenging activity factor (moles of radicals scavenged by each mol of antioxidant) at 20 uM measured at 120 mins by HPLC2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Structural evidence for the DPPH radical-scavenging mechanism of 2-O-α-d-glucopyranosyl-l-ascorbic acid.
AID390102Antioxidant activity by ferric reducing antioxidant power assay2008Journal of natural products, Dec, Volume: 71, Issue:12
S-alkenyl cysteine sulfoxide and its antioxidant properties from Allium cepa var. tropeana (red onion) seeds.
AID652732Antioxidant activity using 1M ethanol as substrate assessed as acetaldehyde level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 4.31 +/- 0.23 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1066679Antioxidant activity assessed as DPPH radical scavenging activity2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Dermacozines H-J isolated from a deep-sea strain of Dermacoccus abyssi from Mariana Trench sediments.
AID1533606Inhibition of human serum BChE using butyrylthiocholine iodide as substrate after 10 mins measured for every mins by Ellman's method2019European journal of medicinal chemistry, Feb-01, Volume: 163Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
AID1428672Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins in presence of silybin by spectrophotometric method2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID590510Antioxidant activity assessed as DPPH free radical scavenging activity after 20 mins by spectrophotometric analysis2011European journal of medicinal chemistry, Apr, Volume: 46, Issue:4
Synthesis, biopharmaceutical characterization, antimicrobial and antioxidant activities of 1-(4'-O-β-D-glucopyranosyloxy-2'-hydroxyphenyl)-3-aryl-propane-1,3-diones.
AID1360870Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ at 5 ug/ml after 25 mins by FRAP assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID183772Effect of AOS scavenger on ventricular fibrillation (VF), arrhythmias induced by ischemia-reperfusion in anesthetized rat, incidence at 3 mg/kg; 6/61988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID355800Antioxidant activity assessed as DPPH free radical scavenging activity by TLC autoradiographic assay2003Journal of natural products, May, Volume: 66, Issue:5
Marine natural products as novel antioxidant prototypes.
AID619977Antioxidant activity assessed as nitric oxide scavenging activity at 75 ug/ml after 150 mins by Griess method relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1487485Antioxidant activity assessed as DPPH free radical scavenging activity at 100 ug/ml after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID1428682Cytotoxicity against human HepG2 cells assessed as reduction in cell viability up to 10 uM after 4 hrs by MTT assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID592726Antioxidant activity assessed as DPPH radical scavenging activity at 64 uM after 10 mins2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID1610479Inhibition of porcine liver carboxylesterase using 4-NPA as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
AID25509Partition ratio obtained from HPLC analysis.1991Journal of medicinal chemistry, Jul, Volume: 34, Issue:7
3-O-alkylascorbic acids as free-radical quenchers: synthesis and inhibitory effect on lipid peroxidation.
AID292584DPPH radical scavenging activity at 50 uM2007Journal of natural products, Jul, Volume: 70, Issue:7
Kadsuphilols A-H, oxygenated lignans from Kadsura philippinensis.
AID722248Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 50 ug/mL2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.
AID502056Antioxidant activity assessed as DPPH radical scavenging activity at 200 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID744464Antioxidant activity of the compound assessed as DPPH free radical scavenging activity at 62.5 uM after 60 mins by spectrophotometric analysis relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.
AID170003Effect of AOS scavenger on premeture ventricular complexes PVCs, arrhythmias induced by ischemia-reperfusion in anesthetized rat, duration at 3 mg/kg1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID1768736Antioxidant activity assessed as hydroxyl radical scavenging activity2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID744463Antioxidant activity of the compound assessed as DPPH free radical scavenging activity at 187.5 uM after 60 mins by spectrophotometric analysis relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.
AID179359Effect of AOS scavenger on ventricular fibrillation (VF), arrhythmias induced by ischemia-reperfusion in anesthetized rat, incidence at 3 mg/kg1988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID416578Stimulation of collagen biosynthesis in primary cultured neonatal HDF at 1 to 1000 uM after 72 hrs by ELISA in presence of fetal bovine serum2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Design and efficient synthesis of novel ascorbyl conjugated peptide with high collagen biosynthesis stimulating effects.
AID1383666Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 25 mins2018European journal of medicinal chemistry, Apr-25, Volume: 150Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
AID642765Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug by spectrophotometer2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID1428681Cytoprotective activity against tert-butyl hydroperoxide-induced toxicity in human HepG2 cells assessed as cell viability at 5 uM pretreated for 1 hr followed by tert-butyl hydroperoxide addition for 3 hrs by MTT assay (Rvb = 16%)2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1193497Thermodynamic equilibrium solubility, log S of the compound PBS at pH 7.4 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1139639Antioxidant activity assessed as DPPH free radical scavenging effect after 30 mins by spectrophotometric analysis2014Journal of medicinal chemistry, May-22, Volume: 57, Issue:10
Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents.
AID1347858Inhibition of tyrosinase in mouse B16 cells assessed as effect on alpha-MSH-induced melanin formation at 25 uM after 24 hrs relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID437944Inhibition of catalase in Wistar rat brain2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID1058429Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
The ameliorating effects of 2,3-dihydroxy-4-methoxyacetophenone on scopolamine-induced memory impairment in mice and its neuroprotective activity.
AID502063Antioxidant activity assessed as ABTS radical scavenging activity2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID652725Cytotoxicity against human RD cells assessed maximun non-toxic concentration2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1076257Antioxidant activity assessed as NO radical scavenging activity after 150 mins by griess reagent method2014European journal of medicinal chemistry, Mar-21, Volume: 75Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines.
AID478245Antioxidant activity in Wistar albino rat assessed as lipid peroxidation level2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID1549509Haemolytic activity in human erythrocytes assessed as induction of hemolysis at 0.625 mM after 30 mins relative to H2022019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID1194981Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader based assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1608424Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins under dark condition2019European journal of medicinal chemistry, Oct-15, Volume: 180Role of sulphur-heterocycles in medicinal chemistry: An update.
AID1234180Antioxidative activity assessed as ABTS cation radical scavenging activity2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Indole Alkaloids from Chaetomium globosum.
AID761967Antioxidant activity assessed as DPPH scavenging activity after 30 mins by UV-visible spectrophotometry2013European journal of medicinal chemistry, Aug, Volume: 66Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetamides as antioxidant and/or anti-inflammatory compounds.
AID615467Antioxidant activity assessed as potassium ferricyanide ion reducing power after 20 mins2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
AID1487137Antioxidant activity assessed as inhibition of ferrous sulfate-induced lipid peroxidation after 30 mins2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
Phenylsulfonylfuroxan NO-donor phenols: Synthesis and multifunctional activities evaluation.
AID478243Antioxidant activity in Wistar albino rat assessed as reduced glutathione activity2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID1389182Antioxidant activity in brain homogenate (unknown origin) assessed as decrease in TBARS formation by UV-visible spectrophotometric method2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
AID1113095Antioxidant activity assessed as DPPH radical scavenging activity at 0.8 mg/ml after 30 min by spectrophotometric analysis2013Journal of agricultural and food chemistry, Mar-27, Volume: 61, Issue:12
Isolation and characterization of new p-Terphenyls with antifungal, antibacterial, and antioxidant activities from halophilic actinomycete Nocardiopsis gilva YIM 90087.
AID1687459Antioxidant activity in human RBC assessed as increase in total antioxidant capacity level up to 400 ug/ml measured after 72 hrs relative to control2020European journal of medicinal chemistry, Jan-15, Volume: 186Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation.
AID502062Antioxidant activity assessed as ABTS radical scavenging activity at 400 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID1575198Antioxidant activity assessed as DPPH free radical scavenging activity at 20 uM2019Bioorganic & medicinal chemistry letters, 02-01, Volume: 29, Issue:3
Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast.
AID1730958Antioxidant activity assessed as DPPH radical scavenging activity at 50 ug/ml (Rvb = 22 to 40.2 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID311562DPPH radical scavenging activity2007Journal of natural products, Oct, Volume: 70, Issue:10
Isoechinulin-type alkaloids, variecolorins A-L, from halotolerant Aspergillus variecolor.
AID652743Antioxidant activity using deaerated 1 M ethylene glycol as substrate assessed as acetaldehyde level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 3.24 +/- 0.19 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID504289Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Chlorinated iridoid glucosides from Veronica longifolia and their antioxidant activity.
AID1347857Inhibition of tyrosinase in human A375 cells assessed as effect on alpha-MSH-induced melanin formation at 25 uM after 24 hrs relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1360875Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ at 100 ug/ml after 25 mins by FRAP assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID1226439Antioxidant activity assessed as DPPH radical scavenging activity after 1 hr2015Journal of medicinal chemistry, May-28, Volume: 58, Issue:10
Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
AID1610481Inhibition of human erythrocyte AChE at 20 uM using acetylthiocholine iodide as substrate preincubated for 10 mins followed by substrate addition by Ellman's method relative to control2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
AID1065886Cytotoxicity against rat primary smooth muscle cells assessed as growth inhibition under normoxic condition at 100 to 200 ug/mL measured over 4 days by WST-1 assay2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions.
AID1614269Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM incubated for 30 mins under dark condition relative to control2019Bioorganic & medicinal chemistry, 02-15, Volume: 27, Issue:4
Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
AID355801Antioxidant activity against TPA-induced ROS production in human HL60 cells by 2',7'-dichlorodihydrofluorescein diacetate cellular-based assay2003Journal of natural products, May, Volume: 66, Issue:5
Marine natural products as novel antioxidant prototypes.
AID487438Antioxidant activity assessed as free radical scavenging activity by lipid peroxidation assay2010European journal of medicinal chemistry, Jun, Volume: 45, Issue:6
Synthesis, anticancer and antioxidant activities of 7-methoxyisoflavanone and 2,3-diarylchromanones.
AID1428669Antioxidant activity against tert-butyl hydroperoxide-induced lipoperoxidation in rat liver microsomal membranes at 100 uM preincubated for 10 mins followed by tert-butyl hydroperoxide addition measured after 60 mins by TBARS assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1065885Growth promoting activity in rat primary smooth muscle cells under normoxic condition at 100 to 200 ug/mL measured over 4 days by WST-1 assay2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions.
AID486890Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Dihydro-beta-agarofuran sesquiterpenes and pentacyclic triterpenoids from the root bark of Osyris lanceolata.
AID1322144Antioxidant activity assessed as DPPH free radical scavenging activity at 3 uM after 30 mins incubation in dark2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Thioflavones as novel neuroprotective agents.
AID754976Inhibition of N-terminal His6-tagged human platelet 12-LOX pseudoperoxidase activity assessed as reduction of active ferric ion to inactive ferrous state measured decomposition of 13-(S)-HPODE at 40 uM after 30 mins by iron-xylenol orange staining assay2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases.
AID1759523Antioxidant activity assessed as reduction in FK506-induced ROS production by DPPH assay2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Identification of gallic acid as a active ingredient of Syzygium aromaticum against tacrolimus-induced damage in renal epithelial LLC-PK1 cells and rat kidney.
AID1882444Antioxidant activity assessed as AAPH radical scavenging activity at 12.5 uM ORAC assay
AID427663Antioxidant activity assessed as potassium ferric cyanide ion reducing power after 10 mins by Oyaizu method2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID1428678Cytoprotective activity against tert-butyl hydroperoxide-induced toxicity in human HepG2 cells assessed as cell viability at 5 uM pretreated for 1 hr followed by co-treatment with tert-butyl hydroperoxide for 3 hrs by MTT assay (Rvb = 22%)2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1743662Antioxidant activity assessed as bleomycin-Fe2+-induced DNA degradation by measuring absorbance at 0.1 mg/ml after 1 hr2020European journal of medicinal chemistry, Dec-15, Volume: 208Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF
AID1555977Selectivity index, ratio of IC50 for electric eel AChE to IC50 for equine serum BuChE2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID1193493Thermodynamic equilibrium solubility, log S of the compound in PBS at pH 7.4 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID539845Antioxidant activity assessed as DPPH radical scavenging activity at 1000 ug by spectrophotometry relative to control2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Synthesis, antimicrobial and antioxidant evaluation of quinolines and bis(indolyl)methanes.
AID652734Antioxidant activity using 1M ethanol as substrate assessed as hydroxy radical additive level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1439750Antioxidant activity assessed as inhibition of nitric oxide radical generation at 1 mM using sodium nitroprusside after 150 mins by Griess assay relative to control2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents.
AID298759Antioxidant activity assessed as DPPH free radical scavenging activity2007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
Synthesis, structural revision, and antioxidant activities of antimutagenic homoisoflavonoids from Hoffmanosseggia intricata.
AID539843Antioxidant activity assessed as DPPH radical scavenging activity at 50 ug by spectrophotometry relative to control2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Synthesis, antimicrobial and antioxidant evaluation of quinolines and bis(indolyl)methanes.
AID1268017Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug/ml after 20 mins by UV-vis spectrophotometry analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
AID719014Antioxidant activity of compound assessed as ferric reducing antioxidant power2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.
AID597947Antioxidant activity assessed as DPPH radical scavenging activity after 10 mins2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
Monoterpenoids from the aerial parts of Aruncus dioicus var. kamtschaticus and their antioxidant and cytotoxic activities.
AID1730965Antioxidant activity assessed as hydrogen peroxide radical scavenging activity at 25 ug/ml (Rvb = 23.6 to 43.1 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID1267471Antioxidant activity assessed as DPPH radical scavenging activity at 0.05 mM after 30 mins2016Bioorganic & medicinal chemistry letters, Jan-01, Volume: 26, Issue:1
Bioactive minor components of the total salvianolic acids injection prepared from Salvia miltiorrhiza Bge.
AID439061Antioxidant activity assessed as inhibition of xanthine/xanthine oxidase system-induced superoxide anion radical scavenging activity after 20 mins2009Bioorganic & medicinal chemistry letters, Nov-01, Volume: 19, Issue:21
Glucose-containing flavones--their synthesis and antioxidant and neuroprotective activities.
AID652738Antioxidant activity using deaerated 1 M ethanol as substrate assessed as acetaldehyde level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 0.18 +/- 0.04 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID536047Antioxidant activity assessed as beta-carotene bleaching activity at 24 uM after 4 hrs by spectrophotometry relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Synthesis and antioxidant properties of pulvinic acids analogues.
AID1511012Antioxidant activity assessed as H2O2 radical scavenging activity2019European journal of medicinal chemistry, Oct-15, Volume: 180Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents.
AID417458Protection against bleomycin-induced damage in calf thymus type 1 DNA assessed as absorbance at 532 nm after 1 hr2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities.
AID625679Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by micro plate reader2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
L-Proline anchored multicomponent synthesis of novel pyrido[2,3-a]carbazoles; investigation of in vitro antimicrobial, antioxidant, cytotoxicity and structure activity relationship studies.
AID379523Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by multilabel counter2006Journal of natural products, Nov, Volume: 69, Issue:11
Terpenoids and a diarylheptanoid from Zingiber ottensii.
AID1428667Antioxidant activity against tert-butyl hydroperoxide-induced lipoperoxidation in rat liver microsomal membranes at 1 mM preincubated for 10 mins followed by tert-butyl hydroperoxide addition measured after 60 mins by TBARS assay relative to control2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1125420Antioxidant activity assessed as total antioxidant capacity by absorbance analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Two sarcoviolins with antioxidative and α-glucosidase inhibitory activity from the edible mushroom Sarcodon leucopus collected in Tibet.
AID1611503Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID652741Antioxidant activity using deaerated 3 M ethylene glycol as substrate assessed as acetaldehyde level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 9.05 +/- 1.03 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1639036Antioxidant activity assessed as increase in total ferric ion reducing activity at 1000 uM using FeCl3.6H2O and TPTZ incubated for 10 mins under dark condition by FRAP assay relative to control2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
AID1313283Antioxidant activity assessed as DPPH radical scavenging activity at 100 ug/ml after 20 mins by spectrophotometry relative to control2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
AID1303222Antioxidant activity assessed as DPPH scavenging activity at 60 ug/ml and 120 degC after 4 hrs by spectrophotometric method2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1198760Antioxidant activity assessed as ROO. radical scavenging activity by TRAP assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
AID753134Antioxidant activity assessed as Fe2+ formation by FRAP assay2013European journal of medicinal chemistry, Jun, Volume: 64Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
AID330319Increase in hepatitis C virus replication in Huh7-K2040 cells in presence of delipidated fetal calf serum medium at 0.3 uM by RT-PCR relative to control2007Proceedings of the National Academy of Sciences of the United States of America, Nov-20, Volume: 104, Issue:47
Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E.
AID1238058Antioxidant activity incubated at 50 degC for 20 mins by FRAP assay2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives.
AID1194984Antioxidant activity assessed as FRAP values at 25 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID722252Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution at 5 ug/mL2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.
AID1810904Binding affinity to human serum BChE assessed as half life
AID549276Cytotoxicity against human HS68 cells up to 100 ug/ml after 72 hrs by MTT assay2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1309173Antioxidant activity assessed as AAPH radical scavenging activity preincubated for 30 mins followed by AAPH addition measured after 60 mins by ORAC assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.
AID1198759Antioxidant activity assessed as ABTS radical scavenging activity by spectrophotometry2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
AID1496216Antioxidant activity assessed as DPPH free radical scavenging activity at 6.25 uM after 30 mins in dark by spectrophotometric method relative to control2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
AID594173Antioxidant activity assessed as ABTS radical scavenging activity at 2 mM2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles.
AID1430036Antioxidant activity assessed as inhibition of DDQ radical by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 03-01, Volume: 27, Issue:5
Synthesis of new chromeno-carbamodithioate derivatives and preliminary evaluation of their antioxidant activity and molecular docking studies.
AID762738Antioxidant activity assessed as reducing power of ferric ion at 100 ug/ml after 20 mins2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID396446Anti-aging activity in human dermal fibroblasts assessed as expression rate of procollagen type 1 formation at 200 uM relative to control2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID1113092Antioxidant activity assessed as ABTS radical scavenging activity at 0.16 mg/ml after 5 min by spectrophotometric analysis2013Journal of agricultural and food chemistry, Mar-27, Volume: 61, Issue:12
Isolation and characterization of new p-Terphenyls with antifungal, antibacterial, and antioxidant activities from halophilic actinomycete Nocardiopsis gilva YIM 90087.
AID1173789Antioxidant activity assessed as DPPH radical scavenging activity after 3 hrs by spectrophotometry2014Bioorganic & medicinal chemistry, Dec-01, Volume: 22, Issue:23
Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones.
AID1496215Antioxidant activity assessed as DPPH free radical scavenging activity at 12.5 uM after 30 mins in dark by spectrophotometric method relative to control2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
AID349360Antioxidant activity assessed as inhibition of ROS-induced linoleic acid peroxidation at 2 mM after 15 mins at 100 degC by modified TBARS assay relative to control2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID389190Antioxidant activity assessed as oxygen radical absorbance capacity index value by fluorescein protection assay2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Antioxidant capacity of human blood plasma and human urine: simultaneous evaluation of the ORAC index and ascorbic acid concentration employing pyrogallol red as probe.
AID637943Antioxidant activity assessed as inhibition of superoxide anion scavenging activity at 1 mg after 60 mins by spectrophotometric analysis2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Design and diversity-oriented synthesis of novel 1,4-thiazepan-3-ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities.
AID761968Antioxidant activity assessed as superoxide radical scavenging activity after 5 mins by spectrophotometry2013European journal of medicinal chemistry, Aug, Volume: 66Novel 2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetamides as antioxidant and/or anti-inflammatory compounds.
AID1610133Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID496823Antimicrobial activity against Trichomonas vaginalis2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID497005Antimicrobial activity against Pneumocystis carinii2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID294913Antioxidant activity assessed as nitric oxide radical scavenging activity at 0.2 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1917388Antioxidant activity in UV-B irradiation induced human HDF cells assessed as decrease in ROS level at 25 uM incubated for 6 hrs by fluorescence microscopy2022Bioorganic & medicinal chemistry letters, 11-15, Volume: 76Photoprotective effect of 18β-glycyrrhetinic acid derivatives against ultra violet (UV)-B-Induced skin aging.
AID1655202Antioxidant activity in pH 7.4 PBS assessed as H2O2 radical scavenging activity2020ACS medicinal chemistry letters, May-14, Volume: 11, Issue:5
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.
AID614057Inhibition of bovine testes hyaluronidase at 170 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID536052Antioxidant activity assessed as DPPH free radical scavenging activity by measuring [DPPH]/antioxidant EC50 ratio measured every 5 mins for 1 hr2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Synthesis and antioxidant properties of pulvinic acids analogues.
AID1557190Antioxidant activity assessed as reduction of Cu2+ in bis-neocuproine-Cu2+ complex to bis-neocuproine-Cu+ complex measured as trolox equivalent antioxidant capacity incubated for 30 mins by CUPRAC assay2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Heterocyclic β-keto sulfide derivatives of carvacrol: Synthesis and copper (II) ion reducing capacity.
AID1065897Growth promoting activity in rat 3T3 cells under anoxic condition at 500 ug/mL measured on day 1 by WST-1 assay2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions.
AID380429Cytotoxicity against human BT549 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID437943Inhibition of superoxide dismutase in Wistar rat brain2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID497112Antioxidant activity assessed as ABTS free radical scavenging activity after 12 hrs2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis and biological evaluation of arylidene analogues of Meldrum's acid as a new class of antimalarial and antioxidant agents.
AID666939Antioxidant activity assessed as DPPH radical scavenging activity at 10 ug/ml after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jul-01, Volume: 22, Issue:13
Evaluation of novel antioxidant triterpenoid saponins from the halophyte Salicornia herbacea.
AID1565353Antioxidant activity assessed as DPPH radical scavenging activity incubated for 20 mins by spectrophotometric method2019European journal of medicinal chemistry, Nov-15, Volume: 182Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
AID496828Antimicrobial activity against Leishmania donovani2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1533609Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 30 mins under dark condition relative to control2019European journal of medicinal chemistry, Feb-01, Volume: 163Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
AID504291Antioxidant activity assessed as nitric oxide scavenging activity after 150 mins by Griess assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Chlorinated iridoid glucosides from Veronica longifolia and their antioxidant activity.
AID1581628Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity incubated for 60 mins by UV-spectrophotometric method2020European journal of medicinal chemistry, Feb-01, Volume: 187Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
AID620059Antioxidant activity assessed as hydrogen peroxide scavenging activity at 75 ug/ml relative to control2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
AID1443229Antioxidant activity assessed as DPPH radical scavenged per mole of compound after 20 mins2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Chemical synthesis, redox transformation, and identification of sonnerphenolic C, an antioxidant in Acer nikoense.
AID1383667Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM after 25 mins2018European journal of medicinal chemistry, Apr-25, Volume: 150Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
AID1405930Antioxidant activity assessed as DPPH radical scavenging activity at 100 mM after 30 mins relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID502054Antioxidant activity assessed as DPPH radical scavenging activity at 50 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID496827Antimicrobial activity against Leishmania amazonensis2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID375991Antioxidant activity assessed as inhibition of 2,2'-azobis(2-amidinopropane)dihydrochloride-induced lipid peroxidation at 3.125 ug/ml by ferric thiocyanate system relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID298758Antioxidant activity assessed as superoxide scavenging activity by NBT reduction assay2007Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5
Synthesis, structural revision, and antioxidant activities of antimutagenic homoisoflavonoids from Hoffmanosseggia intricata.
AID437808Antioxidant activity assessed as hydroxyl free radical scavenging activity at 1 mg assessed per mg2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Green chemoselective synthesis of thiazolo[3,2-a]pyridine derivatives and evaluation of their antioxidant and cytotoxic activities.
AID375988Antioxidant activity assessed as DPPH free radical scavenging activity relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
AID1352200Inhibition of soybean 15-LOX using arachidonic acid or linoleic acid as substrate preincubated with enzyme followed by substrate addition up to 5 mins by chromogenic method2018European journal of medicinal chemistry, Feb-10, Volume: 145Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
AID1565348Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM/ml incubated for 20 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
AID614098Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysisic analysis2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Tylosema esculentum extractives and their bioactivity.
AID1202776Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 10 mins by hydrophilic-TEAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID1233697Antioxidant activity assessed as AAPH radical scavenging activity by measuring Trolox equivalents after 90 mins by fluorescein probe based ORAC assay2015European journal of medicinal chemistry, Jul-15, Volume: 1001,5-Diarylpyrazole and vanillin hybrids: Synthesis, biological activity and DFT studies.
AID1399480Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate incubated for 10 mins followed by substrate addition by Ellman's method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
AID536048Antioxidant activity assessed as beta-carotene bleaching activity at 116 uM after 4 hrs by spectrophotometry relative to contro2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Synthesis and antioxidant properties of pulvinic acids analogues.
AID744462Antioxidant activity of the compound assessed as DPPH free radical scavenging activity at 125 uM after 60 mins by spectrophotometric analysis relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and biological activities of some novel aminomethyl derivatives of 4-substituted-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones.
AID1487484Antioxidant activity assessed as DPPH free radical scavenging activity at 80 ug/ml after 15 mins by spectrophotometric method2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID720996Antioxidant activity assessed as hydroxyl radical scavenging activity after 1 hr by spectrophotometry2013Bioorganic & medicinal chemistry letters, Jan-01, Volume: 23, Issue:1
Synthesis and antioxidant activities of 2-oxo-quinoline-3-carbaldehyde Schiff-base derivatives.
AID764765Antioxidant activity assessed as DPPH radical scavenging activity at 40 uM after 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
AID1549510Antioxidant activity assessed as DPPH radical scavenging activity incubated in dark for 30 mins by spectrophotometric method relative to control2019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID1488290Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins in absence of light2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant and antiproliferative activities of 1,3,4-thiadiazoles derived from phenolic acids.
AID549262Antioxidant activity assessed as DPPH radical scavenging activity at 10 ug/ml after 30 mins2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID616385Antioxidant activity assessed DPPH scavenging activity2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID1368751Inhibition of NOX4 in human ARPE19 cells assessed as suppression of 4-HNE-induced superoxide production at 10 uM pre-incubated for 1 hr before 4-HNE addition for 1 hr by lucigenin chemiluminescence assay2018Bioorganic & medicinal chemistry letters, 01-15, Volume: 28, Issue:2
Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells.
AID511052Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM after 20 mins2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
Synthesis and bioassay of aminosulfonyl-1,3,4-oxadiazoles and their interconversion to 1,3,4-thiadiazoles.
AID1466637Antioxidant activity assessed as inhibition of DPPH free radical at 50 uM after 30 mins relative to control2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
Antioxidant and anticholinesterase potential of diterpenoid alkaloids from Aconitum heterophyllum.
AID497109Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM after 1 hr2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis and biological evaluation of arylidene analogues of Meldrum's acid as a new class of antimalarial and antioxidant agents.
AID157521Inhibition of pancreatic alpha-amylase1998Bioorganic & medicinal chemistry letters, Jul-07, Volume: 8, Issue:13
Ascorbic acid-based inhibitors of alpha-amylases.
AID274158Inhibition of bovine hyaluronidase up to 100 mM at pH 5.02006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
AID1695757Antioxidant activity assessed as DPPH radical scavenging activity at 20 uM after 30 mins under dark condition by DPPH assay relative to control2019Bioorganic & medicinal chemistry, 04-01, Volume: 27, Issue:7
Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
AID1264276Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometric assay2015European journal of medicinal chemistry, Nov-02, Volume: 104Synthesis and pharmacological evaluation of some new fluorine containing hydroxypyrazolines as potential anticancer and antioxidant agents.
AID764766Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 30 mins2013Bioorganic & medicinal chemistry, Sep-01, Volume: 21, Issue:17
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury.
AID1901979Antioxidant activity assessed as free radical scavenging activity incubated for 30 mins under dark condition by DPPH assay2022European journal of medicinal chemistry, Mar-05, Volume: 231Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents.
AID1487487Antioxidant activity assessed as H2O2 free radical scavenging activity at 20 ug/ml after 10 to 15 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID453285Reducing activity assessed as reduction of ferric ion by reducing power assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Synthesis and antioxidant properties of new chromone derivatives.
AID597946Cytotoxicity against human Jurkat T cells after 36 hrs by MTT assay2011Bioorganic & medicinal chemistry letters, Jun-01, Volume: 21, Issue:11
Monoterpenoids from the aerial parts of Aruncus dioicus var. kamtschaticus and their antioxidant and cytotoxic activities.
AID1156819Antioxidant activity assessed as DPPH free radical scavenging activity2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity.
AID1391580Antioxidant activity assessed as DPPH radical scavenging activity up to 0.6 mg/ml after 30 mins by absorbance method relative to control2018Bioorganic & medicinal chemistry letters, 05-15, Volume: 28, Issue:9
Structural analysis and antioxidant activity of the glycoside from Imperial Chrysanthemum.
AID27839Compound was evaluated for its partition between n-octanol and water(pH 7)2002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants.
AID1399484Inhibition of porcine liver carboxylesterase using 4-nitrophenol acetate as substrate incubated for 10 mins followed by substrate addition by spectrophotometric method2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
AID657573Antioxidant activity assessed as DPPH radical scavenging activity by densitometric analysis2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Bioconversion of silybin to phase I and II microbial metabolites with retained antioxidant activity.
AID1599717Antioxidant activity assessed as hydroxyl radical scavenging activity incubated for 1 hr by spectrophotometric analysis2019Bioorganic & medicinal chemistry, 10-15, Volume: 27, Issue:20
Synthesis of N-hydroxycinnamoyl amide derivatives and evaluation of their anti-oxidative and anti-tyrosinase activities.
AID1155576Antioxidant activity assessed as DPPH free radical scavenging activity at 10 uM after 30 mins by UPLC-MS/MS analysis by spectrophotometric analysis2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
AID600559Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Antiprotozoal activity of chloroquinoline based chalcones.
AID386937Antioxidant activity assessed as superoxide radical scavenging activity at 0.40 mg/mL2008European journal of medicinal chemistry, Oct, Volume: 43, Issue:10
The antioxidant activity of 2-(4(or 2)-hydroxyl-5-chloride-1,3-benzene-di-sulfanimide)-chitosan.
AID568567Antioxidant activity assessed as DPPH radical scavenging activity2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Radical scavenging and antioxidant activities of isocoumarins and a phthalide from the endophytic fungus Colletotrichum sp.
AID1264279Antioxidant activity assessed as DPPH free radical scavenging activity at 50 ug/ml after 30 mins by spectrophotometric assay2015European journal of medicinal chemistry, Nov-02, Volume: 104Synthesis and pharmacological evaluation of some new fluorine containing hydroxypyrazolines as potential anticancer and antioxidant agents.
AID644032Antioxidant activity assessed as DPPH free radical scavenging activity at 500 ug by spectrophotometer2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID614059Inhibition of bovine testes hyaluronidase at 400 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID615293Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Synthesis and bio-activity evaluation of tetraphenyl(phenylamino) methylene bisphosphonates as antioxidant agents and as potent inhibitors of osteoclasts in vitro.
AID1453054Antioxidant activity assessed as inhibition of DPPH radical generation at 0.03 mg/ml after 20 mins under dark condition by UV-Visible spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
AID1487488Antioxidant activity assessed as H2O2 free radical scavenging activity at 40 ug/ml after 10 to 15 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID1155649Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 2 uM after 24 hrs by MTT assay relative to control2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties.
AID1486134Antioxidant activity assessed as ABTS radical cation scavenging activity by measuring trolox equivalent antioxidant capacity after 1 hr by UV/Vis spectrophotometric analysis2017Bioorganic & medicinal chemistry, 08-01, Volume: 25, Issue:15
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
AID1377036Antioxidant activity assessed as DPPH radical scavenging activity at test compound/DPPH volume ratio 3:1 incubated under dark condition for 30 mins by spectrophotometric method2017Journal of natural products, 06-23, Volume: 80, Issue:6
Derivatives of the Lignan 7'-Hydroxymatairesinol with Antioxidant Properties and Enhanced Lipophilicity.
AID549266Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 12 to 16 hrs2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1202775Antioxidant activity assessed as trolox equivalent of APPH radical scavenging activity preincubated for 30 mins followed by APPH addition measured after 90 mins by lipophilic-ORAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID183770Effect of AOS scavenger on arrhythmias induced by ischemia-reperfusion in anesthetized rat measured as ventricular tachycardia (VT), incidence at 3 mg/kg; 6/61988Journal of medicinal chemistry, Apr, Volume: 31, Issue:4
Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2-O-alkylascorbic acids.
AID1635493Antioxidant activity assessed as DPPH free radical scavenging activity at 20 uM after 30 secs by spectrophotometry2016Journal of medicinal chemistry, 06-23, Volume: 59, Issue:12
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.
AID387150Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2008Bioorganic & medicinal chemistry letters, Sep-15, Volume: 18, Issue:18
ortho-dihydroxyisoflavone derivatives from aged Doenjang (Korean fermented soypaste) and its radical scavenging activity.
AID195223The compound was tested for the inhibition of lipid peroxidation in rat liver microsomes induced by [Fe3+] at a concentration of 10E-5 M; NT indicates not tested1991Journal of medicinal chemistry, Jul, Volume: 34, Issue:7
3-O-alkylascorbic acids as free-radical quenchers: synthesis and inhibitory effect on lipid peroxidation.
AID637944Antioxidant activity assessed as inhibition of hydroxyl free radical scavenging activity at 1 mg after 60 mins by spectrophotometric analysis2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Design and diversity-oriented synthesis of novel 1,4-thiazepan-3-ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities.
AID1075443Antioxidant activity assessed as inhibition of DPPH free radical scavenging activity2014Journal of medicinal chemistry, Feb-27, Volume: 57, Issue:4
Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule.
AID427665Antioxidant activity assessed as DPPH radical scavenging activity incubated at 40 degC in dark after 30 mins2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.
AID567051Antioxidant activity assessed as inhibition of linoleic acid peroxidation at 0.1 mM by AAPH assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
AID1257011Antioxidant activity assessed as DPPH radical scavenging activity after 25 mins by UV-Visible spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Dec-01, Volume: 25, Issue:23
Chrysin-benzothiazole conjugates as antioxidant and anticancer agents.
AID1454104Inhibition of Agaricus bisporus tyrosinase assessed as reduction in diphenolase activity by measuring L-DOPA oxidation after 30 mins2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Thiosemicarbazones as inhibitors of tyrosinase enzyme.
AID762898Total antioxidant capacity of the compound at 50 uM relative to control2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Phaeolschidins A-E, five hispidin derivatives with antioxidant activity from the fruiting body of Phaeolus schweinitzii collected in the Tibetan Plateau.
AID567789Toxicity in rat erythrocytes assessed as hemolysis at 2 mM2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Cytotoxic and protective DNA damage of three new diterpenoids from the brown alga Dictoyota dichotoma.
AID274168Inhibition of Streptococcus pneumoniae hyaluronidase2006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
AID1246492Antioxidant activity assessed as H2O2 scavenging activity2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis and biological evaluation of new symmetric curcumin derivatives.
AID1877875Antioxidant activity assessed as DPPH radical scavenging activity
AID464440Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents.
AID1250856Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins in dark condition by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
New arylalkanones from Horsfieldia macrobotrys, effective antidiabetic agents concomitantly inhibiting α-glucosidase and free radicals.
AID334586Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2002Journal of natural products, May, Volume: 65, Issue:5
2,3,4-Trimethyl-5,7-dihydroxy-2,3-dihydrobenzofuran, a novel antioxidant, from Penicillium citrinum F5.
AID292586DPPH radical scavenging activity at 12.5 uM2007Journal of natural products, Jul, Volume: 70, Issue:7
Kadsuphilols A-H, oxygenated lignans from Kadsura philippinensis.
AID358943Antioxidant activity assessed as DPPH radical scavenging activity2001Journal of natural products, Dec, Volume: 64, Issue:12
A quinolone alkaloid with antioxidant activity from the aleurone layer of anthocyanin-pigmented rice.
AID1730969Antioxidant activity assessed as DPPH radical scavenging activity at 100 dilution2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID552063Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by ELISA2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Antioxidant, anti-inflammatory and anti-hyperglycaemic activities of heterocyclic homoprostanoid derivatives.
AID1882445Cytoprotective activity against H2O2-induced oxidative injury in rat PC-12 cells assessed as cell viability at 10 uM incubated for 24 hrs (Rvb = 46.91 +/- 3.74%)
AID343716Superoxide-scavenging activity assessed as inhibition of formation of WST1 formazan2008Journal of natural products, Jul, Volume: 71, Issue:7
C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity.
AID1359877Antioxidant activity assessed as ferric ion reducing activity by measuring Fe2+ levels at 10 uM using Fe2+-TPTZ after 15 mins by FRAP assay2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1178160Antioxidant activity of the compound assessed as reduction in absorbance of DPPH after 60 mins incubation by DPPH radical scavenging /microplate assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis, antioxidant and photoprotection activities of hybrid derivatives useful to prevent skin cancer.
AID614062Inhibition of bovine testes hyaluronidase at 63 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614056Inhibition of bovine testes hyaluronidase at 190 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614027Inhibition of Streptococcus agalactiae 4755 hyaluronidase at pH 5.0 after 30 mins by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID416924Antioxidant activity assessed as superoxide anion scavenging activity by NBT reduction method relative to Vitamin C2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Cytotoxic, antioxidant activities and structure activity relationship of some newly synthesized terpenoidal oxaliplatin analogs.
AID1155574Inhibition of 5-LO in human neutrophils using arachidonic acid as substrate preincubated for 15 mins measured after 10 mins by HPLC analysis2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
AID714929Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometry2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues.
AID644033Antioxidant activity assessed as DPPH free radical scavenging activity at 1000 ug by spectrophotometer2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
An efficient synthesis of highly functionalized novel chromeno[4,3-b]pyrroles and indolizino[6,7-b]indoles as potent antimicrobial and antioxidant agents.
AID396457Antioxidant activity assessed as free radical scavenging activity at 10 uM2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID1743177Antioxidant activity assessed as ABTS radical scavenging activity measured after 1 hr by UV-vis spectrophotometric method2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID549277Inhibition of tyrosinase in mouse B16 cells at 10 to 20 ug/ml after 72 hrs by spectrophotometry2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID1875630Antioxidant activity assessed as DPPH radical scavenging activity incubated for 35 mins under dark condition2022Journal of natural products, 11-25, Volume: 85, Issue:11
Cellular Stress-Induced Metabolites in
AID1277568Antioxidant activity assessed as suppression of H2O2/DETAPAC-Fe2+-mediated hydroxyl radical formation by measuring oxidation of dihydrorhodamine after 5 mins by fluorescence assay2016Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4
Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
AID1610487Potency index, ratio of trolox IC50 to test compound IC50 for antioxidant activity assessed as decrease in ABTS radical cation scavenging activity2019Bioorganic & medicinal chemistry letters, 12-01, Volume: 29, Issue:23
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
AID1267474Antioxidant activity assessed as DPPH radical scavenging activity at 0.125 mM after 30 mins2016Bioorganic & medicinal chemistry letters, Jan-01, Volume: 26, Issue:1
Bioactive minor components of the total salvianolic acids injection prepared from Salvia miltiorrhiza Bge.
AID693505Antioxidant activity assessed as inhibition of DPPH free radical production after 30 mins by spectrophotometric analysis2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID1272633Antioxidant activity assessed as DPPH radical scavenging activity by measuring remaining DPPH level at 20 uM after 30 mins by plate reader analysis2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
AID1496214Antioxidant activity assessed as DPPH free radical scavenging activity at 25 uM after 30 mins in dark by spectrophotometric method relative to control2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
AID590867Antioxidant activity assessed as DPPH radical scavenging activity at 10 ug/mL after 30 mins2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Facile synthesis and stereochemical investigation of Mannich base derivatives: evaluation of antioxidant property and antituberculostic potency.
AID1556929Antioxidant activity assessed as DPPH radical scavenging activity at 1 uM measured after 30 mins by spectrophotometric analysis relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
AID426205Antioxidant activity in human HL60 cells assessed as inhibition of relative oxygen species generation by DCFH-DA method2009Journal of natural products, Jun, Volume: 72, Issue:6
Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora.
AID515385Antioxidant activity assessed as peroxyl radical scavenging activity assessed as trolox equivalent by spectrophotometry2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
2,3-diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: a structure-activity relationship study.
AID1178156Antioxidant activity of the compound assessed as reduction in absorbance of DPPH after 60 mins incubation at 1000 uM by DPPH radical scavenging /microplate assay2014Bioorganic & medicinal chemistry, May-01, Volume: 22, Issue:9
Synthesis, antioxidant and photoprotection activities of hybrid derivatives useful to prevent skin cancer.
AID1556930Antioxidant activity assessed as ABTS radical scavenging activity at 1 mg/ml by spectrophotometric analysis relative to control2019European journal of medicinal chemistry, Oct-01, Volume: 179Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
AID652730Antioxidant activity using ethanol as substrate assessed as H2O2 level at 1 mmol/L after gamma-irradiation by spectrophotometry (Rvb = 7.54 +/- 0.27 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1194983Antioxidant activity assessed as FRAP values at 12.5 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1594063Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition
AID1631504Antioxidant activity assessed as superoxide anion radical scavenging activity after 5 mins by spectrophotometric analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Minor Pyranonaphthoquinones from the Apothecia of the Lichen Ophioparma ventosa.
AID637942Antioxidant activity assessed as inhibition of DPPH radical scavenging activity at 1 mg after 30 mins by spectrophotometric analysis2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Design and diversity-oriented synthesis of novel 1,4-thiazepan-3-ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities.
AID437952Antioxidant activity in Wistar rat brain assessed as glutathione content2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID1309172Ratio of resveratrol IC50 to compound IC50 for DPPH free radical scavenging activity2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.
AID1651259Inhibition of electric eel AChE using acetylthiocholine iodide as substrate by Ellman's method2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
AID387801Radical scavenging activity in human HL-60 cells assessed as reduction of hydrogen peroxide-induced ROS generation at 30 uM administered 3 hrs before H2O2 challenge measured after 1 hr by 2',7'-dichlorofluorescein diacetate based flow cytometry2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
2,2'-Pyridoin derivatives protect HL-60 cells against oxidative stress.
AID414769Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader assay2009Bioorganic & medicinal chemistry, Apr-01, Volume: 17, Issue:7
Phenolic compounds with radical scavenging and cyclooxygenase-2 (COX-2) inhibitory activities from Dioscorea opposita.
AID1762408Antioxidant activity assessed as decrease in ABTS radical cation scavenging activity incubated for 24 hrs by UV-Vis spectrophotometric analysis2021European journal of medicinal chemistry, Jun-05, Volume: 218Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
AID1428674Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity at 100 uM measured at >= 5 mins in presence of silybin2017European journal of medicinal chemistry, Feb-15, Volume: 127Novel flavonolignan hybrid antioxidants: From enzymatic preparation to molecular rationalization.
AID1198761Antioxidant activity assessed as superoxide radical scavenging activity after 5 mins by nitrotetrazolium blue chloride assay2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
AID1066680Antioxidant activity of the compound assessed as DPPH free radical scavenging activity after 30 mins2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Polygonumosides A-D, stilbene derivatives from processed roots of Polygonum multiflorum.
AID437807Antioxidant activity assessed as DPPH free radical scavenging activity at 1 mg assessed per mg2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Green chemoselective synthesis of thiazolo[3,2-a]pyridine derivatives and evaluation of their antioxidant and cytotoxic activities.
AID1743180Antioxidant activity in human erythrocytes assessed as protection against AAPH-induced hemolysis at 50 uM preincubated for 20 mins followed by AAPH addition and measured after 2 hrs by spectrophotometric method relative to control2020European journal of medicinal chemistry, Dec-15, Volume: 208Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
AID762900Total antioxidant capacity of the compound at 200 uM relative to control2013Journal of natural products, Aug-23, Volume: 76, Issue:8
Phaeolschidins A-E, five hispidin derivatives with antioxidant activity from the fruiting body of Phaeolus schweinitzii collected in the Tibetan Plateau.
AID1611500Antioxidant activity assessed as DPPH free radical scavenging activity at 400 uM incubated for 60 mins by spectrophotometric method relative to control2019Bioorganic & medicinal chemistry letters, 12-15, Volume: 29, Issue:24
Synthesis and evaluation of 1,3,5-triazine derivatives as sunscreens useful to prevent skin cancer.
AID200332Inhibition of salivary alpha-amylase1998Bioorganic & medicinal chemistry letters, Jul-07, Volume: 8, Issue:13
Ascorbic acid-based inhibitors of alpha-amylases.
AID405700Inhibition of lipid peroxidation in renal failured rat kidney homogenate assessed as inhibition of malondialdehyde level by TBARS assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Antioxidant 2-phenylbenzofurans and a coumestan from Lespedeza virgata.
AID1501904Antioxidant activity assessed as inhibition of ferrous chloride-induced lipid peroxidation in DHA-PA labelled SLPC large unilamellar vesicle measured over 21 mins by fluorescence assay2017Journal of natural products, 09-22, Volume: 80, Issue:9
Lipid Peroxidation and Cyclooxygenase Enzyme Inhibitory Compounds from Prangos haussknechtii.
AID614050Inhibition of bovine testes hyaluronidase at 200 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID496829Antimicrobial activity against Leishmania infantum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1246491Antioxidant activity assessed as DPPH radical scavenging activity2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Synthesis and biological evaluation of new symmetric curcumin derivatives.
AID1244238Antioxidant activity assessed as inhibition of ABTS radical cation generation at 2 mM by colorimetric method relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
AID594793Antioxidant activity in rat liver homogenates assessed as inhibition of lipid peroxidation by measuring formation of thiobarbituric acid-reactive substance after 30 mins2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
AID567788Antioxidant activity in rat brain/kidney homogenates assessed as inhibition of lipid peroxidation at 2 mM by ABTS method2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Cytotoxic and protective DNA damage of three new diterpenoids from the brown alga Dictoyota dichotoma.
AID374241Antioxidant activity assessed as inhibition of ABTS-oxidation in 0.1 M phosphate buffer at pH 72009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines.
AID506735Activity of collagen prolyl 4 hydroxylase-12007Nature chemical biology, Mar, Volume: 3, Issue:3
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
AID1198758Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry2015European journal of medicinal chemistry, Mar-26, Volume: 93Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
AID652735Antioxidant activity using deaerated ethanol as substrate assessed as acetaldehyde level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 1.94 +/- 0.17 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1055052Antioxidant activity assessed as ABTS free radical scavenging activity after 3 mins by spectrophotometry2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Facile preparation of tetrahydro-5H-pyrido[1,2,3-de]-1,4-benzoxazines via reductive cyclization of 2-(8-quinolinyloxy)ethanones and their antioxidant activity.
AID1065899Cytotoxicity against rat 3T3 cells assessed as growth inhibition under normoxic condition at 500 ug/mL after 2 days by WST-1 assay2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions.
AID1506524Antioxidant activity assessed as ABTS radical scavenging activity incubated for 6 mins by spectrophotometry2017MedChemComm, Feb-01, Volume: 8, Issue:2
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
AID496832Antimicrobial activity against Trypanosoma brucei rhodesiense2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID506734Activity of FIH-12007Nature chemical biology, Mar, Volume: 3, Issue:3
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
AID1076258Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Synthesis, docking and evaluation of antioxidant and antimicrobial activities of novel 1,2,4-triazolo[3,4-b][1,3,4]thiadiazol-6-yl)selenopheno[2,3-d]pyrimidines.
AID1202777Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity after 10 mins by lipophilic-TEAC fluorescence assay2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Antioxidative compounds from Garcinia buchananii stem bark.
AID333824Antioxidant activity against lipid peroxidation in Wistar rat brain assessed as inhibition of malondialdehyde release at 12.5 ug/mL by thiobarbituric acid method relative to control2004Journal of natural products, Dec, Volume: 67, Issue:12
Bioactive compounds from the seeds of Punica granatum (pomegranate).
AID294914Antioxidant activity assessed as nitric oxide radical scavenging activity at 0.4 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID693507Antioxidant activity assessed as inhibition of nitric oxide free radical production at 50 ug/mL after 150 mins by Griess method relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID771138Antioxidant activity assessed as DPPH radical scavenging activity at 5 to 500 uM incubated for 20 mins under dark condition by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID294915Antioxidant activity assessed as nitric oxide radical scavenging activity at 0.6 ug/ml after 150 mins2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID1238057Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark conditions2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives.
AID722256Antioxidant activity assessed as DPPH radical scavenging activity in ethanol solution2013Bioorganic & medicinal chemistry letters, Feb-01, Volume: 23, Issue:3
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases.
AID1496212Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM after 30 mins in dark by spectrophotometric method relative to control2018Bioorganic & medicinal chemistry letters, 07-01, Volume: 28, Issue:12
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill.
AID1155571Inhibition of mPGES1-mediated PGE2 production in microsomes of IL-1beta stimulated human A549 cells preincubated for 15 mins by RP-HPLC analysis2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
AID1204379Antioxidant activity assessed as bleomycin-Fe2+-induced DNA degradation after 1 hr by spectrophotometry2015European journal of medicinal chemistry, Jun-05, Volume: 97Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation.
AID1453458Antioxidant activity of the compound in phosphate buffer at pH 6.6 assessed as potassium ferric cyanide ion reducing activity at 2.5 umol/ml after 20 mins by spectrophotometric method relative to control2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect.
AID1194492Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins by UV absorption spectrometry2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1313282Antioxidant activity assessed as DPPH radical scavenging activity at 80 ug/ml after 20 mins by spectrophotometry relative to control2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Synthesis of lignan conjugates via cyclopropanation: Antimicrobial and antioxidant studies.
AID1168137Antioxidant activity assessed as DPPH free radical scavenging activity at 100 uM after 60 mins by spectrophotometry2014European journal of medicinal chemistry, Nov-24, Volume: 87PASS-assisted design, synthesis and antioxidant evaluation of new butylated hydroxytoluene derivatives.
AID1462738Antioxidant activity assessed as DPPH free radical scavenging activity by measuring retention time of AA-2G-DPPH product at 20 uM incubated for 30 mins by HPLC method2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Structural evidence for the DPPH radical-scavenging mechanism of 2-O-α-d-glucopyranosyl-l-ascorbic acid.
AID478247Antioxidant activity in Wistar albino rat assessed as superoxide dismutase level2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Synthesis, spectral characterization and bioassay of 3,3'-(1,4-phenylene)-bis[2-alkoxycarbonyl-alkyl)-2-thio-benzoxa-phosphinines].
AID1233693Antioxidant activity assessed as DPPH radical scavenging activity2015European journal of medicinal chemistry, Jul-15, Volume: 1001,5-Diarylpyrazole and vanillin hybrids: Synthesis, biological activity and DFT studies.
AID1238056Antioxidant activity assessed as DPPH radical scavenging activity at 200 uM incubated for 30 mins under dark conditions2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid and diarylpentanoid derivatives.
AID1462744Antioxidant activity assessed as time duration for DPPH free radical scavenging activity at 20 uM by HPLC2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Structural evidence for the DPPH radical-scavenging mechanism of 2-O-α-d-glucopyranosyl-l-ascorbic acid.
AID738108Antioxidant activity assessed as DPPH radical scavenging activity by by UV-vis spectrophotometry analysis2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Antioxidant and antiproliferative activity of glycosides obtained by biotransformation of xanthohumol.
AID453278Antioxidant activity assessed as singlet oxygen scavenging activity by fluorescent rhodamine formation assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Synthesis and antioxidant properties of new chromone derivatives.
AID1288030Antioxidant activity assessed as H2O2 scavenging activity2016Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7
Biological evaluation and molecular docking studies of new curcuminoid derivatives: Synthesis and characterization.
AID1439749Antioxidant activity assessed as inhibition of DPPH radical generation at 1 mM after 30 mins relative to control2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents.
AID414770Antioxidant activity assessed as superoxide radical scavenging activity after 20 mins by NBT reduction assay2009Bioorganic & medicinal chemistry, Apr-01, Volume: 17, Issue:7
Phenolic compounds with radical scavenging and cyclooxygenase-2 (COX-2) inhibitory activities from Dioscorea opposita.
AID1594573Antioxidant activity assessed as DPPH radical scavenging activity incubated for 15 to 20 mins by UV-visible spectrometry relative to untreated control2019Bioorganic & medicinal chemistry letters, 06-01, Volume: 29, Issue:11
Cu-mediated synthesis of differentially substituted diazepines as AChE inhibitors; validation through molecular docking and Lipinski's filter to develop novel anti-neurodegenerative drugs.
AID274155Inhibition of Streptococcus agalactiae 4755 hyaluronidase at pH 5.02006Bioorganic & medicinal chemistry letters, Oct-15, Volume: 16, Issue:20
Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyases.
AID289320Hydrogen peroxide scavenging activity by assessed as inhibition of lucigenin oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID189511Contralateral rotation produced by intrastriatal injection in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra at 2 microL; turns/5 min1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.
AID1155647Neuroprotective activity against amyloid beta (25 to 35)-induced cell death in human SH-SY5Y cells assessed as cell viability at 0.08 uM after 24 hrs by MTT assay relative to control2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties.
AID1503705Antioxidant activity assessed as H2O2 free radical scavenging activity at IC50 after 1 hr by UV spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Dec-01, Volume: 141Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.
AID1730963Antioxidant activity assessed as nitric oxide radical scavenging activity at 75 ug/ml (Rvb = 25.8 to 41.6 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID638443Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems.
AID767446Antioxidant activity assessed as ABTS free radical scavenging activity after 1 min2013European journal of medicinal chemistry, Sep, Volume: 67Regioselective synthesis of phenanthrenes and evaluation of their anti-oxidant based anti-inflammatory potential.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1333402Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 30 mins2016European journal of medicinal chemistry, Nov-29, Volume: 124Inhibition of the enzymes in the leukotriene and prostaglandin pathways in inflammation by 3-aryl isocoumarins.
AID506732Activity of HIF prolyl hydroxylase-22007Nature chemical biology, Mar, Volume: 3, Issue:3
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
AID693510Antioxidant activity assessed as inhibition of nitric oxide free radical production after 150 mins by Griess method2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID516539Antioxidant activity against superoxide dismutase like activity after 15 mins by NBT spectrometric assay2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Fluorinated 2'-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities.
AID652739Antioxidant activity using deaerated 1 M ethanol as substrate assessed as 2,3-butanediol level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 1.93 +/- 0.15 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1581627Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity incubated for 60 mins by UV-spectrophotometric method relative to control2020European journal of medicinal chemistry, Feb-01, Volume: 187Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
AID1753661Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins under dark condition relative to control2021European journal of medicinal chemistry, Jun-05, Volume: 218New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
AID335901Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2002Journal of natural products, Sep, Volume: 65, Issue:9
Oxidation, reduction, and methylation of carnosic acid by Nocardia.
AID614051Inhibition of bovine testes hyaluronidase at 380 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1453053Antioxidant activity assessed as inhibition of DPPH radical generation at 0.02 mg/ml after 20 mins under dark condition by UV-Visible spectrophotometric analysis relative to control2017European journal of medicinal chemistry, Jul-28, Volume: 135Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.
AID1156024Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ measured per gram of protein by FRAP assay2014European journal of medicinal chemistry, Jul-23, Volume: 82Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
AID762739Antioxidant activity assessed as reducing power of ferric ion at 10 ug/ml after 20 mins2013Bioorganic & medicinal chemistry letters, Aug-15, Volume: 23, Issue:16
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
AID1360872Antioxidant activity assessed as ferric ion reduction by measuring FeSO4 equivalents reducing Fe3+-TPTZ to Fe2+-TPTZ at 20 ug/ml after 25 mins by FRAP assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
AID1418659Antioxidant activity assessed as DPPH-radical scavenging activity at 1 mM incubated for 30 mins under dark condition2018Bioorganic & medicinal chemistry, 11-15, Volume: 26, Issue:21
Design, synthesis and anti-melanogenic effect of cinnamamide derivatives.
AID1610137Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID1255365Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ assessed as fe2+-TPTZ formation after 30 mins by FRAP assay2015European journal of medicinal chemistry, Oct-20, Volume: 103Correlation of antioxidant activities with theoretical studies for new hydrazone compounds bearing a 3,4,5-trimethoxy benzyl moiety.
AID590697Antioxidant activity against nitric oxide scavenging activity at 100 uM after 120 mins by spectrophotometric analysis at pH 7.42011European journal of medicinal chemistry, Apr, Volume: 46, Issue:4
Synthesis and biological activity of 2-(bis((1,3,4-oxadiazolyl/1,3,4-thiadiazolyl)methylthio)methylene)malononitriles.
AID607163Antioxidant activity against DPPH free radical assessed as compound able to consume half the initial amount of DPPH free radical after 30 to 60 mins by spectrophotometry2011Bioorganic & medicinal chemistry letters, Jul-15, Volume: 21, Issue:14
Exploration of antimicrobial and antioxidant potential of newly synthesized 2,3-disubstituted quinazoline-4(3H)-ones.
AID1712224Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 10 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1549508Haemolytic activity in human erythrocytes assessed as induction of hemolysis at 1.25 mM after 30 mins relative to H2022019European journal of medicinal chemistry, May-01, Volume: 169Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
AID1366171Antioxidant activity assessed as DPPH free radical scavenging activity at 5 ug/ml after 30 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry, 11-01, Volume: 25, Issue:21
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
AID387800Radical scavenging activity in human HL-60 cells assessed as reduction of hydrogen peroxide-induced ROS generation at 30 uM after 1 hr by 2',7'-dichlorofluorescein diacetate based flow cytometry2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
2,2'-Pyridoin derivatives protect HL-60 cells against oxidative stress.
AID294919Inhibition of nitric oxide radical scavenging activity2007European journal of medicinal chemistry, Aug, Volume: 42, Issue:8
Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents.
AID1466638Antioxidant activity assessed as inhibition of DPPH free radical at 75 uM after 30 mins relative to control2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
Antioxidant and anticholinesterase potential of diterpenoid alkaloids from Aconitum heterophyllum.
AID274759Antioxidant activity assessed by DPPH radical scavenging assay2007Journal of natural products, Jan, Volume: 70, Issue:1
Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile.
AID486891Antioxidant activity assessed as DPPH radical scavenging activity after 2 hrs2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Dihydro-beta-agarofuran sesquiterpenes and pentacyclic triterpenoids from the root bark of Osyris lanceolata.
AID1555976Inhibition of equine serum BuChE using S-butyrylthiocholine iodide as substrate preincubated with enzyme for 30 mins followed by substrate addition and measured after 30 mins by Ellman's method2019European journal of medicinal chemistry, Sep-01, Volume: 177Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
AID36972Percent inhibition of Alpha-amylase activity was determined at 5 mM2000Bioorganic & medicinal chemistry letters, Jul-17, Volume: 10, Issue:14
Kinetic characterisation of ene-diol-based inhibitors of alpha-amylase.
AID1610135Antiproliferative activity against human HCT116cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019European journal of medicinal chemistry, Dec-15, Volume: 184Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
AID670406Antioxidant activity assessed as superoxide radical scavenging activity2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone, 5-carboethoxymethyl-4',7-dihydroxyflavone and their analogues.
AID1182518Radioprotective activity against gamma-irradiated human MOLT4 cells preincubated for 1 hr at <50 uM before gamma-irradiation measured after 18 hrs by erythrosine B dye-exclusion test2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
AID502060Antioxidant activity assessed as ABTS radical scavenging activity at 100 ug/ml2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
AID1434781Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Anti-HSV-1, antioxidant and antifouling phenolic compounds from the deep-sea-derived fungus Aspergillus versicolor SCSIO 41502.
AID1065896Growth promoting activity in rat 3T3 cells assessed as change in cell growth under anoxic condition at 100 ug/ml measured over 4 days by WST-1 assay2013Journal of medicinal chemistry, Dec-27, Volume: 56, Issue:24
Controlled oxygen release from pyridone endoperoxides promotes cell survival under anoxic conditions.
AID549261Antioxidant activity assessed as DPPH radical scavenging activity at 5 ug/ml after 30 mins2010Journal of natural products, Nov-29, Volume: 73, Issue:11
Inhibition of melanogenesis and oxidation by protocatechuic acid from Origanum vulgare (oregano).
AID351091Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometry2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage.
AID693515Antioxidant activity assessed as inhibition of H2O2 radical scavenging activity by spectrophotometric analysis2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID1462747Antioxidant activity assessed as DPPH free radical scavenging activity by measuring radical-scavenging activity factor (moles of radicals scavenged by each mol of antioxidant) at 20 uM measured at 30 mins by HPLC2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Structural evidence for the DPPH radical-scavenging mechanism of 2-O-α-d-glucopyranosyl-l-ascorbic acid.
AID1655201Antioxidant activity assessed as ABTS radical scavenging activity incubated for 40 mins2020ACS medicinal chemistry letters, May-14, Volume: 11, Issue:5
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.
AID652737Antioxidant activity using deaerated ethanol as substrate assessed as hydroxy radical additive level at 1 mmol/L after gamma-irradiation2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1055053Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometry2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Facile preparation of tetrahydro-5H-pyrido[1,2,3-de]-1,4-benzoxazines via reductive cyclization of 2-(8-quinolinyloxy)ethanones and their antioxidant activity.
AID1730964Antioxidant activity assessed as nitric oxide radical scavenging activity at 100 ug/ml (Rvb = 25.8 to 41.6 %)2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
AID631128Antioxidant activity assessed as trolox equivalent by TEAC assay2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents.
AID652729Antioxidant activity using ethanol as substrate assessed as acetaldehyde level at 1 mmol/L after gamma-irradiation by gas chromatography (Rvb = 7.06 +/- 0.28 10'7 mol/J)2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Radical-regulating and antiviral properties of ascorbic acid and its derivatives.
AID1466639Antioxidant activity assessed as inhibition of DPPH free radical at 100 uM after 30 mins relative to control2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
Antioxidant and anticholinesterase potential of diterpenoid alkaloids from Aconitum heterophyllum.
AID1810883Antioxidant activity of compound assessed as trolox equivalent of AAPH radical scavenging activity preincubated for 15 mins followed by AAPH addition and measured every 2 mins for 90 mins by ORAC fluorescein assay
AID1194985Antioxidant activity assessed as FRAP values at 50 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1487489Antioxidant activity assessed as H2O2 free radical scavenging activity at 60 ug/ml after 10 to 15 mins by spectrophotometric analysis2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID437941Antioxidant activity in Wistar rat brain assessed as inhibition of lipid peroxidation2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
AID380424Cytotoxicity against human HL60 cells by XTT assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1763932Antioxidant activity assessed as DPPH free radical scavenging activity in iron free medium2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Green synthesis of therapeutically active 1,3,4-oxadiazoles as antioxidants, selective COX-2 inhibitors and their in silico studies.
AID693509Antioxidant activity assessed as inhibition of nitric oxide free radical production at 100 ug/mL after 150 mins by Griess method relative to control2012European journal of medicinal chemistry, Dec, Volume: 58Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2009The FEBS journal, Jun, Volume: 276, Issue:12
Polysaccharide binding sites in hyaluronate lyase--crystal structures of native phage-encoded hyaluronate lyase and its complexes with ascorbic acid and lactose.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (41,924)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015548 (37.09)18.7374
1990's5608 (13.38)18.2507
2000's8696 (20.74)29.6817
2010's8915 (21.26)24.3611
2020's3157 (7.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2,497 (5.52%)5.53%
Reviews2,694 (5.95%)6.00%
Case Studies804 (1.78%)4.05%
Observational50 (0.11%)0.25%
Other39,216 (86.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (344)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Evaluation of Vitamin C and Injectable-platelet Rich Fibrin in the Management of Thin Gingival Phenotype: A Split-mouth Randomized Clinical Trial.[NCT05841303]Phase 413 participants (Anticipated)Interventional2023-07-01Not yet recruiting
A Phase 1, Single-Dose Study to Evaluate the Pharmacokinetics of Intravenous Ascorbic Acid in Healthy Male and Female Volunteers[NCT02534753]Phase 18 participants (Actual)Interventional2015-09-30Completed
Local Vasoconstriction in Postural Tachycardia Syndrome[NCT01210430]Early Phase 174 participants (Actual)Interventional2010-07-31Completed
Phase II Double-blind Randomized Placebo-controlled 1-way Crossover Trial to Investigate Safety and Efficacy of the Ascorbic Acid and Tocopherol for the Treatment of the Fragile X Syndrome[NCT01329770]Phase 230 participants (Actual)Interventional2010-12-31Completed
The Effect of Antioxidant Vitamin Supplementation on Muscle Performance and Redox Status After Eccentric Training[NCT01290458]28 participants (Actual)Interventional2009-06-30Completed
The Effect of a Mixture of Micellized Curcumin/Boswellia Serrata/Ascorbic Acid on Health-related Quality of Life in Patients With Post-acute COVID-19 Syndrome.[NCT05150782]32 participants (Anticipated)Interventional2022-01-17Not yet recruiting
Clinical Outcomes of Intravenous Vitamin C Synergy With Tyrosine Kinase Inhibitor in Lung Adenocarcinoma Patients With Epidermal Growth Factor Receptor Mutations[NCT03799094]Phase 1/Phase 2150 participants (Anticipated)Interventional2018-12-05Recruiting
Differences by Sex and Genotype in the Effects of Stress on Executive Functions[NCT04273880]Phase 1146 participants (Anticipated)Interventional2018-04-28Recruiting
Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin C[NCT05843617]10 participants (Actual)Interventional2022-02-28Completed
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outco[NCT03456843]Phase 2190 participants (Anticipated)Interventional2018-03-14Recruiting
Optimization of the Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure[NCT05726097]Phase 3147 participants (Anticipated)Interventional2023-02-01Recruiting
Influence Of Endothelial Function On Central and Peripheral Causes Of Exercise Impairment In Type 2 Diabetes[NCT00786019]47 participants (Actual)Interventional2008-05-31Completed
Tenofovir Disoproxil Fumarat 300 mg - Phyllanthus Urinaria 300mg - Adenosma Glutinosum 150mg - Eclipta Prostrata 150mg, Ascorbic Acid 500 mg Daily is Effective in the Long-term Treatment of Chronic and Acute Hepatitis B.[NCT01198860]0 participants Expanded AccessApproved for marketing
Administration of Intravenous Vitamin C in Novel Coronavirus Infection and Decreased Oxygenation (AVoCaDO): A Phase I/II Safety, Tolerability, and Efficacy Clinical Trial[NCT04357782]Phase 1/Phase 220 participants (Actual)Interventional2020-04-16Completed
The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients: A Double Blind, Placebo-controlled Randomized Clinical Trial[NCT03938584]45 participants (Actual)Interventional2017-10-12Completed
Vitamin C Supplementation Intervention for Patients With Heart Failure-A Pilot Study[NCT04036110]36 participants (Actual)Interventional2018-08-14Completed
Pilot Study for Determining the Impact of Ascorbic Acid Treatment on the Development and Treatment of Vasodilation in Cardiac Surgery[NCT03744702]Early Phase 115 participants (Actual)Interventional2019-06-28Completed
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors; a Phase 3 Pragmatic Randomized Trial.[NCT05974774]Phase 31,600 participants (Anticipated)Interventional2023-12-15Not yet recruiting
Efficacy of Vitamin C, Vitamin E and Their Combination for Treatment of Restless Legs Syndrome in Hemodialysis Patients: a Randomized Double-blind, Placebo-controlled Trial[NCT01125033]Phase 2/Phase 360 participants (Actual)Interventional2008-03-31Completed
Evaluation of the Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicity[NCT03921099]Phase 440 participants (Anticipated)Interventional2019-01-17Recruiting
Prospective Placebo-Controlled Double-Blinded Trial for High-Dose Vitamin C Administration During the Acute Resuscitative Phase of Severe Thermal Injuries[NCT01587261]Phase 20 participants (Actual)Interventional2017-06-30Withdrawn(stopped due to This potential study was held up at the level of the FDA as they wouldn't approve and IND for the dose of vitamin C we wanted to use.)
A Randomized, Double-blind, Placebo-controlled Dose-ranging Study of OPK-88004 Once-a-day Dosing for 16 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia[NCT03297398]Phase 2114 participants (Actual)Interventional2018-02-21Terminated(stopped due to study terminated by sponsor decision)
Docetaxel Plus 6-month Androgen Suppression and Radiation Therapy Versus 6-month Androgen Suppression and Radiation Therapy for Patients With High Risk Localized or Locally Advanced Prostate Cancer: A Randomized Controlled Trial[NCT00116142]Phase 3350 participants (Actual)Interventional2005-06-30Completed
The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture, Prospective Double Blind Study[NCT01338129]100 participants (Anticipated)Interventional2011-04-30Not yet recruiting
Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation: Histological and Clinical Randomized Study[NCT03252418]Phase 410 participants (Actual)Interventional2015-10-07Completed
Pharmacokinetics of Two Different High-dose Regimens of Intravenous Vitamin C in Critically Ill Patients[NCT02455180]Phase 420 participants (Actual)Interventional2015-03-31Completed
Effects of Long-term Vitamin C+E and Statin Therapy on Vasospasm Improvement and Regression of Atheroma in Patients With Variant Angina[NCT03228238]Phase 4300 participants (Anticipated)Interventional2014-09-01Recruiting
The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients[NCT03224572]Phase 1/Phase 240 participants (Anticipated)Interventional2018-01-31Not yet recruiting
Comparison of Efficiency and Tolerance of Sodium Picosulphate/ Magnesium Citrate, Polyethylene Glycol/Ascorbate and Oral Sulfate Solution Before Colonoscopy[NCT03698474]Phase 4612 participants (Actual)Interventional2018-10-25Completed
Balloon Angioplasty of Dialysis AV Fistulae: Effect of Local Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis[NCT03106948]Phase 230 participants (Anticipated)Interventional2017-02-01Recruiting
Vitamins B1 and C to Improve Outcomes in Patients With Severe Sepsis[NCT03592277]Phase 2120 participants (Actual)Interventional2018-09-14Completed
Evaluating Vitamin C in Septic Shock: A Randomized Double Blind Placebo Controlled Trial[NCT03338569]Phase 2/Phase 3125 participants (Actual)Interventional2017-12-20Completed
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer: A Double Blind, Placebo Controlled, Phase II Randomized Controlled Trial[NCT05849129]Phase 290 participants (Anticipated)Interventional2024-02-01Not yet recruiting
The Impact of Intravenous Vitamin C Combined With Nerve Blocks on Postoperative Pain and Recovery After Total Knee Arthroplasty.[NCT05514197]69 participants (Actual)Interventional2022-06-01Completed
Translation of in Vitro and in Vivo Ascorbate Research Into a New Treatment Option for Pancreatic Cancer: Phase I/IIa Clinical Trial[NCT01364805]Phase 114 participants (Actual)Interventional2011-04-30Completed
Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis.[NCT03422159]Phase 2140 participants (Actual)Interventional2018-02-05Completed
Ascorbic Ccid, Hydrocortisone, and Thiamine in Sepsis and Septic Shock - A Randomized, Double-Blind, Placebo-Controlled Trial[NCT03389555]Phase 2/Phase 3205 participants (Actual)Interventional2018-02-09Completed
Randomized, Phase II Trial of Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-Immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC)[NCT03334409]Phase 25 participants (Actual)Interventional2018-02-16Terminated(stopped due to Due to loss of funding from the private foundation source)
The Effect Of Hyaluronic Acid And Melatonin With Systemic Administration of Vitamin C On Implant Stability After Immediate Implant Placement in Anterior and Premolar Region in Systemically Healthy Patients[NCT03804177]Phase 424 participants (Anticipated)Interventional2019-02-10Not yet recruiting
Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries: a Study Protocol for a Randomized Controlled Trial[NCT03800667]Early Phase 10 participants (Actual)Interventional2018-08-08Withdrawn(stopped due to No funds)
The Role of a Single Oral Dose (2g) of Vitamin C in Reducing Intensity of Pain and Opioids Consumption in Patients Undergoing Laparoscopic Cholecystectomy. A Randomized, Double-blinded, Placebo-controlled Study[NCT01322061]Phase 480 participants (Actual)Interventional2010-11-30Completed
A Randomized Clinical Trial of Antioxidants to Prevent Preeclampsia and An Observational Cohort Study to Predict Preeclampsia[NCT00135707]Phase 310,154 participants (Actual)Interventional2003-06-30Completed
A 4-month, Randomized, Placebo-controlled, Double-blind Intervention of Antioxidant Supplementation in Overweight Children Enrolled in an Outpatient Weight-loss Program: Effects on Oxidative and Inflammatory Markers, Hepcidin, Iron Status, and Components [NCT01316081]45 participants (Actual)Interventional2011-03-31Completed
Effect of Oral Vitamin C on The Inflammatory Biomarkers in Hemodialysis[NCT01356433]Phase 4128 participants (Actual)Interventional2011-08-31Completed
Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have No Prior Therapy for Their Metastatic Pancreatic Cancer[NCT03697239]Phase 1/Phase 20 participants (Actual)Interventional2019-06-30Withdrawn(stopped due to FDA indicated the same study could not be conducted under multiple INDs)
Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.[NCT03913468]206 participants (Actual)Observational2019-01-01Completed
Obesity, Inflammation and Oxidative Stress[NCT01028976]Phase 3512 participants (Actual)Interventional2010-01-31Completed
The Effect of Prebiotics on Iron Absorption in Women With Low Iron Stores: Determination of a Dose-dependent Effect of Galacto-oligosaccharides on Iron Absorption, With and Without Addition of Ascorbic Acid[NCT03762148]46 participants (Actual)Interventional2019-04-01Completed
Combination Therapy of Vitamin C and Thiamine for Septic Shock: Multi-center, Double-blinded, Randomized, Controlled Study[NCT03756220]Phase 2116 participants (Actual)Interventional2018-12-01Completed
Chronotherapeutic Use of Vitamin C to Reduce Morning Cardiovascular Risk[NCT03290612]10 participants (Actual)Interventional2018-02-13Completed
A Multi-center, Randomized, Placebo-controlled, Double-blind, Adaptive Clinical Trial of Vitamin C, Thiamine and Steroids as Combination Therapy in Patients With Sepsis.[NCT03509350]Phase 3501 participants (Actual)Interventional2018-08-22Completed
The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial (VITAMINS Trial) - A Prospective, Feasibility, Pilot, Multi-centre, Randomised, Open-label Controlled Trial[NCT03333278]Phase 2216 participants (Actual)Interventional2018-05-02Completed
A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma (MM) Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib[NCT02206425]Phase 1/Phase 245 participants (Actual)Interventional2014-09-30Completed
Treatment of Non-Anemic Iron Deficiency in Pregnancy: a Double-Blind Randomized Control Trial[NCT05423249]150 participants (Anticipated)Interventional2022-08-12Recruiting
Efficacy of Hydroxychloroquine for Post-exposure Prophylaxis (PEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Adults Exposed to Coronavirus Disease (COVID-19): a Blinded, Randomized Study[NCT04328961]Phase 2/Phase 3943 participants (Actual)Interventional2020-03-31Completed
Prospective Double Blind Study of the Effect of Intravenous High Dose Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer[NCT02521077]Phase 20 participants (Actual)Interventional2017-05-31Withdrawn(stopped due to Manufacturer unwilling to provide information needed for IND application.)
"Influence of High Vitamin C Dose on Lactate During Extracorporeal Circulation for Heart Surgery and During the 24 Hours Thereafter. (Double Blind Prospective Randomised Study)"[NCT04046861]200 participants (Anticipated)Interventional2023-02-01Not yet recruiting
Targeting TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia (AML) With Azacitidine and Ascorbic Acid[NCT03397173]Phase 212 participants (Actual)Interventional2018-03-16Completed
Randomized Clinical Trial to Evaluate the Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid in Patients With Past Poor Colonic Preparation[NCT02073552]Phase 4472 participants (Actual)Interventional2014-05-31Completed
Comparative and Additive Effects of Fish Oil and Ascorbic Acid Supplementation on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma[NCT01057615]Phase 114 participants (Actual)Interventional2010-03-31Completed
The Efficacy of Perioperative Parenteral Ascorbic Acid in Reducing Oxidative Stress Among Patients Undergoing Free Flap Reconstructive Surgery: A Prospective Multicenter Randomized Controlled Pilot Trial[NCT05327348]Phase 334 participants (Anticipated)Interventional2022-09-25Recruiting
Effect of Ascorbic Acid Administration on Restenosis of Dysfunctional Hemodialysis Vascular[NCT03524846]Phase 293 participants (Actual)Interventional2011-04-30Completed
Phase 1b/2 Neoadjuvant High Dose Ascorbate With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas of Extremity, Trunk and Retroperitoneum[NCT03508726]Phase 1/Phase 225 participants (Actual)Interventional2019-06-27Active, not recruiting
Oxaloacetate Supplementation for Emotional PMS; Measuring Improvements in Depression, Anxiety, Perceived Stress, and Aggression[NCT03509714]48 participants (Actual)Interventional2016-10-17Completed
Effects of Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients With Iron Overload[NCT02225886]Phase 4100 participants (Anticipated)Interventional2020-02-01Recruiting
The Effect of Liposome Vitamin C on the Absorption[NCT04886752]11 participants (Actual)Interventional2019-06-10Completed
Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)[NCT06150417]Phase 2200 participants (Anticipated)Interventional2024-04-01Not yet recruiting
Vitamins C and Vitamin E and Hypertrophy Adaptations to Resistance Traini[NCT04828642]30 participants (Actual)Interventional2021-02-01Completed
Study of Safty and Efficacy of Adjuvant Vitamin c in Augmenting Iron Chelation[NCT02083575]Phase 2/Phase 350 participants (Anticipated)Interventional2014-04-30Not yet recruiting
Clinical Study of an Ascorbic Acid Derivative Dentifrice in Patients With Gingivitis[NCT02102295]Phase 3300 participants (Actual)Interventional2006-09-30Completed
A Multicentre Concealed-Allocation Parallel-Group Blinded Randomized Controlled Trial to Ascertain the Effect of High-Dose Intravenous Vitamin C Compared to Placebo on Mortality or Persistent Organ Dysfunction at 28 Days in Septic Intensive Care Unit Pati[NCT04404387]Phase 3800 participants (Anticipated)Interventional2022-07-22Recruiting
A Study Evaluating the Therapeutic Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy[NCT05537272]Phase 4120 participants (Anticipated)Interventional2022-09-01Enrolling by invitation
Effect of Ascorbic Acid Administration on Intraoperative Blood Loss and Wound Healing in Total Abdominal Hysterectomy[NCT03965637]Phase 380 participants (Actual)Interventional2019-08-23Completed
Effect of Ascorbic Acid Oral Supplementation in Assessing the Severity of Oral Mucositis in Chemo-radiation Therapy of Head and Neck Cancers.[NCT02868151]Phase 2/Phase 3180 participants (Actual)Interventional2016-08-31Completed
Effect of Vitamin C Infusion on Coronary Reperfusion Indexes[NCT01090895]Phase 480 participants (Anticipated)Interventional2010-03-31Recruiting
A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)[NCT02905578]Phase 265 participants (Anticipated)Interventional2018-11-28Active, not recruiting
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I[NCT01852890]Phase 116 participants (Actual)Interventional2014-01-31Active, not recruiting
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme[NCT01752491]Phase 113 participants (Actual)Interventional2013-04-01Active, not recruiting
Pre-Surgical Androgen Deprivation Therapy With or Without Axitinib in Previously Untreated Prostate Cancer Patients With Known or Suspected Lymph Node Metastasis[NCT01409200]Phase 273 participants (Actual)Interventional2012-03-26Active, not recruiting
Early High-dose Vitamin C in Post-cardiac Arrest Syndrome[NCT03509662]Phase 2270 participants (Anticipated)Interventional2019-10-07Recruiting
Vitamin C 4 Care Homes: a Pilot and Feasibility Study to Assess Daily Vitamin C Requirement of Care Home Residents[NCT05122481]20 participants (Anticipated)Interventional2023-01-15Not yet recruiting
An Open-Label Pilot Study of the Safety, Tolerability and Anti-Viral Activity of High Dose Intravenous Ascorbic Acid in Patients Chronically Infected With Hepatitis C Virus Genotype 1, Who Have Failed Prior Therapy With Interferon-alpha and Ribavirin[NCT01250743]10 participants (Anticipated)Interventional2009-01-31Terminated
Initiation of Vitamin C, Thiamine and Hydrocortisone Therapy for Septic Shock in Adults: A Randomized Clinical Trial[NCT03872011]Phase 3408 participants (Actual)Interventional2019-02-19Completed
Phase 2 Study of High Dose Ascorbic Acid in Solid Tumor Disease[NCT01125449]Phase 230 participants (Anticipated)Interventional2011-01-31Suspended(stopped due to Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche (Ireland).)
Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Had No Prior Therapy for Their Metastatic Pancreatic Cancer[NCT03797443]Phase 1/Phase 20 participants (Actual)Interventional2019-01-01Withdrawn(stopped due to Regulatory Review needed)
Evaluation of the Impact of Rutin and Vitamin C Combination on Oxidative Stress, Insulin Sensitivity and Lipid Profile in Type 2 Diabetic Patients[NCT03437902]Phase 2/Phase 353 participants (Actual)Interventional2018-02-24Completed
Effect of Perioperative Application of Ascorbic Acid on Postoperative Pulmonary Complications in Patients Undergoing Cardiac Surgery[NCT03756727]Early Phase 1110 participants (Anticipated)Interventional2018-12-01Not yet recruiting
Lessening Organ Dysfunction With VITamin C (LOVIT)[NCT03680274]Phase 3872 participants (Actual)Interventional2018-11-08Completed
Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have No Prior Therapy for Their Metastatic Pancreatic Cancer[NCT03908333]Phase 1/Phase 20 participants (Actual)Interventional2019-05-01Withdrawn(stopped due to Request to close per funding sponsor. Site not moving forward with trial.)
A Head-to-head Comparison of Efficiency and Tolerance of 4-L Polyethylene Glycol and Sodium Picosulphate/ Magnesium Citrate, Polyethylene Glycol/Ascorbate Before Colonoscopy[NCT02956057]Phase 41,044 participants (Actual)Interventional2016-11-12Completed
Intensive High-volume Bowel Cleansing Regimen Versus Low-volume Bowel Regimen in Patients With a High Risk of Poor Colonic Cleansing Following a Validated Predictive Score[NCT03830489]Phase 4260 participants (Actual)Interventional2019-02-04Completed
Randomised, Phase III Multicenter, Open Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients Presenting Elevated Chromogranin A Levels[NCT01313273]Phase 33 participants (Actual)Interventional2011-06-30Terminated(stopped due to Poor enrolment)
The Effect of Subconjunctival Vitamin c on Recovery Rate and End Result From Eye Burn.[NCT00734695]Phase 120 participants (Anticipated)Interventional2009-07-31Withdrawn(stopped due to couldn't recruit patients)
Randomized Phase III Trial Comparing Cabazitaxel Combination Hormone Therapy to Hormone Therapy Alone in Metastatic Prostate Cancer or High Risk Disease[NCT01978873]Phase 3400 participants (Anticipated)Interventional2012-11-30Recruiting
A First-in-Human Clinical Trial of Pharmacologic Ascorbate and Ferumoxytol Combined With Concomitant Temozolomide and External Beam Radiation Therapy for Newly Diagnosed Glioblastoma[NCT04900792]Phase 112 participants (Anticipated)Interventional2023-02-28Active, not recruiting
Phase II, Double-blind, Randomized, 1-way Cross-over, to Investigate the Effectiveness of the Combination of Ascorbic Acid (Vitamin C) and Tocopherol (Vitamin E) Versus Placebo for the Treatment of Depressive Disorders in Elderly[NCT02793648]Phase 250 participants (Actual)Interventional2014-10-31Completed
Effect of Ascorbic Acid as a Final Flush on Post-operative Pain After Single Visit Root Canal Treatment for Patients With Symptomatic Irreversible Pulpits Related to Mandibular Molars: Randomized Controlled Trial.[NCT05478044]30 participants (Anticipated)Interventional2022-08-31Not yet recruiting
Sideral Forte in Prosthetic Hip and Knee Surgery[NCT04078880]82 participants (Actual)Interventional2018-12-04Completed
HIGH-dose Intravenous VItamin C in Patients With Septic Shock: HIGH-VIS Trial[NCT04796636]Phase 130 participants (Anticipated)Interventional2021-09-27Recruiting
A Phase I Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection[NCT04482686]Phase 131 participants (Actual)Interventional2020-12-09Active, not recruiting
Advanced ChemoHormonal Therapy for Treatment Naïve Metastatic Prostate Cancer: Apalutamide and Abiraterone Acetate With Prednisone and Androgen Deprivation Therapy After Treatment With Docetaxel and Androgen Deprivation Therapy[NCT04267887]Phase 27 participants (Actual)Interventional2020-05-11Active, not recruiting
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders[NCT03602235]Phase 19 participants (Anticipated)Interventional2019-03-05Recruiting
Clinical Pilot Study on Antioxidant Uptake and Downstream Effects[NCT04463030]24 participants (Anticipated)Interventional2020-07-01Recruiting
Evaluation of the Effect of Local Injected Vitamin C on Accelerating the Orthodontic Movement of Maxillary Canine Impaction: A Clinical Trial[NCT03260829]12 participants (Actual)Interventional2014-01-31Completed
Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0 at Duke University to Improve FEV1[NCT03226431]Phase 16 participants (Actual)Interventional2017-12-11Completed
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy: a Randomised, Comparative, Open-label Trial[NCT03188445]Phase 4201 participants (Actual)Interventional2017-07-11Completed
Comparative Study on Effects of Sublingual Misoprostol in Addition to Standard Active Management of Third Stage of Labour in Low Risk Parturients in Lagos State University Teaching Hospital, Ikeja.[NCT02424201]Early Phase 1660 participants (Anticipated)Interventional2015-06-30Not yet recruiting
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer[NCT05501548]Phase 215 participants (Anticipated)Interventional2023-06-30Recruiting
Phase I/II Randomized Study to Evaluate the Role of Intravenous Ascorbic Acid Supplementation to Conventional Neoadjuvant Chemotherapy in Women With Breast Cancer[NCT03175341]Phase 1/Phase 230 participants (Anticipated)Interventional2018-10-01Not yet recruiting
Effectiveness of Doses of Vitamin c and Zinc in Patients With High Enterocutaneous Fistulas Receiving Nutrition Parenteral Therapy on Closure and Recurrence. Randomized Clinical Trial.[NCT06009744]76 participants (Anticipated)Interventional2023-08-31Recruiting
Evaluation of the Effect of Citicoline (Cebrolux 800 mg) and Docosahexaenoic Acid (DHA) Compound (BrudyPio 1.5 g) on the Visual Function of Patients With Glaucoma With a Pilot Study[NCT05527106]73 participants (Actual)Interventional2015-03-12Completed
The Effect of Acetylcysteine and Ascorbic Acid on the Prevention of Radiographic-contrast-agent Induced Reduction in Renal Function in ICU Patients.[NCT01017796]Early Phase 1100 participants (Anticipated)Interventional2009-01-31Active, not recruiting
Effect of Colon Delivered Vitamin C on Gut Microbiota and Related Health Biomarkers in Healthy Older Adults[NCT05598619]264 participants (Anticipated)Interventional2022-07-01Recruiting
Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)[NCT04938024]135 participants (Actual)Interventional2021-03-28Completed
A Phase 2 Randomized Open-label 2-Treatment 2-Sequence 2-Period Crossover PK Study to Compare Plasma Concentrations of BH4 in Subjects With Endothelial Dysfunction Following 14 Days of Treatment by 2 Regimens: 6R-BH4 With Vitamin C and 6R-BH4 Alone[NCT00532844]Phase 252 participants (Actual)Interventional2007-09-30Completed
Phase I/II Study of the Combination of Bortezomib With Arsenic Trioxide, Ascorbic Acid and High-Dose Melphalan for Patients With Multiple Myeloma[NCT00469209]Phase 1/Phase 260 participants (Actual)Interventional2006-06-30Completed
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia[NCT02735707]Phase 310,000 participants (Anticipated)Interventional2016-04-11Recruiting
Microneedling With Vitamin C Versus Injectable Vitamin C for Depigmentation in Physiological Gingival Melanin Hyperpigmentation: A Randomized Controlled Clinical Trial[NCT05786885]22 participants (Anticipated)Interventional2023-04-30Not yet recruiting
Randomized Controlled Trial on the Effect of Vitamin C Supplementation in Autologous Stem Cell Transplantations[NCT03964688]Phase 247 participants (Actual)Interventional2019-12-10Completed
Randomized, Double -Blind, Placebo Controlled, Trial to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU[NCT04558424]50 participants (Anticipated)Interventional2020-10-01Not yet recruiting
[NCT00000555]Phase 30 participants Interventional1996-08-31Completed
Efficacy of High Dose Vitamin C Parenteral Supplement on Amelioration of Fatigue in Company Workers After Work: A Double-Blind, Randomized Controlled Trial[NCT00633581]Phase 2/Phase 3150 participants (Actual)Interventional2008-03-31Completed
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation, Inpatient Phase I Study to Determine the Safety and Immunogenicity of a Single Oral Dose of a Combined Live, Attenuated, Enterotoxigenic Escherichia Coli (ETEC)-Cholera Vaccine (Peru-15 pCTB)[NCT00654108]Phase 162 participants (Actual)Interventional2008-06-02Completed
The Effect of Hydrocortisone-Ascorbic Acid and Thiamine Therapy on the Outcome of Patients With Sepsis: A Prospective Randomized Double-Blinded Controlled Trial[NCT04160676]80 participants (Actual)Interventional2019-12-01Completed
A Pilot Phase II Study of Decitabine, Arsenic Trioxide and Ascorbic Acid for Patients With Myelodysplastic Syndrome[NCT00621023]Phase 27 participants (Actual)Interventional2007-11-30Completed
Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis[NCT03829683]Phase 220 participants (Actual)Interventional2019-04-16Completed
A Phase I Study of Bevacizumab and Intravenous Ascorbic Acid for Patients With Recurrent High Grade Glioma[NCT02833701]Phase 19 participants (Actual)Interventional2016-03-31Terminated
Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Study Protocol for a Randomized Double Blinded Controlled Trial.[NCT04261036]Early Phase 10 participants (Actual)Interventional2019-07-20Withdrawn(stopped due to Unfortunately, the economic crisis in Lebanon precluded utilization of available funding to recruit patients at the specified institution. No patients were recruited.)
A Phase II Study of High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies[NCT03146962]Phase 261 participants (Actual)Interventional2017-03-29Completed
Pharmacokinetic Evaluation of Intravenous Ascorbic Acid[NCT01833351]Phase 134 participants (Actual)Interventional2011-05-31Completed
A Phase II Trial of Hypofractionated Radiation Therapy for Prostate Cancer With High Risk Features After Radical Prostatectomy[NCT03570827]Phase 252 participants (Actual)Interventional2018-05-08Active, not recruiting
Phase I - II Clinical Trial of Combination Conventional Cytotoxic Chemotherapy and Intravenous Vitamin C in Patients With Advanced Cancer or Hematologic Malignancy for Whom Cytotoxic Chemotherapy Alone is Only Marginally Effective[NCT01050621]Phase 1/Phase 214 participants (Actual)Interventional2010-01-31Completed
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance[NCT04715022]Phase 1/Phase 223 participants (Anticipated)Interventional2021-06-17Recruiting
'A Prospective Randomized Trial to Assess the Impact of Ascorbic Acid on Outcomes and Complications Post Cardiac Surgeries''[NCT03639519]Phase 4100 participants (Anticipated)Interventional2018-04-15Recruiting
Comparison Of The Effects Of Preoperative Melatonin Or Vitamin C Administration On Postoperative Analgesia[NCT02639741]Phase 455 participants (Actual)Interventional2014-11-30Completed
A Double-blind, Randomized, Controlled Study to Compare the Effects of Syrup With EpiCor and Vitamin C to Syrup With Vitamin C Alone on the Common Cold or Influenza in Generally Healthy Children[NCT04093206]221 participants (Actual)Interventional2017-12-22Completed
VItamin C in Thermal injuRY: The VICToRY Trial A Phase III Multi-center Randomized Trial[NCT04138394]Phase 3666 participants (Anticipated)Interventional2020-07-24Recruiting
Intravenous Vitamin C for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation From Deceased Donors[NCT05754242]Phase 270 participants (Anticipated)Interventional2020-11-17Recruiting
Effect of Ferrous Ascorbate Versus Liposomal Iron on Hemoglobin Concentration and Iron Indices in 6 to 59 Months Age Children With Nutritional Iron-Deficiency Anemia: A Double-blinded Single Centre Randomized Clinical Trial[NCT05957328]Phase 396 participants (Anticipated)Interventional2023-08-31Not yet recruiting
Evaluating Low-cost Automatic Water Disinfection Systems to Improve Water Quality and Child Health in Urban Bangladesh[NCT02606981]1,549 participants (Actual)Interventional2015-07-31Completed
Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes[NCT00803530]Phase 255 participants (Anticipated)Interventional2005-09-30Terminated(stopped due to difficulties of enrollement)
The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder: A Pilot Study[NCT00704990]Phase 2/Phase 328 participants (Actual)Interventional2008-09-30Completed
Clinical Trial to Assess the Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Elderly Patients With Spontaneous Hip Fracture[NCT04183075]82 participants (Anticipated)Interventional2020-09-30Not yet recruiting
Phase I-II Study of Vitamin C Infusion in Combination With Local mEHT on Non Small Cell Lung Cancer Patients[NCT02655913]Phase 1/Phase 297 participants (Actual)Interventional2015-12-31Completed
In-Utero Smoke, Vitamin C, and Newborn Lung Function[NCT00632476]282 participants (Actual)Interventional2007-03-31Completed
THE EFFECT OF VITAMIN C ON POST-ORTHODONTIC TREATMENT RELAPSE: A RANDOMIZED CONTROLLED CLINICAL TRIAL[NCT06146296]Phase 2/Phase 336 participants (Anticipated)Interventional2023-11-01Recruiting
Barrow 5-ALA Intraoperative Confocal Evaluation Trial[NCT01502280]Phase 3127 participants (Actual)Interventional2010-11-30Completed
Ascorbic Acid Treatment for Patients With Combined Mineralocorticoid and Glucocorticoid Deficiency Secondary to Nicotinamide Nucleotide Transhydrogenase Mutation[NCT02838472]3 participants (Anticipated)Interventional2016-06-30Enrolling by invitation
Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism Requiring High Levothyroxine Dosage; a Randomized Control Trial[NCT05733078]Phase 240 participants (Anticipated)Interventional2023-04-30Not yet recruiting
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application[NCT02758990]16 participants (Actual)Interventional2016-03-31Terminated(stopped due to Recruiting and financial constraints)
"Effect of Ascorbic Acid and Grape Seed Extract Vitis Vinifera L. in Oxidative Stress Induced by on Pump Coronary Artery by Pass Grafting Surgery"[NCT00839085]72 participants (Actual)Interventional2008-11-30Active, not recruiting
Effect of Age and Fitness on Vascular Function and Oxidative Stress During Acute Inflammation[NCT03889158]Phase 435 participants (Actual)Interventional2019-03-25Terminated(stopped due to COVID-19)
Effects of Vitamin C, Thiamine and Hydrocortisone in Septic Shock: a Randomized, Controlled Trial[NCT04039815]Phase 480 participants (Anticipated)Interventional2019-12-03Enrolling by invitation
A Double Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Koreans[NCT00903357]54 participants (Actual)Interventional2009-08-31Completed
Effect of Low Doses of Vitamin C on Salivary Cortisol , Heart Rate , Blood Pressure During Group Presentation[NCT04135378]Phase 490 participants (Actual)Interventional2018-11-01Completed
ACADEMIC: A Randomized Phase II Clinical Trial of ADT Combined With Abiraterone or Docetaxel in Metastatic Hormone Sensitive Prostate Cancer[NCT03827473]Phase 21 participants (Actual)Interventional2019-02-08Terminated(stopped due to The trial was closed because the changing standard of care landscape, making this trial not impactful anymore.)
Assessment of the Effect of Vitamin C on Anemia in Patients With Continuous Ambulatory Peritoneal Dialysi[NCT02780505]Phase 466 participants (Actual)Interventional2011-11-30Completed
Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial[NCT02745873]Phase 2/Phase 3144 participants (Actual)Interventional2012-05-31Completed
Parenteral Ascorbic Acid Repletion in TransplantatIon (PARTI): A Randomized, Double-Blinded, Placebo-Controlled Trial[NCT04756063]Phase 490 participants (Anticipated)Interventional2024-01-31Not yet recruiting
Phase I/II Trial of Arsenic Trioxide (As2O3) With Ascorbic Acid in the Treatment of Relapsed/Refractory Multiple Myeloma[NCT00006021]Phase 1/Phase 222 participants (Actual)Interventional2000-06-30Completed
A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of Tanreqing Capsule Efficacy and Safety in the Treatment of COVID-19 (Mild and Common Type)[NCT05305456]Phase 3480 participants (Actual)Interventional2022-03-28Completed
The Impact of Ascorbic Acid Therapy on Inflammatory Mediators in Cardiothoracic Surgery Patients: The Atrial Fibrillation Suppression Trial IV (AFIST IV) Pilot Study[NCT00519337]Phase 425 participants (Actual)Interventional2008-10-31Completed
The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients[NCT04035096]Phase 1/Phase 240 participants (Anticipated)Interventional2020-01-01Not yet recruiting
Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children: A Randomized Clinical Trial[NCT00822380]680 participants (Actual)Interventional2003-03-31Completed
A Phase I Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer[NCT01049880]Phase 115 participants (Actual)Interventional2009-12-31Completed
Phase II Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-APL Acute Myelogenous Leukemia[NCT00184054]Phase 211 participants (Actual)Interventional2002-04-30Terminated(stopped due to Competing studies)
Evaluation of Cytotoxicity and Genetic Changes of High Dose Vitamin C Infusions in Castration Resistant Metastatic Human Prostate Cancer[NCT01080352]Phase 231 participants (Actual)Interventional2010-11-30Completed
A Randomized, Double-blind, Crossover Study Comparing the Tolerance of Two Forms of Vitamin C in Acid Sensitive Adults[NCT01873820]50 participants (Actual)Interventional2008-03-31Completed
Evaluation of the Effect of Body Weight and Composition on Iron Absorption and Blood Volume[NCT01884506]64 participants (Actual)Interventional2013-06-30Completed
Ph 2 Trial of G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan & Oxaliplatin), Followed by G-FLIP-DM (G-FLIP + Low Doses Docetaxel & MitomycinC), When Used in Combination With Vitamin C, in Patients With Advanced Pancreatic Cancer[NCT01905150]Phase 234 participants (Actual)Interventional2014-07-31Completed
Mechanisms of Impaired Brain Blood Flow With Aging[NCT03775382]34 participants (Actual)Interventional2017-10-30Completed
A Phase II Study of Arsenic Trioxide in Combination With Thalidomide, Dexamethasone, and Ascorbic Acid[NCT00227682]Phase 22 participants (Actual)Interventional2004-06-30Terminated(stopped due to Terminated early due to funding suspension by grant sponsor.)
Percutaneous Pin Removal in the Outpatient Clinic - do Children Require Analgesia? A Randomized Controlled Trial[NCT01944085]240 participants (Actual)Interventional2008-10-31Completed
Effects of Nutritional Iron Absorption Enhancers and Inhibitors and Daytime on Absorption From Oral Iron Supplements[NCT05414474]35 participants (Anticipated)Interventional2022-06-30Not yet recruiting
a New Spark in Treating Oligorecurrent Prostate Cancer: Adding Systemic Treatment to Stereotactic Body Radiotherapy or Metastasectomy: Key to Long-lasting Event-free Survival?[NCT05352178]Phase 3873 participants (Anticipated)Interventional2022-04-20Recruiting
Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability: Stable Iron Isotope Studies in Young Women (Study 2, Xylotrupes Gideon)[NCT05328141]11 participants (Anticipated)Interventional2022-05-20Enrolling by invitation
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic[NCT04668469]600 participants (Actual)Interventional2020-06-08Completed
A Randomised, Multi-Centre, Single-Blinded, Pivotal Phase III Trial to Assess the Efficacy, Acceptability and Safety of a New 2 Litre Gut Cleansing Solution NRL994 Versus a Standard Colon Preparation With 4L PEG+E.[NCT00389233]Phase 3360 participants (Actual)Interventional2002-06-30Completed
Ascorbic Acid Combined With Ibuprofen in Hypoxic Ischemic Encephalopathy: A Randomized Controlled Trial.[NCT00624871]60 participants (Actual)Interventional2004-04-30Completed
Phase I/II Study of Arsenic Trioxide (Trisenox), Ascorbic Acid and Bortezomib Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma[NCT00590603]Phase 125 participants (Actual)Interventional2008-07-31Terminated(stopped due to Poor accrual - terminated during Phase I; Phase II never started.)
Reducing Frailty for Older Cancer Survivors Using Supplements (ReFOCUS): A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer[NCT04553666]Phase 214 participants (Actual)Interventional2021-03-15Completed
Evaluation of Combination Zinc and Green Tea Extract Supplementation on Reduction in Symptom Duration and Severity Associated With Community Respiratory Viral Infections: a Randomized Control Trial (ZiPhenol Study)[NCT04898023]Phase 216 participants (Actual)Interventional2022-09-21Terminated(stopped due to Loss of funding)
A Randomized Controlled Trial Comparing the Efficacy and Acceptability of Sodium Picosulphate/Magnesium Citrate With Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy.[NCT01603654]Phase 4300 participants (Actual)Interventional2011-01-31Completed
A Multicentre, Randomized, Laboratory-blinded, Parallel-group Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.[NCT01160198]Phase 3271 participants (Actual)Interventional2010-10-13Completed
Lifestyle Intervention and Antioxidants in Children With Nonalcoholic Fatty Liver Disease: A Randomized, Controlled Trial[NCT00655018]Phase 2/Phase 390 participants (Actual)Interventional2003-01-31Completed
Effects of Supplemental Immunonutrition on Healing of Chronic Non-Healing Lower Extremity Ulcers in Diabetic Patients: A Pilot Study[NCT05281562]Phase 2/Phase 31 participants (Actual)Interventional2022-07-01Terminated(stopped due to There are not enough patients at our institution meeting eligibility criteria to complete the study as intended.)
"Open-label, Randomized Comparator Study for Evaluation the Bioavailability of Novo C Plus Vitamin C Containing Dietary Supplement in Healthy Subjects"[NCT02606773]Phase 132 participants (Actual)Interventional2015-06-30Completed
Efficacy and Safety of High-dose Vitamin C Combined With Traditional Chinese Medicine in the Treatment of Moderate and Severe Coronavirus Pneumonia (COVID-19)[NCT04664010]30 participants (Actual)Interventional2020-02-06Completed
Manipulation of L-Ascorbic Acid Level For The Treatment of Selected Cases Of Acute Myeloid Leukemia and Myelodysplastic Syndromes[NCT00329498]Phase 225 participants Interventional1998-05-31Suspended
[NCT01426490]Phase 2/Phase 3300 participants (Anticipated)Interventional2011-08-31Recruiting
Phase II Study of Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients With Relapsed or Refractory Multiple Myeloma[NCT00085345]Phase 20 participants (Actual)InterventionalWithdrawn
Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients[NCT02602483]Phase 1/Phase 296 participants (Actual)Interventional2015-12-31Completed
Chronic Study of the Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function in Patients With Coronary Artery Disease[NCT00554242]40 participants (Anticipated)Interventional2007-07-31Completed
A Randomized, Double-blind, Placebo-controlled Crossover Study Comparing the Bioavailability of Two Forms of Vitamin C in Plasma and Leukocytes Over 24 Hours.[NCT01852903]40 participants (Actual)Interventional2011-05-31Completed
2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation: A Randomized, Non-Inferiority Open Trial[NCT01865916]Phase 4309 participants (Actual)Interventional2013-04-30Completed
Phase Ⅲ Study of IV Ascorbic Acid in Combination With XELOX vs Treatment With XELOX Alone as First-line Therapy for Advanced Gastric Cancer[NCT03015675]Phase 3200 participants (Anticipated)Interventional2017-03-12Recruiting
Pilot Study of the Safety and Efficacy of Intravenous Vitamin C in Patients Undergoing Atrial Fibrillation Ablation[NCT03148236]Phase 220 participants (Actual)Interventional2017-09-18Completed
Prevention of Complex Regional Pain Syndrome Using Liposomal Encapsulated Vitamin C in Programmed Knee Surgery; A Prospective Randomized Trial[NCT04204200]66 participants (Actual)Interventional2014-01-06Completed
Efficacy of Vitamin C Administration for the Prevention of Postpolypectomy Bleeding[NCT03400020]156 participants (Actual)Interventional2018-01-28Completed
The Relationship of Hemoglobin A1c and Diabetic Wound Healing[NCT01350102]Phase 42 participants (Actual)Interventional2012-02-29Terminated(stopped due to study closed due to recruitment problems)
Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF[NCT02690064]13 participants (Actual)Interventional2015-04-30Active, not recruiting
A Phase I Study of Oral Arsenic Trioxide With or Without Ascorbic Acid in Adults With Myelofibrosis[NCT01014546]Phase 15 participants (Actual)Interventional2010-04-30Terminated(stopped due to low accrual)
Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter.[NCT01270152]Phase 221 participants (Actual)Interventional2008-10-31Completed
A Prospective Randomised Single-Blinded Multicentric and Pivotal Phase III Study Comparing the Efficacy, Safety and Acceptability of a New 2 Litres Gut Lavage Solution NRL994 Versus a Sodium Phosphate Solution for Colonoscopy Preparation[NCT00322062]Phase 3340 participants (Actual)Interventional2002-04-30Completed
Antioxidant Effects on the Outcome of Ovarian Cancer[NCT00228319]Phase 1/Phase 227 participants (Actual)Interventional2002-10-31Completed
Pilot Study to Assess Effect of High Dose Ascorbic Acid (Vitamin C) on Inflammation Reduction in Cardiac Surgery Patients.[NCT02762331]Phase 16 participants (Actual)Interventional2017-01-01Terminated(stopped due to Therapy shown effective by larger studies)
The SU.VI.MAX Study. A Randomized, Placebo-controlled Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.[NCT00272428]Phase 313,000 participants Interventional1994-10-31Completed
A Randomised, Single-Centre, Parallel-Group, Pilot Study to Assess the Efficacy, Safety and Patient Acceptability of a New 2-Litre Bowel Preparation Agent (MOVIPREP®) Compared With a Standard Bowel Preparation Agent (PICOLAX®)[NCT00312481]Phase 265 participants (Actual)Interventional2005-07-31Completed
Steroid, Thiamine and Ascorbic Acid During Post-Resuscitation Period for Comatose Out-of-hospital Cardiac Arrest Survivors (STAR) Trial: Multi-center, Randomized, Single-blinded, Controlled Pilot Study[NCT04921189]Phase 2160 participants (Anticipated)Interventional2021-12-31Recruiting
Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury[NCT04153487]Phase 240 participants (Actual)Interventional2019-11-30Completed
The Effect of High Dose Versus Low Dose Intravenous Vitamin C (Ascorbic Acid)on Burn Injury Resuscitation[NCT00350077]0 participants (Actual)Interventional2006-07-31Withdrawn(stopped due to Inadequate resources to submit for approval)
Topical Tranexamic Acid Versus Topical Vitamin C With Microneedling in Periorbital Hyperpigmentation; Comparative Study[NCT04697992]60 participants (Actual)Interventional2019-11-01Completed
"A Randomized, Placebo-controlled, Double Masked 120 Subject Futility Design Clinical Trial of Ascorbic Acid Treatment of Charcot Marie Tooth Disease Type 1A."[NCT00484510]Phase 2/Phase 3110 participants (Actual)Interventional2007-04-30Completed
Combining Active and Passive DNA Hypomethylation: A Randomized, Placebo-Controlled Phase II Study of the Efficacy and Safety of Oral Vitamin C in Combination With Azacitidine in Patients With Higher-Risk MDS, CMML-2 or Low-Blast Count AML[NCT03999723]Phase 2196 participants (Anticipated)Interventional2019-09-11Recruiting
Epigenetics, Vitamin C, and Abnormal Hematopoiesis - Role of Vitamin C in Epigenetic Regulation in Hematopoiesis Sub-Study on CCUS, Low-Risk MDS, and CMML-0/1[NCT03682029]109 participants (Actual)Interventional2017-11-21Active, not recruiting
Vitamin C Intravenously With Chemotherapy in Peritoneal Metastatic Colorectal Cancer With High Expresison Level of GLUT3[NCT04516681]Phase 3400 participants (Anticipated)Interventional2020-09-01Recruiting
Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study[NCT04342728]214 participants (Actual)Interventional2020-04-08Completed
Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes[NCT00845130]42 participants (Actual)Interventional2009-09-30Completed
A Phase 2 Trial of Pharmacological Ascorbate With Concurrent Chemotherapy and Radiation Therapy for Non-small Cell Lung Cancer[NCT02905591]Phase 246 participants (Anticipated)Interventional2018-11-16Recruiting
Vitamins C and E Combined With Cryotherapy on the Pain, Oxidative Stress and Inflammatory Response After Resistance Exercise Session in Untrained Volunteers[NCT02902315]26 participants (Actual)Interventional2017-01-04Completed
Effect of Ascorbic Acid on the Incidence of Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery[NCT01580683]Phase 30 participants (Actual)Interventional2012-07-31Withdrawn(stopped due to No funding obtained to support patient recruitment)
A Phase I Study of High-Dose IV Vitamin C Treatment in Patients With Solid Tumors[NCT00441207]Phase 118 participants (Actual)Interventional2006-08-31Completed
The Effect of Vitamin C on Growth Hormone Secretion[NCT01537094]Phase 20 participants (Actual)Interventional2013-12-31Withdrawn(stopped due to Unable to obtain funding to initiate the study. No subjects were enrolled.)
Phase II Study of Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Patients With Previously Untreated High-Risk or Relapsed or Refractory Multiple Myeloma[NCT00112879]Phase 20 participants (Actual)InterventionalWithdrawn
A Pilot Study of the Efficacy of a Combination of Antioxidants and B Vitamins in Preventing the Recurrence of Hyperlactatemia in Subjects Who Have Limited Antiretroviral Options[NCT00037063]0 participants (Actual)InterventionalWithdrawn
Lessening Organ Dysfunction With VITamin C - COVID[NCT04401150]Phase 3392 participants (Actual)Interventional2020-08-14Completed
The Efficacy of Intravenous Ascorbic Acid in Patients With Severe Sepsis[NCT02734147]Phase 224 participants (Actual)Interventional2016-04-01Terminated(stopped due to The trial prematurely terminated due to the loss of funding.)
Prospective Study of the Effect of Androgen Deprivation Therapy (ADT) in Male Patients Suffered Prostate Cancer in Asian Population[NCT03703778]600 participants (Anticipated)Observational2016-05-22Recruiting
A Randomized Phase III Study Comparing Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by High Dose 3-D Conformal Boost Versus Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by 125-Iodine Brachytherapy Implant Boos[NCT00175396]Phase 3400 participants (Anticipated)Interventional2004-05-31Active, not recruiting
Physiological Effects of Gestational Diabetes on the Placenta and Neonatal Outcome; Role of Antioxidant Administration[NCT02355197]Phase 4200 participants (Actual)Interventional2013-01-31Completed
A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer[NCT06068543]Phase 2118 participants (Anticipated)Interventional2024-01-01Not yet recruiting
A Phase I Study of Metronomic Temozolomide and Intravenous Ascorbic Acid for Patients With Recurrent High Grade Glioma[NCT02168270]Phase 14 participants (Actual)Interventional2014-06-16Terminated
Risk-stratified Frontline Oral Arsenic Trioxide-based Induction in Newly Diagnosed Acute Promyelocytic Leukaemia[NCT03624270]Phase 260 participants (Anticipated)Interventional2018-08-15Recruiting
High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients, A Retrospective Cohort Study[NCT04710329]78 participants (Actual)Observational2021-01-16Completed
Evaluation of the Safety and Efficacy of Standard Dose Gemcitabine Combined With High Dose Intravenous Vitamin C (HDIVC) Treatment for Patients With Metastatic Adenocarcinoma of the Pancreas.[NCT01654861]Phase 13 participants (Actual)Interventional2012-06-30Terminated(stopped due to recruiting or enrolling participants has halted prematurely and will not resume)
Safety of Oral Antioxidants and Intravenous Vitamin C During GYN Cancer Care[NCT00284427]Phase 225 participants (Actual)Interventional2005-09-30Completed
A Phase I Study of Arsenic Trioxide and Ascorbic Acid (ATO/AA) in Combination With Low Dose Velcade-Thalidomide-Dexamethasone (VTD) in Relapsed/Refractory Multiple Myeloma (MM)[NCT00258245]Phase 15 participants (Actual)Interventional2005-05-31Completed
Phase 2 Study of Ascorbic Acid Treatment in Charcot-Marie-Tooth Type 1A[NCT00271635]Phase 213 participants (Actual)Interventional2006-01-31Completed
Prophylactic Administration of Vitamin C in Wrist Fractures; a Randomized Placebo Controlled Multicentre Dose-Finding Study of the Incidence of Complex Regional Pain Syndrome[NCT00296868]Phase 4300 participants Interventional2001-01-31Completed
A Phase II Trial of Combination Therapy With Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients With Chronic Idiopathic Myelofibrosis or Overlap Myelodysplastic/Myeloproliferative Disorders[NCT00274820]Phase 215 participants (Actual)Interventional2005-10-31Completed
A Phase II Trial of Bortezomib + Ascorbic Acid + Melphalan (BAM) Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma[NCT00317811]Phase 235 participants (Anticipated)Interventional2005-11-30Completed
Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity[NCT01501968]Phase 354 participants (Anticipated)Interventional2012-01-31Not yet recruiting
Vitamin C: Assessing Safety After Lung Transplant[NCT04505878]Phase 20 participants (Actual)Interventional2023-04-30Withdrawn(stopped due to Decided not to proceed with study)
EFFICACY, TOLERABILITY, AND SAFETY OF DIFFERENT BOWEL PREPARATIONS FOR COLONOSCOPY IN CHILDREN[NCT01711437]Phase 4400 participants (Anticipated)Interventional2011-01-31Recruiting
Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy[NCT01715597]Phase 350 participants (Actual)Interventional2012-12-31Completed
Randomized Controlled Trial of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy[NCT01740518]360 participants (Anticipated)Observational2012-03-31Enrolling by invitation
A Phase I Pilot Study of Samarium-153 Combined With Neoadjuvant Hormonal Therapy and Radiation Therapy in Men With Locally Advanced Prostate Cancer[NCT00328614]Phase 132 participants (Actual)Interventional2003-03-31Completed
The Role of Oxidative Stress and Opiorphin in Temporomandibular Disorders[NCT03029494]80 participants (Anticipated)Interventional2015-10-01Recruiting
Pharmacological Ascorbate for the Control of Metastatic and Node-Positive Pancreatic Cancer (PACMAN): A Phase II Trial[NCT01515046]Phase 21 participants (Actual)Interventional2012-09-30Terminated(stopped due to Standard of care changed to FOLFIRINOX; poor accrual.)
Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, Vitamin D, Vitamin B12 With or Without Vitamin C, a Multi-centre, International, Randomized Trial: The International ALLIANCE Study[NCT04395768]Phase 2200 participants (Anticipated)Interventional2020-09-09Recruiting
A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies[NCT01332578]Phase 425 participants (Actual)Interventional2011-05-31Completed
Effects of Hydrolyzed Collagen and Vitamin C on Collagen Synthesis and Explosive Performance[NCT03293004]23 participants (Actual)Interventional2017-09-13Completed
Randomized Study to Evaluate the Safety and Antiviral Efficacy of Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Treatment[NCT04334967]Phase 413 participants (Actual)Interventional2020-03-30Suspended(stopped due to suspected unfavorable risk/benefit assessment)
Radiofrequency as the New Opportunity in Treating Overactive Bladder and Urgent Urinary Incontinence - a Prospective Randomized Placebo Controlled Study[NCT06080217]80 participants (Anticipated)Interventional2023-07-10Active, not recruiting
Concentrated Ascorbic Acid in DMSO for Treatment of Squamous Cell Carcinoma of the Skin[NCT05932511]Early Phase 115 participants (Anticipated)Interventional2023-06-12Recruiting
A Phase II Trial of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults[NCT03468075]Phase 210 participants (Actual)Interventional2018-07-11Terminated(stopped due to Stopping rules met)
The Efficacy of High Dose Vitamin C in the Critically Ill Patient Population[NCT01587963]Phase 211 participants (Actual)Interventional2013-02-28Terminated(stopped due to PI's add. responsibilities and time commitment prevent him from completing trial)
IV Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients: A Forgotten Group[NCT04046094]Phase 1/Phase 216 participants (Actual)Interventional2019-10-17Active, not recruiting
An Open-Label, Three-Arm, Parallel, Investigator-Initiated Trial of Three Different Gummies (Curcumin Gummies, Vitamin C Gummies, and Vitamin B Complex Gummies) in Healthy Children[NCT05775237]48 participants (Actual)Interventional2023-05-01Completed
A Randomized Controlled Trial to Compare Prophylaxis With Oral Ascorbic Acid, Oral Amiodarone or Both in Combination With Beta Blockers to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery[NCT00953212]Phase 3304 participants (Actual)Interventional2009-08-31Completed
The Effect of Continuous Sipping of a Glucose Solution on Markers of Oxidation in Men and Women[NCT01440790]18 participants (Actual)Interventional2010-08-31Completed
Oxalate Formation From Ascorbic Acid[NCT04603898]136 participants (Anticipated)Interventional2021-11-15Recruiting
Clinical Utility of Endothelial Dysfunction in PAD[NCT00491751]Phase 1108 participants (Actual)Interventional2004-05-31Terminated(stopped due to Insufficient enrollment)
Post Operative Atril Fibrillation : The Impact of Oral Vitamin C in Reducing the Risk in Egyptian CABG Patients[NCT06074367]Phase 4180 participants (Actual)Interventional2020-10-13Active, not recruiting
Vitamin C to Reduce Exogenous Vasopressor Dose in Septic Shock; a Randomized Clinical Trial[NCT03835286]Phase 3180 participants (Anticipated)Interventional2019-03-01Active, not recruiting
Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Patients With Inactive Ulcerative Colitis; Randomized, Single Blind, Multicenter Study[NCT01929668]114 participants (Actual)Interventional2013-08-31Completed
The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis. Randomized Double-Blind Placebo-Controlled Trial[NCT04773717]60 participants (Actual)Interventional2019-01-01Completed
The Effect of Phenolic Cmpounds in Osteoarthritis; a Nutritional Intervention[NCT04783792]72 participants (Actual)Interventional2020-11-01Completed
The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction[NCT03684213]Phase 150 participants (Anticipated)Interventional2018-10-15Recruiting
Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults: An Adaptive Randomized Platform Trial[NCT04354428]Phase 2/Phase 3289 participants (Actual)Interventional2020-04-16Terminated(stopped due to Low number of events contributing to primary outcome)
PeRiOperative VItamin C to Reduce perSistent paIn After tOtal kNee Arthroplasty (PROVISION): a Pilot Multicentre Randomized Controlled Trial[NCT06123715]Phase 2100 participants (Anticipated)Interventional2024-01-15Not yet recruiting
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)[NCT04344184]Phase 248 participants (Actual)Interventional2020-12-18Completed
Effects of Antioxidants Supplementation on Muscular Function of Patients Affected by Facioscapulohumeral Dystrophy (FSHD)[NCT01596803]54 participants (Actual)Interventional2010-05-01Completed
Ascorbic Acid (Vitamin C) Infusion in Human Sepsis[NCT01434121]Phase 1/Phase 224 participants (Actual)Interventional2010-05-31Completed
A Randomized Phase Ⅲ Study of IV Ascorbic Acid in Combination With FOLFOX+/- Bevacizumab vs Treatment With FOLFOX+/- Bevacizumab Alone as First-line Therapy for Advanced Colorectal Cancer[NCT02969681]Phase 3442 participants (Actual)Interventional2017-01-31Completed
[NCT01926132]Phase 460 participants (Anticipated)Interventional2013-08-31Recruiting
Alcohol Abuse or Alcohol Withdrawal: Risk of Latent Scurvy: A STROBE Compliant Study[NCT03467022]47 participants (Actual)Observational2014-01-02Completed
Investigating the Oral Bioavailability of Vitamin C Administered Using Phosphycell™ Technology - a Phosphatidylcholine-lipid Encapsulation Technology.[NCT05183880]12 participants (Anticipated)Interventional2021-11-26Recruiting
"A Pilot Monocentric, Open Phase II Study to Investigate the Efficacy and Safety of a New Oral Gut Cleansing Solution (Low Dose Bowel Prep) in 30 Patients Submitted to Colonoscopy"[NCT00321230]Phase 230 participants Interventional2001-01-31Completed
Parallel Group Comparison of the New 2 Liter Gut Cleansing Solution NRL 994 Versus Sodium Phosphate Preparation in Routine Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening.[NCT00427089]Phase 3360 participants (Actual)Interventional2004-09-30Completed
Iron Bioavailability Study Of Fortified Oat Drink[NCT01423162]Phase 421 participants (Actual)Interventional2011-08-31Completed
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy. Randomised Controlled Study[NCT03391830]250 participants (Actual)Interventional2018-01-15Completed
Phase I/II Study of Intravenous Ascorbic Acid in Combination With Irinotecan Versus Irinotecan Alone for Advanced Colorectal Cancer[NCT01550510]Phase 1/Phase 24 participants (Actual)Interventional2011-12-31Terminated(stopped due to Closed: low enrollment, many treatment options available for Colorectal Cancer)
Vitamin C Infusion for Treatment in Sepsis Induced Acute Lung Injury[NCT02106975]Phase 2170 participants (Actual)Interventional2014-04-30Completed
Phase II, Open Label Study of Intravenous Ascorbic Acid in Combination With Gemcitabine and Erlotinib in the Treatment of Metastatic Pancreatic Cancer[NCT01555489]Phase 211 participants (Actual)Interventional2011-10-31Terminated(stopped due to Slow accrual)
Phase I/II Study of Intravenous Ascorbic Acid in Treatment of Metastatic Hepatocellular Carcinoma[NCT01754987]Phase 1/Phase 25 participants (Actual)Interventional2012-09-30Completed
Targeting Endoplasmic Reticulum Stress in Aging- and Obesity-Induced Vascular Dysfunction[NCT04001647]Early Phase 160 participants (Anticipated)Interventional2019-06-01Suspended(stopped due to IRB approval has been withdrawn)
Phase 2 Study of Extreme Hypofractionation Including Pelvic Nodes for High Risk Prostate Cancer Using MgRT (MRI Guided Radiation Therapy)[NCT05676463]Phase 288 participants (Anticipated)Interventional2022-11-16Suspended(stopped due to on hold due to pause of outside company)
A Pilot Study of Intravenous Ascorbic Acid and Folfirinox in the Treatment of Advanced Pancreatic Cancer[NCT02896907]Early Phase 18 participants (Actual)Interventional2016-10-18Completed
N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization: NASPI Study-A Randomized Controlled Trial[NCT00356954]Phase 4250 participants Interventional2005-02-28Completed
Comparison the Efficacy Depending on the Order of the Sequential Combination Method Using Sodium Picosulfate and Magnesium Citrate (PMC) and PEG With Ascorbic Acid for Bowel Preparation (The Phase II Prospective Randomized Clinical Trial)[NCT02979223]Phase 2142 participants (Actual)Interventional2016-11-30Completed
Clinical Research of High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors[NCT04033107]Phase 230 participants (Anticipated)Interventional2020-07-01Recruiting
SHARON: Study of Metastatic Cancers in Patients With a Defect in a Homologous Recombination Gene Using Autologous Stems Cells and Potentiated Redox Cycling to Overcome Drug Resistance to Nitrogen Mustard Derivatives[NCT04150042]Phase 110 participants (Anticipated)Interventional2021-01-13Recruiting
A Randomized, Examiner-blind, Comparator-controlled, Cross-over Bioequivalence Study on Vitamin C in Healthy Adults[NCT03562988]35 participants (Actual)Interventional2017-08-01Completed
Radiation Enhancement of Local and Systemic Anti-Prostate Cancer Immune Responses[NCT03649841]Phase 210 participants (Actual)Interventional2020-06-29Terminated(stopped due to Terminated due to low accrual.)
1L Morning-only Polyethylene Glycol Plus Ascorbic Acid With Prepackaged Low-residue Diet Versus 2L Polyethylene Glycol Plus Ascorbic Acid for Bowel Preparation: a Randomized Trial[NCT03329339]200 participants (Actual)Interventional2015-05-15Completed
Targeting the Prostatic Tumor Microenvironment With PLX3397, a Tumor-Associated Macrophage Inhibitor in Men With Unfavorable Risk Prostate Cancer Undergoing Radiation Therapy and Androgen Deprivation Therapy[NCT02472275]Phase 18 participants (Actual)Interventional2015-06-30Completed
Iron Bioavailability From Salt Fortified With Ferrous Sulphate, Zinc Sulphate and Ascorbic Acid Encapsulated in a Polymer Jacket[NCT02353325]20 participants (Actual)Interventional2016-03-31Completed
Topical Ascorbic Acid for Treatment of Basal Cell Carcinoma[NCT04279535]Early Phase 125 participants (Actual)Interventional2018-03-01Completed
The Effect of Melatonin and Vitamin C on COVID-19[NCT04530539]122 participants (Actual)Interventional2020-10-05Completed
Reversing Glucose and Lipid-mediated Vascular Dysfunction (REGAL)[NCT04832009]Early Phase 146 participants (Anticipated)Interventional2022-05-09Recruiting
Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients[NCT03613727]Phase 261 participants (Actual)Interventional2018-10-01Completed
Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries: a Randomized Double-blinded Controlled Trial[NCT05913180]Phase 2180 participants (Anticipated)Interventional2023-06-15Not yet recruiting
Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial[NCT03419234]Phase 2223 participants (Actual)Interventional2018-04-26Active, not recruiting
Double-Blind, Randomized Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients[NCT01167569]Phase 457 participants (Actual)Interventional2007-10-31Completed
Phase III Multicenter Randomized Trial of Adjuvant Androgen Deprivation in Combination With Three-dimensional Conformal Radiotherapy Doses in High and Intermediate Risk Localized Prostate Cancer.[NCT02175212]Phase 3362 participants (Actual)Interventional2005-11-30Completed
A Randomized Phase 2 Trial of Ascorbic Acid in Combination With Docetaxel in Men With Metastatic Prostate Cancer[NCT02516670]Phase 250 participants (Actual)Interventional2016-06-20Terminated(stopped due to insufficient clinical response per DSMB)
Influence of Hesperidin and Vitamin C on Uric Acid Concentration[NCT04316390]40 participants (Actual)Interventional2022-07-15Completed
Phase 2 Trial Pembrolizumab or Pembrolizumab in Combination With Intratumoral SD-101 Therapy in Patients With Hormone-Naïve Oligometastatic Prostate Cancer Receiving Stereotactic Body Radiation Therapy and Intermittent Androgen Deprivation Therapy[NCT03007732]Phase 223 participants (Actual)Interventional2017-05-17Active, not recruiting
A Phase II Trial of High-Dose Ascorbate in Stage IV Non-Small Cell Lung Cancer[NCT02420314]Phase 255 participants (Actual)Interventional2015-04-30Active, not recruiting
Phosphate Lowering to Treat Vascular Dysfunction in Chronic Kidney Disease[NCT02209636]Phase 466 participants (Actual)Interventional2014-09-15Completed
Iron Sucrose Combined With rHuEPO and Ascorbic Acid on Perioperative Allogeneic Red Blood Cell Infusion in Patients Undergoing Elective Major Cardiac Surgery[NCT05353348]370 participants (Anticipated)Interventional2023-02-15Recruiting
Phase IB/II Trial of High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have No Prior Therapy for Their Metastatic Pancreatic Cancer[NCT03410030]Phase 1/Phase 227 participants (Actual)Interventional2017-12-15Completed
The Effect of Vitamin C on the Skin Prick Test Wheal Reaction[NCT05810233]90 participants (Anticipated)Interventional2023-07-15Recruiting
LS1781: Phase 2 Trial of High Dose Intravenous Ascorbic Acid as an Adjunct to Salvage Chemotherapy in Relapsed / Refractory Lymphoma and Patients With Clonal Cytopenia of Undetermined Significance[NCT03418038]Phase 255 participants (Anticipated)Interventional2018-03-23Recruiting
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function[NCT01723696]Phase 2/Phase 3252 participants (Actual)Interventional2012-12-31Completed
Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment[NCT04363216]Phase 266 participants (Anticipated)Interventional2020-05-31Not yet recruiting
Prospective Study of Stereotactic Body Radiotherapy (SBRT) Following Radical Prostatectomy[NCT03541850]Phase 292 participants (Actual)Interventional2019-01-29Active, not recruiting
Effect of Ascorbic Acid Supplementation in Pregnancy on Anemia (AAA)[NCT03564756]0 participants (Actual)Interventional2019-08-01Withdrawn(stopped due to Difficulty with enrollment)
High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda: a Feasibility Trial[NCT04088591]Phase 30 participants (Actual)Interventional2022-10-31Withdrawn(stopped due to Recent studies suggest an increase in mortality due to high-does Vitamin C)
Safety and Efficacy of Preoperative IMRT (Intensity-modulated Radiation Therapy) With Concurrent High-dose Intravenous Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer Patients: a Prospective Study.[NCT04801511]Phase 260 participants (Anticipated)Interventional2021-03-08Recruiting
Contributions of Nitric Oxide Synthase, Cyclooxygenase, and Reactive Oxygen Species to Regional Cerebrovascular Control During Hypoxia and Hypercapnia[NCT03066115]Phase 10 participants (Actual)Interventional2020-12-01Withdrawn(stopped due to This study was never funded, never fully IRB approved, and thus never enrolled anyone.)
Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia (DEODO): a Multi-centered, Pilot Randomized Controlled Trial[NCT03725384]Phase 352 participants (Actual)Interventional2019-01-04Completed
Phase I/II Study of the Combination of Arsenic Trioxide With Ascorbic Acid and High-Dose Melphalan for Patients With Multiple Myeloma[NCT00661544]Phase 1/Phase 248 participants (Actual)Interventional2004-03-31Completed
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate[NCT01603420]Phase 2/Phase 32 participants (Actual)Interventional2012-07-31Terminated(stopped due to enrollment goals not met)
A Randomized, Double Blind, Placebo-Controlled Study to Investigate the Effects of Vitamin C, Hydrocortisone and Thiamine on the Outcome of Patients With Severe Sepsis and Septic Shock[NCT03335124]Phase 45 participants (Actual)Interventional2017-09-26Terminated(stopped due to Due to insufficient recruitment)
Antioxidants Vitamins and Muscle Damage[NCT05127928]18 participants (Actual)Interventional2022-02-10Completed
Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma[NCT01897792]Phase 211 participants (Actual)Interventional2013-05-31Terminated(stopped due to Inability to recruit patients that meet inclusion criteria.)
Phase 4 Study of High Dose Vitamin C in Chronic Hepatitis Patients[NCT01413360]Phase 410 participants (Actual)Interventional2011-08-31Completed
The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis[NCT05350124]Phase 3160 participants (Anticipated)Interventional2022-11-30Not yet recruiting
Antioxidant Activity and Lipid Peroxidation Status in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate[NCT03531749]60 participants (Actual)Interventional2017-01-31Completed
Hyperoxia and Antioxidants During Major Non-cardiac Surgery and Risk of Cardiovascular Complications, a Blinded 2x2 Factorial Randomised Clinical Trial[NCT03494387]Phase 4600 participants (Actual)Interventional2018-04-06Completed
An Observational, Retrospective and Multicenter Study to Evaluate the Effectiveness and Safety of 1L (PEG)+ Ascorbic Acid Given for Bowel Preparation Prior to Colonoscopy in Iberia[NCT05174845]13,393 participants (Actual)Observational2021-10-01Completed
Can Yeast Cells Emulate Vitamin E on In-vitro Protection of Human Spermatozoa Against Oxidative Stress?[NCT02814695]Phase 140 participants (Actual)Interventional2020-08-15Completed
Effect of Resveratrol and Vitamin C on Insulin Resistance and Antioxidant Capacity in Postmenopausal Women. A Randomized Clinical Trial[NCT03090997]45 participants (Anticipated)Interventional2018-02-15Active, not recruiting
Phase II Trial of Primary Radiotherapy With Androgen Ablation With or Without Adjuvant Niraparib for Selected High-Risk Locoregional Prostate Cancer[NCT04947254]Phase 2200 participants (Anticipated)Interventional2021-08-05Recruiting
Pharmacological Ascorbate Combined With Radiation and Temozolomide in Glioblastoma Multiforme: A Phase 2 Trial[NCT02344355]Phase 290 participants (Anticipated)Interventional2017-03-13Active, not recruiting
Difference in Mortality and Evolution in Septic Patients Treated With Vitamin C, Tiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone Treated at the ICU of General Hospital Zone 11 IMSS Piedras Negras Coahuila.[NCT04197115]Phase 319 participants (Actual)Interventional2019-09-01Completed
Tolerability and Efficacy of Low-Volume Sodium Picosulfate/Magnesium Citrate Versus 2L Polyethylene Glycol/Ascorbic Acid in Patients With Ulcerative Colitis Undergoing Colonoscopy: A Randomized Controlled Trial[NCT03581149]Phase 468 participants (Anticipated)Interventional2018-03-26Recruiting
Randomized Controlled Double-blinded Clinical Trial of an Herbal Mouthrinse for Radiotherapy Induced Mucositis in Cancer Patients[NCT01898091]Phase 250 participants (Actual)Interventional2013-07-31Completed
Advancing the Cardiovascular Science of Vitamin C in Cardiac Surgery Patients[NCT03123107]Phase 16 participants (Actual)Interventional2017-07-06Completed
Impact of Low Fiber Diet on Colonic Cleansing Quality Prior to Colonoscopy: Randomized Study Comparing 1 Day Versus 3 Days of Low Fiber Diet[NCT03247452]404 participants (Actual)Interventional2017-12-18Completed
Evaluation of Dermatological Safety of Test Products by 24 Hours Patch Test Under Complete Occlusion or Semi Occlusion or Open Patch on Adult Healthy Human Subjects[NCT05642702]26 participants (Anticipated)Interventional2022-12-05Not yet recruiting
Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments: a Multicentre, Double Blinded, Randomized Controlled Trial: the C-EASIE Trial[NCT04747795]Phase 3301 participants (Actual)Interventional2021-06-01Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Ejection Fraction: Percentage of Blood Leaving the Heart Before and After Exercise at Baseline, After a Vitamin C Infusion, and After Exercise Training
Percent Change in Circumferential Strain Before and After Exercise at Baseline, After Vitamin C Infusion, and After Exercise Training
All-cause Mortality
C-reactive Protein (CRP)
Change in S/F Ratio During High Dose Intravenous Vitamin C (HDIVC)
D-dimer
Hospital-free Days
Intensive Care Unit (ICU)-Free Days
Lactate Dehydrogenase (LDH)
Lymphocyte Count
Neutrophil to Lymphocyte Ratio (NLR)
Number of Participants With Adverse Events Related to High Dose Intravenous Vitamin C (HDIVC)
Number of Participants With Adverse Reactions
Number of Participants With Serious Adverse Reactions
Serum Ferritin
Ventilator-free Days
Serum Vitamin C Level at Baseline
Serum Vitamin C Level at Month 3
Cardiac Function
Health Related Quality of Life Scores
Oxidative Stress
Total MSAS-HF Score
Change From Baseline in PSA (%) to Week 16
International Prostate Symptom Score- IPSS
To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter- Mean Flow Rate (Qave)
To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter- Peak Flow Rate (Qmax)
To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter- Postvoid Residual Volume (PVR)
To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter-voided Volume (Vcomp)
Absolute Change in Lean Body Mass and Fat Mass From Baseline to 16 Weeks
10-year Biochemical Recurrence (PSA Failure)
10-year Prostate Cancer Mortality
10-Year Restricted Mean Survival Time for Overall Survival
Number of Participants With Acute Adverse Events
Number of Participants With Late Adverse Events, Any Grade and Attribution
Hospital Length of Stay
Hours on Vasopressors
Intensive Care Unit Length of Stay
Mortality Rates
Readmission Rate
Ventilator Days
All Cause Mortality at 28 Days
Change in Acute Physiology and Chronic Health Evaluation (APACHE) Scores
Change in Sequential Organ Failure Assessment (SOFA) Score
Change in Serum Creatinine
Duration of ICU Stay Post Intervention Administration
Duration of Vasopressor Therapy
Number of Participants With ICU Mortality
Number of Participants With Need for Renal Replacement Therapy
Rate of Lactate Clearance Post Intervention Administration
Total Intravenous Fluid Administered
Change in Sequential Organ Failure Assessment (SOFA) Score
Hospital Length of Stay
Hospital Mortality
ICU Length of Stay
ICU Mortality
Procalcitonin (PCT) Clearance
Time to Vasopressor Independence (Hours)
Ventilator Free Days
30-day Mortality
Hospital Disposition: Survivors Discharged Home
Hospital Mortality
ICU Free Days
Intensive Care Unit (ICU) Mortality
Number of Participants With Delirium
Renal Failure
Shock Free Days
Ventilator Free Days
Sequential Organ Failure Assessment (SOFA) Score at Baseline and 72 Hours
Duration of Time on Pazopanib Hydrochloride
Frequency of Adverse Events
Overall Response Rate
Overall Survival
Progression Free Survival
Treatment Failure-free Rate
Admission to NICU
Analysis of Primary Composite Outcome in Participants Randomized Before the 13th Week of Pregnancy
Analysis of Primary Composite Outcome in Participants Randomized on or After the 13th Week of Pregnancy
Antepartum Bleeding
Apgar Score <=3 at 5 Minutes
Aspartate Aminotransferase ≥100 U/Liter
Birth Weight
Birth Weight <2500 Grams
Cesarean Delivery
Composite of Pregnancy-associated Hypertension and Serious Adverse Outcomes in the Mother or Fetus or Neonate
Creatinine ≥1.5 mg/dl (133 μmol/Liter)
Gestational Age at Delivery
Hematocrit ≤24% With Transfusion
Intraventricular Hemorrhage, Grade III or IV
Maternal Death
Maternal Hospital Stay
Medically Indicated Delivery Because of Hypertension
Necrotizing Enterocolitis
Neonatal Hospital Stay
Placental Abruption
Postpartum Pulmonary Edema
Pregnancy Associated Hypertension
Premature Rupture of Membranes
Respiratory Distress Syndrome
Retinopathy of Prematurity
Sepsis
Severe Hypertension
Severe or Mild Pregnancy-associated Hypertension With a Fetal Death After 20 Weeks of Gestation or Neonatal Death
Severe or Mild Pregnancy-associated Hypertension With a Fetus That Was Small for Gestational Age (Below the 3rd Percentile) Adjusted for Sex and Race or Ethnic Group
Severe or Mild Pregnancy-associated Hypertension With an Eclamptic Seizure
Severe or Mild Pregnancy-associated Hypertension With an Elevated Serum Creatinine Level
Severe or Mild Pregnancy-associated Hypertension With an Indicated Preterm Birth Before 32 Weeks of Gestation Owing to Hypertension-related Disorders
Severe or Mild Pregnancy-associated Hypertension With Elevated Liver Enzyme Levels
Severe or Mild Pregnancy-associated Hypertension With Thrombocytopenia
Small for Gestational Age
Fetal or Neonatal Death
Preeclampsia (Mild, Severe, HELLP Syndrome, Eclampsia)
Preterm Birth
Controlled Oral Word Association Test (COWAT) Score
Digit Span Test Score
EuroQol, 5 Dimension (EQ-5D) Visual Analog Scale Score
Functional Activities Questionnaire (FAQ) Score
Hayling Test Score
Intensive Care Unit (ICU) Mortality
Katz Index of Independence in Activities of Daily Living (ADL) Score
Length of Hospital Stay
Length of ICU Stay
Mortality at 180 Days
Mortality at 30 Days
Number of Participants Employed
Number of Participants With Delirium Assessed With the DeliriumTelephone Confusion Assessment Method (CAM)
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression 6
Posttraumatic Stress Disorder-8 (PTSD-8) Score
Telephone Interview for Cognitive Status (TICS)
Vasopressor and Ventilator-free Days (VVFD)
Wechsler Adult Intelligence Scale (WAIS)-IV Similarities Score
Wechsler Memory Scale III - Delayed Recall Logical Memory Score
Number of Participants Who Had COVID-19 Disease
Number of Participants Who Had Polymerase Chain Reaction (PCR) Confirmed SARS-CoV-2 Infection
Rate of Participant-reported Adverse Events
The Number of Participants Who Had Polymerase Chain Reaction (PCR) Confirmed SARS-CoV-2 Infection
Number of Participants That Experienced Dose Limiting Toxicities (DLTs) Using CTCAE, Version 4.0
Number of Participants With Pathologic Tumor Necrosis ≥ 95% Following Concurrent Radiation Therapy and Ascorbate
Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)
Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)
Area Under the Curve (AUC0-12hours) for Calculated BH4 (From Total Biopterin)
Area Under the Curve (AUC0-12hrs) of Plasma BH4 Concentration
Area Under the Curve (AUC0-12hrs) of Plasma BH2 and B Concentration
Change From Baseline in Cyclic Guanosine Monophosphate (cGMP)
Change From Baseline in Diastolic Blood Pressure (DBP)
Change From Baseline in Peripheral Arterial Tonometry (PAT)
Change From Baseline in Systolic Blood Pressure (SBP)
Change From Baseline in Urinary 8-isoprostane/Creatinine
Change in Urinary Albumin to Creatinine Ratio (mg/g)
Number of Participants With Urinary Albumin to Creatinine Ratio <30 mg/g
Number of Subjects With Treatment Emergent Adverse Events (TEAEs)
Ratio of BH2, B and BH4 Calculated From Total Biopterin Area Under the Curve (0-12hours) for Subjects Administered Sapropterin Dihydrochloride With Vitamin C to Subjects Administered Sapropterin Alone.
Number of Patients Reaching Complete Response (CR)
Number of Patients With an Overall Response of Complete Response (CR) or Partial Response (PR)
Number of Patients With an Unacceptable Toxicity
Change in Alanine Aminotransferase (ALT) Level
Change in Albumin
Change in Alkaline Phosphatase
Change in Aspartate Aminotransferase (AST) Level
Change in Total Bilirubin
Changes to Corrected QT Interval (QTc)
Changes to Level of Medical Care
Changes to Urine pH
Hospital-free Days
ICU-free Days
Number of Deaths Due to Any Cause
Number of Deaths Due to Any Cause
Number of Treatment-related Adverse Events as Assessed by CTCAE v5.0
Change in Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) Score
Change in Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) Score
Change in Model for End Stage Liver Disease (MELD) Score
Changes to Urine Microscopy
Change in Arterial Stiffness
Change in Endothelial Function
Change in Oxidative Stress
Changes in SCORAD Index
Changes in Urinary EDN
Changes in Urinary LTE4
Prostate Specific Antigen Progression Free Survival (PSA-PFS)
Prostate-specific Antigen (PSA) Response
Change in Quality of Life - FACT-P
Change in Quality of Life - FACT/GOG-NTX
Change in Quality of Life - PROMIS Fatigue
Number of Participants With a Response (Complete Remissions (CR) and Complete Remission With Incomplete Blood Count Recovery (CRi)
Number of Participants With Severe (Grades 3-5) Adverse Events
Change From Baseline in Hemoglobin (Hb) After 8 Weeks of Treatment in Each Ferrous Bisglycinate Chelate Group (1 Tablet Daily and 2 Tablets Daily)
Difference in Percentage of Participants With Gastrointestinal Side Effects During 8 Weeks Treatment With Ferrous Bisglycinate Chelate and Ferrous Ascorbate
Mean Change in Hb From Baseline to 8 Weeks
Percentage of Participants Who Achieved a Target Hb More Than or Equal to 12 gm/dL After 8 Weeks of Treatment
Mean Change in Hb During 8 Weeks Therapy
Change in Creatinine Levels
Change in Creatinine Levels
Change in hsCRP
Change in hsCRP
Change in Interleukin (IL-6)
Change in Interleukin (IL-6)
Change in Plasma Ascorbic Acid Level
Change in Plasma Levels of Ascorbic Acid
Change in Von Willebrand Factor (vWF)
Change in Von Willebrand Factor (vWF)
Post Procedural Pain
Number of Participants Operated for Complex Regional Pain Syndrome Who Had Internal Unicompartmental Arthroplasty for Centralized Arthritis
Number of Participants Operated for Complex Regional Pain Syndrome Who Had Ligamentoplasty ACL According to Kenneth-Jones
Number of Participants Operated for Complex Regional Pain Syndrome Who Had Total Knee Arthroplasty for Eccentric Arthritis
Number of Participants Operated for Complex Regional Pain Syndrome Who Had Transposition of Anterior Tibial Tuberosity
Length of Time for Wound Closure
Hgb A1c Level
Wound Area Measurements
Development of Renal Calculi
Occurence of Atrial Fibrillation
Concentration of Vitamin C in Type 2 Diabetic Patients.
Quantify the Effect of Chronic Hyperglycemia on Cellular Uptake of Vitamin C Across the Blood-brain Barrier
Ascorbic Acid Concentration at 32 Hours
Change in Modified SOFA Score
Change in PIRO Score
Hospital Length of Stay
ICU Length of Stay
Modified SOFA Score
Percentage of Participants Who Died
Adverse Events as a Measure of Safety and Tolerability
Maximum Tolerated Dose of Samarium-153
Number of Drug-related Adverse Events Per Cycle
Overall Survival
Progression Free Survival
Area Under the Concentration/Time Curve From 0 to 30 Minutes (Min) (AUC 0-30 Min)
AUC (0-60 Min)
Maximum Plasma Concentration (Cmax)
Time to Completion of Gastric Emptying
Time to Maximum Plasma Concentration (Tmax)
Time to Onset of Gastric Emptying
Time to Reach Plasma Paracetamol Concentration of 0.25 μg/mL (Microgram Per Milliliter)
Time to Onset and Completion of Disintegration of Reference Tablets
Incidence of Adverse Events (AE) Per CTCAE 4.03
Overall Survival
Progression Free Survival
Tumor Response
Hospital Length of Stay
ICU Length of Stay
Number of Participants With Acute Kidney Injury
Number of Participants With Bradycardia Necessitating Permanent Pacemaker Placement
Number of Participants With Low Output Heart Failure
Number of Participants With Mortality
Number of Participants With Postoperative Vasoplegia
Number of Participants With Readmission to Hospital for Treatment of Atrial Fibrillation
Number of Participants With Readmission to ICU for Treatment of Atrial Fibrillation
Number of Participants With Respiratory Failure Requiring Reintubation
Number of Participants With Stroke
Occurrence of Post-operative Atrial Fibrillation Requiring Treatment After Open Heart Surgery
Change in FMD
Percentage Change in FMD in All Participants With and Without a CVD Event (Not by Treatment Group)
COVID-19-related Hospitalization Days
Number of Participants With Hospitalization or Mortality
Number of Participants With Serious Adverse Events and Adverse Events Resulting in Treatment Discontinuation
Number of Persons With Lower Respiratory Tract Infection (LRTI), Defined as Resting Blood Oxygen Saturation (SpO2<93%) Level Sustained for 2 Readings 2 Hours Apart and Presence of Subjective Dyspnea or Cough
Time to Clearance of Nasal SARS-CoV-2
Time to Resolution of COVID-19 Symptom Resolution in Days
Number of Patients Who Experienced Ascorbic Acid Infusion Related Arterial Hypotension, Vomiting, or Tachycardia in Septic Patients
Percent Iron Absorption
All Cause Mortality to Day 28
Hospital-free Days at Day 60
ICU-free Days at Day 28
Modified Change in Sequential Organ Failure Assessment (mSOFA) Score
Ventilator Free Days to Day 28
Ascorbate Level at Hour 0, 48, 96, 168
C-Reactive Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo
Cardiovascular Function
Coagulation
Liver Function
mSOFA Scores at Hours 0, 48, 96
Oxygenation Index (FiO2 x Mean Airway Pressure/PaO2) at Study Hour 0, 48, 96, 168 if Still Intubated in Ascorbate Infused Patient Compared to Placebo.
Oxygenation Score: Pressure
Oxygenation Score: Saturation
Procalcitonin at Study Hour 0, 48, 96, 168
Receptor for Advanced Glycation Endpoints at Study Hour 0, 48, 96, 168
Renal Function
State of Consciousness
Thrombomodulin Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo
Tissue Factor Pathway Inhibitor at Study Hour 0, 48, 96, 168
VE-40 (Vent RR x TV/Weight) x (PaCO2/40) at Study Hour 0, 48, 96, 168 if Still Intubated, in Ascorbate Infused Patient Compared to Placebo
Change in Quality of Life as Defined by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30
Mean Leucocyte Vitamin C Absorption Rate as Tmax
Mean Leukocyte L-ascorbic Acid as Cmax
Mean Leukocyte L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 Hours)]
Mean Plasma L-ascorbic Acid as Cmax
Mean Plasma L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 Hours)]
Mean Plasma Vitamin C Absorption Rate as Tmax
Incidence of Adverse Events
Rate of Undetectable Prostate Specific Antigen (PSA) (< 0.2)
Determine Related to Vitamin C Therapy Adverse Events (AEs) Reported Using Criteria in the National Cancer Institute Common Terminology Criteria for Adverse Events Version 5.0 (CTCAE v5.0)
The Proportion of Patients That Experience Non-relapse Mortality (NRM)
Time From Transplant to Engraftment
To Determine the Effectiveness of Reducing Acute Graft Versus Host Disease (aGVHD)
Mortality
Biochemical Disease Free Survival: Estimated Percentage of Participants With Biochemical Disease-free Survival at 5 Years
Cause-specific Survival
Metastasis Free Survival: Estimated Percentage of Participants With Metastasis-free Survival at 5 Years
Overall Survival: Estimated Percentage of Participants Alive at 5 Years
Late Toxicity
Average Number of Times Docetaxel Had Dose Reductions
Change in Quality of Life (QoL) as Measured by the FACT-P Questionnaire
Number of Participates With a Decline in Prostate-specific Antigen From Their Baseline Measurement
Radiographic Progression Free Survival (rPFS)
Number of Participants With Adverse Events
Number of Participates Experiencing Serious Adverse Events (SAE)
Number of Serious Adverse Events
Phosphorus Balance Sub-study (COMIRB 15-0384)
Aortic Pulse-wave Velocity
Brachial Artery Flow-mediated Dilation
C-reactive Protein to Measure Systemic Inflammation
Interleukin-6 to Measure Systemic Inflammation
Oxidative Stress-associated Suppression of EDD
Oxidized Low-density Lipoprotein (Ox-LDL) to Measure Systemic Oxidized Stress
Vascular Endothelial Cell Protein Expression
Forced Expiratory Flow at 75% of Expired Volume (FEF75)
Forced Expiratory Flow at 75% of Expired Volume (FEF75)
Incidence of Wheezing Through 12 Months of Age
Response Rate
Assessment of Number of Grade 2 or Higher Genitourinary (GU) and Gastrointestinal (GI) Adverse Events
Assessment of Total Number of Biochemical Failure Events
Assessment of Total Number of Local/Distant Failures
Assessment of Total Number of Salvage Androgen Deprivation Use With Comparison of Arms.
Assessment of Total Number of Survival Events With Comparison of Group Arms
Phase 2 - Assessment of Number of Freedom From Failure Events in the Chemotherapy Arm
Phase 2 - Cumulative Number of Incidences of Grade 3 or Higher Adverse Events.
Mean Number of Days in ICU.
Mean Number of Hospital Stay Days.
Mean Number of Ventilator-free Days for Subjects
Number of Participants With Coagulation Abnormalities
Number of Protocol Violations Per Arm.
Number of Subjects Surviving to Day 28
Number of Subjects With 60-day Survival
Number of Subjects With Organ Injury
Number of Subjects With Ventilator-associated Pneumonia.
Number of Total Blood Product Transfusions
The Change in Serum Alanine Aminotransferase Level From Baseline to 12 Weeks
The Change in Serum Interleukin 22 Level From Baseline to 12 Weeks
Maximum Change in Mean Mouth and Throat Soreness (MTS) Score From Baseline Through Weeks of Radiation Therapy Using the MTS Question of the Modified Oral Mucositis Daily Questionnaire*.

Ejection Fraction: Percentage of Blood Leaving the Heart Before and After Exercise at Baseline, After a Vitamin C Infusion, and After Exercise Training

Evaluate potential changes in cardiac function by echocardiography following 2 interventions: Three months of exercise training and acute vitamin C administration. Ejection fraction (EF) is a measurement of the percentage of blood leaving your heart each time it contracts, typically measure by echocardiography. Numbers listed are absolute EF values. (NCT00786019)
Timeframe: 7 months; Measures are made at rest for baseline, at rest for Vitamin C administration, and at rest following the exercise training

,
Interventionpercentage of blood leaving the heart (Mean)
BaselineVitamin CPost Exercise Training
Ejection Fraction - Control656761
Ejection Fraction - Type 2 Diabetes656365

[back to top]

Percent Change in Circumferential Strain Before and After Exercise at Baseline, After Vitamin C Infusion, and After Exercise Training

Characterize the purported cardiac dysfunction during exercise in people with type 2 diabetes (T2D). In a normal patient when measuring circumferential strain, results are negative with downward tracing (as strain is a relative change in length). Circumferential strain is a measurement of ventricular circumference within the heart vessels, measured via echocardiography. (NCT00786019)
Timeframe: 7 months; Measures are made at rest and after exercise for baseline, at rest and after infusion for Vitamin C administration, and at rest and after exercise following the exercise training

,
Interventionpercentage of change in length (Mean)
BaselineVitamin CPost Exercise Training
Circumferential Strain - Control-24-23-22
Circumferential Strain - Type 2 Diabetes-20-21-22

[back to top]

All-cause Mortality

Incidence of mortality at 28 days by all causes (NCT04357782)
Timeframe: Days 1-28

InterventionParticipants (Count of Participants)
Mild Hypoxemia0
Severe Hypoxemia3

[back to top]

C-reactive Protein (CRP)

"The difference in serum CRP during HDIVC infusion reported in mg/dL~Local lab with upper measurement limit of 19 mg/dL~The change was determined from two time points ie Day 4value minus Day 1 value." (NCT04357782)
Timeframe: Days 1-4

Interventionmg/dL (Mean)
Mild Hypoxemia-3.8
Severe Hypoxemia-2.0

[back to top]

Change in S/F Ratio During High Dose Intravenous Vitamin C (HDIVC)

oxygen saturation by pulse oximetry (SpO2) will be divided by fraction of inspired oxygen (FiO2) at start of study infusion and compared with S/F ratio at end of study infusion (NCT04357782)
Timeframe: Days 1-4

Interventionratio (Mean)
Mild Hypoxemia108
Severe Hypoxemia26

[back to top]

D-dimer

"The difference in D-dimer during HDIVC infusion will be reported in ug/mL~The change was determined from two time points ie Day 4 value minus Day 1 value." (NCT04357782)
Timeframe: Days 1-4

Interventionug/mL (Mean)
Mild Hypoxemia-0.21
Severe Hypoxemia3.71

[back to top]

Hospital-free Days

Documented days free of hospital admission the first 28 days post enrollment (NCT04357782)
Timeframe: Days 1-28

Interventiondays (Median)
Mild Hypoxemia21.5
Severe Hypoxemia8.5

[back to top]

Intensive Care Unit (ICU)-Free Days

Documented days free of ICU admission the first 28 days post enrollment (NCT04357782)
Timeframe: Days 1-28

Interventiondays (Median)
Mild Hypoxemia28
Severe Hypoxemia13.5

[back to top]

Lactate Dehydrogenase (LDH)

"The difference in LDH during HDIVC infusion will be reported in IU/L~The change was determined from two time points ie Day 4 value minus Day 1 value." (NCT04357782)
Timeframe: Days 1-4

InterventionIU/L (Mean)
Mild Hypoxemia-42
Severe Hypoxemia118

[back to top]

Lymphocyte Count

"The difference in lymphocyte count during HDIVC infusion will be reported in 10^3 cells/uL~The change was determined from two time points ie Day 4 value minus Day 1 value." (NCT04357782)
Timeframe: Days 1-4

Intervention10^3 cells/uL (Mean)
Mild Hypoxemia329
Severe Hypoxemia276

[back to top]

Neutrophil to Lymphocyte Ratio (NLR)

"The NLR will be calculated by dividing the absolute neutrophil count (10e3/uL) over the absolute lymphocyte count (10e3/uL)~The change was determined from two time points ie Day 4 value minus Day 1 value." (NCT04357782)
Timeframe: Days 1-4

Interventionratio (Mean)
Mild Hypoxemia-0.89
Severe Hypoxemia-0.04

[back to top] [back to top]

Number of Participants With Adverse Reactions

Number of participants with adverse reactions during study drug infusion (NCT04357782)
Timeframe: Days 1-4

InterventionParticipants (Count of Participants)
Mild Hypoxemia1
Severe Hypoxemia2

[back to top]

Number of Participants With Serious Adverse Reactions

Number of participants with serious adverse events during study drug infusion (NCT04357782)
Timeframe: Days 1-4

InterventionParticipants (Count of Participants)
Mild Hypoxemia0
Severe Hypoxemia2

[back to top]

Serum Ferritin

"The difference in serum ferritin will be calculated from the start of HDIVC infusion to day 4 and reported as ng/mL~The change was determined from two time points ie Day 4 value minus Day 1 value." (NCT04357782)
Timeframe: Days 1-4

Interventionng/mL (Mean)
Mild Hypoxemia-299
Severe Hypoxemia-1170

[back to top]

Ventilator-free Days

Documented days free off mechanical ventilation the first 28 days post enrollment (NCT04357782)
Timeframe: Days 1-28

Interventiondays (Median)
Mild Hypoxemia28
Severe Hypoxemia23.5

[back to top]

Serum Vitamin C Level at Baseline

The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify Vitamin C in serum (NCT04036110)
Timeframe: Baseline

Interventionng/mL (Mean)
Intervention 1 (500 mg)13372
Intervention 2 (1000 mg)16079
Control (Placebo)13111

[back to top]

Serum Vitamin C Level at Month 3

The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify Vitamin C in serum (NCT04036110)
Timeframe: Month 3

Interventionng/mL (Mean)
Intervention 1 (500 mg)21309
Intervention 2 (1000 mg)20574
Control (Placebo)12537

[back to top]

Cardiac Function

The MindWare Mobile impedance cardiograph (model number 50-2303-00) used to measure participant's cardiac function using the parameter of cardiac output. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment

,
InterventionL/min (Mean)
BaselineMonth 3
Control (Placebo)5.614.2
Intervention 1 (500 mg)6.912.7

[back to top] [back to top]

Oxidative Stress

The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify 8-iso-PGF2a isoprostane in serum to reflect oxidative stress. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment

,,
Interventionpg/mL (Mean)
Baseline3 months
Control (Placebo)138322580
Intervention 1 (500 mg)23144507
Intervention 2 (1000 mg)104062431

[back to top]

Total MSAS-HF Score

Symptom burden is measured using items from the Memorial Symptom Assessment Scale-Heart Failure (MSAS-HF). The MSAS-HF is an 8-item questionnaire to measure HF symptoms experienced by patients with HF. Patients will be first asked if the symptom was present during the previous 7 days. If present, three characteristics of each symptom will be rated: frequency of symptom, severity of symptom, and degree of symptom distress. Frequency is rated on a scale from 0 to 5 (1=no symptom to 5=all the time), severity rated on a scale from 0 to 5 (0=not at all to 5=extremely) and distress rated on a scale from 0 to 5 (0=not at all to 5=extremely). Burden score for each symptom can range from 0 (no burden) to 4 (greatest symptom frequency, severity, and distress). The total MAS-HF scores are summed to a range of 0-180, with higher scores indicating higher symptom burden. Measured at Baseline and Month 3. (NCT04036110)
Timeframe: Baseline and up to 3 months after enrollment

,,
Interventionscore on a scale (Mean)
BaselineMonth 3
Control (Placebo)31.220.1
Intervention 1 (500 mg)47.524.5
Intervention 2 (1000 mg)20.224.8

[back to top]

Change From Baseline in PSA (%) to Week 16

The trial will evaluate the effect of two doses of OPK-88004 (15 mg and 25 mg) daily for 16 weeks on serum PSA compared with placebo (NCT03297398)
Timeframe: 16 weeks

InterventionPercentage of serum PSA change (Least Squares Mean)
Other-2.96
Drug Group 1-1.48
Drug Group 2-15.44

[back to top]

International Prostate Symptom Score- IPSS

To evaluate the effects of OPK-88004 on the symptoms of BPH as determined by International prostate symptom score (IPSS score), Total IPSS score as measured by the sum of questions 1 through 7, the IPSS Irritative Domain (sum of questions 2, 4 and 7), and the IPSS Obstructive Domain (sum of questions 1, 3, 5 and 6)IPSS QoL question (IPSS question 8). Mild (symptoms score less than or equal to 7), moderate (symptoms score range 8-19), severe (symptom score 20-35) (NCT03297398)
Timeframe: 16 weeks

InterventionTotal IPSS score (Mean)
Other14.0
Drug Group 112.8
Drug Group 214.2

[back to top]

To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter- Mean Flow Rate (Qave)

Analysis mean flow rate of Uroflowmetry Parameters and Postvoid Residual Volume Observed Change from Baseline to Week 16 (NCT03297398)
Timeframe: 16 weeks

Interventionmillilitre/second (Least Squares Mean)
Other-0.40
Drug Group 1-0.30
Drug Group 20.15

[back to top]

To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter- Peak Flow Rate (Qmax)

Analysis peak flow rate of Uroflowmetry Parameters and Postvoid Residual Volume Observed Change from Baseline to Week 16 (NCT03297398)
Timeframe: 16 weeks

Interventionmillilitre/second (Least Squares Mean)
Other4.26
Drug Group 10.61
Drug Group 21.08

[back to top]

To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter- Postvoid Residual Volume (PVR)

Analysis postvoid residual volume of Uroflowmetry Parameters and Postvoid Residual Volume Observed Change from Baseline to Week 16 (NCT03297398)
Timeframe: 16 weeks

Interventionmillilitre (Least Squares Mean)
Other-0.08
Drug Group 117.63
Drug Group 2-15.19

[back to top]

To Evaluate the Effect of OPK-88004 on Uroflowmetry Parameter-voided Volume (Vcomp)

Analysis voided of Uroflowmetry Parameters and Postvoid Residual Volume Observed Change from Baseline to Week 16 (NCT03297398)
Timeframe: 16 weeks

Interventionmillilitre (Least Squares Mean)
Other-49.12
Drug Group 1-2.28
Drug Group 2-29.12

[back to top]

Absolute Change in Lean Body Mass and Fat Mass From Baseline to 16 Weeks

To assess the effect of OPK-88004 on body composition by DXA, specifically Lean Body Mass (LBM) and fat mass (NCT03297398)
Timeframe: 16 weeks

,,
Interventiongram (Least Squares Mean)
Change from Baseline in Lean Body Mass (g) to Week 16Change from Baseline in Fat Mass (g) to Week 16
Drug Group 11610.3-1468.7
Drug Group 21961.6-1491.3
Other37.8-198.2

[back to top]

10-year Biochemical Recurrence (PSA Failure)

"Time to biochemical recurrence was defined as the time from date of random assignment to the earliest of PSA failure or initiation of salvage therapy, or censored at the date of last disease assessment for those without PSA failure. PSA failure was defined according to the 2006 RTOG-ASTRO Phoenix definition (i.e., A PSA rise by 2 ng/mL or more above the nadir).~10-year biochemical recurrence rate was estimated from a competing risk model where non-prostate cancer death was counted as competing risk." (NCT00116142)
Timeframe: PSA was measured following the end of RT, then every 6 months for 5 years and annually thereafter, 10 years

Interventionpercentage of subjects (Number)
Arm1: Androgen Suppression Therapy + Radiation Therapy48
Arm2: Docetaxel + Androgen Suppression Therapy + Radiation Therapy54

[back to top]

10-year Prostate Cancer Mortality

Measured from the date of random assignment to date of death from prostate cancer, or censored at the date of last follow-up in surviving patients. Patients who died due to other reasons were counted as competing risk in a competing risk model. (NCT00116142)
Timeframe: Following the end of RT patients were seen for follow up every 6 months for 5 years and annually thereafter, 10 years.

Interventionpercentage of subjects (Number)
Arm1: Androgen Suppression Therapy + Radiation Therapy11
Arm2: Docetaxel + Androgen Suppression Therapy + Radiation Therapy15

[back to top]

10-Year Restricted Mean Survival Time for Overall Survival

Overall survival (OS) was measured from the date of random assignment to death from any cause, censored at the date of last follow-up in surviving patients. The 10-Year Restricted Mean Survival Time was calculated as the area under the Kaplan Meier plot for OS, from randomization to 10-years follow-up (NCT00116142)
Timeframe: Following the end of RT patients were seen for follow up every 6 months for 5 years and annually thereafter, 10 years.

Interventionyears (Mean)
Arm1: Androgen Suppression Therapy + Radiation Therapy8.82
Arm2: Docetaxel + Androgen Suppression Therapy + Radiation Therapy9.11

[back to top]

Number of Participants With Acute Adverse Events

Adverse acute events were reported via the clinical database only for toxicities considered reportable via the SAE mechanism (those of grade 2 and grade 3 events that are unexpected and possibly, probably, or definitely related/associated with treatment; or all grade 4 and grade 5 events). Common Toxicity Criteria Volume 3.0 (CTCAE) is used for this study. (NCT00116142)
Timeframe: During study treatment or within 30 days of the last dose of study, up to 7.2 months from randomization

InterventionParticipants (Count of Participants)
Arm1: Androgen Suppression Therapy + Radiation Therapy18
Arm2: Docetaxel + Androgen Suppression Therapy + Radiation Therapy46

[back to top]

Number of Participants With Late Adverse Events, Any Grade and Attribution

Late adverse events will be focused on GU/GI including Urinary/Fecal Incontinence, Hematuria, Diarrhea, Rectal Bleeding and other. (NCT00116142)
Timeframe: Every 6 months post radiation therapy for 5 years (+/-90 days), then annually, up to 13.9 years from randomization

InterventionParticipants (Count of Participants)
Arm1: Androgen Suppression Therapy + Radiation Therapy128
Arm2: Docetaxel + Androgen Suppression Therapy + Radiation Therapy140

[back to top]

Hospital Length of Stay

Total number of days patient is admitted to the hospital (NCT03592277)
Timeframe: From admission to the hospital through hospital discharge, up to 57 days.

Interventiondays (Median)
Vitamins C and B18.5
Placebo7.0

[back to top]

Hours on Vasopressors

Number of hours patient required vasopressors in norepinephrine equivalence. (NCT03592277)
Timeframe: From admission to the ICU through discharge from the ICU, up to 25 days.

InterventionHours (Mean)
Vitamins C and B150.0
Placebo35.9

[back to top]

Intensive Care Unit Length of Stay

Total number of days patient is admitted to the ICU (NCT03592277)
Timeframe: From time of admission to the ICU through discharge from the ICU, up to 25 days

Interventiondays (Median)
Vitamins C and B13.5
Placebo3.0

[back to top]

Mortality Rates

All-cause mortality from time of enrollment/treatment to 30 days post hospital discharge (up to 87 days) (NCT03592277)
Timeframe: From time of treatment to 30 days post hospital discharge, up to 87 days.

InterventionParticipants (Count of Participants)
Vitamins C and B112
Placebo7

[back to top]

Readmission Rate

Readmission to the hospital within 30 days after discharge (NCT03592277)
Timeframe: 30 days after hospital discharge

Interventionparticipants (Number)
Vitamins C and B117
Placebo15

[back to top]

Ventilator Days

Number of days patient required ventilator (NCT03592277)
Timeframe: From admission to the ICU through discharge from the ICU, up to 25 days.

Interventiondays on ventilator (Mean)
Vitamins C and B12.6
Placebo2.3

[back to top]

All Cause Mortality at 28 Days

Outcome is reported as the number of participants who have expired at 28 days post intervention (NCT03338569)
Timeframe: 28 days

InterventionParticipants (Count of Participants)
Placebo26
Intervention16

[back to top]

Change in Acute Physiology and Chronic Health Evaluation (APACHE) Scores

APACHE score is a severity-of-disease classification system that is calculated from a patient's age and 12 routine physiological measurements. Total scores are computed based on several measurements and range from 0 to 71 with higher scores corresponding to more severe disease and a higher risk of death. (NCT03338569)
Timeframe: Baseline and 4 days

Interventionscore on a scale (Mean)
Placebo7
Intervention5

[back to top]

Change in Sequential Organ Failure Assessment (SOFA) Score

SOFA score is a mortality prediction score that is based on the degree of dysfunction of 6 organ systems. Total scores range from 0 to 24, with higher scores indicating higher likely mortality. (NCT03338569)
Timeframe: Baseline and 4 days

Interventionscore on a scale (Median)
Placebo4
Intervention4

[back to top]

Change in Serum Creatinine

Outcome is report as the change in serum creatinine between baseline and 4 days following treatment. Outcome is reported in units of mg/dl. (NCT03338569)
Timeframe: Baseline and 4 days

Interventionmg/dl (Median)
Placebo0.5
Intervention.4

[back to top]

Duration of ICU Stay Post Intervention Administration

Outcome is reported as the duration (in days) that participants require care in the intensive care unit (ICU) post intervention administration (NCT03338569)
Timeframe: 28 days

Interventiondays (Mean)
Placebo2.6
Intervention2.9

[back to top]

Duration of Vasopressor Therapy

Outcome is reported as the duration in hours of vasopressor therapy post intervention administration (NCT03338569)
Timeframe: 28 days

Interventionhours (Median)
Placebo27.1
Intervention27.7

[back to top]

Number of Participants With ICU Mortality

Outcome is reported as the number of patients who expired while receiving care in the intensive care unit (ICU). (NCT03338569)
Timeframe: 28 days

InterventionParticipants (Count of Participants)
Placebo20
Intervention14

[back to top]

Number of Participants With Need for Renal Replacement Therapy

Outcome is reported as the number of participants who require renal replacement therapy (NCT03338569)
Timeframe: 4 days

InterventionParticipants (Count of Participants)
Placebo2
Intervention10

[back to top]

Rate of Lactate Clearance Post Intervention Administration

Outcome is reported as the number of participants who clear lactate from the bloodstream at 24, 48, 72, and 96 hours post intervention. Clearance is defined as a serum concentration of 2.0 mmol/l or less. (NCT03338569)
Timeframe: 24, 48, 72, and 96 hours post intervention

,
InterventionParticipants (Count of Participants)
24 hours48 hours72 hours96 hours
Intervention12161818
Placebo13181819

[back to top]

Total Intravenous Fluid Administered

Outcome is reported as the total volume of intravenous fluid (in liters) administered to participants during 24 hours following the initiation of study treatment. (NCT03338569)
Timeframe: 24 hours

,
Interventionliters (Mean)
6 hours post initiation of study treatment24 hours post initiation of study treatment
Intervention1.073.59
Placebo.763.37

[back to top]

Change in Sequential Organ Failure Assessment (SOFA) Score

Defined as the day 4 post-randomization SOFA score minus the initial SOFA score. The Sequential Organ Failure Assessment (SOFA) Score is a mortality prediction score that is based on the degree of dysfunction of six organ systems. The score is calculated on admission and every 24 hours until discharge using the worst parameters measured during the prior 24 hours SOFA score ranges from 0 (no organ dysfunction) to 24 (highest possible score / organ dysfunction). (NCT03422159)
Timeframe: 4 days post-randomization

Interventionscore on a scale (Mean)
Treatment Arm2.9
Placebo Arm1.93

[back to top]

Hospital Length of Stay

Time from admitting to discharge of hospital stay. (NCT03422159)
Timeframe: From admission to the hospital until final discharge, up to 28 days.

InterventionDays (Mean)
Treatment Arm11.5
Placebo Arm11

[back to top]

Hospital Mortality

In-hospital mortality rate. (NCT03422159)
Timeframe: Survival until hospital discharge, up to 28 days.

InterventionParticipants (Count of Participants)
Treatment Arm11
Placebo Arm13

[back to top]

ICU Length of Stay

Time from admitting to ICU to discharge. (NCT03422159)
Timeframe: From admission to the ICU until final discharge from the ICU, up to an average of 7 days.

Interventiondays (Mean)
Treatment Arm4.76
Placebo Arm4.66

[back to top]

ICU Mortality

ICU mortality rate (NCT03422159)
Timeframe: From admission to hospital until final discharge from the ICU, up to 28 days.

InterventionParticipants (Count of Participants)
Treatment Arm6
Placebo Arm10

[back to top]

Procalcitonin (PCT) Clearance

PCT at 96 hours minus initial PCT, divided by the initial PCT multiplied by 100. (NCT03422159)
Timeframe: 4 days post-randomization

InterventionPercent (Mean)
Treatment Arm63
Placebo Arm58

[back to top]

Time to Vasopressor Independence (Hours)

Defined as the time from starting the active treatment/placebo to discontinuation of all pressors. (NCT03422159)
Timeframe: From start of vasopressor medication to final discontinuation of vasopressor medication, up to 7 days.

Interventionhours (Mean)
HAT Treatment27
Comparator53

[back to top]

Ventilator Free Days

Number of days alive and off of the ventilator at day 28. (NCT03422159)
Timeframe: 28 Days post-randomization

InterventionDays (Mean)
Treatment Arm22
Placebo Arm22.4

[back to top]

30-day Mortality

Mortality rate (NCT03389555)
Timeframe: Enrollment until 30-days after enrollment

InterventionParticipants (Count of Participants)
Vitamin C, Vitamin B1, Corticosteroids35
Placebo29

[back to top]

Hospital Disposition: Survivors Discharged Home

Home hospital disposition in patients who survive to discharge (NCT03389555)
Timeframe: Enrollment until hospital discharge, death, or 30-days, whichever comes first.

InterventionParticipants (Count of Participants)
Vitamin C, Vitamin B1, Corticosteroids34
Placebo35

[back to top]

Hospital Mortality

Hospital mortality rate (NCT03389555)
Timeframe: Enrollment until hospital discharge, death, or 30-days. Whichever comes first.

InterventionParticipants (Count of Participants)
Vitamin C, Vitamin B1, Corticosteroids28
Placebo23

[back to top]

ICU Free Days

Number of days that the patient was not in the ICU. Timeframe listed below. (NCT03389555)
Timeframe: From enrollment until 28 days after enrollment

InterventionDays (Median)
Vitamin C, Vitamin B1, Corticosteroids22
Placebo21

[back to top]

Intensive Care Unit (ICU) Mortality

ICU mortality rate (NCT03389555)
Timeframe: Enrollment until ICU discharge, death, or 30-days. Whichever comes first.

InterventionParticipants (Count of Participants)
Vitamin C, Vitamin B1, Corticosteroids23
Placebo20

[back to top]

Number of Participants With Delirium

"Describes if patient has delirium as defined by the Confusion Assessment Method (CAM)-ICU. The CAM-ICU method requires that the patient have 3 features to qualify for delirium:~Acute Onset of Changes or Fluctuations in the Course of Mental Status (AND )~Inattention (AND)~Disorganized thinking (OR) Altered Level of Consciousness" (NCT03389555)
Timeframe: On day 3 (at approximately 72 hours) after the first study drug dose

InterventionParticipants (Count of Participants)
Vitamin C, Vitamin B1, Corticosteroids31
Placebo35

[back to top]

Renal Failure

"Development of renal failure as defined by a Kidney Disease Improving Global Outcomes [KDIGO] stage 3 or higher. There are 3 stages in the KDIGO scale with stage 3 being the worst (corresponds to renal failure).~Stage 1- serum creatinine 1.5 to 1.9 times baseline OR an increase in serum creatinine ≥ 0.3 mg/dL OR urine output < 0.5ml/kg/hour for 6-12 hours. Stage 2- serum creatinine 2.0-2.9 times baseline OR urine output <0.5mg/kg/hour for ≥ 12 hours Stage 3- serum creatinine 3.0 times baseline (or serum creatinine of more than or equal to 4.0 mg/dl with an acute increase of at least 0.5 mg/dl) (OR) Urine output less than 0.3 ml/kg/hour for 24 hours or anuria for 12 hours or new renal replacement therapy" (NCT03389555)
Timeframe: Enrollment until 7-days or discharge from the ICU

InterventionParticipants (Count of Participants)
Vitamin C, Vitamin B1, Corticosteroids32
Placebo27

[back to top]

Shock Free Days

Days not receiving vasopressor (NCT03389555)
Timeframe: Vasopressor free days over the first 7-days after enrollment

InterventionDays (Median)
Vitamin C, Vitamin B1, Corticosteroids5
Placebo4

[back to top]

Ventilator Free Days

Days not receiving invasive mechanical ventilation (NCT03389555)
Timeframe: Ventilator free days over the first 7-days after enrollment

InterventionDays (Median)
Vitamin C, Vitamin B1, Corticosteroids6
Placebo6

[back to top]

Sequential Organ Failure Assessment (SOFA) Score at Baseline and 72 Hours

Sequential Organ Failure Assessment (SOFA) Score at Baseline and 72 Hours. The SOFA score ranges from a minimum of 0 to a maximum of 24, with higher scores meaning worse outcomes. (NCT03389555)
Timeframe: Enrollment to 72-hours

,
InterventionUnits on a scale (Mean)
Enrollment SOFA score72 hour SOFA score
Placebo9.25.1
Vitamin C, Vitamin B1, Corticosteroids9.14.4

[back to top]

Duration of Time on Pazopanib Hydrochloride

Will be described as the median time on treatment by arm. (NCT03334409)
Timeframe: 10 months

InterventionMonths (Median)
Arm A (Pazopanib Hydrochloride, Ascorbic Acid)5.9
Arm B (Pazopanib Hydrochloride)9.2

[back to top]

Frequency of Adverse Events

Graded according to National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0. Adverse events and toxicities will be evaluated using all patients who have received any study treatment as well as summarizing those who have been included in the efficacy analyses. The overall adverse event frequencies for grade 3 or higher adverse events, will be compared using Chi-Square tests between the 2 treatment arms. (NCT03334409)
Timeframe: 10 Months

InterventionParticipants (Count of Participants)
Arm A (Pazopanib Hydrochloride, Ascorbic Acid)1
Arm B (Pazopanib Hydrochloride)2

[back to top]

Overall Response Rate

Per Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by CT scan, PET/CT, or MRI: Complete Response (CR), Disappearance of all target lesions and all target lymph nodes must have reduction in short axis to <1.0 cm; Partial Response (PR), >=30% decrease in the sum of the longest diameter of target lesions plus the sum of the short axis of all the target lymph nodes at current evaluation; Overall Response (OR) = CR + PR. Will be compared using a Chi-Square test. (NCT03334409)
Timeframe: 16 Months

InterventionParticipants (Count of Participants)
Arm A (Pazopanib Hydrochloride, Ascorbic Acid)0
Arm B (Pazopanib Hydrochloride)1

[back to top]

Overall Survival

Will be estimated using the method of Kaplan-Meier and be compared using log rank tests. (NCT03334409)
Timeframe: 26 months

InterventionMonths (Median)
Arm A (Pazopanib Hydrochloride, Ascorbic Acid)7.8
Arm B (Pazopanib Hydrochloride)NA

[back to top]

Progression Free Survival

Will be estimated using the Kaplan-Meier method. (NCT03334409)
Timeframe: 16 Months

InterventionMonths (Median)
Arm A (Pazopanib Hydrochloride, Ascorbic Acid)5.7
Arm B (Pazopanib Hydrochloride)11.8

[back to top]

Treatment Failure-free Rate

Treatment failure is defined as any of the following: radiographic disease progression, off-protocol treatment due to adverse event, initiation of alternative therapy (except metastasectomy post clinical benefit (complete response [CR], partial response [PR], or stable disease [SD] per Response Evaluation Criteria in Solid Tumors [RECIST] 1.1 to treatment), and death due to any cause. (NCT03334409)
Timeframe: At 40 weeks

InterventionParticipants (Count of Participants)
Arm A (Pazopanib Hydrochloride, Ascorbic Acid)0
Arm B (Pazopanib Hydrochloride)2

[back to top]

Admission to NICU

NICU denotes neonatal intensive care unit. (NCT00135707)
Timeframe: Delivery through discharge

InterventionParticipants (Count of Participants)
Vitamins577
Placebo557

[back to top]

Analysis of Primary Composite Outcome in Participants Randomized Before the 13th Week of Pregnancy

Subgroup analysis of the primary composite outcome (severe pregnancy associated hypertension or severe or mild hypertension with elevated liver-enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, indicated preterm birth, fetal-growth restriction or prenatal death) in participants who were randomized before the 13th week of pregnancy. (NCT00135707)
Timeframe: During pregnancy

InterventionParticipants (Count of Participants)
Vitamins144
Placebo127

[back to top]

Analysis of Primary Composite Outcome in Participants Randomized on or After the 13th Week of Pregnancy

Subgroup analysis of the primary composite outcome (severe pregnancy associated hypertension or severe or mild hypertension with elevated liver-enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, indicated preterm birth, fetal-growth restriction or prenatal death) in participants who were randomized on or after the 13th week of pregnancy. (NCT00135707)
Timeframe: During pregnancy

InterventionParticipants (Count of Participants)
Vitamins161
Placebo158

[back to top]

Antepartum Bleeding

(NCT00135707)
Timeframe: During pregnancy

InterventionParticipants (Count of Participants)
Vitamins56
Placebo46

[back to top]

Apgar Score <=3 at 5 Minutes

(NCT00135707)
Timeframe: At birth

Interventionparticipants (Number)
Vitamins23
Placebo27

[back to top]

Aspartate Aminotransferase ≥100 U/Liter

(NCT00135707)
Timeframe: 20 weeks through discharge

InterventionParticipants (Count of Participants)
Vitamins35
Placebo48

[back to top]

Birth Weight

(NCT00135707)
Timeframe: At birth

Interventiongrams (Mean)
Vitamins3247
Placebo3244

[back to top]

Birth Weight <2500 Grams

(NCT00135707)
Timeframe: At birth

InterventionParticipants (Count of Participants)
Vitamins345
Placebo369

[back to top]

Cesarean Delivery

(NCT00135707)
Timeframe: Delivery

InterventionParticipants (Count of Participants)
Vitamins1269
Placebo1224

[back to top]

Composite of Pregnancy-associated Hypertension and Serious Adverse Outcomes in the Mother or Fetus or Neonate

Severe hypertension (blood pressure [BP]>= 160/110) or mild hypertension (BP>= 140/90) >= 20 weeks gestation in conjunction with one of the following: elevated liver enzymes, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, an indicated preterm birth before 32 weeks of gestation owing to hypertension-related disorders, a fetus that was small for gestational age (below 3rd percentile) adjusted for sex and race or ethnic group, fetal death after 20 weeks of gestation, or neonatal death (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins305
Placebo285

[back to top]

Creatinine ≥1.5 mg/dl (133 μmol/Liter)

(NCT00135707)
Timeframe: 20 weeks through discharge

InterventionParticipants (Count of Participants)
Vitamins9
Placebo12

[back to top]

Gestational Age at Delivery

(NCT00135707)
Timeframe: Delivery

Interventionweeks (Median)
Vitamins38.9
Placebo38.8

[back to top]

Hematocrit ≤24% With Transfusion

(NCT00135707)
Timeframe: Delivery admission to discharge

InterventionParticipants (Count of Participants)
Vitamins40
Placebo59

[back to top]

Intraventricular Hemorrhage, Grade III or IV

(NCT00135707)
Timeframe: Delivery through discharge

InterventionParticipants (Count of Participants)
Vitamins6
Placebo7

[back to top]

Maternal Death

(NCT00135707)
Timeframe: Delivery through hospital discharge

InterventionParticipants (Count of Participants)
Dietary Supplement/Vitamins1
Placebo for Vitamin C and Vitamin E1

[back to top]

Maternal Hospital Stay

(NCT00135707)
Timeframe: Delivery through discharge

Interventiondays (Median)
Vitamins2.0
Placebo2.0

[back to top]

Medically Indicated Delivery Because of Hypertension

(NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins509
Placebo473

[back to top]

Necrotizing Enterocolitis

(NCT00135707)
Timeframe: Delivery through discharge

InterventionParticipants (Count of Participants)
Vitamins10
Placebo14

[back to top]

Neonatal Hospital Stay

(NCT00135707)
Timeframe: Birth through discharge from hospital

Interventiondays (Median)
Vitamins2.0
Placebo2.0

[back to top]

Placental Abruption

(NCT00135707)
Timeframe: During pregnancy

InterventionParticipants (Count of Participants)
Vitamins24
Placebo36

[back to top]

Postpartum Pulmonary Edema

(NCT00135707)
Timeframe: After delivery through discharge

InterventionParticipants (Count of Participants)
Vitamins3
Placebo10

[back to top]

Pregnancy Associated Hypertension

(NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins1457
Placebo1322

[back to top]

Premature Rupture of Membranes

(NCT00135707)
Timeframe: During pregnancy

InterventionParticipants (Count of Participants)
Vitamins124
Placebo129

[back to top]

Respiratory Distress Syndrome

(NCT00135707)
Timeframe: Delivery through discharge

InterventionParticipants (Count of Participants)
Vitamins150
Placebo144

[back to top]

Retinopathy of Prematurity

(NCT00135707)
Timeframe: Within 1 month of birth

InterventionParticipants (Count of Participants)
Vitamins19
Placebo16

[back to top]

Sepsis

(NCT00135707)
Timeframe: Delivery through discharge

InterventionParticipants (Count of Participants)
Vitamins30
Placebo23

[back to top]

Severe Hypertension

Included here are women who had severe hypertension only and those who had severe hypertension with elevated liver enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, medically indicated preterm birth, fetal-growth restriction, or fetal death after 20 weeks of gestation, or neonatal death. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins210
Placebo204

[back to top]

Severe or Mild Pregnancy-associated Hypertension With a Fetal Death After 20 Weeks of Gestation or Neonatal Death

Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. (NCT00135707)
Timeframe: 20 weeks through discharge or prior to discharge following delivery admission

InterventionParticipants (Count of Participants)
Vitamins12
Placebo11

[back to top]

Severe or Mild Pregnancy-associated Hypertension With a Fetus That Was Small for Gestational Age (Below the 3rd Percentile) Adjusted for Sex and Race or Ethnic Group

Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins60
Placebo46

[back to top]

Severe or Mild Pregnancy-associated Hypertension With an Eclamptic Seizure

Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins10
Placebo4

[back to top]

Severe or Mild Pregnancy-associated Hypertension With an Elevated Serum Creatinine Level

Elevated serum creatinine defined as ≥1.5 mg per deciliter or 132.6 μmol per liter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins7
Placebo11

[back to top] [back to top]

Severe or Mild Pregnancy-associated Hypertension With Elevated Liver Enzyme Levels

Elevated liver enzyme levels are specified as an aspartate aminotransferase level of >= 100 U per liter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

InterventionParticipants (Count of Participants)
Vitamins26
Placebo33

[back to top]

Severe or Mild Pregnancy-associated Hypertension With Thrombocytopenia

Thrombocytopenia defined as a platelet count of <100,000 per cubic millimeter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

Interventionparticipants (Number)
Vitamins21
Placebo31

[back to top]

Small for Gestational Age

A baby whose birth weight is less than the 3rd percentile is considered to be small for gestational age (adjusted for sex and race or ethnic group) (NCT00135707)
Timeframe: At birth

InterventionParticipants (Count of Participants)
Vitamins133
Placebo132

[back to top]

Fetal or Neonatal Death

(NCT00135707)
Timeframe: During pregnancy or thorugh discharge

,
InterventionParticipants (Count of Participants)
All Fetal or Neonatal DeathsFetal loss at < 20 weeksFetal death at ≥20 weeksNeonatal death
Placebo122593627
Vitamins113553820

[back to top]

Preeclampsia (Mild, Severe, HELLP Syndrome, Eclampsia)

HELLP denotes hemolytic anemia, elevated liver enzymes, and low platelet count. (NCT00135707)
Timeframe: 20 weeks through discharge following delivery

,
InterventionParticipants (Count of Participants)
Total PreeclampsiaMild PreeclampsiaSevere PreeclampsiaHELLP SyndromeEclampsia
Placebo33219112984
Vitamins358212134210

[back to top]

Preterm Birth

(NCT00135707)
Timeframe: Delivery

,
InterventionParticipants (Count of Participants)
<37 weeks' gestation<32 weeks' gestation
Placebo526173
Vitamins513149

[back to top]

Controlled Oral Word Association Test (COWAT) Score

Language is assessed with the Controlled Oral Word Association Test (COWAT). Participants generate words beginning with selected letters within 60 seconds. Generating a higher number of words indicates greater language skills. (NCT03509350)
Timeframe: Day 180

Interventionwords (Mean)
Treatment Protocol40
Control Protocol40

[back to top]

Digit Span Test Score

The Digit Span Test is used to assesses attention. In the Digit Span Test, participants are read a series of numbers and are asked to repeat them back in the same order. The Digit Span test is scored by the number of digits the participant is able to remember in each test. Higher scores indicate greater ability to pay attention and to remember sequences. The average adult can remember about 7 numbers, plus or minus two, without making an error. (NCT03509350)
Timeframe: Day 180

Interventionnumbers recalled (Mean)
Treatment Protocol8.3
Control Protocol9.5

[back to top]

EuroQol, 5 Dimension (EQ-5D) Visual Analog Scale Score

Quality of life is assessed with the Visual Analog Scale of the EuroQol, 5 dimension (EQ-5D) questionnaire. The EQ-5D asks about 5 dimensions of health (mobility, self-care, usual activities, pain, and depression). The questionnaire includes a visual analog scale where respondents rate their current health where 0 = worst health imaginable and 100 = best health imaginable. (NCT03509350)
Timeframe: Day 180

Interventionunits on a scale (Mean)
Treatment Protocol66
Control Protocol67

[back to top]

Functional Activities Questionnaire (FAQ) Score

Instrumental activities of daily living is assessed with the Functional Activities Questionnaire (FAQ). The FAQ includes 10 items which are scored on a scale from 0 to 3 where 0 = normal and 3 = dependent. Total scores range from 0 to 30 and lower scores indicate that the respondent is able to perform daily activities. A score of 9 (where the person is dependent in 3 activities) is used as a cut-point indicating impairments with functioning. (NCT03509350)
Timeframe: Day 180

Interventionscore on a scale (Mean)
Treatment Protocol9.5
Control Protocol7.7

[back to top]

Hayling Test Score

Executive function is assessed with the Hayling Test. The Hayling Test includes two parts of 15 items each where participants complete sentences by providing the missing word. The test is scored as the amount of time it takes, in seconds, to recite a correct response and the appropriateness of the response (in Part 2). Scaled scores range from 1 to 10 where 1 = impaired, 6 = average, and 10 = very superior. (NCT03509350)
Timeframe: Day 180

Interventionunits on a scale (Mean)
Treatment Protocol4.2
Control Protocol4.2

[back to top]

Intensive Care Unit (ICU) Mortality

The number of participants who died while in the ICU is compared between study arms. (NCT03509350)
Timeframe: Day 30

InterventionParticipants (Count of Participants)
Treatment Protocol52
Control Protocol49

[back to top]

Katz Index of Independence in Activities of Daily Living (ADL) Score

Activities of daily living is assessed with the Katz ADL instrument. The Katz ADL has 6 items asking if participants can perform daily tasks independently. Responses are scored as 1 = yes and 0 = no. Total scores range from 0 to 6 with higher scores indicating greater independence. (NCT03509350)
Timeframe: Day 180

Interventionscore on a scale (Mean)
Treatment Protocol2.8
Control Protocol2.4

[back to top]

Length of Hospital Stay

The number of days that participants were in the hospital is compared between study arms. (NCT03509350)
Timeframe: Day 30

Interventiondays (Mean)
Treatment Protocol12.6
Control Protocol13.5

[back to top]

Length of ICU Stay

The number of days that participants were in the ICU is compared between study arms. (NCT03509350)
Timeframe: Day 30

Interventiondays (Mean)
Treatment Protocol6.7
Control Protocol6.4

[back to top]

Mortality at 180 Days

The number of participants who did not survive until Day 180 is compared between study arms. (NCT03509350)
Timeframe: Day 180

InterventionParticipants (Count of Participants)
Treatment Protocol102
Control Protocol94

[back to top]

Mortality at 30 Days

The number of participants who did not survive until Day 30 is compared between study arms. (NCT03509350)
Timeframe: Day 30

InterventionParticipants (Count of Participants)
Treatment Protocol56
Control Protocol60

[back to top]

Number of Participants Employed

The Employment Questionnaire is a brief measure of the participant's employment history and ability or capacity to work. The number of participants who indicated being employed are presented here. (NCT03509350)
Timeframe: Day 180

InterventionParticipants (Count of Participants)
Treatment Protocol17
Control Protocol25

[back to top]

Number of Participants With Delirium Assessed With the DeliriumTelephone Confusion Assessment Method (CAM)

The Telephone CAM evaluates dementia with 9-items, where additional questions are asked if symptoms are present. Rather than providing a summary score, if participants exhibit signs of a change in mental status which fluctuates and they experience inattention, along with disorganized thinking or altered level of consciousness, delirium is suggested. (NCT03509350)
Timeframe: Day 180

InterventionParticipants (Count of Participants)
Treatment Protocol0
Control Protocol0

[back to top]

Patient-Reported Outcomes Measurement Information System (PROMIS) Depression 6

Depression is assessed with the PROMIS Depression 6 instrument. This tool includes 6 items with response options on a scale of 1 to 5. Total raw scores range from 6 to 30 with higher scores indicating greater symptoms of depression. (NCT03509350)
Timeframe: Day 180

Interventionscore on a scale (Mean)
Treatment Protocol11.9
Control Protocol11.9

[back to top]

Posttraumatic Stress Disorder-8 (PTSD-8) Score

Posttraumatic Stress Disorder (PTSD) is assessed with the Posttraumatic Stress Disorder - 8 instrument. The PTSD-8 includes 8 items which are answered on a 4 point scale where 01 = not at all and 3 = all of the time. Total scores range from 0 to 24 where higher scores indicate greater symptoms of PTSD. (NCT03509350)
Timeframe: Day 180

Interventionscore on a scale (Mean)
Treatment Protocol5.7
Control Protocol5.2

[back to top]

Telephone Interview for Cognitive Status (TICS)

The Telephone Interview for Cognitive Status (TICS) is an 11-item instrument assessing orientation. Correct responses to the items are scored in a variety of ways, depending on how much of the response is correct. Total scores range from 0 to 41 with higher scores indicating increased cognitive orientation. (NCT03509350)
Timeframe: Day 180

Interventionscore on a scale (Mean)
Treatment Protocol30.6
Control Protocol31.2

[back to top]

Vasopressor and Ventilator-free Days (VVFD)

The primary outcome measure is VVFD in the first 30 days after the start of treatment. The endpoint was recorded to the nearest day. Participants who died are scored zero days, even if there was a period during which the participant was alive and free of vasopressors and mechanical ventilation. Participants who must return to ventilation and/or vasopressors had their counters reset at zero days. (NCT03509350)
Timeframe: Up to Day 30

Interventiondays (Median)
Treatment Protocol25
Control Protocol26

[back to top]

Wechsler Adult Intelligence Scale (WAIS)-IV Similarities Score

Reasoning is assessed with the WAIS-IV Similarities instrument. Participants were asked to explain how two words are alike. Responses are scored according to how correct they are, with a score of 0 for incorrect answers. After 3 consecutive scores of 0 the survey is stopped. Total raw scores vary depending on the number of word pairs presented. Higher scores indicate better performance. Scores will be compared between study arms. (NCT03509350)
Timeframe: Day 180

Interventionscore on a scale (Mean)
Treatment Protocol7.7
Control Protocol8.2

[back to top]

Wechsler Memory Scale III - Delayed Recall Logical Memory Score

Memory is assessed with the Logical Memory subtest from the Wechsler Memory Scale III. Participants listened to two short paragraphs and were asked to recall details from each story after 30 minutes. Scores represent the number of correctly remembered details. Total scores range from 0 to 25 with higher scores reflecting better memory. (NCT03509350)
Timeframe: Day 180

Interventioncorrect story details (Mean)
Treatment Protocol6.9
Control Protocol8.1

[back to top]

Number of Participants Who Had COVID-19 Disease

Participants who had a PCR-confirmed SARS-CoV-2 infection and met the Center for Disease Control (CDC) defined criteria for symptomatic COVID-19 disease. (NCT04328961)
Timeframe: 28 days from enrolment

InterventionParticipants (Count of Participants)
Ascorbic Acid26
Hydroxychloroquine37

[back to top]

Number of Participants Who Had Polymerase Chain Reaction (PCR) Confirmed SARS-CoV-2 Infection

Polymerase chain reaction (PCR) confirmed severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus (SARS-CoV-2) infection from self-collected samples collected daily for 14 days (NCT04328961)
Timeframe: Day 1 through Day 14 after enrolment

InterventionParticipants (Count of Participants)
Ascorbic Acid45
Hydroxychloroquine53

[back to top]

Rate of Participant-reported Adverse Events

Safety and tolerability of Hydroxychloroquine as SARS-CoV-2 PEP in adults (NCT04328961)
Timeframe: 28 days from start of Hydroxychloroquine therapy

InterventionParticipants (Count of Participants)
Ascorbic Acid46
Hydroxychloroquine66

[back to top]

The Number of Participants Who Had Polymerase Chain Reaction (PCR) Confirmed SARS-CoV-2 Infection

Polymerase chain reaction (PCR) confirmed SARS-CoV-2 infection from self-collected samples collected at study exit (NCT04328961)
Timeframe: Day 28 after enrolment

InterventionParticipants (Count of Participants)
Ascorbic Acid48
Hydroxychloroquine58

[back to top]

Number of Participants That Experienced Dose Limiting Toxicities (DLTs) Using CTCAE, Version 4.0

To examine the toxicity related to the therapy by measuring the number attributed adverse event (definite, probable or possible) according to CTCAE version 4.0. (NCT03508726)
Timeframe: Start of treatment up to 4 weeks after the last ascorbate infusion

Interventionparticipants (Number)
Phase I: Ascorbate 75 mg IV Infusion0

[back to top]

Number of Participants With Pathologic Tumor Necrosis ≥ 95% Following Concurrent Radiation Therapy and Ascorbate

To estimate the efficacy of neoadjuvant ascorbate and radiotherapy as assessed by the pathological complete response rates (pCR) in subjects with locally advanced high grade soft tissue sarcomas. (NCT03508726)
Timeframe: Start of treatment up to 6 weeks after the last ascorbate infusion

InterventionParticipants (Count of Participants)
Phase I: Ascorbate 75 mg IV Infusion2
Phase II: Ascorbate 75 mg IV Infusion1

[back to top]

Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2)

Bowel preparation score 1+2 expressed on Aronchick scale (1 the best, 5 the worst) (NCT02956057)
Timeframe: One day

InterventionParticipants (Count of Participants)
PEG1D110
PEG2D145
SPMC1D100
SPMC2D134
PEGA1D121
PEGA2D55

[back to top]

Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2)

Tolerance of Bowel Preparation Assessed by VAS score 1+2 ( 1-excellent, 5-very poor) (NCT02956057)
Timeframe: One day

InterventionParticipants (Count of Participants)
PEG1D56
PEG2D72
SPMC1D134
SPMC2D139
PEGA1D85
PEGA2D80

[back to top]

Area Under the Curve (AUC0-12hours) for Calculated BH4 (From Total Biopterin)

Total biopterin concentration area under the curve (AUC0-12hours) at the end of each regimen in subjects with endothelial dysfunction is theoretically the sum of BH4, BH2 and B. Biopterin is the metabolite of BH4 after oxidative conversion of BH4 and BH2 to biopterin. Total biopterin concentrations represent the summation of drug and metabolites: BH4, BH2 and B. The total biopterin concentrations can be converted to BH4 concentration using the conversion factor 2.150. (NCT00532844)
Timeframe: At 30 minutes prior to dosing, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 10.0, and 12.0 hours after dosing.

InterventionnM*hr (Mean)
Sapropterin Dihydrochloride440
Sapropterin Dihydrochloride+Vitamin C440

[back to top]

Area Under the Curve (AUC0-12hrs) of Plasma BH4 Concentration

Plasma BH4 concentration area under the curve (AUC0-12 hrs) at the end of each regimen in subjects with endothelial dysfunction. (NCT00532844)
Timeframe: At 30 minutes prior to dosing, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 10.0, and 12.0 hours after dosing.

InterventionnM*hr (Mean)
Sapropterin Dihydrochloride 10 mg/kg633
Sapropterin Dihydrochloride+Vitamin C 10 mg/kg993

[back to top]

Area Under the Curve (AUC0-12hrs) of Plasma BH2 and B Concentration

Plasma BH2 and B concentration area under the curve (AUC0-12hrs) at the end of each regimen in subjects with endothelial dysfunction. (NCT00532844)
Timeframe: At 30 minutes prior to dosing, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 10.0, and 12.0 hours after dosing.

,
InterventionnM*hr (Mean)
BH2B
Sapropterin Dihydrochloride875231
Sapropterin Dihydrochloride+Vitamin C772185

[back to top]

Change From Baseline in Cyclic Guanosine Monophosphate (cGMP)

Biomarkers of endothelial function, oxidative stress, and inflammation as measured by cyclic guanosine monophosphate (cGMP). (NCT00532844)
Timeframe: At Baseline, Day 14 and Day 28.

,
Interventionpmol/mL (Mean)
BaselineChange from Baseline to Day 14Change from Day 14 to Day 28
Sapropterin Dihydrochloride 10mg/kg Vitamin C3.79410.6278-0.0507
Sapropterin dihydrochloride10mg/kg and Vitamin C3.85330.2088-0.0078

[back to top]

Change From Baseline in Diastolic Blood Pressure (DBP)

"Change is calculated as follows: end time measurement - starting time measurement.~Mean daytime diastolic blood pressure measured by ambulatory blood pressure monitoring (ABPM)" (NCT00532844)
Timeframe: At Baseline, Day 13 and Day 27

,
Interventionmm Hg (Mean)
BaselineChange from Baseline to Day 13Change from Day 13 to Day 27
Sapropterin Dihydrochloride 10mg/kg and Vitamin C80.150.451.23
Sapropterin dihydrochloride10mg/kg77.32-2.31-2.01

[back to top]

Change From Baseline in Peripheral Arterial Tonometry (PAT)

PAT measures pulse wave amplitude of the small arteries of the finger as a surrogate to assess endothelial function and arterial stiffness using a finger plethysmographic probe and 5-minute occlusion of the brachial artery. Endothelial dysfunction, a protocol inclusion criteria, is defined by an abnormal PAT of < or = 1.70. Change is calculated as follows: end time measurement - starting time measurement. (NCT00532844)
Timeframe: At Baseline, Day 13 and Day 27

,
InterventionRatio (Mean)
BaselineDay 13Change from Baseline to Day 13Day 27Change from Day 13 to Day 27
Sapropterin Dihydrochloride 10mg/kg1.51131.85090.34671.90470.1293
Sapropterin Dihydrochloride 10mg/kg and Vitamin C1.48591.77540.29021.6482-0.1641

[back to top]

Change From Baseline in Systolic Blood Pressure (SBP)

"Change is calculated as follows: end time measurement - starting time measurement.~Mean daytime systolic blood pressure measured by ambulatory blood pressure monitoring (ABPM)" (NCT00532844)
Timeframe: At Baseline, Day 13 and Day 27

,
Interventionmm Hg (Mean)
BaselineChange from Baseline to Day 13Change from Day 13 to Day 27
Sapropterin Dihydrochloride 10mg/kg and Vitamin C131.29-0.103.31
Sapropterin dihydrochloride10mg/kg125.14-3.24-1.67

[back to top]

Change From Baseline in Urinary 8-isoprostane/Creatinine

Biomarkers of endothelial function, oxidative stress, and inflammation as measured by 8-isoprostane. (NCT00532844)
Timeframe: At Baseline, Day 14 and Day 28

,
Interventionpg/mg (Mean)
BaselineChange from Baseline to Day 14Change from Day 14 to Day 28
Sapropterin Dihydrochloride 10mg/kg898.01-192.13-117.61
Sapropterin dihydrochloride10mg/kg and Vitamin C992.38-31.7532.44

[back to top]

Change in Urinary Albumin to Creatinine Ratio (mg/g)

Change in Urinary Albumin to Creatinine Ratio (mg/g) from Baseline to Day 14, Baseline to Day 28, and from Day 14 to Day 28 (NCT00532844)
Timeframe: Baseline, Day 14 and Day 28

,
Interventionmg/g (Mean)
BaselineChange from Baseline to Day 14Change from Day 14 to Day 28
Sapropterin Dihydrochloride 10mg/kg13.3-1.2-2.2
Sapropterin Dihydrochloride 10mg/kg and Vitamin C12.32.74.9

[back to top]

Number of Participants With Urinary Albumin to Creatinine Ratio <30 mg/g

Summary of Urinary Albumin to Creatinine Ratio (mg/g) by subjects with ratio <30 mg/g and subjects with ratios >=30 mg/g at Baseline, Day 14 and Day 28 (NCT00532844)
Timeframe: Baseline, Day 14 and Day 28

,
InterventionParticipants (Count of Participants)
Baseline < 30 mg/gBaseline >=30 mg/gDay 14 < 30 mg/gDay 14 >=30 mg/gDay 28 < 30 mg/gDay 28 >=30 mg/g
Sapropterin Dihydrochloride 10mg/kg131102121
Sapropterin Dihydrochloride 10mg/kg and Vitamin C162131102

[back to top]

Number of Subjects With Treatment Emergent Adverse Events (TEAEs)

A treatment-emergent Adverse Events (TEAE) is any Adverse Events that newly appeared, increased in frequency or worsened in severity following initiation of study drug administration. (NCT00532844)
Timeframe: Up to 56 ± 3 Days.

,
InterventionParticipants (Count of Participants)
Subjects with any Adverse EventSubjects with any Serious Adverse EventSubjects with any treatment-related Adverse EventAny treatment-related Serious Adverse EventDeathAny AEs Leading to Study Discontinuation
Sapropterin Dihydrochloride19016001
Sapropterin Dihydrochloride+Vitamin C16013000

[back to top]

Ratio of BH2, B and BH4 Calculated From Total Biopterin Area Under the Curve (0-12hours) for Subjects Administered Sapropterin Dihydrochloride With Vitamin C to Subjects Administered Sapropterin Alone.

Ratio of Mean AUC (0-12 hours) for subjects receiving (Sapropterin dihydrochloride + Vitamin C)/ Mean AUC (0-12 hours) for subjects receiving Sapropterin dihydrochloride alone) for BH4, BH2, B, BH4/BH2 Ratio, and BH4 Calculated from Total Biopterin. (NCT00532844)
Timeframe: At 30 minutes prior to dosing, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 10.0, and 12.0 hours after dosing.

Interventionratio (Mean)
BH2BCalculated BH4 (from Total Biopterin)
(Sapropterin Dihydrochloride+Vitamin C)/(Sapropterin Dihydrochloride)0.9981.041.03

[back to top]

Number of Patients Reaching Complete Response (CR)

Number of participants with CR at Day 180 who had maintained CR for at minimum of 4 weeks, and who had: No monoclonal protein in urine/serum when analyzed by immunofixation electrophoresis; bone marrow normal by morphological examination with <5% plasma cells, <1% aneuploid light chain restricted population by flow cytometry for DNA/cIg; and, while healing of bony lesion is not required, no new lytic lesion should appear. Further compression fracture of spine not considered progressive disease. (NCT00469209)
Timeframe: Baseline through Day 180, with assessments at Day 90 and Day 180

Interventionparticipants (Number)
No Bortezomib4
Bortezomib 1.0 mg/m^21
Bortezomib 1.5 mg/m^24

[back to top]

Number of Patients With an Overall Response of Complete Response (CR) or Partial Response (PR)

Complete response and Partial response are defined using 2000 international working group (IWG) criteria. The Primary criteria for a CR is a repeat bone marrow showing < 5% myeloblasts with normal maturation of all cell lines, with no evidence for dysplasia . A PR meets all the CR criteria except Blasts decreased by >50% over pretreatment, or a less advanced myelodysplastic syndrome (MDS) French American British (FAB) classification than pretreatment. (NCT00621023)
Timeframe: after 4 cycles of therapy

Interventionparticipants (Number)
All Participants0

[back to top]

Number of Patients With an Unacceptable Toxicity

Any of the following non-hematologic toxicities that causes a patient's therapy to be suspended or discontinued: Creatinine > 2x baseline value; serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), Total bilirubin > 2x the upper limit of normal; Febrile neutropenia; Uncontrolled infection; Hepatotoxicity defined as an increase in serum bilirubin, SGOT, or alkaline phosphatase to >5 times baseline value); nephrotoxicity (defined as serum creatinine >3.5 times the ULN); neurological impairment (defined as somnolence, seizures, or impaired mentation); severe peripheral neuropathy, or any non-hematologic grade 4 toxic event. (NCT00621023)
Timeframe: During the treatment period and for 30 days after last dose of study drug

Interventionparticipants (Number)
All Participants4

[back to top]

Change in Alanine Aminotransferase (ALT) Level

Standard blood test used to determine the severity and nature of liver problems. (NCT03829683)
Timeframe: Baseline and 96 hours

InterventionIU/L (Mean)
Vitamin C Infusion (Ascorbic Acid)62.71
Placebo1.00

[back to top]

Change in Albumin

Standard blood test used to determine the severity and nature of liver problems. (NCT03829683)
Timeframe: Baseline and 96 hours

Interventiong/dL (Mean)
Vitamin C Infusion (Ascorbic Acid)-0.10
Placebo0.06

[back to top]

Change in Alkaline Phosphatase

Standard blood test used to determine the severity and nature of liver problems. (NCT03829683)
Timeframe: Baseline and 96 hours

InterventionU/L (Mean)
Vitamin C Infusion (Ascorbic Acid)-5.71
Placebo-7.50

[back to top]

Change in Aspartate Aminotransferase (AST) Level

Standard blood test used to determine the severity and nature of liver problems. (NCT03829683)
Timeframe: Baseline and 96 hours

InterventionIU/L (Mean)
Vitamin C Infusion (Ascorbic Acid)176.0
Placebo-16.5

[back to top]

Change in Total Bilirubin

Standard blood test used to determine the severity and nature of liver problems. (NCT03829683)
Timeframe: Baseline and 96 hours

Interventionmg/dL (Mean)
Vitamin C Infusion (Ascorbic Acid)-0.30
Placebo0.45

[back to top]

Changes to Corrected QT Interval (QTc)

An electrocardiogram (ECG or test of the electrical activity of the heart) is performed to determine if there are changes to the heart rhythm. (NCT03829683)
Timeframe: Baseline and 96 hours

Interventionmilliseconds (Mean)
Vitamin C Infusion (Ascorbic Acid)-10.00
Placebo-58.17

[back to top]

Changes to Level of Medical Care

Documentation of the need for more intensive medical care such as ventilator (breathing machine) or vasopressors (intravenous medications use increase blood pressure) when not needed at baseline (NCT03829683)
Timeframe: up to 168 hours

InterventionParticipants (Count of Participants)
Vitamin C Infusion (Ascorbic Acid)2
Placebo1

[back to top]

Changes to Urine pH

Urine samples are collected to determine changes in pH (acidity) that could indicate a risk for kidney stones. The pH scale ranges from 0 to 14, with smaller numbers meaning more acidic and higher numbers meaning more basic. A pH of 7 is considered to be neutral. Normal levels of urine pH range from 4.6 - 8 on the pH scale. (NCT03829683)
Timeframe: Baseline and 96 hours

Interventionunits on a scale (Mean)
Vitamin C Infusion (Ascorbic Acid)5.31
Placebo5.17

[back to top]

Hospital-free Days

The number of days spent outside of the hospital (NCT03829683)
Timeframe: Day 90

Interventiondays (Mean)
Vitamin C Infusion (Ascorbic Acid)58.40
Placebo48.88

[back to top]

ICU-free Days

The number of days not spent in an intensive care unit (ICU) (NCT03829683)
Timeframe: Day 28

Interventiondays (Mean)
Vitamin C Infusion (Ascorbic Acid)16.40
Placebo13.20

[back to top]

Number of Deaths Due to Any Cause

Any cause of death that is anticipated or unanticipated (NCT03829683)
Timeframe: Day 28

InterventionDeaths (Number)
Vitamin C Infusion (Ascorbic Acid)4
Placebo3

[back to top]

Number of Deaths Due to Any Cause

Any cause of death that is anticipated or unanticipated (NCT03829683)
Timeframe: Day 90

InterventionDeaths (Number)
Vitamin C Infusion (Ascorbic Acid)5
Placebo4

[back to top] [back to top]

Change in Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) Score

A number that ranges from 0 (least sick) to 24 (most sick) and ranks the degree of sickness from liver failure and several other organ systems in a critically ill person. The score is determined by evaluating a person's liver function, kidney function, nervous system (brain), coagulation (blood clotting), circulation (blood pressure), and respiratory status (breathing) (NCT03829683)
Timeframe: Baseline and 96 hours

Interventionscore on a scale (Mean)
Baseline
Vitamin C Infusion (Ascorbic Acid)14

[back to top]

Change in Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) Score

A number that ranges from 0 (least sick) to 24 (most sick) and ranks the degree of sickness from liver failure and several other organ systems in a critically ill person. The score is determined by evaluating a person's liver function, kidney function, nervous system (brain), coagulation (blood clotting), circulation (blood pressure), and respiratory status (breathing) (NCT03829683)
Timeframe: Baseline and 96 hours

Interventionscore on a scale (Mean)
BaselineDay 4
Placebo15.3312.75

[back to top]

Change in Model for End Stage Liver Disease (MELD) Score

Change in MELD score from Day 0 to Day 4. MELD score ranges from 6 (least sick) to 40 (most sick) based on blood tests which ranks the degree of sickness from liver disease. The lab tests used to determine the MELD score are creatinine, bilirubin, and international normalized ratio (INR). (NCT03829683)
Timeframe: Baseline and 96 hours

,
Interventionscore on a scale (Mean)
All patientsPatients alive at 4 weeks
Placebo-2.9-2.4
Vitamin C Infusion (Ascorbic Acid)-0.13-2.3

[back to top]

Changes to Urine Microscopy

Urine samples are collected to check for the presence of crystalluria (microscopic crystals) that could indicate a risk for kidney stones. (NCT03829683)
Timeframe: Baseline and 96 hours

,
InterventionParticipants (Count of Participants)
Number of participants with crystalluria at baselineNumber of patients with crystalluria at Day 4
Placebo00
Vitamin C Infusion (Ascorbic Acid)00

[back to top]

Change in Arterial Stiffness

Central pulse wave velocity - Approximately 20-sec of pressure waveforms will be collected at the brachial, common carotid, and femoral arteries using a high-fidelity strain-gauge transducer. Pulse wave velocity will be calculated from the distances between measurement points and the measured time delay between proximal (carotid) and distal (femoral) waveforms. (NCT03889158)
Timeframe: Visit 1: At [BASELINE] and 2 hours following Vit C [BASELINE+VIT C]; Visit 2 (>72 hours after Visit 1): At baseline [PRE-INFLAMMATION BASELINE]; Visit 3 (24 hours after Visit 2): At baseline [INFLAMMATION] and 2 hours following Vit C [INFLAMMATION+VIT C]

,
Interventionm/s (Mean)
BaselineBaseline + Vit CPre-inflammationInflammationInflammation + Vit C
Older Adults9.39.98.88.88.9
Younger Adults5.85.95.65.65.7

[back to top]

Change in Endothelial Function

Flow-mediated dilation - Brachial artery vasodilator function will be noninvasively measured through assessment of brachial artery dilation using ultrasonography. The brachial artery will be imaged proximal to placement of a blood pressure cuff just below the antecubital fossa. Endothelium-dependent dilation of the brachial artery will be measured at baseline and again for 5 minutes following ischemic stimulus (inflation of a blood pressure cuff around the forearm to 250 mmHg for 5 minutes). (NCT03889158)
Timeframe: Visit 1: At [BASELINE] and 2 hours following Vit C [BASELINE+VIT C]; Visit 2 (>72 hours after Visit 1): At baseline [PRE-INFLAMMATION BASELINE]; Visit 3 (24 hours after Visit 2): At baseline [INFLAMMATION] and 2 hours following Vit C [INFLAMMATION+VIT C]

,
Intervention% change in diameter (Mean)
BaselineBaseline + Vit CPre-Inflammation BaselineInflammationInflammation + Vit C
Older Adults2.43.43.41.62.8
Younger Adults5.55.76.35.86.1

[back to top]

Change in Oxidative Stress

Oxidized low-density lipoprotein, vitamin C and total antioxidant capacity will be assessed using standard ELISAs from a venous blood draw. The analyses of the oxidized LDL and total antioxidant capacity failed. Only data on Vitamin C are presented. (NCT03889158)
Timeframe: Visit 1: At [BASELINE] and 2 hours following Vit C [BASELINE+VIT C]; Visit 2 (>72 hours after Visit 1): At baseline [PRE-INFLAMMATION BASELINE]; Visit 3 (24 hours after Visit 2): At baseline [INFLAMMATION] and 2 hours following Vit C [INFLAMMATION+VIT C]

,
Interventionug/mL (Mean)
BaselineBaseline + Vit CPre-InflammationInflammationInflammation + Vit C
Older Adults6.213.35.86.613.4
Younger Adults4.711.75.47.213.3

[back to top]

Changes in SCORAD Index

Changes of SCORAD(SCORing Atopic Dermatitis) index after taking Montelukast or placebo drug. SCORAD calculation: Extent(%)/5 + 7*Intensity/2 + subjective symptoms (minimum score 0, maximum score 103) (SCORAD index >40: severe, 15-40:moderate, <15: mild) (NCT00903357)
Timeframe: 18 weeks after patient recruitment

Interventionunits on a scale (Mean)
Montelukast Sodium-3.0
Placebo Drug-5.7

[back to top]

Changes in Urinary EDN

Changes of Urinary EDN(Eosinophil Derived Neurotoxin) after taking Montelukast or placebo drug. Urinary EDN levels were measured using an ELISA (MBL, Woburn, MA, USA) and the intra-assay and inter-assay variations were 3.0 ± 0.5 and 7.7 ± 1.5, respectively. Minimum value: 0, Maximum value: 2040 ng/ml. (NCT00903357)
Timeframe: 18 weeks after participants recruitment

InterventionUrine EDN (ng/ml) (Mean)
Montelukast Sodium37.0
Placebo Drug-195.8

[back to top]

Changes in Urinary LTE4

Changes of Urinary LTE4(Leukotrien E4) after taking Montelukast or placebo drug. Urinary LTE4 levels were measured using an enzyme-linked immunoassay (ELISA) (Cayman Chemical, Michigan, USA) and the intra-assay and inter-assay variations were 7.4 ± 2.1 and 12.4 ± 7.8, respectively. Minimum value : 0 Maximum vlaue: 1000 pg/ml. (NCT00903357)
Timeframe: 18 weeks after patient recruitment

InterventionUrinary LTE4 (pg/ml) (Mean)
Montelukast Sodium-65.9
Placebo Drug87.7

[back to top]

Prostate Specific Antigen Progression Free Survival (PSA-PFS)

Prostate Specific Antigen (PSA) will be measured every three months while on study. PSA Progression Free Survival (PSA-PSF) will be reported as the number of participants who have not demonstrated PSA progression by the end of the follow-up period. PSA progression is defined by meeting the following criteria: 1) an increase in PSA of greater than or equal to 25% from baseline or nadir, AND 2) an increase in PSA of at least 2 ng/dL, AND 3) the increase is confirmed at least 3 weeks later. This analysis was planned for up to 18 months following study enrollment, but the only participant enrolled on the study was only followed for 3 months. (NCT03827473)
Timeframe: Planned up to 18 months, but actual was 3 months

InterventionParticipants (Count of Participants)
Arm A (ADT, Docetaxel)1

[back to top]

Prostate-specific Antigen (PSA) Response

PSA evaluations will occur every 3 months while on study. PSA response is defined as a reduction in PSA value of greater than or equal to 90% from baseline, reported as a count of participants who had a PSA response on the study. (NCT03827473)
Timeframe: Planned for up to 18 months, but actual was 3 months

InterventionParticipants (Count of Participants)
Arm A (ADT, Docetaxel)1

[back to top]

Change in Quality of Life - FACT-P

The impact of abiraterone acetate and docetaxel on health related quality of life will be assessed every 3 months from screening to month 12 of treatment or follow-up. The scale used will be the Functional Assessment of Cancer Therapy-Prostate (FACT-P) scale. The total score ranges from 0 to 156, with higher scores indicating a higher quality of life. The primary endpoint was intended to be quality of life at 12 months, but since no participants completed 12 months of treatment/follow-up, scores at baseline and 3 months are reported instead. (NCT03827473)
Timeframe: Planned for up to one year, but actual was 3 months

Interventionscore on a scale (Number)
Baseline ScoreMonth 3 Score
Arm A (ADT, Docetaxel)139.83127

[back to top]

Change in Quality of Life - FACT/GOG-NTX

Quality of Life questionnaires will be done every 3 months while participants are on treatment. The scale used will be the Functional Assessment of Cancer Therapy (FACT)/Gynecologic Oncology Group (GOG)-Neurotoxicity (NTX) (FACT/GOG-NTX) scale (version 4). FACT/GOG-NTX total score ranges from 0 to 152, with higher scores indicating a higher quality of life. (NCT03827473)
Timeframe: Planned for up to 18 months, but actual was 3 months

Interventionscore on a scale (Number)
Baseline ScoreMonth 3 Score
Arm A (ADT, Docetaxel)131.83126

[back to top]

Change in Quality of Life - PROMIS Fatigue

Quality of Life questionnaires will be done every 3 months while participants are on treatment. The scale used will be the Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue scale. Total raw scores range from 7 to 35, with higher scores indicating a higher level of fatigue. (NCT03827473)
Timeframe: Planned for up to 18 months, but actual was 3 months

Interventionscore on a scale (Number)
Baseline ScoreMonth 3 Score
Arm A (ADT, Docetaxel)1016

[back to top]

Number of Participants With a Response (Complete Remissions (CR) and Complete Remission With Incomplete Blood Count Recovery (CRi)

Complete Remission (CR): ANC >=1000/mcl, Platelet count >=100,000/mcl, Bone marrow <5% blasts. Complete Remission with incomplete blood count recovery (CRi): Same as CR but ANC may be <1,000/mcl and/or platelet count <100,000/mcl. Patients who failed to achieve CR or CRi after two cycles were considered treatment failures. Patients who did not complete at least two cycles were not evaluated for response. (NCT00184054)
Timeframe: Up to 1 year

Interventionparticipants (Number)
CRCRiTreatment FailureNot Evaluable
Arsenic Trioxide (ATO) Plus Ascorbic Acid1541

[back to top]

Number of Participants With Severe (Grades 3-5) Adverse Events

Patients who received any amount of ATO plus Ascorbic Acid are included in the safety analyses. (NCT00184054)
Timeframe: Days 1, 8, 15, 21, 28, 35 of each cycle and at end of treatment (30 days after last dose or start of new therapy)

InterventionParticipants (Number)
AnorexiaAlanine aminotransferase increasedConjunctivitis infectiveDifferentiation syndromeElectrocardiogram QT corrected interval prolongedNeuropathy: sensorySepsis
Arsenic Trioxide (ATO) Plus Ascorbic Acid1121114

[back to top]

Change From Baseline in Hemoglobin (Hb) After 8 Weeks of Treatment in Each Ferrous Bisglycinate Chelate Group (1 Tablet Daily and 2 Tablets Daily)

At fortnightly visits, blood was collected for Hb. Baseline (Visit 0) was not more than 5 days from Week 1 or randomization. Change from Baseline was calculated by subtracting Baseline values from post-Baseline values. (NCT01160198)
Timeframe: Baseline and Week 8

InterventionGram per deciliter (gm/dL) (Mean)
Ferrous Bisglycinate Chelate 60 mg 1 Once-daily2.6
Ferrous Bisglycinate Chelate 60 mg 1 Twice-daily2.8

[back to top]

Difference in Percentage of Participants With Gastrointestinal Side Effects During 8 Weeks Treatment With Ferrous Bisglycinate Chelate and Ferrous Ascorbate

The comparison in percentage of participants with gastrointestinal side effects during 8 week treatment period is reported. Gastrointestinal side effects during 8 weeks treatment included abdominal discomfort, gastritis, nausea, dyspepsia, change in bowel habit, constipation, faeces discolored, diarrhea and flatulence. (NCT01160198)
Timeframe: Up to Week 8

InterventionPercentage of participants (Number)
Ferrous Bisglycinate Chelate 60 mg 1 Once-daily6.7
Ferrous Bisglycinate Chelate 60 mg 1 Twice-daily9.9
Ferrous Ascorbate 100 mg 1 Once-daily11.1

[back to top]

Mean Change in Hb From Baseline to 8 Weeks

At fortnightly visits, blood was collected for Hb. Baseline (Visit 0) was not more than 5 days from Week 1 or randomization. Change from Baseline was calculated by subtracting Baseline values from post-Baseline values. (NCT01160198)
Timeframe: Baseline to Week 8

Interventiongm/dL (Mean)
Ferrous Bisglycinate Chelate 60 mg 1 Once-daily2.6
Ferrous Bisglycinate Chelate 60 mg 1 Twice-daily2.8
Ferrous Ascorbate 100 mg 1 Once-daily2.6

[back to top]

Percentage of Participants Who Achieved a Target Hb More Than or Equal to 12 gm/dL After 8 Weeks of Treatment

At fortnightly visits, blood was collected for Hb. Number of participants who achieved a target Hb of more than or equal to 12 gm/dL is presented. (NCT01160198)
Timeframe: Up to Week 8

InterventionPercentage of participants (Number)
Ferrous Bisglycinate Chelate 60 mg 1 Once-daily34.2
Ferrous Bisglycinate Chelate 60 mg 1 Twice-daily36.1
Ferrous Ascorbate 100 mg 1 Once-daily33.3

[back to top]

Mean Change in Hb During 8 Weeks Therapy

At fortnightly visits, blood was collected for Hb. Mean change in Hb at Week 2, Week 4, Week 6 and Week 8 are presented. (NCT01160198)
Timeframe: Up to Week 8

,,
Interventiongm/dL (Mean)
Week 2Week 4Week 6Week 8
Ferrous Ascorbate 100 mg 1 Once-daily0.71.41.92.6
Ferrous Bisglycinate Chelate 60 mg 1 Once-daily0.61.21.82.6
Ferrous Bisglycinate Chelate 60 mg 1 Twice-daily0.61.31.92.8

[back to top]

Change in Creatinine Levels

Change in Kidney Function (NCT03148236)
Timeframe: Baseline to 24 hours

Interventionmg/dL (Median)
Vitamin C-0.1
Placebo-0.1

[back to top]

Change in Creatinine Levels

Change in kidney function (NCT03148236)
Timeframe: Baseline to 30 days

Interventionmg/dL (Median)
Vitamin C0
Placebo0.1

[back to top]

Change in hsCRP

Biomarker of inflammation (NCT03148236)
Timeframe: baseline to 24 hours

Interventionmg/L (Median)
Vitamin C5.31
Placebo16.01

[back to top]

Change in hsCRP

Biomarker of inflammation (NCT03148236)
Timeframe: baseline to 30 days

Interventionmg/L (Median)
Vitamin C-0.30
Placebo-0.64

[back to top]

Change in Interleukin (IL-6)

Biomarker of inflammation (NCT03148236)
Timeframe: baseline to 24 hours

Interventionpg/mL (Median)
Vitamin C13.3
Placebo6.6

[back to top]

Change in Interleukin (IL-6)

Biomarker of inflammation (NCT03148236)
Timeframe: baseline to 30 days

Interventionpg/mL (Median)
Vitamin C0
Placebo0.1

[back to top]

Change in Plasma Ascorbic Acid Level

Change in plasma ascorbic acid level (NCT03148236)
Timeframe: Baseline to 30 days

Interventionmicromolar (Median)
Vitamin C3
Placebo-5

[back to top]

Change in Plasma Levels of Ascorbic Acid

Change in plasma levels of ascorbic acid (NCT03148236)
Timeframe: baseline to 24 hours

Interventionmicromolar (Median)
Vitamin C267
Placebo-4

[back to top]

Change in Von Willebrand Factor (vWF)

Biomarker of blood vessel damage (NCT03148236)
Timeframe: baseline to 24 hours

Interventionmicrograms/mL (Median)
Vitamin C0.4
Placebo0.4

[back to top]

Change in Von Willebrand Factor (vWF)

Biomarker of blood vessel damage (NCT03148236)
Timeframe: baseline to 30 days

Interventionmicrograms/mL (Median)
Vitamin C-2.3
Placebo-3.8

[back to top]

Post Procedural Pain

Sum of pain scores every six hours for the 24 hour period following ablation measured on a visual analog scale scored on a level from zero (no pain) to 10 (maximum pain) (NCT03148236)
Timeframe: baseline to 24 hours

Interventionscore on a scale (Median)
Vitamin C4.5
Placebo0.3

[back to top]

Number of Participants Operated for Complex Regional Pain Syndrome Who Had Internal Unicompartmental Arthroplasty for Centralized Arthritis

Radiographs of the knee in Schuss with an external decoaptation which must be close to 0 cm and a pan gono gram standing from the front (NCT04204200)
Timeframe: After one-year follow-up

Interventionparticipants (Number)
Allocated to Conventional Vitamin C (n= 22)0
Allocated to Liposomal Vitamin C (n= 22)0
Allocated to Placebo (n= 22)0

[back to top]

Number of Participants Operated for Complex Regional Pain Syndrome Who Had Ligamentoplasty ACL According to Kenneth-Jones

Radiographs of the knee in monopodial support at 30° flexion (schuss) were taken. Measurement analysis of the translation of the tibia relative to the femur which must be close to 0 cm for the patient to be positive for the outcome. (NCT04204200)
Timeframe: After one-year follow-up

Interventionparticipants (Number)
Allocated to Conventional Vitamin C (n= 22)1
Allocated to Liposomal Vitamin C (n= 22)0
Allocated to Placebo (n= 22)0

[back to top]

Number of Participants Operated for Complex Regional Pain Syndrome Who Had Total Knee Arthroplasty for Eccentric Arthritis

X-rays of the knee and Schuss profile with an internal and external decoaptation which must be close to 0 cm with pan gonogram standing from the front (x-rays of the long axes of the pelvis of the ankles with measurement of the HKA axes on the prosthesis side and on the non-side operated which must be close to 180°) to have eccentric arthritis. (NCT04204200)
Timeframe: After one-year follow-up

Interventionparticipants (Number)
Allocated to Conventional Vitamin C (n= 22)1
Allocated to Liposomal Vitamin C (n= 22)0
Allocated to Placebo (n= 22)2

[back to top]

Number of Participants Operated for Complex Regional Pain Syndrome Who Had Transposition of Anterior Tibial Tuberosity

We take an x-ray of the knee then we calculate of the Index of Caton and Deschamps AT / AP which must be close to 1 cm (from the upper edge to the lower edge of the patella which must be equal to the distance between the tip of the patella and anterior tibial tuberosity) to be interpreted as a transposed tuberosity. (NCT04204200)
Timeframe: After one-year of follow-up

Interventionparticipants (Number)
Allocated to Conventional Vitamin C (n= 22)1
Allocated to Liposomal Vitamin C (n= 22)0
Allocated to Placebo (n= 22)2

[back to top]

Length of Time for Wound Closure

Length of time for wound closure will be measured in days (NCT01350102)
Timeframe: Patients are assessed every other week (bi-weekly) until 100% wound healing is achieved, which may take up to 6 months

InterventionDays (Number)
Bacitracin With Vit C141

[back to top]

Hgb A1c Level

Hgb A1c measures the average blood glucose over three months (% of hemoglobin). All subjects will be asked to get their hemoglobin A1c level at the beginning of the study and every three months for as long as they participate in the study. (NCT01350102)
Timeframe: Patients are assessed every 3 months from enrollment through end of study participation, which may be 6 months

,
Interventionpercentage of hemoglobin (Number)
Enrollment A1c3 Month A1c
AmeriGel® Wound Care Dressing Alone12.1NA
Bacitracin With Vit C5.26.1

[back to top]

Wound Area Measurements

Wound area measurements in length, width, and depth throughout the course of the study(measured in cm). (NCT01350102)
Timeframe: Patients are assessed every other week (bi-weekly) until 100% wound healing is achieved, which may take up to 6 months

,
Interventioncm (Number)
Week 0 Width of WoundWeek 0 Depth of WoundWeek 0 Length of WoundWeek 2 Width of WoundWeek 2 Depth of WoundWeek 2 Length of WoundWeek 4 Width of WoundWeek 4 Depth of WoundWeek 4 Length of WoundWeek 6 Width of WoundWeek 6 Depth of WoundWeek 6 Length of WoundWeek 8 Width of WoundWeek 8 Depth of WoundWeek 8 Length of WoundWeek 10 Width of WoundWeek 10 Depth of WoundWeek 10 Length of WoundWeek 12 Width of WoundWeek 12 Depth of WoundWeek 12 Length of WoundWeek 14 Width of WoundWeek 14 Depth of WoundWeek 14 Length of WoundWeek 16 Width of WoundWeek 16 Depth of WoundWeek 16 Length of WoundWeek 18 Width of WoundWeek 18 Depth of WoundWeek 18 Length of WoundWeek 20 Width of WoundWeek 20 Depth of WoundWeek 20 Length of Wound
AmeriGel® Wound Care Dressing Alone0.30.220.50.20.5NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Bacitracin With Vit C0.90.21.00.40.10.50.40.10.50.20.10.20.10.30.10.10.10.20.10.10.30.10.10.30.10.10.10.30.10.30.00.00.0

[back to top]

Development of Renal Calculi

We will assess for develop of renal calculi as a safety measure. (NCT02762331)
Timeframe: 48 hours

InterventionParticipants (Count of Participants)
Vitamin C0
Normal Saline0

[back to top]

Occurence of Atrial Fibrillation

Atrial fibrillation is a common complication of CABG surgery. We will monitor EKG status for development of atrial fibrillation for 48 hours post-op. (NCT02762331)
Timeframe: 48 hours

InterventionParticipants (Count of Participants)
Vitamin C0
Normal Saline0

[back to top]

Concentration of Vitamin C in Type 2 Diabetic Patients.

Concentrations of vitamin C were measured in the brains of type 2 Diabetic patients and healthy controls. (NCT00845130)
Timeframe: Pre-Vitamin C infusion

Interventionumol/g tissue (Mean)
Diabetic Type II Subjects1.1
Healthy Subjects1.2

[back to top]

Quantify the Effect of Chronic Hyperglycemia on Cellular Uptake of Vitamin C Across the Blood-brain Barrier

Concentrations of vitamin C after IV infusion of Vitamin C were measured in the brains of patients with type 2 diabetes and healthy controls to examine whether the concentrations are different between two groups. (NCT00845130)
Timeframe: 2 hour post infusion

Interventionµmol/g tissue (Mean)
Diabetic Type II Subjects1.1
Healthy Subjects1.4

[back to top]

Ascorbic Acid Concentration at 32 Hours

Ascorbic Acid Concentration Normal Ascorbic Acid Range 0.4-2.0 mg/dL (NCT02734147)
Timeframe: 32 Hours

Interventionmg/dL (Mean)
High Dose IV Ascorbic Acid13.8
Placebo0.22

[back to top]

Change in Modified SOFA Score

Sequential Organ Failure Assessment (SOFA) Score included the degree of dysfunction of six organ systems (Respiratory, Cardiovascular, Liver, Renal, Coagulation, Neurologic. A modification of the SOFA includes the exclusion of the Liver function. Total score is reported, minimum score = 0 maximum score = 20. Higher scores indicate greater degree of dysfunction. (NCT02734147)
Timeframe: Baseline and 72 hours

Interventionunits on a scale (Mean)
High Dose IV Ascorbic Acid-1.0
Placebo-1.75

[back to top]

Change in PIRO Score

PIRO consists of 4 assessments, Predisposition (scored 0-9), Infection (scored 0-4), Response (scored 0-6), and Organ Failure (scored 0-14) (PIRO). The total PIRO score is the sum of all subscores and ranges from 0-33 with higher scores indicating worse health. (NCT02734147)
Timeframe: Baseline and 72 hours

Interventionunits on a scale (Mean)
High Dose IV Ascorbic Acid-3.7
Placebo-4.5

[back to top]

Hospital Length of Stay

From admission until discharge from ICU in days (NCT02734147)
Timeframe: From ICU admission through ICU discharge, up to 2 weeks

InterventionDays (Median)
High Dose IV Ascorbic Acid7
Placebo6

[back to top]

ICU Length of Stay

ICU Length of Stay in Hours (NCT02734147)
Timeframe: Length of ICU stay up to 200 hours

InterventionHours (Median)
High Dose IV Ascorbic Acid29
Placebo47

[back to top]

Modified SOFA Score

Sequential Organ Failure Assessment (SOFA) Score included the degree of dysfunction of six organ systems (Respiratory, Cardiovascular, Liver, Renal, Coagulation, Neurologic. A modification of the SOFA includes the exclusion of the Liver function. Total score is reported, minimum score = 0 maximum score = 20. Higher scores indicate greater dysfunction. (NCT02734147)
Timeframe: at 72 Hours

Interventionunits on a scale (Mean)
High Dose IV Ascorbic Acid4.1
Placebo3.3

[back to top]

Percentage of Participants Who Died

(NCT02734147)
Timeframe: From initial hospital admission through discharge, up to 2 weeks.

InterventionPercentage of participants (Number)
High Dose IV Ascorbic Acid16.7
Placebo16.7

[back to top]

Adverse Events as a Measure of Safety and Tolerability

Adverse events, whether volunteered by the study subject, discovered by the investigators during questioning, or detected by physical examination, laboratory tests, or other means will be collected and recorded at each visit. Events will be recorded from the time the consent is signed until 4 weeks after the study protocol is discontinued. Subjects experiencing Grade 4 neutropenia, Grade ≥3 thrombocytopenia, or Grade 2 peripheral neuropathy who do not recover will have treatment protocol discontinued. (NCT01654861)
Timeframe: Weekly for up to 6 months.

Interventionparticipants (Number)
HDIVC0

[back to top]

Maximum Tolerated Dose of Samarium-153

"To determine the maximum tolerated dose (MTD) of Samarium as adjuvant to combined hormonal therapy (HT) and external beam radiation therapy (RT).~Dose levels:~Dose I: 0.25 mCi/kg IV Dose II: 0.5 mCi/kg IV Dose III: 0.75 mCi/kg IV Dose IV: 1.0 mCi/kg IV Dose V: 1.5 mCi/kg IV Dose VI: 2.0 mCi/kg IV~Dose-limiting toxicity will be defined as Grade 3 hematologic toxicity per NCI Common Toxicity Criteria. The maximally tolerated dose (MTD) will then be the last dose studied or the previous dose, based on clinical judgment of the degree of toxicity seen at the last dose." (NCT00328614)
Timeframe: 5 months (1 month HT, administration of drug, 4 months HT and RT)

InterventionmCi/kg (Number)
Samarium-1532.0

[back to top] [back to top]

Overall Survival

Time to event outcome measure (death), measured in days from cycle 1 day 1. (NCT01515046)
Timeframe: up to 5 years

Interventiondays (Number)
Gemcitabine With Escalating IV Ascorbate268

[back to top]

Progression Free Survival

Time-to-event outcome measure (initial disease progression) measured in days from cycle 1 day 1 to day of first progression as defined by RECIST criteria from NCI. (NCT01515046)
Timeframe: up to 5 years

Interventiondays (Number)
Gemcitabine With Escalating IV Ascorbate80

[back to top]

Area Under the Concentration/Time Curve From 0 to 30 Minutes (Min) (AUC 0-30 Min)

AUC (0-30 min) was determined from paracetamol plasma concentration time profiles using trapezoidal rule. (NCT01332578)
Timeframe: Blood samples taken within 15-30 min prior to dosing and at 3, 5, 7, 9, 11, 15, 20, 30, 45, 90, 120 and 180 minutes post-dose

Interventionnanograms (ng)*hours (h)/mL (Mean)
Hot Drink Remedy1535.80
Standard Paracetamol Tablets387.28

[back to top]

AUC (0-60 Min)

AUC (0-60 min) was determined from paracetamol plasma concentration time profiles using trapezoidal method. (NCT01332578)
Timeframe: Blood samples taken within 15-30 min prior to dosing and at 3, 5, 7, 9, 11, 15, 20, 30, 45, 90, 120 and 180 minutes post-dose

Interventionng*h/mL (Mean)
Hot Drink Remedy5007.11
Standard Paracetamol Tablets1874.22

[back to top]

Maximum Plasma Concentration (Cmax)

Cmax was determined using plasma paracetamol concentration time profile. (NCT01332578)
Timeframe: Blood samples taken within 15-30 min prior to dosing and at 3, 5, 7, 9, 11, 15, 20, 30, 45, 90, 120 and 180 minutes post-dose

Interventionng/mL (Mean)
Hot Drink Remedy8309.58
Standard Paracetamol Tablets9225.20

[back to top]

Time to Completion of Gastric Emptying

Time to completion of gastric emptying of hot drink remedy and standard paracetamol tablets was assessed using Gamma Scintigraphy images and WebLink image analysis program. Completion of gastric emptying was confirmed by two consecutive images with negligible gastric activity. (NCT01332578)
Timeframe: Baseline to 10 hours

Interventionminutes (Least Squares Mean)
Hot Drink Remedy202.59
Standard Paracetamol Tablets168.38

[back to top]

Time to Maximum Plasma Concentration (Tmax)

Time after administration when the maximum plasma concentration was reached. (NCT01332578)
Timeframe: Blood samples taken within 15-30 min prior to dosing and at 3, 5, 7, 9, 11, 15, 20, 30, 45, 90, 120 and 180 minutes post-dose

Interventionhours (Median)
Hot Drink Remedy1.50
Standard Paracetamol Tablets1.99

[back to top]

Time to Onset of Gastric Emptying

The individual anterior and posterior images were assessed using Gamma Scintigraphy images and WebLink Image Analysis program to determine the time to onset of gastric emptying of hot drink remedy and standard paracetamol tablets. (NCT01332578)
Timeframe: Baseline to 10 hours

Interventionminutes (Least Squares Mean)
Hot Drink Remedy7.86
Standard Paracetamol Tablets54.23

[back to top]

Time to Reach Plasma Paracetamol Concentration of 0.25 μg/mL (Microgram Per Milliliter)

Time to reach plasma paracetamol concentration of 0.25 μg/mL was determined using plasma concentration time profiles. (NCT01332578)
Timeframe: Blood samples taken within 15-30 minutes prior to dosing and at 3, 5, 7, 9, 11, 15, 20, 30, 45, 90, 120 and 180 minutes post-dose

Interventionminutes (Median)
Hot Drink Remedy4.59
Standard Paracetamol Tablets23.14

[back to top]

Time to Onset and Completion of Disintegration of Reference Tablets

Qualitative onset and completion of tablet disintegration was determined using Gamma scintigraphy images and WebLink image analysis program. (NCT01332578)
Timeframe: Baseline to 10 hours post dose

Interventionminutes (Mean)
Onset Time of DisintegrationCompletion Time of Disintegration
Standard Paracetamol Tablets42.5062.88

[back to top]

Incidence of Adverse Events (AE) Per CTCAE 4.03

Categorize and quantify adverse events from start of therapy (day 1, cycle 1) to end of study per (CTCAE) version 4.03. (NCT03468075)
Timeframe: Up to 30 days after completion of study treatment

Interventionadverse events (Number)
Blood and lymphatic system disordersGastrointestinal disordersInfections and infestationsInvestigationsMetabolism and nutrition disordersMusculoskeletal and connective tissue disordersPsychiatric disordersRenal and urinary disordersRespiratory, thoracic and mediastinal disordersSkin and subcutaneous tissue disordersVascular disordersGeneral disorders and administration site conditions
Gemcitabine + High-Dose Ascorbate47143211111327

[back to top]

Overall Survival

Time from start of therapy (day 1, cycle 1) to death. (NCT03468075)
Timeframe: Every 2 months for first 6 months, then every 3 months up to 2 years post treatment

InterventionParticipants (Count of Participants)
AliveDead
Gemcitabine + High-Dose Ascorbate55

[back to top]

Progression Free Survival

Time from start of therapy (day 1, cycle 1) to documented disease progression or death due to any cause. Progression will be defined using the RECIST 1.1 guidelines. Results are provided in nominal categories (CR, PR, SD, PD) as per RECIST. (NCT03468075)
Timeframe: Every 2 months for first 6 months, then every 3 months up to 2 years post treatment

InterventionParticipants (Count of Participants)
2 months3 months6 months9 months
Gemcitabine + High-Dose Ascorbate7111

[back to top]

Tumor Response

From first day of treatment to documented disease progression as described by RECIST 1.1 criteria. Results are provided in nominal categories (CR, PR, SD, PD) as per RECIST. (NCT03468075)
Timeframe: Every 2 months for first 6 months, then every 3 months up to 2 years post treatment

InterventionParticipants (Count of Participants)
PDSDPR
Gemcitabine + High-Dose Ascorbate811

[back to top]

Hospital Length of Stay

(NCT00953212)
Timeframe: 30 days

Interventiondays (Mean)
Amiodarone - Yes7.0
Amiodarone - No6.6
Ascorbic Acid - Yes6.8
Ascorbic Acid - No6.8

[back to top]

ICU Length of Stay

(NCT00953212)
Timeframe: 30 days

Interventiondays (Mean)
Amiodarone - Yes2.0
Amiodarone - No1.9
Ascorbic Acid - Yes2.0
Ascorbic Acid - No1.9

[back to top]

Number of Participants With Acute Kidney Injury

Using the Akin definition (NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes19
Amiodarone - No13
Ascorbic Acid - Yes22
Ascorbic Acid - No11

[back to top]

Number of Participants With Bradycardia Necessitating Permanent Pacemaker Placement

(NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes0
Amiodarone - No2
Ascorbic Acid - Yes0
Ascorbic Acid - No2

[back to top]

Number of Participants With Low Output Heart Failure

(NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes12
Amiodarone - No10
Ascorbic Acid - Yes7
Ascorbic Acid - No9

[back to top]

Number of Participants With Mortality

Mortality measured within length of hospital stay (NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Beta Blockers, Ascorbic Acid and Amiodarone1
Beta Blockers and Ascorbic Acid1
Beta Blockers and Amiodarone1
Beta Blockers Alone0

[back to top]

Number of Participants With Postoperative Vasoplegia

(NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes17
Amiodarone - No15
Ascorbic Acid - Yes14
Ascorbic Acid - No16

[back to top]

Number of Participants With Readmission to Hospital for Treatment of Atrial Fibrillation

(NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes4
Amiodarone - No4
Ascorbic Acid - Yes4
Ascorbic Acid - No4

[back to top]

Number of Participants With Readmission to ICU for Treatment of Atrial Fibrillation

(NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes1
Amiodarone - No1
Ascorbic Acid - Yes2
Ascorbic Acid - No0

[back to top]

Number of Participants With Respiratory Failure Requiring Reintubation

(NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes4
Amiodarone - No2
Ascorbic Acid - Yes2
Ascorbic Acid - No5

[back to top]

Number of Participants With Stroke

Cerebral vascular accident occurring within hospital length of stay (NCT00953212)
Timeframe: 30 days

InterventionParticipants (Count of Participants)
Amiodarone - Yes1
Amiodarone - No3
Ascorbic Acid - Yes1
Ascorbic Acid - No1

[back to top]

Occurrence of Post-operative Atrial Fibrillation Requiring Treatment After Open Heart Surgery

Atrial fibrillation is a common complication of cardiac surgery which is associated with increased morbidity, length of stay and cost. The opportunity to use ascorbic acid for AF prophylaxis is attractive because of its low side effect profile, wide acceptance and low cost. This prospective, randomized trial used a 2 X 2 factorial design to determine whether prophylactic ascorbic acid alone, ascorbic acid with amiodarone, or amiodarone alone, when given along with beta blockers would decrease the incidence of postoperative AF in adult cardiac surgery when compared with beta blockers alone, all combinations failed to show any difference between the four groups. While there have been trials that have shown the addition of amiodarone to beta-blockers to be more effective, this analysis does not support that conclusion. (NCT00953212)
Timeframe: 5 postoperative days

InterventionParticipants (Count of Participants)
Amiodarone - Yes50
Amiodarone - No56
Ascorbic Acid - Yes58
Ascorbic Acid - No48

[back to top]

Change in FMD

Change in flow mediated dilation with treatment: FMD visit 2 - FMD visit 1 FMD is measured by using vascular ultrasound to determine the baseline diameter of the brachial artery. Endothelium-dependent vasodilation is induced by 5-minute arterial occlusion with a blood pressure cuff. When the cuff is released, the resultant increase in blood flow (reactive hyperemia) stimulates vasodilation of the brachial artery. This flow-mediated dilation (FMD) is expressed as the percent change from baseline. Healthy individuals typical dysplay a 10 to 12% dilation. Individuals with PAD had markedly impaired dilation of 6-7. The currernt study sought to determine whether a change in FMD would occur following intervention. (NCT00491751)
Timeframe: 1-4 weeks

Interventionpercent change of FMD (Mean)
Atorvastatin0.88
Ascorbic Acid0.41
Placebo0.88

[back to top]

Percentage Change in FMD in All Participants With and Without a CVD Event (Not by Treatment Group)

This outcome is independent of the treatment group so the groups are 'CVD event' and ' No CVD Event'. Cardiovascular events (CVD) included cardiovascular disease, myocardial infarction, congestive heart failure, stroke, and unstable angina. (NCT00491751)
Timeframe: 2 months

Interventionpercent change of flow-mediated dilation (Mean)
CVD Event0.5
No CVD Event0.7

[back to top] [back to top]

Number of Participants With Hospitalization or Mortality

Number of participants with hospitalization or mortality (NCT04354428)
Timeframe: Day 28 after enrolment

InterventionParticipants (Count of Participants)
Ascorbic Acid and Folic Acid4
Hydroxychloroquine and Folic Acid2
Hydroxychloroquine and Azithromycin3
Lopinavir-ritonavir0
Ascorbic Acid1

[back to top]

Number of Participants With Serious Adverse Events and Adverse Events Resulting in Treatment Discontinuation

Serious adverse events (including death and hospitalization) and adverse events resulting in treatment discontinuation (NCT04354428)
Timeframe: 28 days from enrolment

InterventionParticipants (Count of Participants)
Ascorbic Acid and Folic Acid6
Hydroxychloroquine and Folic Acid6
Hydroxychloroquine and Azithromycin8
Lopinavir-ritonavir9
Ascorbic Acid1

[back to top]

Number of Persons With Lower Respiratory Tract Infection (LRTI), Defined as Resting Blood Oxygen Saturation (SpO2<93%) Level Sustained for 2 Readings 2 Hours Apart and Presence of Subjective Dyspnea or Cough

Resting blood oxygen saturation (SpO2<93%) level sustained for 2 readings 2 hours apart and presence of subjective dyspnea or cough (NCT04354428)
Timeframe: 28 days from enrolment

InterventionParticipants (Count of Participants)
Ascorbic Acid and Folic Acid2
Hydroxychloroquine and Folic Acid0
Hydroxychloroquine and Azithromycin4
Lopinavir-ritonavir2
Ascorbic Acid1

[back to top]

Time to Clearance of Nasal SARS-CoV-2

Time to clearance of nasal SARS-CoV-2, defined as 2 consecutive negative swabs (NCT04354428)
Timeframe: Day 1 through Day 14 after enrolment

InterventionDays (Median)
Ascorbic Acid and Folic Acid7
Hydroxychloroquine and Folic Acid5
Hydroxychloroquine and Azithromycin6
Lopinavir-ritonavir4
Ascorbic Acid5

[back to top]

Time to Resolution of COVID-19 Symptom Resolution in Days

"COVID-19 symptoms are based on the following criteria:~At least TWO of the following symptoms: Fever (≥ 38ºC), chills, rigors, myalgia, headache, sore throat, new olfactory and taste disorder(s), OR~At least ONE of the following symptoms: cough, shortness of breath or difficulty breathing, OR~Severe respiratory illness with at least 1 of the following:~Clinical or radiological evidence of pneumonia, OR~Acute respiratory distress syndrome (ARDS), OR~LRTI, defined by resting SpO2<93% sustained for 2 readings 2 hours apart AND presence of subjective dyspnea or cough Death or COVID-19-related hospitalizations will count as a failure to resolve symptoms." (NCT04354428)
Timeframe: Day 1 through Day 14 after enrolment

InterventionDays (Median)
Ascorbic Acid and Folic Acid11.5
Hydroxychloroquine and Folic Acid10.5
Hydroxychloroquine and AzithromycinNA
Lopinavir-ritonavirNA
Ascorbic AcidNA

[back to top] [back to top]

Percent Iron Absorption

Percentage of iron available for absorption from fortified oat drink with and without added vitamin C (NCT01423162)
Timeframe: 14 days after administration

Interventionpercentage of Iron absorbed (Mean)
Fortified Oat Drink With Vitamin C7.14
Fortified Oat Drink Without Vitamin C5.65

[back to top]

All Cause Mortality to Day 28

(NCT02106975)
Timeframe: Up to Day 28

Interventionpercentage of participants (Number)
Ascorbic Acid30
5% Dextrose in Water46

[back to top]

Hospital-free Days at Day 60

(NCT02106975)
Timeframe: Up to Day 60

Interventiondays (Mean)
Ascorbic Acid23
5% Dextrose in Water15

[back to top]

ICU-free Days at Day 28

(NCT02106975)
Timeframe: Up to Day 28

Interventiondays (Mean)
Ascorbic Acid11
5% Dextrose in Water8

[back to top]

Modified Change in Sequential Organ Failure Assessment (mSOFA) Score

mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status. (NCT02106975)
Timeframe: 96 hours

Interventionscore on a scale (Mean)
Ascorbic Acid-2.96
5% Dextrose in Water-3.20

[back to top]

Ventilator Free Days to Day 28

(NCT02106975)
Timeframe: Up to Day 28

Interventiondays (Mean)
Ascorbic Acid13
5% Dextrose in Water11

[back to top]

Ascorbate Level at Hour 0, 48, 96, 168

(NCT02106975)
Timeframe: Up to hour 168

,
InterventionµM (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water26242628
Ascorbic Acid2530139790

[back to top]

C-Reactive Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo

(NCT02106975)
Timeframe: up to 168 hours

,
Interventionµg/ml (Mean)
0 hours48 hours96 hours168 hours
5% Dextrose in Water119845946
Ascorbic Acid109805654

[back to top]

Cardiovascular Function

Cardiovascular function as measured by Mean arterial pressure. Scores less than 70 mmHg indicate worse outcomes. (NCT02106975)
Timeframe: Up to hour 168

,
InterventionmmHg (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water73798483
Ascorbic Acid73788481

[back to top]

Coagulation

Coagulation as measured by Platelets per unit of blood. Scores range from less than 20 to more than 150. Lower scores indicate worse outcomes (NCT02106975)
Timeframe: Up to hour 168

,
InterventionPlatelets/uL of Blood (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water175147165228
Ascorbic Acid173171182226

[back to top]

Liver Function

Liver function as measured by Total Bilirubin. Normal levels range from 0.2 - 1.2. Levels greater than 1.2 indicate worse outcomes (NCT02106975)
Timeframe: Up to hour 168

,
InterventionMg/dL (Median)
0 hour48 hours96 hours168 hours
5% Dextrose in Water1111
Ascorbic Acid1111

[back to top]

mSOFA Scores at Hours 0, 48, 96

mSOFA is a single score based on patient status of five different biological systems: respiratory, cardiovascular, coagulation, renal, and neurological. Scores range from 0 to 20 with higher scores indicated worse status. (NCT02106975)
Timeframe: Up to hour 96

,
Interventionunits on a scale (Median)
0 hours48 hours96 hours
5% Dextrose in Water1086
Ascorbic Acid1096

[back to top]

Oxygenation Index (FiO2 x Mean Airway Pressure/PaO2) at Study Hour 0, 48, 96, 168 if Still Intubated in Ascorbate Infused Patient Compared to Placebo.

(NCT02106975)
Timeframe: Up to hour 168

,
InterventionIndex (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water10778
Ascorbic Acid11798

[back to top]

Oxygenation Score: Pressure

Oxygenation as measure by the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2). Scores range from 100 to 300 with lower values indicating more worse outcomes (NCT02106975)
Timeframe: Up to hour 168

,
Interventionmm Mercury (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water214246244254
Ascorbic Acid189233226233

[back to top]

Oxygenation Score: Saturation

Oxygenation as measure by the ratio of arterial oxygen saturation to fraction of inspired oxygen SpO2/FiO2 (NCT02106975)
Timeframe: Up to hour 168

,
InterventionRatio (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water177220244299
Ascorbic Acid168231250268

[back to top]

Procalcitonin at Study Hour 0, 48, 96, 168

(NCT02106975)
Timeframe: Up to hour 168

,
Interventionng/ml (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water27943
Ascorbic Acid12732

[back to top]

Receptor for Advanced Glycation Endpoints at Study Hour 0, 48, 96, 168

(NCT02106975)
Timeframe: Up to hour 168

,
Interventionng/ml (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water7432
Ascorbic Acid6443

[back to top]

Renal Function

Renal function as measured by Creatinine. Scores range from less than 1.2 to greater than 5.0 with higher scores indicating worse outcomes (NCT02106975)
Timeframe: Up to hour 168

,
InterventionMg/dL (Median)
0 hour48 hours96 hours168 hours
5% Dextrose in Water2111
Ascorbic Acid1211

[back to top]

State of Consciousness

State of consciousness as measure by Glasgow Coma Scale which gives a score based on eye, verbal, and motor responses. Scores range from 3 to 15 with lower scores indicating worse outcome (NCT02106975)
Timeframe: Up to hour 168

,
Interventionunits on a scale (Median)
0 hour48 hours96 hours168 hours
5% Dextrose in Water791012
Ascorbic Acid891010

[back to top]

Thrombomodulin Protein at Study Hours 0, 48, 96, 168 When Compared to Placebo

(NCT02106975)
Timeframe: Up to 168 hours

,
Interventionng/ml (Mean)
0 hours48 hours96 hours168 hours
5% Dextrose in Water14151514
Ascorbic Acid14151514

[back to top]

Tissue Factor Pathway Inhibitor at Study Hour 0, 48, 96, 168

(NCT02106975)
Timeframe: Up to hour 168

,
Interventionng/ml (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water43424442
Ascorbic Acid46424244

[back to top]

VE-40 (Vent RR x TV/Weight) x (PaCO2/40) at Study Hour 0, 48, 96, 168 if Still Intubated, in Ascorbate Infused Patient Compared to Placebo

Estimate of Shunt (NCT02106975)
Timeframe: Up to hour 168

,
InterventionmmMercury (Mean)
0 hour48 hours96 hours168 hours
5% Dextrose in Water121123114131
Ascorbic Acid127127127115

[back to top]

Change in Quality of Life as Defined by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C-30

Change in quality of life over the six measurement times will be modeled using mixed effects linear regression to account for correlation among repeated measurements from the same subjects. Average change in QoL from baseline to follow-up will be computed. (NCT02896907)
Timeframe: Baseline to up to 28 days after the last treatment

Interventionscore on a scale (Mean)
Treatment (FOLFIRINOX, Ascorbic Acid)NA

[back to top]

Mean Leucocyte Vitamin C Absorption Rate as Tmax

Mean Time of maximum Vitamin C concentration (NCT03562988)
Timeframe: baseline, 0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 hours

Interventionhours (Mean)
Vitamin C Gummy6.73
Vitamin C Tablet4.58

[back to top]

Mean Leukocyte L-ascorbic Acid as Cmax

Mean Leukocyte L-ascorbic Acid as Cmax (NCT03562988)
Timeframe: baseline, 0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 hours

Interventionnmol/10^8 leukocytes (Mean)
Vitamin C Gummy22.96
Vitamin C Tablet22.74

[back to top]

Mean Leukocyte L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 Hours)]

Mean Leukocyte L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 hours)] for All Study Participants (NCT03562988)
Timeframe: baseline, 0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 hours

Interventionnmol*min/10^8 leukocytes (Mean)
Vitamin C Gummy273.20
Vitamin C Tablet297.20

[back to top]

Mean Plasma L-ascorbic Acid as Cmax

Mean Plasma L-ascorbic Acid as Cmax (NCT03562988)
Timeframe: baseline, 0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 hours

Interventionμmol/L (Mean)
Vitamin C Gummy72.75
Vitamin C Tablet78.97

[back to top]

Mean Plasma L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 Hours)]

Mean Plasma L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 hours)] (NCT03562988)
Timeframe: baseline, 0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 hours

Interventionμmol*min/L (Mean)
Vitamin C Gummy1114.66
Vitamin C Caplet1149.09

[back to top]

Mean Plasma Vitamin C Absorption Rate as Tmax

Mean Time of maximum Vitamin C concentration (NCT03562988)
Timeframe: baseline, 0.5, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 hours

Interventionhours (Mean)
Vitamin C Gummy2.59
Vitamin C Tablet2.88

[back to top]

Incidence of Adverse Events

Will be assessed per Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Safety and tolerability as evaluated by the incidence, severity, duration, causality, seriousness of adverse events. Toxicities will be summarized as the number of patients with grade 3 or higher toxicities per CTCAE v4.0, in addition to total number of toxicities (allowing for multiple toxicities within a patient) among all patients, and per treatment arm. (NCT03649841)
Timeframe: Up to 6 months

InterventionParticipants (Count of Participants)
Arm I (ADT, Abiraterone, Prednisone)2
Arm II (ADT, Abiraterone, Prednisone, Radiation Therapy)0

[back to top]

Rate of Undetectable Prostate Specific Antigen (PSA) (< 0.2)

The number of patients with undetectable PSA at 6-months will be summarized by each arm and all combined. (NCT03649841)
Timeframe: At 6 months after start of abiraterone acetate

InterventionParticipants (Count of Participants)
Arm I (ADT, Abiraterone, Prednisone)1
Arm II (ADT, Abiraterone, Prednisone, Radiation Therapy)1

[back to top] [back to top]

The Proportion of Patients That Experience Non-relapse Mortality (NRM)

To determine the effect of parenteral vitamin C on non-relapse mortality (NRM) at one year following myeloablative allogeneic HCT. Non-relapse mortality is defined as defined as mortality from complications of HCT but not tumor relapse, is usually from graft versus host disease (GVHD), infection, or organ failure. (NCT03613727)
Timeframe: 1 year following myeloablative allogeneic hematopoietic cell transplant (HCT)

InterventionParticipants (Count of Participants)
IV Vitamin C Followed by Oral Vitamin C5

[back to top]

Time From Transplant to Engraftment

To determine the effect of the vitamin C regimen on the time to hematopoietic engraftment. (NCT03613727)
Timeframe: 30 Days after myeloablative allogeneic hematopoietic cell transplant (HCT)

InterventionNumber of Days to engraftment (Median)
IV Vitamin C Followed by Oral Vitamin C12

[back to top]

To Determine the Effectiveness of Reducing Acute Graft Versus Host Disease (aGVHD)

Percentage of patients with a diagnosis of acute GVHD (NCT03613727)
Timeframe: 0 - 180 days after myeloablative allogeneic HCT

Interventionpercentage of participants (Number)
IV Vitamin C Followed by Oral Vitamin C33

[back to top]

Mortality

Number of patients who expire within 30 days of their surgery (both in patients and discharged patients) (NCT01167569)
Timeframe: 30 days

Interventionparticipants (Number)
A-Ascorbic Acid (Vitamin C)0
B-Placebo0

[back to top]

Biochemical Disease Free Survival: Estimated Percentage of Participants With Biochemical Disease-free Survival at 5 Years

Biochemical relapse was defined as the time from inclusion in the study (randomization) until the patient meets criteria for Biochemical failure (Phoenix criteria: PSA nadir plus 2 ng/ml). (NCT02175212)
Timeframe: 5 years

Interventionpercentage of patients (Number)
Long Term Androgen Deprivation90
Short Term Androgen Deprivation81

[back to top]

Cause-specific Survival

Cause-specific survival included all deaths from prostate cancer or treatment complications, and deaths from unknown causes in patients with either active cancer or a previously documented relapse (NCT02175212)
Timeframe: 5 years

Interventionparticipants (Number)
Long Term Androgen Deprivation177
Short Term Androgen Deprivation173

[back to top]

Metastasis Free Survival: Estimated Percentage of Participants With Metastasis-free Survival at 5 Years

Metastasis free survival: defined as the time from inclusion in the study (randomization) until the appearance of distant metastases: a positive result in any of the tests performed (scintigraphy, chest radiography, thorax, abdominal and pelvic CT and MRI). (NCT02175212)
Timeframe: 5 years

Interventionpercentage of participants (Number)
Long Term Androgen Deprivation94
Short Term Androgen Deprivation83

[back to top]

Overall Survival: Estimated Percentage of Participants Alive at 5 Years

Overall Survival: defined as the time that elapses from the patient enters the study until the patient dies from any cause. (NCT02175212)
Timeframe: 5 years

Interventionpercentage of patients (Number)
Long Term Androgen Deprivation95
Short Term Androgen Deprivation86

[back to top]

Late Toxicity

"Defined as the maximal rectal, urinary and cardiovascular (CV) toxicity per patient more than 90 days after completion of RT.~Scoring scales used were the radiation morbidity scoring criteria of the European Organization for Research and Treatment of Cancer-Radiation Therapy Oncology Group (EORTC/RTOG) and the Common Terminology Criteria for Adverse Events (CTCAEs) v 3.0 for the remained toxicity.~CV events were defined according to the World Health Organization criteria" (NCT02175212)
Timeframe: 5 years

,
Interventionpercentage of patients (Number)
Grade 2 of more rectal toxicityGrade 2 of more urinary toxicityCardiovascular
Long Term Androgen Deprivation11.18.217.6
Short Term Androgen Deprivation7.67.37.2

[back to top]

Average Number of Times Docetaxel Had Dose Reductions

The number of dose reductions and total number of completed cycles will be summarized by study arm. (NCT02516670)
Timeframe: Up to 24 weeks

Interventiondose reductions (Mean)
Arm A (Docetaxel, Ascorbic Acid)7
Arm B (Docetaxel, Placebo)9

[back to top]

Change in Quality of Life (QoL) as Measured by the FACT-P Questionnaire

The (FACT-P) is made up of 39 question, with the total score ranging between 0 and 156 with 0 being the best and 156 as the worst. (NCT02516670)
Timeframe: Up to course 6 of therapy (18 weeks)

Interventionscore on a scale (Mean)
Arm A (Docetaxel, Ascorbic Acid)116.4580
Arm B (Docetaxel, Placebo)113.9834

[back to top]

Number of Participates With a Decline in Prostate-specific Antigen From Their Baseline Measurement

prostate-specific antigen decline will be defined as ≥ 50% from baseline measurement (NCT02516670)
Timeframe: up to 24 weeks

InterventionParticipants (Count of Participants)
Arm A (Docetaxel, Ascorbic Acid)13
Arm B (Docetaxel, Placebo)5

[back to top]

Radiographic Progression Free Survival (rPFS)

To determine the rPFS of participates that receive at least one dose of ascorbic acid compared to those who received placebo (NCT02516670)
Timeframe: Up to 3 years

Interventionmonths (Median)
Arm A (Docetaxel, Ascorbic Acid)10.12
Arm B (Docetaxel, Placebo)9.97

[back to top]

Number of Participants With Adverse Events

Number of participants experiencing fatigue, nausea, bone pain, and anorexia as defined by CTCAE 4.0 (NCT02516670)
Timeframe: Up to 30 days after the last dose of study drug

,
InterventionParticipants (Count of Participants)
fatiguenauseabone painanorexia
Arm A (Docetaxel, Ascorbic Acid)2517212
Arm B (Docetaxel, Placebo)11622

[back to top]

Number of Participates Experiencing Serious Adverse Events (SAE)

Number of serious adverse events defined as grade 3 or higher (fatigue, nausea, bone pain, and anorexia) in participates as defined by CTCAE 4.0 (NCT02516670)
Timeframe: Up to 24 weeks

,
InterventionParticipants (Count of Participants)
fatiguenauseabone painanorexia
Arm A (Docetaxel, Ascorbic Acid)0001
Arm B (Docetaxel, Placebo)0000

[back to top]

Number of Serious Adverse Events

"Number of serious adverse events of all types as defined by Common Terminology Criteria for Adverse Events 4.0.~A serious adverse event is an undesirable sign, symptom, or medical condition that:~Results in death~Is life threatening~Requires inpatient hospitalization or causes prolongation of existing hospitalization for >24 hours~Results in persistent or significant disability/incapacity~Is a congenital anomaly/birth defect~Is an important medical event" (NCT02516670)
Timeframe: Up to 30 days after last dose of study drug

,
Interventionevents (Number)
grade 1grade 2grade 3grade 4grade 5
Arm A (Docetaxel, Ascorbic Acid)041830
Arm B (Docetaxel, Placebo)00600

[back to top]

Phosphorus Balance Sub-study (COMIRB 15-0384)

Balance is defined as oral intake minus urine output minus stool output. (NCT02209636)
Timeframe: 9 days from the start of the sub-study, approximately 13 weeks and 2 days from the start of the Main/Parent Study

Interventionmg/d (Mean)
Lanthanum Carbonate-131
Placebo320

[back to top]

Aortic Pulse-wave Velocity

"The speed that blood travels from the carotid artery to the femoral artery, expressed as cm/s (centimeters/second). It is a measure of arterial stiffness.~Aortic pulse-wave velocity will be measured at baseline and at 12 weeks (end-of-study) in the treatment and placebo groups to determine if there is a change aortic pulse wave velocity from baseline to 12 weeks and if this change is significantly different between the treatment and placebo groups." (NCT02209636)
Timeframe: baseline and 12 weeks

,
Interventionchange in aPWV, cm/s (Mean)
baselineweek 12
Lanthanum Carbonate12141216
Placebo993977

[back to top]

Brachial Artery Flow-mediated Dilation

"Measurement of how well the brachial artery dilates in response to shear stress. It is a measure of endothelial function. It is reported as percent change, which represents the change in dilation of the artery before and after occlusion.~Brachial artery flow-mediated dilation will be measured at baseline and at 12 weeks (end-of-study) in the treatment and placebo groups to determine if there is a change brachial artery flow mediated dilation from baseline to 12 weeks and if this change is significantly different between the treatment and placebo groups." (NCT02209636)
Timeframe: baseline and 12 weeks

,
Interventionpercent change FMD (Mean)
baselineweek 12
Lanthanum Carbonate3.132.73
Placebo3.743.09

[back to top]

C-reactive Protein to Measure Systemic Inflammation

This is a blood test. C-reactive protein will be measured at baseline and at 12 weeks (end-of-study) in the treatment and placebo groups to determine if there is a change in C-reactive protein from baseline to 12 weeks and if this change is significantly different between the treatment and placebo groups. (NCT02209636)
Timeframe: baseline and 12 weeks

,
Interventionmg/ml (Median)
C-reactive protein, baselineC-reactive protein, week 12
Lanthanum Carbonate2.923.06
Placebo2.722.24

[back to top]

Interleukin-6 to Measure Systemic Inflammation

This is a blood test. Interleukin-6 and C-reactive protein will be measured at baseline and at 12 weeks (end-of-study) in the treatment and placebo groups to determine if there is a change in interleukin-6 and C-reactive protein from baseline to 12 weeks and if this change is significantly different between the treatment and placebo groups. (NCT02209636)
Timeframe: baseline and 12 weeks

,
Interventionpg/ml (Median)
Interleukin-6, baselineInterleukin-6, week 12
Lanthanum Carbonate1.581.61
Placebo1.281.34

[back to top]

Oxidative Stress-associated Suppression of EDD

The influence of oxidative stress on FMD will be determined by infusing a supraphysiologic dose of ascorbic acid or isovolemic saline. The difference in FMD, expressed as percentage change in FMD, which represents the change in dilation of the artery before and after occlusion, during ascorbic acid vs. saline infusion will be taken as a measure of the modulation of EDD/stiffness by oxidative stress. (NCT02209636)
Timeframe: baseline and 12 weeks

,
Interventionpercent change in FMD (Mean)
baseline FMDbaseline FMD after ascorbic acidweek 12 FMDweek 12 FMD w/ ascorbic acid
Lanthanum Carbonate2.913.242.483.44
Placebo3.543.442.953.69

[back to top]

Oxidized Low-density Lipoprotein (Ox-LDL) to Measure Systemic Oxidized Stress

This is a blood test art. Oxidized low-density lipoprotein (ox-LDL) will be measured at baseline and at 12 weeks (end-of-study) in the treatment and placebo groups to determine if there is a change in ox-LDL from baseline to 12 weeks and if this change is significantly different between the treatment and placebo groups. (NCT02209636)
Timeframe: baseline and 12 weeks

,
InterventionmU/ml (Median)
baselineweek 12
Lanthanum Carbonate6183759725
Placebo6292768057

[back to top]

Vascular Endothelial Cell Protein Expression

Measures of different protein markers on endothelial cells. Will help understand the underlying pathophysiology of vascular dysfunction in chronic kidney disease. Vascular endothelial cell protein expression will be measured at baseline and at 12 weeks (end-of-study) in the treatment and placebo groups to determine if there is a change vascular endothelial cell protein expression from baseline to 12 weeks and if this change is significantly different between the treatment and placebo groups. The expression of endothelial cells collected from patients will be compared to the expression in HUVEC (human umbilical vein endothelial cell) controls and this ratio will be reported as the outcomes measure. (NCT02209636)
Timeframe: baseline and 12 weeks

,
Interventionratio (Mean)
baselineweek 12
Lanthanum Carbonate1.541.44
Placebo1.411.40

[back to top]

Forced Expiratory Flow at 75% of Expired Volume (FEF75)

The measurement of forced expiratory flows and specifically FEF75 will be done at 12 months of age in infants born to pregnant smoking women randomized to vitamin C versus placebo during pregnancy. FEF75 will be measured with the raised volume rapid thoracic compression technique. (NCT01723696)
Timeframe: 12 months of age

InterventionmL/s (Mean)
Placebo Tablet+Prenatal Vitamin324
Vitamin C +Prenatal Vitamin351.6

[back to top]

Forced Expiratory Flow at 75% of Expired Volume (FEF75)

The primary outcome was the comparison of infant FEFs at 3 months of age obtained using the raised volume rapid thoracic compression (RVRTC) technique in offspring of pregnant smokers randomized to vitamin C versus placebo. The specific primary outcome parameter was the measurement of FEF at 75% of the expired volume (FEF75) (NCT01723696)
Timeframe: 3 months of age

Interventionml/s (Mean)
Placebo Tablet+Prenatal Vitamin188.7
Vitamin C +Prenatal Vitamin200.7

[back to top]

Incidence of Wheezing Through 12 Months of Age

The incidence of wheezing through 12 months of age will be compared in the infants delivered to smoking pregnant women who were randomized to vitamin C (500 mg) versus placebo during pregnancy. (NCT01723696)
Timeframe: 12 months of age

InterventionParticipants (Count of Participants)
Placebo Tablet+Prenatal Vitamin63
Vitamin C +Prenatal Vitamin51

[back to top]

Response Rate

Bone marrow aspirate and biopsy performed to assess complete response and overall response rate. (NCT00661544)
Timeframe: 3, 6 and 12 months

InterventionParticipants (Number)
Complete ResponseOverall Response (Complete + Partial Response)
Arsenic Trioxide + Vitamin C + Melphalan1136

[back to top]

Assessment of Number of Grade 2 or Higher Genitourinary (GU) and Gastrointestinal (GI) Adverse Events

Assessment will be performed using CTCAE v 4 criteria. (NCT01603420)
Timeframe: at 6 months

Interventionincidences (Number)
Radiation + 24mo Luteinizing Hormone-releasing Hormone (LHRH)0
Radiation + Chemo + 6mo Luteinizing Hormone-releasing Hormone1

[back to top]

Assessment of Total Number of Biochemical Failure Events

The number of biochemical failure events will be assessed on both arms. (NCT01603420)
Timeframe: at study closure (22 months)

Interventionparticipants (Number)
Radiation + 24mo LHRH0
Radiation + Chemo + 6mo LHRH0

[back to top]

Assessment of Total Number of Local/Distant Failures

The total number of local/distant failures will be assessed. (NCT01603420)
Timeframe: at time of study closure (22 months)

Interventionparticipants (Number)
Radiation + 24mo LHRH0
Radiation + Chemo + 6mo LHRH0

[back to top]

Assessment of Total Number of Salvage Androgen Deprivation Use With Comparison of Arms.

The total number of subjects with salvage androgen deprivation use will be assessed. (NCT01603420)
Timeframe: At study closure (22 months)

Interventionparticipants (Number)
Radiation + 24mo LHRH0
Radiation + Chemo + 6mo LHRH0

[back to top]

Assessment of Total Number of Survival Events With Comparison of Group Arms

The number of deaths in both arms will be assessed. (NCT01603420)
Timeframe: at study closure (22 months)

Interventionparticipants (Number)
Radiation + 24mo LHRH0
Radiation + Chemo + 6mo LHRH0

[back to top]

Phase 2 - Assessment of Number of Freedom From Failure Events in the Chemotherapy Arm

"Measurement of Freedom from Failure i.e. the first occurence of clinical failure (local recurrence, regional recurrence, or distant metastasis), biochemical failure by the Phoenix definition (Prostate Specific Antigen [PSA] > = 2 ng/ml over the nadir PSA discounting bounces per the investigators discretion), or the start of salvage therapy including androgen deprivation.~This study was terminated prior to the time frame of 2 years being reached. Therefore, this outcome was assessed at time of study closure (22 months)." (NCT01603420)
Timeframe: No failures were reported at the time of study termination (22 months). This outcome was originally written to assess failure at 2 years. However, that end point was not reached.

Interventionfailure events (Number)
Radiation + 24mo Luteinizing Hormone-releasing Hormone (LHRH)0
Radiation + Chemo + 6mo Luteinizing Hormone-releasing Hormone0

[back to top]

Phase 2 - Cumulative Number of Incidences of Grade 3 or Higher Adverse Events.

"Assessment will be performed using CTCAE v4 criteria.~This study was terminated prior to the time frame of 2 years being reached. Therefore, this outcome was assessed at time of study closure (22 months)." (NCT01603420)
Timeframe: 2 years

Interventionevents (Number)
Radiation + 24mo LHRH0
Radiation + Chemo + 6mo LHRH0

[back to top]

Mean Number of Days in ICU.

the mean number of days each subject was in the ICU in each arm (NCT01897792)
Timeframe: from enrollment up to 60 days post enrollment

Interventiondays (Mean)
Vitamins C and E15
0.9% Saline and Sugar Pill11

[back to top]

Mean Number of Hospital Stay Days.

The mean number of days subjects were in the hospital in each arm of the study (NCT01897792)
Timeframe: from enrollment up to 60 days post enrollment

Interventiondays (Mean)
Vitamins C and E18.3
0.9% Saline and Sugar Pill18.2

[back to top]

Mean Number of Ventilator-free Days for Subjects

The mean number of ventilator free days (not on ventilator) for subjects in each arm (NCT01897792)
Timeframe: from enrollment up to 60 days post enrollment

Interventiondays (Mean)
Vitamins C and E12
0.9% Saline and Sugar Pill6.2

[back to top]

Number of Participants With Coagulation Abnormalities

Coagulation parameters are evaluated using standard functional tests (prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen and platelet count)and point of care functional analysis using thromboelastogram (TEG-ROTEM). A blood sample is collected upon arrival in the emergency department at 0 hours only and analyzed for markers of activation of coagulation, inflammation, and levels of vitamin C/E. (NCT01897792)
Timeframe: From enrollment up to 3 days

Interventionparticipants (Number)
Vitamins C and E2
0.9% Saline and Sugar Pill1

[back to top]

Number of Protocol Violations Per Arm.

The number of times that there was a deviation or violation from how the protocol was to be implemented. (NCT01897792)
Timeframe: from enrollment up to 60 days post enrollment

Interventionprotocol deviations (Number)
Vitamin C and E Participants -1
0.9% Saline and Sugar Pill Participants - Protocol Violations0

[back to top]

Number of Subjects Surviving to Day 28

Number of subjects that survived to day 28 after enrollment (NCT01897792)
Timeframe: from enrollment up to 28 days post enrollment

Interventionparticipants (Number)
Vitamins C and E6
0.9% Saline and Sugar Pill5

[back to top]

Number of Subjects With 60-day Survival

Number of subjects in each arm that survived to day 60 (NCT01897792)
Timeframe: from enrollment up to 60 days post enrollment

Interventionparticipants (Number)
Vitamins C and E6
0.9% Saline and Sugar Pill5

[back to top]

Number of Subjects With Organ Injury

Any injury to internal organs (thoracic, abdominal or cranial cavity) (NCT01897792)
Timeframe: From enrollment to 3 days

Interventionparticipants (Number)
Vitamins C and E0
0.9% Saline and Sugar Pill0

[back to top]

Number of Subjects With Ventilator-associated Pneumonia.

Number of subjects diagnosed with pneumonia and requiring ventilator support. (NCT01897792)
Timeframe: From enrollment to 3 days

Interventionparticipants (Number)
Vitamins C and E4
0.9% Saline and Sugar Pill2

[back to top]

Number of Total Blood Product Transfusions

the number of blood product transfusions for all subjects in each group over the course of 3 days. (NCT01897792)
Timeframe: From enrollment to 3 days

Interventionblood transfusions (Number)
Vitamins C and E11
0.9% Saline and Sugar Pill5

[back to top]

The Change in Serum Alanine Aminotransferase Level From Baseline to 12 Weeks

Serum alanine aminotransferase (ALT) level after 12 weeks of high dose vitamin C administration and Baseline serum ALT level (NCT01413360)
Timeframe: Baseline and 12 weeks

InterventionIU/L (Median)
ALT baselineALT 12 weeks
HD Vitamin C77.5105.5

[back to top]

The Change in Serum Interleukin 22 Level From Baseline to 12 Weeks

Serum interleukin 22(IL-22)level after 12 weeks of high vitamin C administration and Baseline IL-22 level (NCT01413360)
Timeframe: Baseline and 12 weeks

Interventionpg/mL (Median)
IL-22 baselineIL-22 after 12 weeks
HD Vitamin C3.664.04

[back to top]

Maximum Change in Mean Mouth and Throat Soreness (MTS) Score From Baseline Through Weeks of Radiation Therapy Using the MTS Question of the Modified Oral Mucositis Daily Questionnaire*.

"Severity is assessed as the maximum change in mean mouth and throat soreness (MTS) score from baseline during the weeks of RT, using MTS question of the validated Oral Mucositis Daily Questionnaire (modified OMDQ): During the past 24 hours, how much mouth and throat soreness did you have? The MTS score is a 5-point score, ranging from 0=No soreness to 4=Extreme soreness. We compared the maximum change in MTS score between the two groups using the Wilcoxon rank sum test with a one-sided alpha of 0.05." (NCT01898091)
Timeframe: MTS score is collected at the baseline visit and once each week during the 7 weeks of radiation therapy.

Interventionunits on a scale (Mean)
Neem Mouthrinse1.91
Placebo Mouthrinse1.47

[back to top]

Research Highlights

Safety/Toxicity (815)

ArticleYear
Exploring the mechanism of exopolysaccharides in mitigating cadmium toxicity in rice through analyzing the changes of antioxidant system.
Journal of hazardous materials, 01-05, Volume: 461
2024
Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer.
International journal of nanomedicine, Volume: 18
2023
Increased ascorbic acid synthesis by overexpression of AcGGP3 ameliorates copper toxicity in kiwifruit.
Journal of hazardous materials, 10-15, Volume: 460
2023
Silicon as an attenuator of the toxic effects of aluminum in Schinus terebinthifolius plants.
Brazilian journal of biology = Revista brasleira de biologia, Volume: 83
2023
Ascorbic acid modulates testicular toxicity of Ampligo® 150 ZC insecticide in male rabbit (Oryctolagus cuniculus).
Reproductive toxicology (Elmsford, N.Y.), Volume: 121
2023
Efficacy and safety of 1 L polyethylene glycol plus ascorbic acid for bowel preparation in elderly: comparison with oral sulfate solution.
The Korean journal of internal medicine, Volume: 38, Issue: 5
2023
Ascorbic acid reduces Ropivacaine-induced myotoxicity in cultured human osteoporotic skeletal muscle cells.
BMC musculoskeletal disorders, Jul-15, Volume: 24, Issue: 1
2023
The Prophylactic Effect of Vitamin C and Vitamin B12 against Ultraviolet-C-Induced Hepatotoxicity in Male Rats.
Molecules (Basel, Switzerland), May-24, Volume: 28, Issue: 11
2023
Potential application of melatonin in reducing boron toxicity in rice seedlings through improved growth, cell wall composition, proline, and defense mechanisms.
Chemosphere, Volume: 335
2023
Evaluating the in-vivo effects of olive oil, soya bean oil, and vitamins against oxidized ghee toxicity.
Acta biochimica Polonica, May-10, Volume: 70, Issue: 2
2023
Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers.
European review for medical and pharmacological sciences, Volume: 27, Issue: 8
2023
Elucidation of the role of α-lipoic acid and vitamin C in methotrexate-induced hepatoxicity in mice.
European review for medical and pharmacological sciences, Volume: 27, Issue: 6
2023
Thiamine pharmaconutrition in sepsis: Monotherapy, combined therapy, or neither? Current evidence on safety and efficacy.
Nutrition (Burbank, Los Angeles County, Calif.), Volume: 109
2023
Oxidative Status Determines the Cytotoxicity of Ascorbic Acid in Human Oral Normal and Cancer Cells.
International journal of molecular sciences, Mar-02, Volume: 24, Issue: 5
2023
Evaluation of acute oral toxicity, anti-diabetic and antioxidant effects of Aloe vera flowers extract.
Journal of ethnopharmacology, Jun-12, Volume: 309
2023
Further optimisation of a macromolecular ocular irritation test (OptiSafe
Cutaneous and ocular toxicology, Volume: 42, Issue: 1
2023
The Effect of Ascorbic Acid and Nicotinamide on Panton-Valentine Leukocidin Cytotoxicity: An Ex Vivo Study.
Toxins, 01-04, Volume: 15, Issue: 1
2023
Ameliorative effect of ellagic acid and Vitamin C against malathion-induced toxicity in testis of adult Wistar rats.
Journal of biochemical and molecular toxicology, Volume: 37, Issue: 5
2023
Antioxidant associated chemoprophylaxis effect of natural spice and green vegetable on hepatotoxicity.
Brazilian journal of biology = Revista brasleira de biologia, Volume: 84
2023
Boosting Endogenous Copper(I) for Biologically Safe and Efficient Bioorthogonal Catalysis via Self-Adaptive Metal-Organic Frameworks.
Journal of the American Chemical Society, 01-25, Volume: 145, Issue: 3
2023
Vitamin C protects the spleen against PFOA-induced immunotoxicity.
The Science of the total environment, Mar-20, Volume: 865
2023
The efficacy and safety of vitamin C administration to women with history of premature preterm rupture of membrane in prevention of such event in current pregnancy: Randomized controlled clinical trial.
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, Volume: 29, Issue: 4
2022
Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 55, Issue: 8
2023
Bioremediation of Cadmium Toxicity in Wheat (
International journal of environmental research and public health, 10-04, Volume: 19, Issue: 19
2022
Bowel Preparation Efficacy and Safety of 1 L vs 2 L Polyethylene Glycol With Ascorbic Acid for Colonoscopy: A Randomized Controlled Trial.
Clinical and translational gastroenterology, 03-01, Volume: 14, Issue: 3
2023
Triptolide and l-ascorbate palmitate co-loaded micelles for combination therapy of rheumatoid arthritis and side effect attenuation.
Drug delivery, Volume: 29, Issue: 1
2022
Vanillic acid and vitamin C attenuated di-2-ethylhexyl phthalate-induced testicular toxicity in adult male rats.
Reproduction & fertility, 07-01, Volume: 3, Issue: 3
2022
Amelioration of lead toxicity by ascorbic acid in sugarcane (Saccharum officinarum L.) under in vitro condition.
Environmental science and pollution research international, Volume: 29, Issue: 56
2022
Ameliorative potential of vitamin C and E against Roundup-glyphosate induced genotoxicity triggering apoptosis in caprine granulosa cells.
Environmental and molecular mutagenesis, Volume: 63, Issue: 5
2022
Silicon-mediated metabolic upregulation of ascorbate glutathione (AsA-GSH) and glyoxalase reduces the toxic effects of vanadium in rice.
Journal of hazardous materials, 08-15, Volume: 436
2022
Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study.
Journal of Crohn's & colitis, Nov-23, Volume: 16, Issue: 11
2022
Efficacy and Safety of Nutrient Supplements for Glycaemic Control and Insulin Resistance in Type 2 Diabetes: An Umbrella Review and Hierarchical Evidence Synthesis.
Nutrients, May-30, Volume: 14, Issue: 11
2022
Safety of a novel 1L-polyethylene glycol-ascorbate solution for colonoscopy cleansing (REAL Study).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 54, Issue: 11
2022
Safety Assessment of Ethers and Esters of Ascorbic Acid as Used in Cosmetics.
International journal of toxicology, Volume: 41, Issue: 2_suppl
2022
Clinical efficacy and safety of vitamin C in the treatment of septic shock patients: systematic review and meta-analysis.
Annals of palliative medicine, Volume: 11, Issue: 4
2022
Exogenous melatonin mitigates cadmium toxicity through ascorbic acid and glutathione pathway in wheat.
Ecotoxicology and environmental safety, Jun-01, Volume: 237
2022
The effectiveness of vitamin C on quinalphos ileal toxicity: a study of histological, ultrastructural, and oxidative stress markers.
Environmental science and pollution research international, Volume: 29, Issue: 38
2022
Mitigation of benznidazole toxicity and oxidative stress following ascorbic acid supplementation in an adult traveller with chronic indeterminate Chagas' disease.
The Journal of antimicrobial chemotherapy, 05-29, Volume: 77, Issue: 6
2022
Safety profile of laser-assisted drug delivery of vitamin C, E, and ferulic acid serum following ablative fractional resurfacing: A retrospective chart review.
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, Nov-17, Volume: 23, Issue: 7-8
2021
Improving the tolerability and safety of 1-L polyethylene glycol plus low-dose ascorbic acid for bowel preparation in a healthy population: a randomized multicenter clinical trial.
Gastrointestinal endoscopy, Volume: 96, Issue: 2
2022
Systematic review of clinical studies assessing the needling for treatment of melasma: Focusing on efficacy, safety, and recurrence rate.
Journal of cosmetic dermatology, Volume: 21, Issue: 5
2022
Efficacy and safety of perioperative vitamin C in patients undergoing noncardiac surgery: a systematic review and meta-analysis of randomised trials.
British journal of anaesthesia, Volume: 128, Issue: 4
2022
A Comparative Analysis of Ascorbic Acid-induced Cytotoxicity and Differentiation between SHED and DPSC.
Current stem cell research & therapy, Volume: 17, Issue: 6
2022
Ascorbic acid specifically reduces the misclassification of nonirritating reactive chemicals in the OptiSafe™ macromolecular eye irritation test.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 80
2022
Tissue Distribution, Histopathological and Genotoxic Effects of Magnetite Nanoparticles on Ehrlich Solid Carcinoma.
Biological trace element research, Volume: 200, Issue: 12
2022
Integrative omics analysis reveals the protective role of vitamin C on perfluorooctanoic acid-induced hepatoxicity.
Journal of advanced research, Volume: 35
2022
Vitamin C Mitigates Oxidative Stress and Behavioral Impairments Induced by Deltamethrin and Lead Toxicity in Zebrafish.
International journal of molecular sciences, Nov-24, Volume: 22, Issue: 23
2021
Safety and efficacy of mesotherapy in the treatment of melasma: A review article.
Journal of cosmetic dermatology, Volume: 21, Issue: 1
2022
Efficacy and Safety of TJP-008 Compared to 2 L PEG with Ascorbate in Colon Cleansing: A Randomized Phase 3 Trial.
Gut and liver, Mar-15, Volume: 16, Issue: 2
2022
Cytotoxicity and genotoxicity of blue LED light and protective effects of AA2G in mammalian cells and associated DNA repair deficient cell lines.
Mutation research. Genetic toxicology and environmental mutagenesis, Volume: 872
2021
Comparison of efficacy & safety of iron polymaltose complex & ferrous ascorbate with ferrous sulphate in pregnant women with iron-deficiency anaemia.
The Indian journal of medical research, Volume: 154, Issue: 1
2021
Exogenous ascorbic acid application alleviates cadmium toxicity in seedlings of two wheat (Triticum aestivum L.) varieties by reducing cadmium uptake and enhancing antioxidative capacity.
Environmental science and pollution research international, Volume: 29, Issue: 15
2022
Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study.
Journal of cosmetic dermatology, Volume: 21, Issue: 7
2022
Effectiveness of Clinical-Grade Chondroitin Sulfate and Ascorbic Acid in Mitigating Cryoprotectant Toxicity in Porcine Articular Cartilage.
Biopreservation and biobanking, Volume: 20, Issue: 4
2022
Comparative physiological and transcriptomic analyses reveal ascorbate and glutathione coregulation of cadmium toxicity resistance in wheat genotypes.
BMC plant biology, Oct-08, Volume: 21, Issue: 1
2021
A network meta-analysis of the effectiveness and safety of drugs for restless legs syndrome in dialysis patients.
Seminars in dialysis, Volume: 35, Issue: 4
2022
Vitamin D (Cholecalciferol) with Low Dose Vitamin C as a Safe and Effective Therapeutic Modality in an Adult with COVID-19 Pneumonia.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 1
2021
Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases.
Journal of cancer research and clinical oncology, Volume: 147, Issue: 10
2021
Alleviation of adverse effects of nickel on growth and concentration of copper and manganese in wheat through foliar application of ascorbic acid.
International journal of phytoremediation, Volume: 24, Issue: 7
2022
Antioxidant effect of ascorbic acid against cisplatin-induced nephrotoxicity and P-glycoprotein expression in rats.
European journal of pharmacology, Oct-15, Volume: 909
2021
Could Vitamin C Protect Against Mercuric Chloride Induced Lung Toxicity In The Offspring Rat: A Histological And Immunohistochemical Study.
Ultrastructural pathology, May-04, Volume: 45, Issue: 3
2021
Modeling the antioxidant properties of the eye reduces the false-positive rate of a nonanimal eye irritation test (OptiSafe).
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 76
2021
Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix (RJX).
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Volume: 141
2021
Ameliorative role of ascorbic acid on the oxidative stress and genotoxicity induced by acetamiprid in Nile tilapia (Oreochromis niloticus).
Environmental science and pollution research international, Volume: 28, Issue: 39
2021
Ecotoxicity evaluation of polymeric nanoparticles loaded with ascorbic acid for fish nutrition in aquaculture.
Journal of nanobiotechnology, May-31, Volume: 19, Issue: 1
2021
Therapeutic effects of chitosan-embedded vitamin C, E nanoparticles against cisplatin-induced gametogenic and androgenic toxicity in adult male rats.
Environmental science and pollution research international, Volume: 28, Issue: 40
2021
Keap1/Nrf2 pathway in sodium fluoride-induced cardiac toxicity and the prophylactic role of vitamin C versus platelet-rich plasma.
Folia morphologica, Volume: 81, Issue: 3
2022
Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 53, Issue: 9
2021
Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes.
Redox report : communications in free radical research, Volume: 26, Issue: 1
2021
Efficacy and Safety of Parenteral High-Dose Vitamin C Therapy in Pediatric Patients: A Scoping Review.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 06-01, Volume: 22, Issue: 6
2021
Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination.
Nutrients, Feb-13, Volume: 13, Issue: 2
2021
The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study.
Aging, 02-26, Volume: 13, Issue: 5
2021
Dexpanthenol and ascorbic acid ameliorate colistin-induced nephrotoxicity in rats.
European review for medical and pharmacological sciences, Volume: 25, Issue: 2
2021
Vitamin C and kidney transplantation: Nutritional status, potential efficacy, safety, and interactions.
Clinical nutrition ESPEN, Volume: 41
2021
Jasmonic acid-mediated enhanced regulation of oxidative, glyoxalase defense system and reduced chromium uptake contributes to alleviation of chromium (VI) toxicity in choysum (Brassica parachinensis L.).
Ecotoxicology and environmental safety, Jan-15, Volume: 208
2021
Vitamin C attenuates vancomycin induced nephrotoxicity through the reduction of oxidative stress and inflammation in HK-2 cells.
Annals of palliative medicine, Volume: 10, Issue: 2
2021
Evaluation of vitamin C protective effect on the cerebrocortical antioxidant defense, histopathological, pro-apoptotic p53 and anti-apoptotic Bcl2 expressions against tramadol neurotoxicity in rats.
Journal of chemical neuroanatomy, Volume: 112
2021
The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial.
JAMA network open, 11-02, Volume: 3, Issue: 11
2020
Vitamin K protects against 7,12-dimethylbenz(A)anthracene induced hepatotoxicity in Wistar rats.
Environmental toxicology, Volume: 36, Issue: 3
2021
Vitamin C protects early mouse embryos against juglone toxicity.
Reproductive toxicology (Elmsford, N.Y.), Volume: 98
2020
Potential amelioration of waterborne iron toxicity in channel catfish (Ictalurus punctatus) through dietary supplementation of vitamin C.
Ecotoxicology and environmental safety, Dec-01, Volume: 205
2020
Effects of ascorbate and carbonate on the conversion and developmental toxicity of halogenated disinfection byproducts during boiling of tap water.
Chemosphere, Volume: 254
2020
Pyrethroid-Induced Organ Toxicity and Anti-Oxidant-Supplemented Amelioration of Toxicity and Organ Damage: The Protective Roles of Ascorbic Acid and α-Tocopherol.
International journal of environmental research and public health, 08-25, Volume: 17, Issue: 17
2020
Silicon tackles butachlor toxicity in rice seedlings by regulating anatomical characteristics, ascorbate-glutathione cycle, proline metabolism and levels of nutrients.
Scientific reports, 08-21, Volume: 10, Issue: 1
2020
A pilot study on secondary anemia in "frailty" patients treated with Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine: safety of treatment explored by HRV non-linear analysis as predictive
European review for medical and pharmacological sciences, Volume: 24, Issue: 14
2020
Naphthalene Toxicity in a Three-Year-Old Child Complicated by Severe Hemolytic Anemia and Mild Methemoglobinemia: A Case Report.
The Journal of emergency medicine, Volume: 59, Issue: 4
2020
Ascorbic acid is essential for inducing chromium (VI) toxicity tolerance in tomato roots.
Journal of biotechnology, Oct-10, Volume: 322
2020
Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 52, Issue: 8
2020
Effects of exogenous melatonin and glutathione on zinc toxicity in safflower (Carthamus tinctorius L.) seedlings.
Ecotoxicology and environmental safety, Sep-15, Volume: 201
2020
Evaluation of the toxic effect of silver nanoparticles and the possible protective effect of ascorbic acid on the parotid glands of albino rats: An
Toxicology and industrial health, Volume: 36, Issue: 6
2020
[High dose vitamin C significantly reduces the nephrotoxicity of vancomycin in critically ill patients].
Zhonghua wei zhong bing ji jiu yi xue, Volume: 32, Issue: 4
2020
Nitric oxide-mediated regulation of sub-cellular chromium distribution, ascorbate-glutathione cycle and glutathione biosynthesis in tomato roots under chromium (VI) toxicity.
Journal of biotechnology, Jul-20, Volume: 318
2020
Protective potency of ascorbic acid supplementation against cytotoxicity and DNA fragmentation induced by triphenyltin on human liver carcinoma cells.
Environmental science and pollution research international, Volume: 27, Issue: 23
2020
The Radioprotective Effect of Ascorbic Acid and Kefir against Genotoxicity Induced by Exposure in Mice Blood Lymphocytes.
Nutrition and cancer, Volume: 73, Issue: 3
2021
A novel screening test to predict the developmental toxicity of drugs using human induced pluripotent stem cells.
The Journal of toxicological sciences, Volume: 45, Issue: 4
2020
The possible neurobehavioral protective effects of natural antioxidant against phototoxicity attenuation of antimicrobial quinolone group in rats.
Journal of biochemical and molecular toxicology, Volume: 34, Issue: 7
2020
Safety, Pharmacodynamics, and Efficacy of High- Versus Low-Dose Ascorbic Acid in Severely Burned Adults.
Journal of burn care & research : official publication of the American Burn Association, 07-03, Volume: 41, Issue: 4
2020
Sodium arsenite toxicity on hematology indices and reproductive parameters in Teddy goat bucks and their amelioration with vitamin C.
Environmental science and pollution research international, Volume: 27, Issue: 13
2020
Silicon and plant growth promoting rhizobacteria differentially regulate AgNP-induced toxicity in Brassica juncea: Implication of nitric oxide.
Journal of hazardous materials, 05-15, Volume: 390
2020
Therapeutic role of garlic and vitamins C and E against toxicity induced by lead on various organs.
Environmental science and pollution research international, Volume: 27, Issue: 9
2020
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (92)

ArticleYear
Efficacy of topical vitamin C in melasma and photoaging: A systematic review.
Journal of cosmetic dermatology, Volume: 22, Issue: 7
2023
The diabetogenic effects of chronic supplementation of vitamin C or E in rats: Interplay between liver and adipose tissues transcriptional machinery of lipid metabolism.
Life sciences, Oct-01, Volume: 306
2022
Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
Journal of cosmetic dermatology, Volume: 21, Issue: 7
2022
Vitamin C Enema Advances Induction of Remission in the Dextran Sodium Sulfate-Induced Colitis Model in Rats.
Journal of nutritional science and vitaminology, Volume: 67, Issue: 2
2021
Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
American journal of kidney diseases : the official journal of the National Kidney Foundation, Volume: 74, Issue: 3
2019
Vitamin C and E chronic supplementation differentially affect hepatic insulin signaling in rats.
Life sciences, Feb-01, Volume: 194
2018
Sub-chronic boldine treatment exerts anticonvulsant effects in mice.
Neurological research, Volume: 40, Issue: 2
2018
Functional interaction between N-methyl-D-aspartate receptor and ascorbic acid during neuropathic pain induced by chronic constriction injury of the sciatic nerve.
Journal of basic and clinical physiology and pharmacology, Nov-27, Volume: 28, Issue: 6
2017
Long-term ascorbic acid administration causes anticonvulsant activity during moderate and long-duration swimming exercise in experimental epilepsy.
Acta neurobiologiae experimentalis, Volume: 75, Issue: 2
2015
Influence of ascorbic acid supplementation on type 2 diabetes mellitus in observational and randomized controlled trials; a systematic review with meta-analysis.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, Volume: 17, Issue: 4
2014
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study.
International journal of cosmetic science, Volume: 36, Issue: 1
2014
Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies.
Nutrients, Jul-31, Volume: 5, Issue: 8
2013
Metal accumulation, biochemical response and yield of Indian mustard grown in soil amended with rural roadside pond sediment.
Ecotoxicology and environmental safety, Volume: 92
2013
High-dose supplements of vitamins C and E, low-dose multivitamins, and the risk of age-related cataract: a population-based prospective cohort study of men.
American journal of epidemiology, Mar-15, Volume: 177, Issue: 6
2013
Polyphenols prevent ageing-related impairment in skeletal muscle mitochondrial function through decreased reactive oxygen species production.
Experimental physiology, Volume: 98, Issue: 2
2013
Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
Archives of pharmacal research, Volume: 35, Issue: 3
2012
Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells.
Amino acids, Volume: 43, Issue: 3
2012
Antioxidant effect of red mould rice in hypercholesterolemic Wistar male rats.
Cell biochemistry and function, Volume: 29, Issue: 7
2011
Dietary supplementation with phytosterol and ascorbic acid reduces body mass accumulation and alters food transit time in a diet-induced obesity mouse model.
Lipids in health and disease, Jun-28, Volume: 10
2011
Acute and chronic hypermethioninemia alter Na+ K+-ATPase activity in rat hippocampus: prevention by antioxidants.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, Volume: 29, Issue: 4
2011
Ascorbate uptake is decreased in the hippocampus of ageing rats.
Neurochemistry international, Volume: 58, Issue: 4
2011
Age-related cataract in a randomized trial of vitamins E and C in men.
Archives of ophthalmology (Chicago, Ill. : 1960), Volume: 128, Issue: 11
2010
The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression.
The Journal of surgical research, Volume: 173, Issue: 1
2012
Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats.
American journal of hypertension, Volume: 23, Issue: 5
2010
Peroxidation processes in rats during the delayed period after chronic administration of dihydroquercetin.
Bulletin of experimental biology and medicine, Volume: 147, Issue: 5
2009
Effect of an antioxidant functional food beverage on exercise-induced oxidative stress: a long-term and large-scale clinical intervention study.
Toxicology, Nov-28, Volume: 278, Issue: 1
2010
High-fat diet and hydrochlorothiazide increase oxidative stress in brain of rats.
Cell biochemistry and function, Volume: 27, Issue: 7
2009
Lipoperoxidation and hemodialysis.
Metabolism: clinical and experimental, Volume: 57, Issue: 10
2008
Antioxidant nutrient intake and the long-term incidence of age-related cataract: the Blue Mountains Eye Study.
The American journal of clinical nutrition, Volume: 87, Issue: 6
2008
Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study.
Renal failure, Volume: 30, Issue: 1
2008
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer.
American journal of respiratory and critical care medicine, Mar-01, Volume: 177, Issue: 5
2008
Protective effects of cysteine, methionine and vitamin C on the stomach in chronically alcohol treated rats.
Journal of applied toxicology : JAT, Volume: 28, Issue: 5
2008
Ovarian toxicity in rats caused by methidathion and ameliorating effect of vitamins E and C.
Human & experimental toxicology, Volume: 26, Issue: 6
2007
A quercetin-modified biosensor for amperometric determination of uric acid in the presence of ascorbic acid.
Analytica chimica acta, Mar-07, Volume: 585, Issue: 2
2007
Antioxidant is a useful supportive agent for the treatment of coronary vasospasm with endothelial dysfunction in pig.
Coronary artery disease, Volume: 18, Issue: 2
2007
Cassava-enriched diet is not diabetogenic rather it aggravates diabetes in rats.
Fundamental & clinical pharmacology, Volume: 20, Issue: 6
2006
Endometrial damage and apoptosis in rats induced by dichlorvos and ameliorating effect of antioxidant vitamins E and C.
Reproductive toxicology (Elmsford, N.Y.), Volume: 22, Issue: 4
2006
Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma.
BioFactors (Oxford, England), Volume: 25, Issue: 1-4
2005
Selected haematological and biochemical parameters of blood in rats after subchronic administration of vanadium and/or magnesium in drinking water.
Archives of environmental contamination and toxicology, Volume: 51, Issue: 2
2006
Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior.
Life sciences, Apr-04, Volume: 78, Issue: 19
2006
Supplement nephropathy due to long-term, high-dose ingestion of ascorbic acid, calcium lactate, vitamin D and laxatives.
Clinical nephrology, Volume: 64, Issue: 3
2005
Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.
Metabolic brain disease, Volume: 20, Issue: 2
2005
Protective effect of antioxidants on brain oxidative damage caused by proline administration.
Neuroscience research, Volume: 52, Issue: 1
2005
The clinical course of interstitial pneumonia alias chronic fatigue syndrome under the control of megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex.
International journal of molecular medicine, Volume: 15, Issue: 1
2005
Effects of antioxidants on coronary microvascular spasm induced by epicardial coronary artery endothelial injury in pigs.
Coronary artery disease, Volume: 15, Issue: 1
2004
Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility.
Experimental eye research, Volume: 78, Issue: 3
2004
Studying long-term effect of phenytoin either alone or combined with ascorbic acid on the anesthetic effect of urethane in rats.
Fundamental & clinical pharmacology, Volume: 18, Issue: 2
2004
Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function.
Journal of the American College of Cardiology, Feb-18, Volume: 43, Issue: 4
2004
Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.
Free radical research, Volume: 37, Issue: 11
2003
The effect of Cyclosporine A chronic administration on the antioxidant pattern of rat liver mitochondria: structural and functional consequences.
BioFactors (Oxford, England), Volume: 18, Issue: 1-4
2003
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration.
Journal of the American College of Cardiology, Sep-03, Volume: 42, Issue: 5
2003
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus.
American journal of physiology. Heart and circulatory physiology, Volume: 285, Issue: 6
2003
Ascorbic acid prevents water maze behavioral deficits caused by early postnatal methylmalonic acid administration in the rat.
Brain research, Jun-27, Volume: 976, Issue: 2
2003
Influence of vitamin C on baroreflex sensitivity in chronic heart failure.
Hypertension (Dallas, Tex. : 1979), Volume: 41, Issue: 6
2003
Ascorbic acid prevents cognitive deficits caused by chronic administration of propionic acid to rats in the water maze.
Pharmacology, biochemistry, and behavior, Volume: 73, Issue: 3
2002
Caffeine inhibits the development of Ehrlich ascites carcinoma cells in female mice.
Indian journal of experimental biology, Volume: 39, Issue: 8
2001
Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities.
The American journal of clinical nutrition, Volume: 75, Issue: 3
2002
Chemoprevention of colorectal cancer.
The American journal of gastroenterology, Volume: 97, Issue: 1
2002
[Serum levels of vitamin C in young adults who chronically use drugs of abuse].
Investigacion clinica, Volume: 42, Issue: 3
2001
Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
Diabetes, Volume: 50, Issue: 8
2001
Effects of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients.
Artificial organs, Volume: 25, Issue: 6
2001
The role of folate, antioxidant vitamins and other constituents in fruit and vegetables in the prevention of cardiovascular disease: the epidemiological evidence.
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Volume: 71, Issue: 1
2001
Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells.
Journal of cardiovascular pharmacology, Volume: 37, Issue: 3
2001
Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume: 10, Issue: 1
2001
Vitamin supplement use and incident cataracts in a population-based study.
Archives of ophthalmology (Chicago, Ill. : 1960), Volume: 118, Issue: 11
2000
Antioxidant strategy to counteract the side effects of antipsychotic therapy: an in vivo study in rats.
European journal of pharmacology, Nov-10, Volume: 408, Issue: 1
2000
Antioxidants: what role do they play in physical activity and health?
The American journal of clinical nutrition, Volume: 72, Issue: 2 Suppl
2000
Ascorbic acid and alpha-tocopherol attenuate methylmalonic acid-induced convulsions.
Neuroreport, Jul-13, Volume: 10, Issue: 10
1999
Antioxidant systems in rat lens as a function of age: effect of chronic administration of vitamin E and ascorbate.
Aging (Milan, Italy), Volume: 11, Issue: 1
1999
Dietary carotenoids and vitamins A, C, and E and risk of breast cancer.
Journal of the National Cancer Institute, Mar-17, Volume: 91, Issue: 6
1999
[The effect of furosemide on urinary excretion of oxalic acid, vitamin C and vitamin B6 in chronic kidney failure].
Vnitrni lekarstvi, Volume: 44, Issue: 3
1998
Enhancement of nitroxide-reducing activity in rats after chronic administration of vitamin E, vitamin C, and idebenone examined by an in vivo electron spin resonance technique.
Magnetic resonance in medicine, Volume: 40, Issue: 2
1998
Dietary vitamin C and bone mineral density in postmenopausal women in Washington State, USA.
Journal of epidemiology and community health, Volume: 51, Issue: 5
1997
Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women.
The American journal of clinical nutrition, Volume: 65, Issue: 6
1997
[The modifying effect of long-term administration of ascorbic acid with drinking water on asbestos-induced pleural carcinogenesis in Wistar rats].
Voprosy onkologii, Volume: 42, Issue: 1
1996
Long term administration of testosterone on ascorbic acid metabolism in castrated rats.
Indian journal of experimental biology, Volume: 32, Issue: 7
1994
N,N'-bis-dibenzyl ethylenediaminediacetic acid (DBED): a site-specific hydroxyl radical scavenger acting as an "oxidative stress activatable" iron chelator in vitro.
Free radical research, Volume: 22, Issue: 1
1995
Antiparkinsonian therapies and brain mitochondrial complex I activity.
Movement disorders : official journal of the Movement Disorder Society, Volume: 10, Issue: 3
1995
Effects of high dose application of lindane to rats and influence of L-ascorbic acid supplementation.
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Volume: 52, Issue: 4
1982
Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol.
The American journal of clinical nutrition, Volume: 54, Issue: 6 Suppl
1991
The prevalence of oral lesions in smokeless tobacco users and an evaluation of risk factors.
Cancer, Dec-01, Volume: 70, Issue: 11
1992
Tolerance to sympathomimetic bronchodilators in guinea-pig isolated lungs following chronic administration in vivo.
British journal of pharmacology, Volume: 55, Issue: 4
1975
Adrenocortical changes in rats during acute and chronic administration of delta-9-tetrahydrocannabinol.
Endocrinologia experimentalis, Volume: 10, Issue: 2
1976
Effects of chloroquine on the adrenocortical function. II. Histological, histochemical and biochemical changes in the suprarenal gland of rats on long-term administration of chloroquine.
Arzneimittel-Forschung, Volume: 26, Issue: 11
1976
Studies on L-ascorbic acid metabolism in rats under chronic toxicity due to organophosphorus insecticides: effects of supplementation of L-ascorbic acid in high doses.
The Journal of nutrition, Volume: 108, Issue: 6
1978
Hypocholesterolemic effect of ascorbic acid in maturity-onset diabetes mellitus.
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Volume: 48, Issue: 4
1978
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (106)

ArticleYear
Efficacy of different bowel preparation regimen volumes for colorectal cancer screening and compliance with European Society of Gastrointestinal Endoscopy performance measures.
United European gastroenterology journal, Volume: 11, Issue: 5
2023
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study.
Clinical pharmacokinetics, Volume: 61, Issue: 9
2022
Development of stabilized fuzapladib solution for injection: forced degradation study and pharmacokinetic evaluation.
Pharmaceutical development and technology, Volume: 27, Issue: 5
2022
Oral sulfate solution versus low-volume polyethylene glycol for bowel preparation: Meta-analysis of randomized controlled trials.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, Volume: 34, Issue: 4
2022
Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix (RJX).
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Volume: 141
2021
Efficacy of ultra-low volume (≤1 L) bowel preparation fluids: Systematic review and meta-analysis.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, Volume: 34, Issue: 1
2022
Autologous Biological Vitamin-C-added (ABC) Filler for Facial Volume Restoration.
Aesthetic plastic surgery, Volume: 45, Issue: 5
2021
Novel 1-L polyethylene glycol + ascorbate versus high-volume polyethylene glycol regimen for colonoscopy cleansing: a multicenter, randomized, phase IV study.
Gastrointestinal endoscopy, Volume: 94, Issue: 4
2021
Potentiometric Biosensing of Ascorbic Acid, Uric Acid, and Cysteine in Microliter Volumes Using Miniaturized Nanoporous Gold Electrodes.
Biosensors, Dec-28, Volume: 11, Issue: 1
2020
Safety, Pharmacodynamics, and Efficacy of High- Versus Low-Dose Ascorbic Acid in Severely Burned Adults.
Journal of burn care & research : official publication of the American Burn Association, 07-03, Volume: 41, Issue: 4
2020
Predictive factors for inadequate bowel preparation using low-volume polyethylene glycol (PEG) plus ascorbic acid for an outpatient colonoscopy.
Scientific reports, 12-23, Volume: 9, Issue: 1
2019
Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, Volume: 21, Issue: 4
2019
The Pharmacokinetics of Vitamin C.
Nutrients, Oct-09, Volume: 11, Issue: 10
2019
Vitamin C, omega-3 and paracetamol pharmacokinetic interactions using saliva specimens as determiners.
Journal of basic and clinical physiology and pharmacology, Aug-06, Volume: 30, Issue: 5
2019
A novel volume-reduced CT colonography regimen using hypertonic laxative (polyethylene glycol with ascorbic acid): randomized controlled trial.
European radiology, Volume: 29, Issue: 10
2019
Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens.
Chest, Volume: 153, Issue: 6
2018
In vitro stabilization and in vivo improvement of ocular pharmacokinetics of the multi-therapeutic agent baicalin: Delineating the most suitable vesicular systems.
International journal of pharmaceutics, Mar-25, Volume: 539, Issue: 1-2
2018
A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial.
International journal of colorectal disease, Volume: 32, Issue: 12
2017
The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-15, Volume: 109
2017
Yields and Nutritional of Greenhouse Tomato in Response to Different Soil Aeration Volume at two depths of Subsurface drip irrigation.
Scientific reports, 12-20, Volume: 6
2016
Feasibility and safety of bowel cleansing using low-volume polyethylene glycol with ascorbic acid before pediatric colonoscopy: A pilot study.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, Volume: 29, Issue: 2
2017
Effect of Oral Coadministration of Ascorbic Acid with Ling Zhi Preparation on Pharmacokinetics of Ganoderic Acid A in Healthy Male Subjects: A Randomized Crossover Study.
BioMed research international, Volume: 2016
2016
Low-Volume Polyethylene Glycol with Ascorbic Acid for Colonoscopy Preparation in Elderly Patients: A Randomized Multicenter Study.
Digestion, Volume: 94, Issue: 2
2016
Maternal vitamin C deficiency does not reduce hippocampal volume and β-tubulin III intensity in prenatal Guinea pigs.
Nutrition research (New York, N.Y.), Volume: 36, Issue: 7
2016
Solution properties and taste behavior of lactose monohydrate in aqueous ascorbic acid solutions at different temperatures: Volumetric and rheological approach.
Food chemistry, Nov-15, Volume: 211
2016
[Effective bowel preparation before coloscopy - low-volume PEG in the divided dose regimen].
Vnitrni lekarstvi, Volume: 62, Issue: 4
2016
Pharmacokinetics and Plasma Cellular Antioxidative Effects of Flavanols After Oral Intake of Green Tea Formulated with Vitamin C and Xylitol in Healthy Subjects.
Journal of medicinal food, Volume: 19, Issue: 2
2016
Development of a novel method for determination of mercury based on its inhibitory effect on horseradish peroxidase activity followed by monitoring the surface plasmon resonance peak of gold nanoparticles.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Jan-15, Volume: 153
2016
Volumetric and UV absorption studies on understanding the solvation behavior of polyhydroxy solutes in l-ascorbic acid(aq) solutions at T=(288.15 to 318.15)K.
Food chemistry, Feb-01, Volume: 192
2016
The use of low-volume polyethylene glycol containing ascorbic acid versus 2 L of polyethylene glycol plus bisacodyl as bowel preparation for colonoscopy.
Scandinavian journal of gastroenterology, Volume: 50, Issue: 8
2015
The lower vitamin C plasma concentrations in elderly men compared with elderly women can partly be attributed to a volumetric dilution effect due to differences in fat-free mass.
The British journal of nutrition, Mar-14, Volume: 113, Issue: 5
2015
Carbon nanoparticles with tosyl functional group for distinguishing voltammetric peaks of ascorbic acid and uric acid.
Materials science & engineering. C, Materials for biological applications, Volume: 47
2015
A randomized, prospective trial on efficacy and tolerability of low-volume bowel preparation methods for colonoscopy.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 47, Issue: 2
2015
Randomized controlled trial of low-volume bowel preparation agents for colonic bowel preparation: 2-L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate.
International journal of colorectal disease, Volume: 30, Issue: 2
2015
Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue.
Free radical biology & medicine, Volume: 77
2014
Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: a pharmacokinetic evaluation.
Basic & clinical pharmacology & toxicology, Volume: 116, Issue: 4
2015
Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid.
Journal of pharmaceutical and biomedical analysis, Volume: 100
2014
A meta-analysis of randomized controlled trials of low-volume polyethylene glycol plus ascorbic acid versus standard-volume polyethylene glycol solution as bowel preparations for colonoscopy.
PloS one, Volume: 9, Issue: 6
2014
A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C.
Nutrients, Nov-11, Volume: 5, Issue: 11
2013
A low-volume polyethylene glycol plus ascorbate solution for bowel cleansing prior to colonoscopy: the NORMO randomised clinical trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 45, Issue: 10
2013
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.
Cancer chemotherapy and pharmacology, Volume: 72, Issue: 1
2013
Efficacy and acceptability of sodium picosulphate/magnesium citrate vs low-volume polyethylene glycol plus ascorbic acid for colon cleansing: a randomized controlled trial.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, Volume: 15, Issue: 9
2013
Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterial.
Antimicrobial agents and chemotherapy, Volume: 57, Issue: 6
2013
Effects of vitamin C and E intake on peak expiratory flow rate of asthmatic children exposed to atmospheric particulate matter.
Archives of environmental & occupational health, Volume: 68, Issue: 2
2013
Flexible micro(bio)sensors for quantitative analysis of bioanalytes in a nanovolume of human lachrymal liquid.
Analytical and bioanalytical chemistry, Volume: 405, Issue: 11
2013
A pilot study evaluating a new low-volume colon cleansing procedure for capsule colonoscopy.
Endoscopy, Volume: 44, Issue: 5
2012
Low-volume plus ascorbic acid vs high-volume plus simethicone bowel preparation before colonoscopy.
World journal of gastroenterology, Nov-14, Volume: 17, Issue: 42
2011
Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics.
The Journal of antimicrobial chemotherapy, Volume: 67, Issue: 2
2012
Simultaneous determination of a novel antitrypanosomal compound (OSU-36) and its ester derivative (OSU-40) in plasma by HPLC: application to first pharmacokinetic study in rats.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, Volume: 14, Issue: 1
2011
Low-volume PEG plus ascorbic acid versus high-volume PEG as bowel preparation for colonoscopy.
Scandinavian journal of gastroenterology, Volume: 45, Issue: 11
2010
Preparation of CLA ascorbyl ester with improved volumetric productivity by an ionic liquid-based reaction system.
Organic & biomolecular chemistry, Sep-07, Volume: 6, Issue: 17
2008
Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
Puerto Rico health sciences journal, Volume: 27, Issue: 1
2008
[A comparative research on quality of Vitmin C Yinqiao tablets from different manufacturers].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, Volume: 32, Issue: 22
2007
Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy.
The American journal of gastroenterology, Volume: 103, Issue: 4
2008
Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Feb-02, Volume: 831, Issue: 1-2
2006
In vivo assessment of toxicity and pharmacokinetics of methylglyoxal. Augmentation of the curative effect of methylglyoxal on cancer-bearing mice by ascorbic acid and creatine.
Toxicology and applied pharmacology, Apr-01, Volume: 212, Issue: 1
2006
Metabolic clearance of the antioxidant ascorbic acid in surgical patients.
The Journal of surgical research, Volume: 129, Issue: 1
2005
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
Diabetologia, Volume: 48, Issue: 8
2005
Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation.
Free radical biology & medicine, May-15, Volume: 38, Issue: 10
2005
Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Pharmacotherapy, Volume: 25, Issue: 2
2005
Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.
Journal of medicinal chemistry, Feb-10, Volume: 48, Issue: 3
2005
Vitamin C pharmacokinetics of plain and slow release formulations in smokers.
Clinical nutrition (Edinburgh, Scotland), Volume: 23, Issue: 5
2004
Voltammetric peak separation of dopamine from uric acid in the presence of ascorbic acid at greater than ambient solution temperatures.
Analytical chemistry, Jul-15, Volume: 76, Issue: 14
2004
Vitamin C pharmacokinetics: implications for oral and intravenous use.
Annals of internal medicine, Apr-06, Volume: 140, Issue: 7
2004
The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Journal of clinical pharmacology, Volume: 43, Issue: 10
2003
Effect of smoking on erythorbic acid pharmacokinetics.
The British journal of nutrition, Volume: 89, Issue: 5
2003
Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people.
Neuroscience letters, May-08, Volume: 341, Issue: 3
2003
Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults.
European journal of endocrinology, Volume: 148, Issue: 3
2003
Improvement of an automatic HPLC system for nitropolycyclic aromatic hydrocarbons: removal of an interfering peak and increase in the number of analytes.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, Volume: 19, Issue: 2
2003
Clearance of ascorbic acid in plasma in patients before major maxillofacial surgery compared with that in volunteers.
Nutrition and cancer, Volume: 42, Issue: 1
2002
Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.
Research in veterinary science, Volume: 71, Issue: 1
2001
Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study.
Archives of surgery (Chicago, Ill. : 1960), Volume: 135, Issue: 3
2000
Low midpregnancy placental volume in rural Indian women: A cause for low birth weight?
American journal of obstetrics and gynecology, Volume: 182, Issue: 2
2000
The effect of 61 days of combined iron (Chemiron) and single iron therapy on haemoglobin, packed cell volume, platelets and reticulocytes during pregnancy. Preliminary report.
Clinical and experimental obstetrics & gynecology, Volume: 25, Issue: 3
1998
Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
Artificial organs, Volume: 22, Issue: 9
1998
Reduced resuscitation fluid volume for second-degree experimental burns with delayed initiation of vitamin C therapy (beginning 6 h after injury).
The Journal of surgical research, Volume: 73, Issue: 1
1997
Pharmacokinetic perspectives on megadoses of ascorbic acid.
The American journal of clinical nutrition, Volume: 66, Issue: 5
1997
Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion.
Pharmaceutical research, Volume: 14, Issue: 9
1997
Reduced resuscitation fluid volume for second-degree burns with delayed initiation of ascorbic acid therapy.
Archives of surgery (Chicago, Ill. : 1960), Volume: 132, Issue: 2
1997
Evidence for a recommended dietary allowance for vitamin C from pharmacokinetics: a comment and analysis.
Proceedings of the National Academy of Sciences of the United States of America, Dec-10, Volume: 93, Issue: 25
1996
Changes in dietary intake, urinary nitrogen, and urinary volume across the menstrual cycle.
The American journal of clinical nutrition, Volume: 57, Issue: 1
1993
Differential pulse voltammetry in the anaesthetized rat: identification of ascorbic acid, catechol and indoleamine oxidation peaks in the striatum and frontal cortex.
British journal of pharmacology, Volume: 75, Issue: 3
1982
The effect of vitamin C on the pharmacokinetics of caffeine in elderly men.
The American journal of clinical nutrition, Volume: 35, Issue: 3
1982
Theophylline clearance. Lack of effect of influenza vaccination and ascorbic acid.
The American review of respiratory disease, Volume: 129, Issue: 5
1984
Pharmacokinetics of ascorbic acid in horses.
Equine veterinary journal, Volume: 16, Issue: 1
1984
Cardiopulmonary blood volume during acute blood pressure elevations in dogs.
Acta physiologica Scandinavica, Volume: 122, Issue: 2
1984
Use of technetium ( 99m Tc) as a bacterial label in lung clearance studies.
Applied microbiology, Volume: 25, Issue: 4
1973
Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states.
The Journal of clinical investigation, Volume: 76, Issue: 4
1985
Interstitial ascorbate in turtle brain is modulated by release and extracellular volume change.
Journal of neurochemistry, Volume: 49, Issue: 4
1987
Plasma clearance in the rat of the LH bioactivity of two human LH standards of differing molecular composition.
The Journal of endocrinology, Volume: 119, Issue: 2
1988
L-dihydroxyphenylalanine-induced asymmetric changes in striatal uric acid peak: determination by in vivo electrochemical detection in rats with unilateral nigrostriatal lesions.
Life sciences, Sep-14, Volume: 41, Issue: 11
1987
A new electron spin resonance assay for membrane asymmetry and entrapped volume of unilamellar lipid vesicles based on photoreduced flavin adenine dinucleotide.
Biochemistry, Mar-07, Volume: 28, Issue: 5
1989
Effect of ascorbic acid on plasma alcohol clearance.
Journal of the American College of Nutrition, Volume: 9, Issue: 3
1990
Pharmacokinetics of oral 6-mercaptopurine: relationship between plasma levels and urine excretion of parent drug.
Therapeutic drug monitoring, Volume: 12, Issue: 3
1990
A physiological pharmacokinetic model describing the disposition of lead in the absence and presence of L-ascorbic acid in rats.
Toxicology letters, Volume: 50, Issue: 2-3
1990
Effects of gender on vitamin C pharmacokinetics in man.
Journal of the American College of Nutrition, Volume: 10, Issue: 5
1991
The effect of sulphide on cytochrome aa3. Isosteric and allosteric shifts of the reduced alpha-peak.
Biochimica et biophysica acta, Jul-08, Volume: 396, Issue: 1
1975
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (436)

ArticleYear
Comparison of different drying technologies for brocade orange (Citrus sinensis) peels: Changes in color, phytochemical profile, volatile, and biological availability and activity of bioactive compounds.
Food chemistry, Nov-01, Volume: 425
2023
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial.
International journal of molecular sciences, Mar-07, Volume: 24, Issue: 6
2023
Low bioavailability of dietary iron among Brazilian children: Study in a representative sample from the Northeast, Southeast, and South regions.
Frontiers in public health, Volume: 11
2023
Effect of liposomal formulation of ascorbic acid on corneal permeability.
Scientific reports, 03-01, Volume: 13, Issue: 1
2023
Effectiveness of Dietary Intervention with Iron and Vitamin C Administered Separately in Improving Iron Status in Young Women.
International journal of environmental research and public health, 09-20, Volume: 19, Issue: 19
2022
Vitamin C Improves Dasatinib Concentrations Under Hypochlorhydric Conditions of the Simulated Stomach Duodenum Model.
Pharmaceutical research, Volume: 39, Issue: 9
2022
Double Nutri (Liposomal Encapsulation) Enhances Bioavailability of Vitamin C and Extends Its Half-Life in Plasma.
Journal of biomedical nanotechnology, Mar-01, Volume: 18, Issue: 3
2022
Ascorbic acid can alleviate the degradation of levodopa and carbidopa induced by magnesium oxide.
Brain and behavior, Volume: 12, Issue: 7
2022
The effect of acute intradermal administration of ascorbate on heat loss responses in older adults with uncomplicated controlled hypertension.
Experimental physiology, Volume: 107, Issue: 8
2022
Vitamin C and Omega-3 Fatty Acid Intake Is Associated with Human Periodontitis-A Nested Case-Control Study.
Nutrients, May-05, Volume: 14, Issue: 9
2022
Elucidation of chickpea hydration, effect of soaking temperature, and extent of germination on characteristics of malted flour.
Journal of food science, Volume: 87, Issue: 5
2022
Iron Bioavailability from Infant Cereals Containing Whole Grains and Pulses: A Stable Isotope Study in Malawian Children.
The Journal of nutrition, 03-03, Volume: 152, Issue: 3
2022
Ascorbic acid 2-glucoside: An ascorbic acid pro-drug with longer-term antioxidant efficacy in skin.
International journal of cosmetic science, Volume: 43, Issue: 6
2021
Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
Acta biomaterialia, Volume: 130
2021
Identification of gallic acid as a active ingredient of Syzygium aromaticum against tacrolimus-induced damage in renal epithelial LLC-PK1 cells and rat kidney.
Bioorganic & medicinal chemistry letters, 06-01, Volume: 41
2021
Heat shock induces cross adaptation to aluminum stress through enhancing ascorbate-glutathione cycle in wheat seedlings.
Chemosphere, Volume: 278
2021
Protection and controlled release of vitamin C by different micro/nanocarriers.
Critical reviews in food science and nutrition, Volume: 62, Issue: 12
2022
Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability.
Journal of the science of food and agriculture, Volume: 101, Issue: 9
2021
Activation of adenosine A3 receptors regulates vitamin C transport and redox balance in neurons.
Free radical biology & medicine, 02-01, Volume: 163
2021
Natural Exogenous Antioxidant Defense against Changes in Human Skin Fibroblast Proteome Disturbed by UVA Radiation.
Oxidative medicine and cellular longevity, Volume: 2020
2020
The effects of surgery on plasma/serum vitamin C concentrations: a systematic review and meta-analysis.
The British journal of nutrition, 01-28, Volume: 127, Issue: 2
2022
Impact of Ascorbic Acid on the In Vitro Iron Bioavailability of a Casein-Based Iron Fortificant.
Nutrients, Sep-11, Volume: 12, Issue: 9
2020
Evaluation and clinical comparison studies on liposomal and non-liposomal ascorbic acid (vitamin C) and their enhanced bioavailability.
Journal of liposome research, Volume: 31, Issue: 4
2021
Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19.
Nitric oxide : biology and chemistry, 10-01, Volume: 103
2020
Therapeutic treatment with vitamin C reduces focal cerebral ischemia-induced brain infarction in rats by attenuating disruptions of blood brain barrier and cerebral neuronal apoptosis.
Free radical biology & medicine, 08-01, Volume: 155
2020
Ascorbic acid, sucrose and olive oil lipids mitigate the inhibitory effects of pectin on the bioaccessibility and Caco-2 cellular uptake of ferulic acid and naringenin.
Food & function, May-01, Volume: 11, Issue: 5
2020
Fabrication and assessment of milk phospholipid-complexed antioxidant phytosomes with vitamin C and E: A comparison with liposomes.
Food chemistry, Sep-15, Volume: 324
2020
Dielectric barrier atmospheric cold plasma applied on camu-camu juice processing: Effect of the excitation frequency.
Food research international (Ottawa, Ont.), Volume: 131
2020
Ascorbic Acid 2-Glucoside Pretreatment Protects Cells from Ionizing Radiation, UVC, and Short Wavelength of UVB.
Genes, 02-25, Volume: 11, Issue: 3
2020
Green Synthesized BSA-Coated Selenium Nanoparticles Inhibit Bacterial Growth While Promoting Mammalian Cell Growth.
International journal of nanomedicine, Volume: 15
2020
Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations.
Oxidative medicine and cellular longevity, Volume: 2019
2019
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology, Volume: 96, Issue: 5
2019
Impact of acute antioxidant administration on inflammation and vascular function in heart failure with preserved ejection fraction.
American journal of physiology. Regulatory, integrative and comparative physiology, 11-01, Volume: 317, Issue: 5
2019
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
The Journal of biological chemistry, 11-15, Volume: 294, Issue: 46
2019
Conjugation of vitamin C with serum proteins: A potential application for vitamin delivery.
International journal of biological macromolecules, Sep-15, Volume: 137
2019
New oral liposomal vitamin C formulation: properties and bioavailability.
Journal of liposome research, Volume: 30, Issue: 3
2020
Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil.
International journal of molecular sciences, Feb-04, Volume: 20, Issue: 3
2019
Intervention against hypertension in the next generation programmed by developmental hypoxia.
PLoS biology, Volume: 17, Issue: 1
2019
Antioxidant Components of Brassica Vegetables Including Turnip and the Influence of Processing and Storage on their Anti-oxidative Properties.
Current medicinal chemistry, Volume: 26, Issue: 24
2019
Conjugation to Ascorbic Acid Enhances Brain Availability of Losartan Carboxylic Acid and Protects Against Parkinsonism in Rats.
The AAPS journal, 10-22, Volume: 20, Issue: 6
2018
A food synergy approach in a national program to improve the micronutrient status of preschoolers: a randomized control trial protocol.
Annals of the New York Academy of Sciences, Volume: 1438, Issue: 1
2019
Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin.
MedChemComm, Feb-01, Volume: 8, Issue: 2
2017
Comparative assessment and suitability of iron and the nutritional composition of fortified foods for young children.
Nutrition and health, Volume: 24, Issue: 2
2018
Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes.
Critical care (London, England), Dec-11, Volume: 21, Issue: 1
2017
High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study.
Scientific reports, 12-07, Volume: 7, Issue: 1
2017
Dietary Factors Modulate Iron Uptake in Caco-2 Cells from an Iron Ingot Used as a Home Fortificant to Prevent Iron Deficiency.
Nutrients, Sep-12, Volume: 9, Issue: 9
2017
A novel mechanism of ascorbate direct modulation of soluble epoxide hydrolase.
Prostaglandins & other lipid mediators, Volume: 131
2017
Vitamin C, Aging and Alzheimer's Disease.
Nutrients, Jun-27, Volume: 9, Issue: 7
2017
Bioavailability of iron multi-amino acid chelate preparation in mice and human duodenal HuTu 80 cells.
The British journal of nutrition, Volume: 117, Issue: 6
2017
In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics.
European journal of nutrition, Volume: 57, Issue: 2
2018
Glutathione Depletion, Pentose Phosphate Pathway Activation, and Hemolysis in Erythrocytes Protecting Cancer Cells from Vitamin C-induced Oxidative Stress.
The Journal of biological chemistry, 10-28, Volume: 291, Issue: 44
2016
Preparation and Self-Assembly Mechanism of Bovine Serum Albumin-Citrus Peel Pectin Conjugated Hydrogel: A Potential Delivery System for Vitamin C.
Journal of agricultural and food chemistry, Oct-05, Volume: 64, Issue: 39
2016
Acute ascorbic acid infusion increases left ventricular diastolic function in postmenopausal women.
Maturitas, Volume: 92
2016
Dairy cheese consumption ameliorates single-meal sodium-induced cutaneous microvascular dysfunction by reducing ascorbate-sensitive oxidants in healthy older adults.
The British journal of nutrition, Volume: 116, Issue: 4
2016
Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
International urology and nephrology, Volume: 48, Issue: 9
2016
Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25-35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease.
Neuropeptides, Volume: 58
2016
The epigenetic role of vitamin C in health and disease.
Cellular and molecular life sciences : CMLS, Volume: 73, Issue: 8
2016
Vitamin C: the known and the unknown and Goldilocks.
Oral diseases, Volume: 22, Issue: 6
2016
An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG).
Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue: 4
2016
Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue: 4
2016
Therapeutic treatment with ascorbate rescues mice from heat stroke-induced death by attenuating systemic inflammatory response and hypothalamic neuronal damage.
Free radical biology & medicine, Volume: 93
2016
Iron binding efficiency of polyphenols: Comparison of effect of ascorbic acid and ethylenediaminetetraacetic acid on catechol and galloyl groups.
Food chemistry, Apr-15, Volume: 197 Pt B
2016
Lipid-lowering Activity of Natural and Semi-Synthetic Sterols and Stanols.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, Volume: 18, Issue: 4
2015
L-dehydroascorbic acid can substitute l-ascorbic acid as dietary vitamin C source in guinea pigs.
Redox biology, Volume: 7
2016
Oxidative stability of a heme iron-fortified bakery product: Effectiveness of ascorbyl palmitate and co-spray-drying of heme iron with calcium caseinate.
Food chemistry, Apr-01, Volume: 196
2016
In Vitro Bioaccessibility and Bioavailability of Iron from Potatoes with Varying Vitamin C, Carotenoid, and Phenolic Concentrations.
Journal of agricultural and food chemistry, Oct-21, Volume: 63, Issue: 41
2015
Total Iron Bioavailability from the US Diet Is Lower Than the Current Estimate.
The Journal of nutrition, Volume: 145, Issue: 11
2015
New Reference Values for Vitamin C Intake.
Annals of nutrition & metabolism, Volume: 67, Issue: 1
2015
Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Drug design, development and therapy, Volume: 9
2015
Regulation of the Epigenome by Vitamin C.
Annual review of nutrition, Volume: 35
2015
Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation.
European journal of medicinal chemistry, Jun-05, Volume: 97
2015
Synergistic effect of reductive and ligand-promoted dissolution of goethite.
Environmental science & technology, Jun-16, Volume: 49, Issue: 12
2015
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue: 7
2015
Antioxidants in health and disease.
Bratislavske lekarske listy, Volume: 115, Issue: 10
2014
Evaluation of l-arginine on kidney function and vascular reactivity following ischemic injury in rats: protective effects and potential interactions.
Pharmacological reports : PR, Volume: 66, Issue: 6
2014
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study.
Molecular vision, Volume: 20
2014
Iron sucrose and ferric carboxymaltose: no correlation between physicochemical stability and biological activity.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, Volume: 28, Issue: 1
2015
High-dose vitamin C supplementation increases skeletal muscle vitamin C concentration and SVCT2 transporter expression but does not alter redox status in healthy males.
Free radical biology & medicine, Volume: 77
2014
Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid.
Journal of pharmaceutical and biomedical analysis, Volume: 100
2014
Nanoscopic poly-DNA-cleaver for breast cancer regression with induced oxidative damage.
Molecular pharmaceutics, Nov-03, Volume: 11, Issue: 11
2014
Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial.
European journal of preventive cardiology, Volume: 22, Issue: 11
2015
Vitamin C supplementation does not influence plasma and blood mononuclear cell IL-6 and IL-10 levels after exercise.
Journal of sports sciences, Volume: 32, Issue: 17
2014
Mechanism and regulation of peroxidase-catalyzed nitric oxide consumption in physiological fluids: critical protective actions of ascorbate and thiocyanate.
Free radical biology & medicine, Volume: 72
2014
Laser assisted drug delivery: a review of an evolving technology.
Lasers in surgery and medicine, Volume: 46, Issue: 4
2014
Bioaccessibility of vitamin A, vitamin C and folic acid from dietary supplements, fortified food and infant formula.
International journal of food sciences and nutrition, Volume: 65, Issue: 4
2014
Brassica foods as a dietary source of vitamin C: a review.
Critical reviews in food science and nutrition, Volume: 54, Issue: 8
2014
Antioxidants in food: content, measurement, significance, action, cautions, caveats, and research needs.
Advances in food and nutrition research, Volume: 71
2014
Adjuvant activity of CpG-ODN formulated as a liquid crystal.
Biomaterials, Volume: 35, Issue: 8
2014
Does vitamin C enhance nitric oxide bioavailability in a tetrahydrobiopterin-dependent manner? In vitro, in vivo and clinical studies.
Nitric oxide : biology and chemistry, Jan-30, Volume: 36
2014
A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C.
Nutrients, Nov-11, Volume: 5, Issue: 11
2013
Synthetic or food-derived vitamin C--are they equally bioavailable?
Nutrients, Oct-28, Volume: 5, Issue: 11
2013
A randomized steady-state bioavailability study of synthetic versus natural (kiwifruit-derived) vitamin C.
Nutrients, Sep-17, Volume: 5, Issue: 9
2013
Micronutrient status of children receiving prolonged enteral nutrition.
Annals of nutrition & metabolism, Volume: 63, Issue: 1-2
2013
Is a 40 % absorption of iron from a ferrous ascorbate reference dose appropriate to assess iron absorption independent of iron status?
Biological trace element research, Volume: 155, Issue: 3
2013
Sodium iron EDTA and ascorbic acid, but not polyphenol oxidase treatment, counteract the strong inhibitory effect of polyphenols from brown sorghum on the absorption of fortification iron in young women.
The British journal of nutrition, Volume: 111, Issue: 3
2014
Iron and zinc nutrition in the economically-developed world: a review.
Nutrients, Aug-13, Volume: 5, Issue: 8
2013
Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy.
The Journal of physiology, Oct-15, Volume: 591, Issue: 20
2013
Differential iron-bioavailability with relation to nutrient compositions in polished rice among selected Chinese genotypes using Caco-2 cell culture model.
International journal of food sciences and nutrition, Volume: 64, Issue: 7
2013
Iron bioavailability from a lipid-based complementary food fortificant mixed with millet porridge can be optimized by adding phytase and ascorbic acid but not by using a mixture of ferrous sulfate and sodium iron EDTA.
The Journal of nutrition, Volume: 143, Issue: 8
2013
Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2.
European journal of nutrition, Volume: 53, Issue: 2
2014
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (677)

ArticleYear
Ex Vivo Anti-Leukemic Effect of Exosome-like Grapefruit-Derived Nanovesicles from Organic Farming-The Potential Role of Ascorbic Acid.
International journal of molecular sciences, Oct-27, Volume: 24, Issue: 21
2023
Oxidative Stress and Male Infertility: The Protective Role of Antioxidants.
Medicina (Kaunas, Lithuania), Oct-04, Volume: 59, Issue: 10
2023
Associations between vitamin C intake and serum uric acid in US adults: Findings from National Health and Nutrition Examination Survey 2011-2016.
PloS one, Volume: 18, Issue: 10
2023
Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis.
BMC cardiovascular disorders, 09-21, Volume: 23, Issue: 1
2023
Melatonin or vitamin C attenuates lead acetate-induced testicular oxidative and inflammatory damage in mice by inhibiting oxidative stress mediated NF-κB signaling.
Ecotoxicology and environmental safety, Oct-01, Volume: 264
2023
The effects of vitamin C supplementation on glycemic control in patients with type 2 diabetes: A systematic review and meta-analysis.
Diabetes & metabolic syndrome, Volume: 17, Issue: 8
2023
EGCG attenuates METH self-administration and reinstatement of METH seeking in mice.
Addiction biology, Volume: 28, Issue: 8
2023
Vitamin C Supplementation and Athletic Performance: A Review.
Current sports medicine reports, Jul-01, Volume: 22, Issue: 7
2023
Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model.
Nutrients, Jun-09, Volume: 15, Issue: 12
2023
Dose-response relationship between dietary antioxidant intake and diabetic kidney disease in the US adults with diabetes.
Acta diabetologica, Volume: 60, Issue: 10
2023
Blue light promotes vitamin C-mediated ferroptosis of melanoma through specifically upregulating transporter SVCT2 and generating Fe
Biomaterials, Volume: 299
2023
Vitamin C as a Potential Prophylactic Measure Against Frozen Shoulder in an In Vivo Shoulder Contracture Animal Model.
The American journal of sports medicine, Volume: 51, Issue: 8
2023
Highly stable and fast-dissolving ascorbic acid-loaded microneedles.
International journal of cosmetic science, Volume: 45, Issue: 5
2023
[Vitamin C and D supplementation in critically ill patients].
Medizinische Klinik, Intensivmedizin und Notfallmedizin, Volume: 118, Issue: 2
2023
A randomized trial of once daily versus twice daily dosing of oral iron in CKD.
Scientific reports, 01-04, Volume: 13, Issue: 1
2023
Effects of injectable vitamin C at weaning and prior to transit on growth performance of early-weaned beef steers.
Journal of animal science, Jan-03, Volume: 101
2023
Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator-blinded trial.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, Volume: 35, Issue: 6
2023
Effect of antioxidant intake patterns on risks of dementia and cognitive decline.
European geriatric medicine, Volume: 14, Issue: 1
2023
Effects of Hypovitaminosis D on Preoperative Pain Threshold and Perioperative Opioid Use in Colorectal Cancer Surgery: A Cohort Study.
Pain physician, Volume: 25, Issue: 7
2022
Quantitative 1HNMR Spectroscopy: Analysis of Zinc Gluconate in Utozinc® Tablets, a Mixture of Zinc Gluconate and Vitamin C.
Journal of AOAC International, Dec-22, Volume: 106, Issue: 1
2022
Nanosponges-based Drug Delivery System for the Cosmeceutical Applications of Stabilized Ascorbic Acid.
Current drug delivery, Volume: 20, Issue: 10
2023
Variation of the Oxidative Profile in Pregnant Women With and Without Gestational Complications.
Maternal and child health journal, Volume: 26, Issue: 10
2022
Abnormal Micronutrient Intake Is Associated with the Risk of Periodontitis: A Dose-response Association Study Based on NHANES 2009-2014.
Nutrients, Jun-14, Volume: 14, Issue: 12
2022
Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back.
Molecules (Basel, Switzerland), Jun-14, Volume: 27, Issue: 12
2022
The Association between Dietary Vitamin C Intake and the Risk of Esophageal Cancer: An Updated Dose-Response Meta-Analysis.
Nutrition and cancer, Volume: 74, Issue: 10
2022
Ascorbic acid in solid organ transplantation: A literature review.
Clinical nutrition (Edinburgh, Scotland), Volume: 41, Issue: 6
2022
Vitamin C intake and multiple health outcomes: an umbrella review of systematic reviews and meta-analyses.
International journal of food sciences and nutrition, Volume: 73, Issue: 5
2022
A Narrative Review on Pediatric Scurvy: The Last Twenty Years.
Nutrients, Feb-06, Volume: 14, Issue: 3
2022
1 L- versus 2 L-polyethylene glycol with ascorbic acid for bowel preparation in elderly patients: a randomized multicenter study.
Surgical endoscopy, Volume: 36, Issue: 8
2022
Dietary Antioxidants and Risk of Parkinson's Disease: A Systematic Review and Dose-Response Meta-analysis of Observational Studies.
Advances in nutrition (Bethesda, Md.), 10-02, Volume: 13, Issue: 5
2022
A highly sensitive switch-on spectrofluorometric method for determination of ascorbic acid using a selective eco-friendly approach.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Apr-05, Volume: 270
2022
The Role of Immunomodulatory Nutrients in Alleviating Complications Related to SARS-CoV-2: A Scoping Review.
Advances in nutrition (Bethesda, Md.), Volume: 13, Issue: 2
2022
Eggs Immersion with Vitamin C on Hatching Rate, Growth and Mortality of Giant Gourami Larvae.
Pakistan journal of biological sciences : PJBS, Volume: 24, Issue: 11
2021
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients.
The American journal of emergency medicine, Volume: 51
2022
Cost-effective and earth-friendly chemometrics-assisted spectrophotometric methods for simultaneous determination of Acetaminophen and Ascorbic Acid in pharmaceutical formulation.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Feb-05, Volume: 266
2022
Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment.
BMC pharmacology & toxicology, 09-16, Volume: 22, Issue: 1
2021
Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study.
Journal of pharmaceutical sciences, Volume: 110, Issue: 12
2021
Vitamin C and scar strength: analysis of a historical trial and implications for collagen-related pathologies.
The American journal of clinical nutrition, 01-11, Volume: 115, Issue: 1
2022
Vitamin C, Hydrocortisone, and the Combination Thereof Significantly Inhibited Two of Nine Inflammatory Markers Induced by Escherichia Coli But Not by Staphylococcus Aureus - When Incubated in Human Whole Blood.
Shock (Augusta, Ga.), 01-01, Volume: 57, Issue: 1
2022
Vitamin C for Sepsis and Septic Shock.
American journal of therapeutics, Jul-05, Volume: 28, Issue: 6
2021
Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants.
Cancer medicine, Volume: 10, Issue: 15
2021
Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
Acta biomaterialia, Volume: 130
2021
Benefits of combination therapy of hydrocortisone, ascorbic acid and thiamine in sepsis and septic shock: A systematic review.
Nutrition and health, Volume: 28, Issue: 1
2022
Does vitamin C supplementation exert profitable effects on serum lipid profile in patients with type 2 diabetes? A systematic review and dose-response meta-analysis.
Pharmacological research, Volume: 169
2021
A meta-analysis of randomized clinical trials on the impact of oral vitamin C supplementation on first-year outcomes in orthopedic patients.
Scientific reports, 04-29, Volume: 11, Issue: 1
2021
Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc.
Nutrients, Apr-12, Volume: 13, Issue: 4
2021
Comparison of 1L Adjuvant Auxiliary Preparations with 2L Solely Polyethylene Glycol plus Ascorbic Acid Regime for Bowel Cleaning: A Meta-analysis of Randomized, Controlled Trials.
BioMed research international, Volume: 2021
2021
Effect of high-dose intravenous vitamin C on point-of-care blood glucose level in septic patients: a retrospective, single-center, observational case series.
Current medical research and opinion, Volume: 37, Issue: 4
2021
Altered Gut Microbiota is Involved in the Anti-Hypertensive Effects of Vitamin C in Spontaneously Hypertensive Rat.
Molecular nutrition & food research, Volume: 65, Issue: 7
2021
Chemical reactivity of nitrite and ascorbate in a cured and cooked meat model implication in nitrosation, nitrosylation and oxidation.
Food chemistry, Jun-30, Volume: 348
2021
Vitamin C in orthopedic practices: Current concepts, novel ideas, and future perspectives.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society, Volume: 39, Issue: 4
2021
Ascorbic acid mitigates cadmium-induced stress, and contributes to ionome stabilization in fission yeast.
Environmental science and pollution research international, Volume: 28, Issue: 12
2021
Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study.
Annals of palliative medicine, Volume: 10, Issue: 2
2021
Vitamin Analysis Comparison Study.
American journal of ophthalmology, Volume: 222
2021
Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin.
Pharmacology research & perspectives, Volume: 8, Issue: 4
2020
High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
The American journal of emergency medicine, Volume: 38, Issue: 11
2020
[High dose vitamin C significantly reduces the nephrotoxicity of vancomycin in critically ill patients].
Zhonghua wei zhong bing ji jiu yi xue, Volume: 32, Issue: 4
2020
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review.
Nutrients, Jun-08, Volume: 12, Issue: 6
2020
Development and uniformity evaluation of low-dose medicated chewing gums prepared by compression method.
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,Winter, Volume: 69, Issue: 1
2020
The effect of ascorbic acid pretreatment on amphetamine-induced dopamine depletion in male and female mice.
Neuroreport, 07-10, Volume: 31, Issue: 10
2020
Ozonation as a Method of Abiotic Elicitation Improving the Health-Promoting Properties of Plant Products-A Review.
Molecules (Basel, Switzerland), May-22, Volume: 25, Issue: 10
2020
Stereolithography (SLA) 3D printing of ascorbic acid loaded hydrogels: A controlled release study.
International journal of pharmaceutics, Jun-30, Volume: 584
2020
Detoxification and immobilization of chromite ore processing residue using the alkali-activated cementitious materials mixed with ascorbic acid.
Journal of environmental management, Jul-01, Volume: 265
2020
Safety, Pharmacodynamics, and Efficacy of High- Versus Low-Dose Ascorbic Acid in Severely Burned Adults.
Journal of burn care & research : official publication of the American Burn Association, 07-03, Volume: 41, Issue: 4
2020
Treating sepsis with vitamin C, thiamine, and hydrocortisone: Exploring the quest for the magic elixir.
Journal of critical care, Volume: 57
2020
Nutrition in Sepsis: A Bench-to-Bedside Review.
Nutrients, Feb-02, Volume: 12, Issue: 2
2020
Effect of high-dose vitamin C therapy on severe burn patients: a nationwide cohort study.
Critical care (London, England), 12-12, Volume: 23, Issue: 1
2019
Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock.
Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, Volume: 21, Issue: 4
2019
Study on the interaction between lovastatin and three digestive enzymes and the effect of naringin and vitamin C on it by spectroscopy and docking methods.
International journal of biological macromolecules, Jul-15, Volume: 155
2020
The Pharmacokinetics of Vitamin C.
Nutrients, Oct-09, Volume: 11, Issue: 10
2019
Combination of bisacodyl suppository and 1 L polyethylene glycol plus ascorbic acid is a non-inferior and comfortable regimen compared to 2 L polyethylene glycol plus ascorbic acid.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, Volume: 32, Issue: 4
2020
Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage.
BMC research notes, Sep-18, Volume: 12, Issue: 1
2019
Network analysis, and human and animal studies disclose the anticystitis glandularis effects of vitamin C.
BioFactors (Oxford, England), Volume: 45, Issue: 6
2019
Effective degradation of the mycotoxin patulin in pear juice by porcine pancreatic lipase.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 133
2019
Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol + ascorbate or oral sulfate solution.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Volume: 51, Issue: 12
2019
The Validity of Children's Fruit and Vegetable Intake Using Plasma Vitamins A, C, and E: The SAYCARE Study.
Nutrients, Aug-06, Volume: 11, Issue: 8
2019
Redox states of hemoglobin determine left ventricle pressure recovery and activity of mitochondrial complex IV in hypoxic rat hearts.
Free radical biology & medicine, Volume: 141
2019
Effects of in ovo injection of L-ascorbic acid on growth performance, carcass composition, plasma antioxidant capacity, and meat quality in broiler chickens1,2,3.
Poultry science, Sep-01, Volume: 98, Issue: 9
2019
Quantitative magnetic resonance elastography for polymer-gel dosimetry phantoms.
Medical engineering & physics, Volume: 66
2019
Scurvy, an old story in a new time: The hematologist's experience.
Blood cells, molecules & diseases, Volume: 76
2019
Dietary and circulating vitamin C, vitamin E, β-carotene and risk of total cardiovascular mortality: a systematic review and dose-response meta-analysis of prospective observational studies.
Public health nutrition, Volume: 22, Issue: 10
2019
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
Critical care (London, England), 01-09, Volume: 23, Issue: 1
2019
Dietary vitamin and carotenoid intake and risk of age-related cataract.
The American journal of clinical nutrition, 01-01, Volume: 109, Issue: 1
2019
On infusion of high-dose ascorbate in treating cancer: Is it time for N-acetylcysteine pretreatment to enhance susceptibility and to lower side effects?
Medical hypotheses, Volume: 122
2019
Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity.
International journal for parasitology. Drugs and drug resistance, Volume: 9
2019
Retinol palmitate and ascorbic acid: Role in oncological prevention and therapy.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Volume: 109
2019
Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.
The American journal of clinical nutrition, 11-01, Volume: 108, Issue: 5
2018
A Meta-analysis of Randomized Control Trials: The Impact of Vitamin C Supplementation on Serum CRP and Serum hs-CRP Concentrations.
Current pharmaceutical design, Volume: 24, Issue: 30
2018
Dietary Antioxidants, Circulating Antioxidant Concentrations, Total Antioxidant Capacity, and Risk of All-Cause Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Observational Studies.
Advances in nutrition (Bethesda, Md.), 11-01, Volume: 9, Issue: 6
2018
Accuracy of Point-of-Care Blood Glucose Level Measurements in Critically Ill Patients with Sepsis Receiving High-Dose Intravenous Vitamin C.
Pharmacotherapy, Volume: 38, Issue: 11
2018
Vitamin C to Improve Organ Dysfunction in Cardiac Surgery Patients-Review and Pragmatic Approach.
Nutrients, Jul-27, Volume: 10, Issue: 8
2018
The influence of dietary supplementation with cranberry tablets on the urinary risk factors for nephrolithiasis.
World journal of urology, Volume: 37, Issue: 3
2019
Optimal dosage and early intervention of L-ascorbic acid inhibiting K
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), Volume: 48
2018
Rapid automated process development of a continuous capsule-filling process.
International journal of pharmaceutics, Jul-30, Volume: 546, Issue: 1-2
2018
Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System.
Diabetes technology & therapeutics, Volume: 20, Issue: 5
2018
Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens.
Chest, Volume: 153, Issue: 6
2018
Effects of in ovo administration of L-ascorbic acid on broiler hatchability and its influence on the effects of pre-placement holding time on broiler quality characteristics,.
Poultry science, Jun-01, Volume: 97, Issue: 6
2018
Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide.
Lipids in health and disease, Feb-14, Volume: 17, Issue: 1
2018
Treatment of pancreatic cancer with intravenous vitamin C: a case report.
Anti-cancer drugs, Volume: 29, Issue: 4
2018
Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study.
Journal of bone and mineral metabolism, Volume: 37, Issue: 1
2019
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (90)

ArticleYear
Effects of swimming exercise combined with silymarin and vitamin C supplementation on hepatic inflammation, oxidative stress, and histopathology in elderly rats with high-fat diet-induced liver damage.
Nutrition (Burbank, Los Angeles County, Calif.), Volume: 115
2023
Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.
European journal of medicinal chemistry, Oct-05, Volume: 258
2023
Effects of vitamin C combined with rbFGF on inflammatory factors and oxygen environment in patients with high-voltage electrical burns.
International wound journal, Volume: 20, Issue: 7
2023
Hydrocortisone Combined with Vitamin C and Thiamine in the Treatment of Sepsis/Septic Shock: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.
Clinical and investigative medicine. Medecine clinique et experimentale, 03-26, Volume: 46, Issue: 1
2023
Effects of hydrocortisone combined with vitamin C and vitamin B1 versus hydrocortisone alone on microcirculation in septic shock patients: A pilot study.
Clinical hemorheology and microcirculation, Volume: 84, Issue: 2
2023
Antiangiogenic Activity of Quinine Alone and in Combination with vitamin C in both ex vivo and in vivo Assays.
Asian Pacific journal of cancer prevention : APJCP, Dec-01, Volume: 23, Issue: 12
2022
Melanin Treatment Effect of Vacuoles-Zinc Oxide Nanoparticles Combined with Ascorbic Acid.
Molecular biotechnology, Volume: 65, Issue: 7
2023
Effects of Vitamin C Combined with Growth Inhibitors on Gastrointestinal Bleeding in Cirrhosis.
Contrast media & molecular imaging, Volume: 2022
2022
Comparison of Ferric Sodium EDTA in Combination with Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate, and Selenomethionine as Therapeutic Option for Chronic Kidney Disease Patients with Improvement in Inflammatory Status.
Nutrients, May-19, Volume: 14, Issue: 10
2022
Enzyme-triggered click chemistry combined with surface-enhanced Raman spectroscopy for the simple and sensitive detection of alkaline phosphatase activity from complex biological samples.
The Analyst, May-30, Volume: 147, Issue: 11
2022
Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway.
The Journal of international medical research, Volume: 50, Issue: 4
2022
[Therapeutic effect of hydrocortisone combined with vitamin C and vitamin B1 on patients with sepsis: a Meta-analysis].
Zhonghua wei zhong bing ji jiu yi xue, Volume: 33, Issue: 9
2021
Cleanup of arsenic, cadmium, and lead in the soil from a smelting site using N,N-bis(carboxymethyl)-L-glutamic acid combined with ascorbic acid: A lab-scale experiment.
Journal of environmental management, Oct-15, Volume: 296
2021
Clinical efficacy of Curcuvet and Boswellic acid combined with conventional nutraceutical product: An aid to canine osteoarthritis.
PloS one, Volume: 16, Issue: 5
2021
Thiamine combined with vitamin C in sepsis or septic shock: a systematic review and meta-analysis.
European journal of emergency medicine : official journal of the European Society for Emergency Medicine, Jun-01, Volume: 28, Issue: 3
2021
Drug repurposing for COVID-19: could vitamin C combined with glycyrrhizic acid be at play by the findings of Li et al.'s database-based network pharmacology analysis?
Briefings in bioinformatics, 03-22, Volume: 22, Issue: 2
2021
A pilot study on secondary anemia in "frailty" patients treated with Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine: safety of treatment explored by HRV non-linear analysis as predictive
European review for medical and pharmacological sciences, Volume: 24, Issue: 14
2020
Evaluation of the Anti-Inflammatory Activities of Diclofenac Sodium, Prednisolone and Atorvastatin in Combination with Ascorbic Acid.
Anti-inflammatory & anti-allergy agents in medicinal chemistry, Volume: 19, Issue: 3
2020
Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.
Anticancer research, Volume: 39, Issue: 2
2019
Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
PLoS neglected tropical diseases, Volume: 12, Issue: 9
2018
Preliminary randomized controlled trial of antiaging effects of l-ascorbic acid applied in combination with no-needle and microneedle mesotherapy.
Journal of cosmetic dermatology, Volume: 18, Issue: 3
2019
Effect of strength training combined with antioxidant supplementation on muscular performance.
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, Volume: 43, Issue: 8
2018
Ascorbic acid co-administered with rosuvastatin reduces reproductive impairment in the male offspring from male rats exposed to the statin at pre-puberty.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 118
2018
Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: A comparative study.
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, Volume: 19, Issue: 5
2017
Comparable Efficacy of a 1-L PEG and Ascorbic Acid Solution Administered with Bisacodyl versus a 2-L PEG and Ascorbic Acid Solution for Colonoscopy Preparation: A Prospective, Randomized and Investigator-Blinded Trial.
PloS one, Volume: 11, Issue: 9
2016
Effect of Astaxanthin, Vitamin E, and Vitamin C in Combination with Calorie Restriction on Sperm Quality and Quantity in Male Rats.
Journal of dietary supplements, May-04, Volume: 14, Issue: 3
2017
In vivo inhibition of tumor progression by 5 hydroxy-1,4-naphthoquinone (juglone) and 2-(4-hydroxyanilino)-1,4-naphthoquinone (Q7) in combination with ascorbate.
Biochemical and biophysical research communications, 09-02, Volume: 477, Issue: 4
2016
Efficacy of 694-nm fractional Q-switched ruby laser (QSRL) combined with sonophoresis on levorotatory vitamin C for treatment of melasma in Chinese patients.
Lasers in medical science, Volume: 31, Issue: 5
2016
The rat closely mimics oxidative stress and inflammation in humans after exercise but not after exercise combined with vitamin C administration.
European journal of applied physiology, Volume: 116, Issue: 4
2016
Evaluation of multiple ancillary therapies used in combination with an antimicrobial in newly received high-risk calves treated for bovine respiratory disease.
Journal of animal science, Volume: 93, Issue: 7
2015
Effects of X‑ray irradiation in combination with ascorbic acid on tumor control.
Molecular medicine reports, Volume: 12, Issue: 4
2015
Vitamin E supplementation is associated with lower levels of C-reactive protein only in higher dosages and combined with other antioxidants: The Cooperative Health Research in the Region of Augsburg (KORA) F4 study.
The British journal of nutrition, Jun-14, Volume: 113, Issue: 11
2015
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.
PloS one, Volume: 10, Issue: 4
2015
DNA damage and inhibition of akt pathway in mcf-7 cells and ehrlich tumor in mice treated with 1,4-naphthoquinones in combination with ascorbate.
Oxidative medicine and cellular longevity, Volume: 2015
2015
[Stimulation of pelvic fracture healing by local injection of autologous plasma in combination with metabolically active substances that have an antioxidant and antihypoxic effect].
Vestnik Rossiiskoi akademii meditsinskikh nauk, Issue: 7-8
2014
Mefloquine in combination with hemin causes severe damage to adult Schistosoma japonicum in vitro.
Acta tropica, Volume: 131
2014
Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.
Free radical biology & medicine, Volume: 68
2014
Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery?
Cardiovascular journal of Africa, Volume: 24, Issue: 7
2013
Antioxidant action of ganghwayakssuk (Artemisia princeps Pamp.) in combination with ascorbic acid to increase the shelf life in raw and deep fried chicken nuggets.
Meat science, Volume: 95, Issue: 3
2013
Alteration of chemical behavior of L-ascorbic acid in combination with nickel sulfate at different pH solutions in vitro.
Asian Pacific journal of tropical biomedicine, Volume: 2, Issue: 3
2012
Sodium vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy.
BMC medicine, Feb-14, Volume: 11
2013
Effect of packing on changes in erythrocyte osmotic fragility and malondialdehyde concentration in donkeys administered with ascorbic acid.
The Onderstepoort journal of veterinary research, Dec-05, Volume: 79, Issue: 1
2012
Repressive effects of a capacitive-resistive electric transfer (CRet) hyperthermic apparatus combined with provitamin C on intracellular lipid-droplets formation in adipocytes.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, Volume: 29, Issue: 1
2013
Gentamicin in combination with ascorbic acid regulates the severity of Staphylococcus aureus infection-induced septic arthritis in mice.
Scandinavian journal of immunology, Volume: 76, Issue: 6
2012
Rectal temperature responses of donkeys administered with ascorbic acid and subjected to load carrying (packing) during the harmattan season in Nigeria.
Tropical animal health and production, Volume: 45, Issue: 2
2013
[Antiviral activity of recombinant interferon-alpha-2b in combination with certain antioxidant].
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], Volume: 56, Issue: 9-10
2011
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
PloS one, Volume: 7, Issue: 1
2012
Inhibitory effect of vitamin C in combination with vitamin K3 on tumor growth and metastasis of Lewis lung carcinoma xenografted in C57BL/6 mice.
Nutrition and cancer, Volume: 63, Issue: 7
2011
In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 25, Issue: 8
2011
Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Cancer chemotherapy and pharmacology, Volume: 68, Issue: 5
2011
Vitamins C and E treatment combined with exercise modulates oxidative stress markers in blood of patients with fibromyalgia: a controlled clinical pilot study.
Stress (Amsterdam, Netherlands), Volume: 13, Issue: 6
2010
Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis.
FEMS yeast research, Aug-01, Volume: 10, Issue: 5
2010
alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.
British journal of cancer, Apr-13, Volume: 102, Issue: 8
2010
Effects of resistance training combined with antioxidant supplementation on fat-free mass and insulin sensitivity in healthy elderly subjects.
Diabetes research and clinical practice, Volume: 87, Issue: 1
2010
Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy.
Brain research, Apr-17, Volume: 1266
2009
Effect of astaxanthin in combination with alpha-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats.
Journal of nutritional science and vitaminology, Volume: 54, Issue: 4
2008
Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study.
Alzheimer's & dementia : the journal of the Alzheimer's Association, Volume: 4, Issue: 3
2008
Staphylococcal enterotoxin C injection in combination with ascorbic acid promotes the differentiation of bone marrow-derived mesenchymal stem cells into osteoblasts in vitro.
Biochemical and biophysical research communications, Sep-05, Volume: 373, Issue: 4
2008
[Effects of vitamin C combined with arsenic trioxide on the apoptosis of Hep-2 cell].
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, Volume: 22, Issue: 4
2008
Organosulfur compounds alone or in combination with vitamin C protect towards N-nitrosopiperidine- and N-nitrosodibutylamine-induced oxidative DNA damage in HepG2 cells.
Chemico-biological interactions, May-09, Volume: 173, Issue: 1
2008
Protective effects of isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine or N-nitrosopiperidine-induced oxidative DNA damage in the single-cell gel electrophoresis (SCGE)/HepG2 assay.
Journal of applied toxicology : JAT, Volume: 28, Issue: 2
2008
Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin.
American journal of physiology. Heart and circulatory physiology, Volume: 291, Issue: 6
2006
The effect of N-acetylcysteine in combination with vitamin C on the activity of ornithine decarboxylase of lung carcinoma cells--In vitro.
Life sciences, Jul-10, Volume: 79, Issue: 7
2006
Protective effects of vitamin C, alone or in combination with vitamin A, on endotoxin-induced oxidative renal tissue damage in rats.
The Tohoku journal of experimental medicine, Volume: 206, Issue: 2
2005
Natural health product-HIV drug interactions: a systematic review.
International journal of STD & AIDS, Volume: 16, Issue: 3
2005
Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids.
Free radical biology & medicine, May-01, Volume: 36, Issue: 9
2004
Studying long-term effect of phenytoin either alone or combined with ascorbic acid on the anesthetic effect of urethane in rats.
Fundamental & clinical pharmacology, Volume: 18, Issue: 2
2004
Bioavailability of iron, zinc, folate, and vitamin C in the IRIS multi-micronutrient supplement: effect of combination with a milk-based cornstarch porridge.
Food and nutrition bulletin, Volume: 24, Issue: 3 Suppl
2003
Modulation of liver fibrosis and pathophysiological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C.
Journal of helminthology, Volume: 77, Issue: 3
2003
Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E).
Arzneimittel-Forschung, Volume: 53, Issue: 3
2003
Identify and manage potentially serious OC/drug interactions.
Contraceptive technology update, Volume: 8, Issue: 7
1987
[Ascorbic acid enhances the apoptosis of U937 cells induced by arsenic trioxide in combination with DMNQ and its mechanism].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, Volume: 23, Issue: 1
2002
Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin.
Cancer chemotherapy and pharmacology, Volume: 47, Issue: 1
2001
Bone tissue composition, dimensions and strength in female rats given an increased dietary level of vitamin A or exposed to 3,3',4, 4',5-pentachlorobiphenyl (PCB126) alone or in combination with vitamin C.
Toxicology, Oct-26, Volume: 151, Issue: 1-3
2000
[Detection of drug-drug interaction by ESR spectroscopy].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica, Volume: 113, Issue: 6
1999
DNA-drug interaction. The effects of vitamin C on the solution structure of Calf-thymus DNA studied by FTIR and laser Raman difference spectroscopy.
Journal of biomolecular structure & dynamics, Volume: 13, Issue: 2
1995
Promotive action of acylated ascorbate on cellular DNA synthesis and growth at low doses in contrast to inhibitory action at high doses or upon combination with hyperthermia.
Journal of cancer research and clinical oncology, Volume: 122, Issue: 1
1996
Induction and promotion of forestomach tumors by sodium nitrite in combination with ascorbic acid or sodium ascorbate in rats with or without N-methyl-N'-nitro-N-nitrosoguanidine pre-treatment.
International journal of cancer, Jan-02, Volume: 56, Issue: 1
1994
[Drug interactions with oral contraceptive steroids].
Akusherstvo i ginekologiia, Volume: 23, Issue: 5
1984
The antibacterial activity of a siderophore. 1. In vitro activity of deferoxamine alone and in combination with ascorbic acid on Staphylococcus aureus.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, Volume: 97, Issue: 5
1989
The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureus.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, Volume: 99, Issue: 10
1991
Evaluation of the characteristics of the differential amperometric detector in combination with anion-exchange chromatography, using L-ascorbic acid as test compound.
Journal of chromatography, Apr-21, Volume: 172
1979
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (6)

ArticleYear
Naturally Derived Wearable Strain Sensors with Enhanced Mechanical Properties and High Sensitivity.
ACS applied materials & interfaces, May-13, Volume: 12, Issue: 19
2020
Sanguinarine-induced oxidative stress and apoptosis-like programmed cell death(AL-PCD) in root meristem cells of Allium cepa.
Plant physiology and biochemistry : PPB, Volume: 112
2017
Fast screening and structural elucidation of G-quadruplex ligands from a mixture via G-quadruplex recognition and NMR methods.
Biochimie, Volume: 91, Issue: 2
2009
Protective effect of saponins derived from the roots of Platycodon grandiflorum against carbon tetrachloride induced hepatotoxicity in mice.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 46, Issue: 5
2008
DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane.
International journal of pharmaceutics, Jun-29, Volume: 338, Issue: 1-2
2007
Asiaticoside-induced elevation of antioxidant levels in healing wounds.
Phytotherapy research : PTR, Volume: 13, Issue: 1
1999
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]